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Summary 
 
At least four phylogenetically distinct groups of bacteria encode repeat proteins with 
the common ability to bind specific DNA sequences with a unique but conserved 
code. Each repeat binds a single DNA base, and specificity is determined by the 
amino acid residue at position 13 of each repeat. Repeats are typically 33-35 amino 
acids long. Comparing repeat sequences across all groups reveals that only three 
positions are hyper-conserved. Repeats are in most cases functionally compatible 
such that they can be assembled together into a single chimeric array. This 
functional conformity and inter-compatibility is a result of structural conservation. 
Repeat arrays of these proteins have been demonstrated or predicted to form 
almost identical tertiary structures: a right-handed super helix that wraps around the 
DNA double strand with the base specifying residue of each repeat positioned in the 
major groove next to its cognate target base. The mechanism of DNA binding is 
conserved. 
The first discovered group, providing the name for the rest, are the Transcription 
Activator Like Effectors (TALEs) of plant-pathogenic Xanthomonas bacteria. The 
eukaryotic transactivation domain, which lends this group their name, allows them 
to activate specifically targeted host genes for the benefit of the bacterial invader. 
The other groups, discovered after the TALEs, are the RipTALs of Ralstonia 
solanacearum, the Bats of Burkholderia rhizoxinica, and MOrTL1 and MOrTL2 of 
unknown marine bacteria. Together they are designated TALE-likes. Each 
designation contains some allusion to the TALEs. The term RipTAL stands for 
Ralstonia injected proteins TALE-like, the Bats are Burkholderia TALE likes, and the 
MOrTLs Marine Organism TALE-likes. This unity of terminology belies disunity in the 
lifestyles of these different bacteria, and the biological roles fulfilled by these 
proteins. 
The TALEs have already been researched extensively. The code that describes the 
relationship between the base specifying residues and their cognate bases is often 
referred to as the TALE code. This code was deciphered by two groups 
independently and published in 2009, a year before I began my doctoral work. Since 
then research into TALEs has not slowed and a great deal has been learnt both 
about the native biology and biotechnological uses of TALEs. My work has been 
focused on the other TALE-like groups, none of which had been previously 
characterized in terms of DNA recognition properties, before I began my work. 
RipTALs are effector proteins delivered during bacterial wilt disease caused by R. 
solanacearum strains. This devastating disease affects numerous crop species 
worldwide. Characterizing the molecular properties of the RipTALs provides a first 
step towards uncovering their role in the disease. The Bats and MOrTLs are 
primarily of interest as comparison groups to the TALEs and RipTALs and as 
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sources of sequence diversity for future efforts into TALE repeat engineering. 
In the introduction of this dissertation, which explores TALE biology, a particular 
focus will be placed on the DNA binding properties of TALEs and how this can be 
put to use in TALE technology. After this the RipTALs, Bats and MOrTLs are each 
introduced, explaining what is known about their provenance and sequence 
features. The aims of my doctoral work are then listed and expounded in turn. The 
proximal goal of my doctoral work was to carry out a comparative molecular 
characterization of each group of non-TALE TALE-likes. In doing so we hoped to 
gain insights into the principles of TALE-like DNA-binding properties, evolutionary 
history of the different groups and their potential uses in biotechnology. In the case 
of the RipTALs this work should begin to unravel the role these proteins play in 
bacterial wilt disease, as a means to fight this devastating pathogen. 
The articles I have worked on covering the molecular characterizations of RipTALs, 
Bats and MOrTLs are then presented in turn. Working together with others I was 
able to show that repeats from each group of TALE-likes mediate sequence specific 
DNA binding, revealing a conserved code in each case. This code links position 13 
of any TALE-like repeat to a specific DNA base preference in a reliable fashion. 
I will argue that the TALE-likes represent a fascinating case of conserved structure 
and function in a diverse sequence space. In addition the TALEs and RipTALs may 
simply represent one face of the TALE-likes, a protein family mediating as yet 
unknown biological roles as bacterial DNA binding proteins. 
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Zusammenfassung !
Gene die ähnlichen repeat-enthaltende Proteine kodieren finden sich in den 
Genomen von mindestens vier phylogenetischen Gruppen von Bakterien. Alle diese 
verschiedene Proteine nutzen den gleichen, einzigartigen Code um bestimmte DNS 
Basen zu binden. Repeats bestehen in der Regel aus 33-35 Aminosäuren und jeder 
Repeat bindet eine einzige Base, wobei die  Spezifität durch die Aminosäure an 
Position 13 im Repeat bestimmt wird. Ein Vergleich der Repeatsequenzen aus den 
verschiedenen Proteinen zeigt nur drei hyperkonservierte Aminosäuren, aber 
chimäre Repeat-domänen sind meistens dennoch Funktionsfähig. Funktionseinigkeit 
und Kompatibilität sind Folge struktureller Konservation.  Es wurde schon gezeigt 
oder vorhergesagt dass die Repeat-Domäne dieser Proteine fast identische 
Strukturen bilden: Eine rechtsgängige Superhelix die sich um die DNS wickelt, 
wobei die basenbestimmenden Aminosäuren in der großen Furche neben der 
verwandte Base positioniert werden. Dieser Bindungsmechanismus ist innerhalb 
dieser Gruppe von Proteinen konserviert.  
Die erste beschriebene Gruppe sind die Transcription Activator Like Effectors 
(TALEs) aus pflanzenkrankheitserregenden Xanthomonas Bakterien, und ist 
namensgebend für diese Klasse von Proteinen. Der Name stammt von der 
eukaryotischen Aktivierungsdomäne  durch die ermöglicht wird, dass die TALEs  
spezifische Wirtsgene aktivieren zum Vorteil der Bakterien. Die anderen Gruppen 
sind RipTALs aus Ralstonia solanacearum, Bats aus Burkholderia rhizoxinica, und 
MOrTL1 und MOrTL2 aus bis jetzt unbekannten Meeresbakterien. Kollektivbegriff 
dafür ist TALE-likes. Der Name jeder Gruppe deutet darauf hin, dass diese Proteine 
TALEs ähnlich sind. RipTAL bedeutet Ralstonia injected proteins TALE-like; Bats 
sind Burkholderia TALE likes; und die MOrTLs Marine Organism TALE-likes. Diese 
Namenseinigkeit verbirgt die unterschiedliche Lebensweisen dieser Bakterien und 
die verschiedenen natürliche Rollen dass die TALE-likes annehmen könnten.  
TALEs werden schon seit langem erforscht. Der TALE-Code beschreibt die 
Beziehung zwischen bestimmten Resten und passenden Basen. Er wurde in 2009 
entschlüsselt und von zwei unabhängigen Forschungsgruppen veröffentlicht. Das 
war ein Jahr bevor ich mit meiner Doktorarbeit anfing. Seitdem hat die TALE-
Forschung stark weiterentwickelt und vieles wurde über die natürliche Biologie und 
biotechnische Applikation dieser Proteine gelernt. Meine Arbeit fokussiert sich auf 
die anderen TALE-likes, von denen zuvor kein einziges charakterisiert war.  
RipTALs sind Effektor-Proteine, die von R. solanacearum im Laufe der Entwicklung 
der bakterieller Schleimkrankheit sekretiert werden. Diese Krankheit betrifft weltweit 
viele wichtige Nutz- und Kulturpflanzen. Eine Charakterisierung der molekularen 
Eigenschaften der RipTALs ist der erste Schritt um die Rolle dieser Proteine in der 
Patho
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TALEs und RipTALs relevant. Ausserdem könnten die Polymorphismen die einen 
leichten Einfluss auf DNS-Bindung als eine Ressource genutzt werden um TALE-
Technologie zu verstärke.  
Die Einleitung dieser Dissertation erklärt das Wesentliche über TALE Biologie mit 
Schwerpunkt auf DNA-Bindung und wie diese zur TALE-Technologie entwickelt 
wurde. Anschließend werden die RipTALs, Bats und MOrTLs der Reihe nach 
vorgestellt, und das Wissen über Herkunft und Sequenzmerkmale präsentiert. Die 
Ziele meiner Doktorarbeit werden dann ausgeführt. Das Hauptziel meiner Arbeit war 
ein Vergleich der molekularen Eigenschaften der einzelnen TALE-like Gruppen 
anzustellen. Davon  erhofften wir neue Einblicke in die Interaktion zwischen TALE-
likes und DNS, die Evolution der TALE-likes sowie eventuelle Biotechnologische 
Anwendungen zu gewinnen. Im Falle der RipTALs ist dieses Wissen direkt 
einsetzbar um die bakterielle Schleimkrankheit zu bekämpfen. 
Artikel zur Charakterisierung von RipTALs, Bats und MOrTls sind Resultate meiner 
Doktorarbeit und kommen als Ergebnisteil der Dissertation vor. Zusammen mit 
Kollegen konnte ich zeigen dass die Repeats aus jeder TALE-like Gruppe Basen-
spezifisch DNS-Binden. Der TALE Code, aus dem hervorgeht welche 
Aminosäurereste an Position 13 Bindung an welche Base vermitteln, ist in allen 
Gruppen konserviert.  
Ich beschreibe auch wie ich die TALE-likes als faszinierender Fall von struktureller 
Konservation in einem vielfaltigem Sequenzraum verstehe. Überdies könnte es sein 
dass die TALE-likes, trotz dem akzeptierten Bild als eukaryotische 
Transkriptionsfaktoren, eine viel diversere Gruppe sind mit Exemplaren die bis jetzt 
unerklärte Rollen erfüllen.  
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1 Introduction 
1.1 Molecular plant pathology in the context of food security for the 21st 
century.  
In the age of cloud computing, 3D-printing and humanoid robotics it is easy to feel 
that inorganic technologies will be the major shaping force in humanities 
development for the coming century. Yet we are still biological beings. We are born, 
we grow old, we get sick and we die. Along the way we grow and we reproduce and 
to do so we require sustenance. This sustenance comes in the form of organic 
matter, and specifically it comes from plant tissue, either directly or to feed livestock. 
The advent of the lab grown burger may challenge this paradigm somewhat but no 
one has yet seriously challenged the notion that crop plants will continue to sustain 
human life on this planet for the next centuries, much as they have done for the 
previous millennia of human existence.  
The major challenge will be the scale of crop production required:  latest UN 
projections put the human population of the earth at 9.5 billion by 2050 (UN 
Department of Economic and Social Affairs: 2012 Revision of World Population 
Prospects). Moreover, this population needs to be fed without critically depleting the 
earth’s natural resources or worsening our already catastrophic impact on climate 
and biodiversity. 
There are three main ways to increase agricultural productivity: increased land 
utilization (plant more), yield maximization (grow more from what you plant), and 
reducing waste during storage and transportation (lose less of what you grow). The 
first of these, additional land use is undesirable if sustainability and a reduced 
environmental impact are to be achieved. Yield maximization, depending on the 
method used, offers, in contrast, the promise of more for less. That is more food, 
with fewer inputs and a smaller ecological imprint. This strategy should also be 
coupled to infrastructure optimization, to reduce losses after harvesting, since a third 
of food is currently wasted worldwide (1). 
The modern population explosion, which began in the 18th century, has at each 
point been made possible through agricultural yield increases, with a few specific 
innovations standing out. Artificial Nitrogen-based fertilizer production, allowed huge 
yield boosts at the start of the twentieth century. In the latter half of the twentieth 
century, agronomy, the science of crop improvement, came into its own in the form 
of the green revolution lead by Norman Borlaug. Whilst humans had been 
domesticating and gradually selecting for improved crop varieties for millennia the 
rational exploration of crop traits allowed for the selection of high-yield, dwarf 
varieties of rice and wheat, which together with fertilizer application and use of 
improved agricultural techniques allowed yield increases of 208% and 109% for 
wheat and rice respectively in the developing world (2). 
Among the traits that could benefit from additional research for crop improvement, 
pathogen and pest resistance are surely among the most vital. One study records 
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that 5-25% of staple crop yield was lost to plant pathogens at the start of the 
millennium (3). Farmers can apply a range of anti-microbials to reduce the impact of 
plant pathogens, with an associated cost and environmental impact. Alternatively, 
resistant crop lines can be developed, either by breeding for resistance or direct 
genetic modification (GM) allowing the plant to produce anti-microbials or otherwise 
defend itself. The latter approach has already proved successful in the fight against 
insect pests. The insecticidal Cry proteins of Bacillus thuringiensis have been 
transformed into various crops (Bt-maize, Bt-cotton and most recently Bt-brinjal, 
among others) rendering them resistant to certain insect pests and reducing the 
need for insecticide applications (4). The most successful implemented GM 
approach for pathogen resistance project is the Rainbow papaya resistant to Papaya 
Ringspot Virus due to expression of the viral coat protein gene (5). Yet in all these 
cases one or a few genes have been inserted, to achieve simple dominant 
phenotypes. This trait limitation is due to a limitation in the tools available to create 
transgenics. All the GM crops currently grown were developed by the insertion of 
one or a few genes via Agrobacterium-mediated transformation or biolistic 
bombardment. In both methods genes are inserted at random producing an array of 
transgenic lines with different properties depending on the position of the 
transgenes. The lines must be subsequently screened to identify those transgenic 
insertion events resulting in suitable gene expression levels. In the last five years 
tools have become available to manipulate specific genomic loci allowing the 
insertion of transgenes into predetermined locations (6). Additionally, instead of 
being limited to the insertion of genes, molecular tools are now available to activate, 
suppress or modify endogenous loci (7). The nascent field of plant synthetic biology 
aims to harness these new tools to substantially redesign plant traits to human 
benefit (8). Thus tools have become available to produce GM crop lines faster than 
ever before and with qualitatively novel modifications. Biotechnology should be high 
on the agenda when devising strategies for global food security over the coming 
century. Of course GM approaches to tackle plant disease will rely on our 
understanding of plant diseases and immune responses. The research I have 
undertaken during my doctoral work combines these two important areas, bringing 
together plant disease research and biotechnology through the node of TALE 
biology.  
1.2 Introduction to TALE biology 
TALEs are secreted by Xanthomonas bacteria through the needle-like Type III 
secretion system (T3SS) during infection. Species of the genus Xanthomonas fill 
three of the top ten slots in a list of most important bacterial plant pathogens for 
economic and scientific impact (9). The TALEs are unusual among pathogen 
effectors in working as eukaryotic transcription factors, manipulating host gene 
expression to the benefit of the pathogen. Most effectors produced by plant 
pathogenic bacteria function by blocking elements of the immune response pathway 
(10). Considering that till now no TALEs have been found to suppress host immunity 
they stand out amongst characterized effectors. Another intriguing feature of TALEs 
is the diversity of TALE DNA binding domains, and thus of host target preferences, 
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within and between strains (11). This allows a level of adaptability that makes them a 
fascinating subject of study for pathogen effector biology, and is also the key to their 
popularity as tools for biotechnology.  
The key to the adaptability of the TALEs is in their domain structure. TALE-DNA 
binding is mediated by a tandem repeat array forming the largest and central region 
of a given TALE protein (Figure 1.1). The repeat array can be divided into the core 
group of near-identical canonical repeats, and then flanking them several sequence-
degenerate non-canonical repeats. The N-terminal non-canonical-repeats are 
particularly important for DNA binding. The repeat domain is itself flanked N- and C-
terminally by non-repetitive domains encoding other necessary functions. An N-
terminal secretion signal allows transportation of TALE proteins from the bacterial to 
the host cell through the T3SS. C-terminal of the binding domain nuclear localization 
signals (NLSs) allow TALEs to penetrate the host nucleus. An activation domain (AD), 
rich in acidic residues and therefore alternatively referred to as the acidic activation 
domain (AAD) mediates induction of host promoters after binding (12). The domain 
structure of a TALE is illustrated in Figure 1.1.  
Figure 1.1: An overview of TALE functional domains and TALE-DNA interaction 
 
 
A) A schematic of a TALE and its functional domains: canonical DNA binding repeats 
are displayed as purple polygons, non-canonical repeats as purple ovals. NLSs as 
blue bars and the AS a blue triangle. B) Canonical repeats each bind a single base in 
the corresponding EBE. Base specificity is dertermined by position 13 of each 
repeat. This residue is referred to as the base specifying residue (BSR). BSRs of 
each repeat are given using the single letter amino acid code. The BSR composition 
illustrated here is arbitrary. Non-canonical repeats are numbered, and the thymine 
bound by repeat -1 is indicated (T0).  
 
1.3 The DNA binding properties of TALEs 
 
Sequence specific DNA binding is mediated by the canonical repeats according to 
the TALE code 
Examining the canonical repeats of any TALE reveals that sequence diversity is 
extremely limited (Figure 1.2). Position 12 and position 13, are by far the most 
variable. In fact, the variability of these two residues was the initial inspiration behind 
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the hypothesis that TALE repeats each bind one base with a simple cipher. Residues 
12 and 13 were termed the repeat variable diresidue (RVD) and were indeed found to 
co-vary with target bases (13, 14). Yet residue 12 in TALE repeats is almost always 
occupied by a His or Asn residue, and is therefore not as variable as position 13. 
Structural and functional studies later showed that only position 13 interacts with the 
DNA base and determines specificity (15, 16). For historical reasons the term RVD is, 
however, still widely used but the term base specifying residue (BSR) referring to 
position 13 is preferable.  
The canonical DNA binding repeats of TALEs are modular with each repeat binding a 
single nucleotide (Figure 1.1). In addition to non-specific interactions with the 
phosphate backbone, each repeat can make a single base specific interaction. This 
is mediated by the BSR. BSR-base interactions lend TALEs their sequence 
specificity. In natural TALEs only a few residues are found at the BSR 
(overwhelmingly Asp, Gly, Asn, Ile and Ser (17)), and each mediates a different base 
specificity. Some BSRs are highly selective for a single base (e.g. Asp-C or Ile-A), 
whilst others are more promiscuous (e.g. Asn – G/A, Ser – A/C/G/T). Since other 
positions within the repeat remain largely constant in a given array TALE repeats can 
be defined based on their BSRs. Thus one can talk of a Gly repeat or an Asp repeat, 
meaning a repeat with position 13 occupied by residues Gly or Asp respectively. The 
full complement of repeats with different BSRs and their orders within the array can 
be referred to as the BSR composition.  
The reliable relationships between repeats with a certain BSR and their 
corresponding DNA base partners form what is known as the TALE code. This code 
allows researchers to search for potential host target genes bioinformatically. Several 
such search algorithms are available (18, 19) and when combined with 
transcriptomics allow for candidate target promoters to be rapidly identified. 
Additionally the TALE code lays the foundation for the use of TALEs in 
biotechnology, explored below.  
N-terminal non-canonical repeats encode a fixed T0 preference 
Beyond the canonical repeats, the other key element of the sequence specificity of 
TALE DNA-binding is the preference for a thymine at the position immediately 5’ of 
the base bound by the first canonical repeat. This thymine is referred to as T0. This T0 
preference is so strong that till now only one case has been discovered of a natural 
TALE-promoter interaction where the T0 is violated and a C found at this position in 
the target box instead (20). Studies examining the sequence specificity of TALEs 
using unbiased approaches have consistently returned T as the preferred base at the 
zero position (21, 22). 
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Figure 1.2: An alignment of the canonical repeats of TALE AvrBs3.  
                1111111111222222222233333 
       1234567890123456789012345678901234 
 1     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2     LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3     LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4     LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5     LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 6     LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 7     LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 8     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10     LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11     LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12     LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16     LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
17     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 
Amino acids that are identical between the repeat units are displayed as white letters 
on a black background. A white background indicates residues differing from the 
consensus at that position. Grey background indicates residues with similar 
chemical properties at the same position. Numbers above the sequence (5, 10, 15, 
20, 25, 30) indicate the position of the given amino acid within the repeat. 
An appreciation of the three-dimensional structure helps explain the DNA binding 
properties of TALEs 
Structures have been solved for canonical-repeat regions of several natural and 
constructed TALEs alone and together with their cognate DNA targets. The first 
structures were published in tandem in the journal Science in 2012. These were of 
natural TALE PthXo1 (15), and dHax3, derived from TALE Hax3 (16). Following these 
were crystal structures of AvrBs3 (23) and various derivatives of dHax3 as well as a 
constructed TALE designated dTALE2 (24, 25). These studies all returned the same 
structure for the canonical repeat domain (Figure 1.3). The whole repeat array forms 
a right-handed super helix with 11 repeats per turn and a pitch of 60Å, contracting to 
35Å in contact with the DNA. The repeats are arranged such that BSR-loops trace 
along the major groove. Each repeat is a pair of alpha-helices with the BSR-loops 
interpolating into the major groove allowing close proximity to target bases. 
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Figure 1.3: Crystal structure of TALE PthXo1 bound to DNA 
 
The crystal structure of the DNA binding domain of TALE PthXo1 bound to DNA 
shown from longitudinal (A) and transverse (B) perspectives. This figure is taken with 
permission from Mak et al., Science 2012 (15). The repeat array forms a right-handed 
super helix wrapping around the DNA. Each individual repeat is constituted by a pair 
of alpha-helices, a BSR loop pointing into the major groove of the double-helix and a 
flexible inter-repeat loop. Repeats are individually and arbitrarily coloured, with green 
shades for the N-terminal and yellow shades for the C-terminal repeats.  
 
As expected each canonical repeat forms an almost identical structure, a helix-turn-
helix motif with a flexible linker region to join to the next repeat (Figure 1.4A). Position 
1 of each canonical repeat, as traditionally defined, is in the middle of the flexible 
region. The first alpha-helix, termed the short-helix, then runs from positions 2 to 10. 
The BSR-loop at positions 11-15 is framed by helix-breaking serine and glycine 
residues. The long-helix is formed by residues 16-32, with a kink caused by Pro27.  
The crystal structures provided evidence that only residue 13 interacts with the 
specific base (Figure 1.4A), corroborating studies showing that only base 13 
determines specificity (26). Another important finding was that different BSRs 
mediate qualitatively different interactions with their target bases. Asp and Asn are 
able to form strong hydrogen bonds, making sense of the higher affinity interactions 
in a truncated RVD loop that extends less deep-
ly into the DNA major groove, with the glycine
at position 13 located a considerable distance
(>6 Å) from the corresponding sense strand
base. Consistent with this observation, the ob-
served specificity of the N* repeat is relatively
lax (4).
Finally, NI, which is the second most com-
mon RVD overall, accounting for roughly 20%
of all TAL effector repeats, occurs seven times
in PthXo1 and displays an unusual contact pat-
tern to adenosine or cytosine bases. The ali-
phatic side chain of the isoleucine residue is
observed to make nonpolar van der Waals con-
tacts to C8 (and N7) of the adenine purine ring,
or to C5 of the cytosine pyrimidine ring. These
contacts would appear to necessitate desolva-
tion of at least one polar atom in the adenosine
ring, without the formation of a compensat-
ing hydrogen bond, and might therefore reason-
ably be expected to represent a reduced-affinity
interaction.
N-terminal to the canonical repeats, the PthXo1
structure reveals two degenerate repeat folds that
appear to cooperate to specify the conserved thy-
mine that precedes the RVD-specified sequence
(Fig. 4). We have designated these as the 0th
and –1st repeats. Residues 221 to 239 and resi-
dues 256 to 273 each form a helix and an ad-
joining loop that resembles helix 1 and the RVD
loop in the canonical repeats; the remaining resi-
dues in each region are poorly ordered. Those
two N-terminal regions converge near the 5′ thy-
mine base, with the indole ring of tryptophan
232 (in the –1st repeat) making a van der Waals
contact with the methyl group of that base. Mu-
tation of the thymine reduces TAL effector ac-
tivity at the target (3, 15). Tryptophan-232, as
well as the surrounding residues, is highly con-
served across available, intact TAL effector se-
quences. Some TAL effectors efficiently target
sequences preceded by a cytosine rather than
a thymine (14, 16). Though less favorable, the
packing of tryptophan 232 would be expected to
accommodate this substitution.
In addition to revealing folding and inter-
actions of the N-terminal cryptic repeats with
the 5′ end of the DNA target site and illustrating
the functions of the sixmost common repeat types
in TAL effector–DNA recognition, the structure
provides a basis for prediction of structures that
are not represented. For example, an alignment of
the 35-residue repeat type found in some TAL
effectors with the more common 34-residue re-
peat type found in PthXo1 (fig. S5) indicates that
the additional residue (a proline) at position 33
would be located within the relatively disordered
turn region that connects the helices of one repeat
to the next. The 35-residue repeat therefore can
be predicted to be functionally indistinguishable
from the 34. Likewise, although the sole NS re-
peat in PthXo1 is in an apparently disordered part
of the protein-DNA complex, the overall homo-
geneity of the repeat structures and the consistent
role of the first RVD residue in stabilizing the
RVD loop to facilitate specific contacts of the
second residue with the DNA should make it
possible to computationally model the potential
nucleotide interactions of NS, as well as those of
rare or artificial RVDs.
The protein-DNA complex studied leaves
some questions unanswered, such as the struc-
ture of the N- and C-terminal portions of TAL
effectors that are, respectively, required for trans-
location and interaction with host transcriptional
Fig. 2. Structure of the PthXo1 DNA binding region in complex with its target site. The coloring of
individual repeats matches the schematic in Fig. 1.
Table 1. Crystallographic data and refinement statistics. WT, wild type; SeMet, selenomethionine;
RMSD, root mean square deviation; ALS, Advanced Light Source; APS, Advanced Photon Source.
Data statistics
Dataset WT SeMet
X-ray source ALS 5.0.2 APS 21-ID-F
Wavelength (Å) 1.177 1.378
Space group P212121 P212121
Unit cell (Å) a = 95.6
b = 248.5
c = 54.6
a = 100.7
b = 247.8
c = 54.2
Resolution (Å) 50–3.0 (3.11–3.0) 50–4.0 (4.14–4.0)
Rmerge (%) 0.121 (0.431) 0.087 (0.139)
I/s (I) 9.3 (3.5) 10.3 (3.7)
Redundancy 5.6 (4.9) 4.9 (5.0)
Completeness (%) 96.6 (90.4) 95.8 (97.7)
Mosaicity (°) 0.8 0.8
Unique reflections 25841 11591
Refinement
Rwork 0.264
Rfree 0.294
Protein atoms 6086
DNA atoms 1552
Heteroatoms (waters) 216
RMSD bond lengths (Å) 0.021
RMSD bond angles (o) 2.4
Average B factor (Å2) 85.1
Ramachandran
(% core, allowed, generous, disallowed)
73.6%, 26.4%,
0%, 0%
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found to be mediated by such repeats (22, 27). Gly is able to form van der Waals 
interactions with T, whilst the Ile-A interaction is promoted only by desolvation 
energy. These different interaction forms can be seen in Figure 1.4A. Further 
modeling, based on the available crystal structures, revealed that negative 
discrimination of sterically incompatible bases by the BSR is an important part of 
base specificity (28). 
It should be noted that most of the binding energy for the DNA-canonical repeat 
interaction comes from non-base-specific interactions between the DNA phosphate 
backbone and positively charged residues 16-17, forming an electropositive stripe 
running alongside the DNA (16, 28).  
Structures of the non-canonical-repeats 0 and -1 have been resolved for PthXo1 (15) 
and AvrBs3 (23). In addition structures are available for repeats -3 to 0 for dTALE2 
bound to DNA (25). It seems that the same overall structure unites the non-canonical 
with the canonical repeats, but that they differ as to the degree of interpolation into 
the major groove, with an impact on DNA binding properties. What sets apart 
canonical repeats is not sequence similarity alone but the presence of a loop region 
from positions 11-15, at the apex of which lies the BSR, penetrating close to the 
DNA base at and forming base specific interactions. It is thus a functional distinction. 
Of the N-terminal non-canonical repeats of TALEs only repeat -1 displays a BSR 
loop, and Trp232 in this loop region mediates the T0 interaction (Figure 1.4B). 
However, canonical TALE repeats bearing Trp as the BSR are non-functional (29, 30) 
likely reflecting differences in the angle and distance of approach for repeat -1 and 
the T0 compared to canonical BSR-base interactions (Figure 1.4) (15). It is thus 
justifiable to assert that the -1 to T0 interaction is non-canonical. Positively charged 
residues, found in abundance, across all the N-terminal non-canonical-repeats 
mediate a strong non-base-specific DNA affinity, crucial for successful TALE-DNA 
interactions (25). 
In addition to these static views there is some information available about 
conformational changes taking place during binding. Most notably there is a 
contraction along the longitudinal axis of the super helix during DNA binding. This 
insight was first made by comparing crystal structures of bound and unbound TALEs 
(15). However, a recent study on the movement of TALEs along DNA to identify 
target boxes has revealed further insights (31). It seems that during one-dimensional 
scanning along the DNA target the TALE is in its extended confirmation and only the 
N-terminal non-canonical repeats contact the DNA. Once a potential target 
sequence is encountered contraction occurs leading to a tight and highly stable (32) 
interaction.  
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Figure 1.4: Structures of individual repeats from the crystal structure of TALE PthXo1 
 
 
 
1.4 TALEs in the context of plant disease 
 
Although the sequence identity of individual TALE repeats and non-repeat regions is 
high, the BSR compositions of TALEs are diverse both within and between strains 
(Figure 1.5). Whatever the mechanism that controls this, it seems that repeat number 
machinery. As well, because of the observed
disorder at either end, it does not yet precisely
define the minimal TAL effector–DNA binding
domain. However, by demonstrating the essen-
tial features that accomplish interaction speci-
ficity, the structure provides a foundation for
more accurately predicting and efficiently exploit-
ing TAL effector–DNA targeting. More funda-
mentally, it reveals the hitherto enigmatic structural
nature of a simple solution that an important
group of pathogens has evolved to manipulate
host gene expression in a specific yet highly
adaptable manner.
References and Notes
1. S. Kay, S. Hahn, E. Marois, G. Hause, U. Bonas, Science
318, 648 (2007).
2. P. Römer et al., Science 318, 645 (2007).
3. J. Boch et al., Science 326, 1509 (2009).
4. M. J. Moscou, A. J. Bogdanove, Science 326, 1501
(2009).
5. J. Boch, U. Bonas, Annu. Rev. Phytopathol. 48,
419 (2010).
6. A. J. Bogdanove, D. F. Voytas, Science 333, 1843
(2011).
7. A. J. Bogdanove, S. Schornack, T. Lahaye, Curr. Opin.
Plant Biol. 13, 394 (2010).
8. M. T. Murakami et al., Proteins Struct. Funct. Bioinf. 78,
3386 (2010).
9. A. Leaver-Fay et al., Methods Enzymol. 487, 545
(2011).
10. L. D. D’Andrea, L. Regan, Trends Biochem. Sci. 28,
655 (2003).
11. N. Jiménez-Menéndez et al., Nat. Struct. Mol. Biol. 17,
891 (2010).
12. N. H. Hopcroft et al., J. Mol. Biol. 338, 43 (2004).
13. R. Rohs et al., Annu. Rev. Biochem. 79, 233
(2010).
14. J. C. Miller et al., Nat. Biotechnol. 29, 143
(2011).
15. P. Römer et al., New Phytol. 187, 1048 (2010).
16. Y. Yu et al., Mol. Plant Microbe Interact. 24, 1102
(2011).
Acknowledgments: This project was funded by NIH (grants
RL1 0CA833133 to B.L.S., R01GM098861 to B.L.S. and A.J.B.,
and R01 GM088277 to P.H.B.), NSF grant 0820831 to A.J.B.,
and a Searles Scholars Fellowship to P.H.B. A.N-S.M. was
supported by a training grant from the Northwest Genome
Engineering Consortium. We thank the staff of the Advanced
Light Source beamline 5.0.2 and L. Doyle, B. Shen,
R. Takeuchi, J. Bolduc, and C. Schmidt for technical assistance
and advice; T. Edwards and M. Clifton for collecting SeMet
data; and C. Pabo for helpful discussion. A.J.B. is an inventor
on a patent application titled “TAL effector-mediated DNA
modification” (US-2011/0145940-A1 and PCT/US2010/059932).
This intellectual property, co-owned by Iowa State University
and the University of Minnesota, has been licensed to Cellectis.
The refined coordinates and corresponding x-ray intensities
for the PthXo1-DNA structure have been deposited in the RCSB
Protein Database (accession code 3UGM).
Supporting Online Material
www.sciencemag.org/cgi/content/full/science.1216211/DC1
Materials and Methods
Figs. S1 to S5
Table S1
References (17–29)
4 November 2011; accepted 21 December 2011
Published online 5 January 2012;
10.1126/science.1216211
Fig. 3. Topology and contacts between TAL effector
repeats and DNA bases. (A) Eight distinct com-
binations of RVDs and DNA bases are observed in
the structure. HD (repeat 5) forms a steric and elec-
trostatic contact with cytosine; HG (repeat 4) and NG
(repeat 6) both form nonpolar interactions between
the glycine a-carbon and the thymine methyl group.
A “mismatch” between NG and a cytosine (repeat
11) results in a longer distance from the RVD to the
base. NN associates with either guanine (repeat 16)
or with adenine (which would interact with the
same N7 nitrogen of the purine base). NI forms a
desolvating interface with either adenine (repeat 3)
or cytosine (repeat 19). The reduction in loop
length by one residue in the N* RVD (repeat 7)
results in an increased distance to the base. (B) Two
adjacent repeats form a tightly packed left-handed bundle of helices that position the
second amino acid of each RVD in proximity to corresponding consecutive bases in an
unperturbed B-form DNA duplex. The first residue of each RVD (position 12, either His or
Asn) forms H-bonds to the backbone carbonyl oxygen of amino acid position 8 of the
same repeat.
Fig. 4. N-terminal cryptic repeats and contacts
with 5′ thymine. (A) 2Fo-Fc electron density maps
contoured around thymine at position “0” and
tryptophan 232 in the “–1” repeat. (B) Residues
221 to 239 and residues 256 to 273 each form a
helix and an adjoining loop that resembles helix
1 and the RVD loop in the canonical repeats; the
remaining residues in each region are poorly
ordered. W232 forms a nonpolar van der Waals
contact with the methyl carbon of the thymine
base at position 0.
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Canonical repeats, indicating the 
common BSR-base interactions (A) and 
the special case of repeat 0 and -1 
interacting with the T0 base (B). This 
figure is taken with permission from Mak 
et al., Science 2012 (15). Repeats are 
shown as arbitrarily coloured ribbon-
spirals (alpha-helices) and loop regions, 
with the side-chain structures of 
residues 12 and 13 shown. Numbers 
indicate the position of the rep at within 
the PthXo1 repeat array. The single letter 
code is used for amino acids. 
Nucleotides and base-base hydrogen 
bonds are also shown in each case. 
 
The Asp-C and the Asn-N interactions 
are ea h mediated by a hydrogen bond 
(dashed line). Gly-T is mediated by 
hydrophobic van der Waals interactions, 
while Ile-A forms instead weak interface 
promoted by the displacement of 
solvent molecules.  
 
In the case of repeats 0 and -1 (B), 
Trp232 of repeat -1 forms non-polar van 
der Waals interactions with T0.  
A 
B 
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and BSR polymorphisms arise frequently in Xanthomonas strains providing raw 
material for TALE evolution. This raw material has been guided by natural selection 
to create TALEs with DNA binding domains targeting diverse host genes. Amongst 
the S-genes so far identified are sugar transporters, transcription factors, and RNA 
processing factors (33). The genes targeted by TALEs provide an insight into the 
lifestyle of the pathogen. For example, two sucrose exporters of the rice SWEET 
family (OsSWEET11 and OsSWEET14) have been convergently targeted by at least 
six X. oryzae pv oryzae TALEs (33). TALEs of closely related X. oryzae pv oryzicola do 
not target SWEET genes, yet TAL20Xam668 of more distantly related X. axonopodis pv 
manihotis was found to target MeSWEET10a, an ortholog of OsSWEET11 and 
OsSWEET14 in cassava. Since X. oryzae pvoryzae and X. axonopodis pv manihotis 
both proliferate in the xylem, unlike X. oryzae pv oryzicola this may reflect a 
requirement of an apoplastic sugar source for xylem-dwelling xanthomonads. 
Understanding how the pathogen operates within the host can also inform resistance 
breeding or engineering approaches. For instance, it has been shown that rice 
SWEET gene knockouts are resistant to bacterial streak (34).  
TALEs not only activate S-genes, but also in some cases trigger the expression of 
resistance genes (R-genes), which trigger a hypersensitive response preventing 
pathogen growth. Several such R-genes have been discovered in cultivars amongst 
otherwise susceptible hosts (Bs3 and Bs4C in pepper (35, 36), Xa10 and Xa23 in rice 
(37, 38)) indicating that R-genes have evolved as a response to pathogen pressure. 
Evidence is already available to show that TALE repeat domain evolution is a 
mechanism to avoid host recognition (39). The impressive diversity of TALE BSR 
compositions (Figure 1.5) thus needs to be considered in the context of competing 
pressures to induce S-genes and avoid R-genes. This evolutionary dynamism makes 
TALEs a fascinating case of pathogen effectors at the frontline of the arms race 
between host and pathogen.  
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Figure 1.5: TALE complements of three Xanthomonas strains 
 
Canonical repeat arrays and repeat +1 are shown for complete TALE complements 
of three Xanthomonas strains, as listed in (17). Repeats are shown as polygons 
coloured by BSR, which is given in single letter amino-acid code inside each repeat. 
An asterisk indicates a shorter repeat with a single amino acid missing at position 13 
when compared to other TALE repeats (termed GSL repeats; (7)). A brown edge 
indicates repeat +1, always the C-terminal most repeat of each array. Repeats are 
shown N to C terminal as indicated above the repeats of Hax2.  
 
1.5 Introduction to TALE technology 
TALE technology was born with the publication of the TALE code. One of the two 
publications describing the TALE code made use of synthesized TALEs with novel 
BSR compositions to test the code (13). This laid the foundation for the creation of 
what is generally referred to as a designer TALE (dTALE). The key trait of a dTALE is 
having a predetermined BSR composition and therefore a predetermined sequence 
preference. Tests on dTALE specificity have shown that their activity is limited to 
target sequences only, even in complex genomes (40). This makes dTALEs a 
straightforward and reliable molecular tool to target specific DNA sequences.  
The tandem repeat composition, which makes dTALE design so straightforward also 
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makes assembly complicated. PCR based methods and classical restriction enzyme 
based methods are unsuitable for assembling long arrays of near-identical 
sequences. One of the solutions arrived at independently by several research groups 
is to create a library of individual segments encoding TALE repeats with different 
RVDs and to use the golden gate cloning method to assemble these segments in a 
desired order in only a few steps (18, 41). Golden gate cloning uses type IIS 
restriction enzymes, which cleave outside of their binding sites and generate four 
base-pair sticky ends, to allow reliable user-defined multi-fragment assembly.  
Whilst user-defined plant transcription factors are a desirable tool for many 
researchers, the success of TALE technology rides on the compatibility of the DNA 
binding domain with other functional domains. The AD and much of the rest of the 
NTR and CTR can be truncated without impairing DNA binding, and other functional 
domains can then be fused in their place. This has resulted in a panoply of TALE-
based tools (Figure 1.6). The C-terminal fusion of the FokI nuclease domain to create 
a TALE nuclease (TALEN; Figure 1.6B) has been the most studied and most used. 
The generation of knock-out lines is a key step in most reverse genetics approaches. 
In the past such knock-outs had to be first randomly generated and then screened 
and characterized, TALENs allow researchers to create specific knock-outs. This 
was already possible to some extent thanks to Zinc-Finger Nucleases (ZFN), which 
can reasonably be called the predecessors to TALENs, since this technology is now 
little used but the basic design is analogous and was directly copied to create 
TALENs. Functional TALENs and ZFNs are both paired-sets of DNA binding domains 
with C-terminal FokI nuclease domain fusions. Whilst ZFNs are modular DNA binding 
proteins there is no particular code that can be used to predict DNA binding 
specificity from primary protein structure. For these reasons the popularity of ZFNs 
as a tool declined with the advent of TALENs. Today the popularity of TALENs is 
challenged by an RNA-guided programmable nuclease system known as CRISPR-
Cas9, explored in more detail in 1.2.7 
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Figure 1.6: Overview of TALE fusion protein designs  
 
TALE technology for manipulating transcriptome (A), genome (B) and epigenome (C). 
Source: de Lange et al., Plant J, 2014. TALE DNA binding domains are illustrated 
with blue ovals, binding their DNA target sites, shown as blue regions on otherwise 
grey DNA. Yellow bars indicate NTR and CTR regions. C-terminally fused functional 
domains are shown as a green triangle (AD), red box (repressor domain), red scissors 
(nuclease activity), red hooks or rings (recombination) or red polygons (epigenetic 
modifications). 
All of these construct designs have been created and confirmed for the desired 
function. In particular TALE activators and repressors (a) have been employed in the 
creation of synthetic genetic circuitry and as tools for fundamental biology. The 
paired C-terminal FokI fusion protein design is what is commonly referred to as 
TALENs and has been employed extensively for the creation of gene-knockouts and 
gene-targeting. Numerous epigenetic modifier domains have all been demonstrated 
in a proof of concept study (42) but have yet to be employed beyond that context.  
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1.6 TALE-like proteins have so far been identified in three sources outside of 
Xanthomonas bacteria 
My doctoral work has been focused on characterizing TALE-like proteins from non-
Xanthomonas bacteria. In studying TALE-like proteins I hoped to reveal unexpected 
insights about the TALEs themselves, which might prove useful in biotechnology and 
tackling plant disease. In addition, one of the TALE-like producing bacteria, R. 
solanacearum, is itself a devastating plant pathogen causing bacterial wilt disease. I 
hope that the molecular characterization of R. solanacearum TALE-like proteins 
described in this thesis may prove useful in the fight against bacterial wilt.  
What follows is first an introduction to the TALE-like proteins so far identified and 
their host organisms. After that I will introduce and expound on each of the central 
questions of this thesis. Do non-Xanthomonas TALE-likes adhere to the TALE 
paradigm in terms of functional domain structure and DNA-binding properties?  
What are the unifying features of the TALE-likes? Can they reveal anything about 
TALE-evolution? Finally, could TALE-likes be useful additions to TALE technology? 
Three groups of TALE-like proteins of non-Xanthomonas origins have been identified 
to date. They are the RipTALs of R. solanacearum, The Bats of Burkholderia 
rhizoxinica strain HKI 454, and the MOrTLs of uncertain marine bacterial origin. The 
latter group actually contains two TALE-like repeat-proteins each as different from 
one another at the sequence level as they are from any other TALE-like group, and 
therefore considered two groups: MOrTL1 and MOrTL2. All of these different TALE-
likes were first recognized in the results of genome sequencing projects. In the case 
of the RipTALs some functional information was available prior to the beginning of 
this work, reviewed below. In addition, molecular characterizations of the RipTALs 
and Bat1 have been carried out by other research groups and were published shortly 
before those presented in this thesis. Information from those publications is 
integrated into the discussion. The next paragraphs provide information on the 
providence of each group and the existing literature prior to the initiation of this work. 
1.6.1 Prior knowledge about Ralstonia TALE-likes 
Discovery and early work: R. solanacearum TALE-likes are T3Es found across much 
of the species complex 
The first report of a TALE-like protein comes from the early years of TALE research. 
In 2002 the genome of R. solanacearum strain GMI1000 was sequenced (43). 
Amongst the newly identified putative effector genes was one, Rsc1815, likely 
homologous to TALEs. This assessment was based on sequence similarity: 40% 
identical to AvrBs3 at the protein level; and on domain structure: 16 tandem repeats 
of 35 amino acids (Figure 1.7) flanked by more sequence degenerate repeats and 
then NTR and CTR domains. The term RipTAL was coined for these TALE-likes in 
2013 as part of an integrated approach to R. solanacearum T3E nomenclature (44). 
Rip stands for Ralstonia injected protein, and is common to all, whilst the TAL 
alludes to their TALE-like nature.  
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A screen for genes regulated by the T3SS master regulator HrpB pulled out 
Rsc1815, providing it the designation brg11 (HrpB-regulated 11; (45)). Around the 
same time the homolog from closely related strain RS100 was pulled out from a 
screen for T3E’s based on tagging genes with adenylate cyclase and observing 
spikes in cAMP after infection of plant leaves (46). The homolog in RS100 was 
named Hpx17 (hrpB dependent expression 17). Unlike brg11 this gene lacks the bulk 
of the repeat region, encoding a protein with only a single canonical repeat. 
Together, these studies confirmed that the RipTALs are indeed type-III-secreted.  
A descriptive study has been carried out on RipTALs from a set of, mostly Asian, R. 
solanacearum strains. The strains were tested by PCR for the presence of a Brg11 or 
Hpx17 homolog. ripTALs were detected in 285 out of 319 strains.  Repeat regions 
were amplified and characterized based on length and restriction digest pattern (47). 
This revealed that the vast majority of ripTALs were the same length as brg11. The 
other major isoform was the hpx17-likes. A few ripTALs were found with a length 
matching neither brg11 nor hpx17, but these mostly differed in size by just one or 
two repeats.  
In 2010 a report into virulence contributions of GMI1000 T3Es found Brg11 to be 
amongst the most influential (48). The study compared the growth of wild type and 
effector knock-out strains infiltrated together into aubergine leaf (Solanum 
melongena cv. Zebrina). The brg11 knock-out strain grew at 20% of the rate of the 
wild-type indicating compromised in planta growth properties, such that Brg11 must 
provide some virulence contribution in wild-type strains. Several R. solanacearum 
genomes had already been sequenced in addition to GMI1000 prior to our work on 
the molecular characterization of Brg11 and other phylotype I RipTALs. Specifically 
strain Molk2 from Phylotype II, Psi07 of Phylotype IV and closely related Banana 
Blood Disease Bacterium (BDB) strain R229 had all been sequenced and found to 
encode RipTALs. However, ripTALs were not found in other sequenced strains such 
as K60, CFB2957 and many of the strains studied by Heuer et al.. 
Thus the state of knowledge as to the RipTALs prior to the work presented in this 
thesis was that many, but not all, R. solanacearum strains possess RipTALs; 
sequence similarity to TALEs is high enough to be able to make a confident 
assignment of homology; at least some individual strains were shown to 
regulate/deliver their RipTALs with the type III secretion system; and Brg11 had been 
found to contribute to in planta growth in at least one natural host species. It was 
therefore already assumed within the field that RipTALs, like TALEs, are T3Es and 
mediate some virulence contribution by acting as eukaryotic transcription factors 
and inducing target host genes. Yet besides translocation, none of these molecular 
details had been studied.  
RipTAL domain structure is similar to that of TALEs but the repeats display a level of 
inter-repeat polymorphism far exceeding that of TALEs 
The domain composition of Brg11 seems at first glance rather like that of TALEs 
(Figure 1.8A). A tandem array of 16 repeats of high sequence similarity (average of 
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75%; Figure 1.7) are flanked by more sequence degenerate repeats and the whole 
repeat region is framed by large sections of NTR and CTR. The repeats of RipTALs 
and TALEs are similar enough to suggest a conserved molecular function, yet the 
most striking observation from a comparison of TALE and RipTAL repeat arrays is 
the number of inter-repeat polymorphisms. RipTAL repeats vary from one another 
not only at positions 12 and 13, but also across a section of the C-terminal end of 
each repeat, as well as a few other positions (Figure 1.7). 
Figure 1.7: Brg11 canonical repeat alignment  
                11111111112222222222333333 
       12345678901234567890123456789012345 
 1     LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2     LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3     LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4     LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5     LSTEQVVAIASHNGGKQALEAVKAHLLDLRGVPYA 
 6     LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7     LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8     LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9     LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10     LSTAQVVAIASHDGGNQALEAVGTQLVALRAAPYA 
11     LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12     LNTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13     LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14     LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15     LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16     LNTAQIVAIASHDGGKPALEAVWAKLPVLRGAPYA!
 
Amino acids that are identical between the repeat units are displayed as white letters 
on black background. A white background indicates residues differing from the 
consensus at that position. Grey background indicates residues with similar 
chemical properties at the same position. Numbers above the sequence (5, 10, 15, 
20, 25, 30, 35) indicate the position of the given amino acid within the repeat. 
1.6.2 Prior knowledge about Burkholderia TALE-likes 
The genome of the rather esoteric fungal endobacterium Burkholderia rhizoxinica 
(strain HKI 454) was sequenced in 2011 (49). Amongst the many novel predicted 
proteins in the genome were a set of three genes similar enough to TALEs to be 
picked up by BLAST or HMM based searches using any TALE as a template (many 
thanks to Diana Horvath for initially alerting us to this fact). No information was or is 
available as to the expression of these predicted proteins within the bacterium, and 
the interesting lifestyle of this bacterium adds to the mystery shrouding the biological 
function of these proteins. B. rhizoxinica is naturally an obligate endosymbiont of 
zygomycete fungus Rhizopus microsporus. This fungus is a plant pathogen causing 
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seedling blight (50), and in rare cases it has been found to cause nosocomial 
infections in humans with compromised immune systems. It should be noted though, 
that whilst plant pathogenesis of R. microsporus requires the bacterial 
endosymbiont, human pathogenesis proceeds in the absence of the endosymbiont 
(51). R. microsporus and B. rhizoxinica are of greater interest for the toxin produced 
during pathogenesis, rhizoxin, which has been shown to have anti-tumorigenic 
properties (52). This toxin is actually produced by B. rhizoxinica and delivered to the 
fungus (53). It is also possible, though far from facile, to culture B. rhizoxinica 
independently of its fungal host, raising the possibility of a fermentation system for 
rhizoxin production (53). There is thus cause to research the biology of this 
bacterium though it cannot be said to pose a great threat to agriculture or human 
health. 
The Burkholderia TALE-likes (Bats) consist only of tandem repeat arrays divisible into 
canonical repeats and a few flanking sequence-degenerate repeats and a short (17 
AA in the case of Bat1) N-terminal non-repetitive region (Figure 1.8A). Moreover, the 
repeats are less than 40% identical to consensus repeats of AvrBs3 or Brg11 (Figure 
1.8B). Like RipTAL repeats, Bat repeats also display a lot of inter-repeat 
polymorphism. Yet despite this similar or identical residues are found in the region 
around position 13 in repeats of Bats, RipTALs and TALEs (Figure 1.8B) providing 
encouragement to test the hypothesis that the repeat arrays of the Bat proteins 
mediate sequence specific DNA binding. 
1.6.3 Prior knowledge about Marine Organism TALE-likes 
The TALEs, RipTALs and Bats all hail from terrestrial plant-pathogenic or plant-
pathogen-associated bacteria. The final two TALE-likes addressed in this thesis are 
from as yet unspecified marine bacteria from the waters of the Gulf of Mexico. They 
were picked up as part of the J. Craig Venter Institute Global Oceanic Survey (54, 
55). The Marine Organism TALE-likes (MOrTLs) come from orphan contigs from this 
dataset but based on size filtering of environmental samples prior to genomic library 
construction they are almost certainly bacterial. Similar to the Bats they seem to be 
formed only of tandem repeats with some flanking sequence degenerate repeats. 
However, the available sequences likely do not fully cover the complete coding 
sequences and it is not possible to make definitive statements about gene structure. 
The two genes mortl1 and mortl2 encode repeat arrays with lower inter-repeat 
variability than found among Bats. However, whilst repeats of MOrTL1 are all similar 
to one another and the same for MOrTL2, the repeats differ greatly between the two 
proteins. In fact they differ as much from another as they do from repeats of the 
TALEs, Bats and RipTALs (consensus repeat sequences in figure 1.8B). However, 
repeat length (33 amino acids) and certain motifs seen in other TALE-like repeats 
was enough to mark these repeats out as similar to TALE-like repeats and worthy of 
further investigation (Figure 1.8B). The MOrTLs were first suggested to be TALE-likes 
in a publication from another group in 2013 (56) based on sequence similarities but 
they were not further investigated. 
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Figure 1.8: Domain composition and repeat sequence differences between 
representative TALE-likes 
 
 
Domain composition (A) and consensus repeat sequences (B) of representatives of 
each TALE-like group addressed in this work. Different TALE-likes are given arbitrary 
colour groups. Ovals represent canonical repeats, and polygons non-canonical. 
Rectangles are used for N-terminal non-repetitive regions and triangles for C-
terminal non-repetitive regions. All domain graphics are sized within the same scale 
and the scale bar allows graphic lengths to be related to amino acid sequence length 
of each functional domain. Below an alignment is shown with representative 
consensus repeats made form canonical repeat alignments for different TALE-likes, 
with the number taken from each group reflecting to some extent the number of 
known representatives of that group: TALEs (AvrBs3, AvrXa7, AvrHah1), RipTALs 
(Brg11, RipTALI-14), Bats (Bat1), MOrTL1 and MOrTL2. Pink background is used to 
indicate polymorphisms. Repeat position is indicated above and repeat length to the 
side. Alignments and consensus repeat calculations were carried out in CLC Main 
Workbench 7.  
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2 Aims of this work 
My goal was to characterize the functional domains of all identified TALE-like groups, 
with a particular focus on DNA-binding properties. Four specific questions guided 
this analysis: 
1. Do other TALE-likes conform to the TALE paradigm as pertains to (a) functional 
domains and (b) DNA binding properties? 
2. What are the unifying features of TALE-likes and which of these could be said to 
be defining? 
3. Can we gain insights into TALE-like evolution from the comparison of TALE-like 
protein sequences? 
4. Could TALE-likes be used to make novel contributions to TALE technology? 
These are introduced in turn and placed in their relevant context within the existing 
body of TALE research.   
2.1 Conformity to the TALE paradigm? 
Question one: Do TALE-like proteins conform to the TALE paradigm as pertains to 
functional domains and DNA binding properties? 
(a) Functional domains and biological role 
Whilst TALEs are highly diverse in the BSR compositions of their repeat arrays they 
are uniform in their domain composition. The particular domain structure of TALEs 
can be understood in terms of their biological function as pathogen effectors working 
as eukaryotic transcription factors. TALEs can be divided into three regions the N-
terminal non-Repeat region (NTR), with a length of around 150 amino acids (157; 
AvrBs3), the repeat region, and the C-terminal non-repeat region (CTR), around 250 
amino acids (229; AvrBs3). The repeat region can be further subdivided into 
canonical and non-canonical repeats, of which there are four N-terminal and two C-
terminal of the canonical repeats. In addition the NTR and CTR contain smaller 
functional domains: the T3SS in the NTR and the NLSs and AAD in the CTR.  
Some conclusions can already be made on the relative functional domain structures 
of the non-Xanthomonas TALE-likes. As shown in Figure 1.8A the RipTALs share a 
similar domain structure to that of the TALEs and although sequence identity is 
highest across the canonical repeats there are patches of clearly homologous 
sequences across the NTR and CTR. The functional domains of the RipTALs may 
well fulfill a similar biological function to those of TALEs. The same cannot be said 
for the Bats and MOrTLs. In the case of the MOrTLs it is not clear whether all the 
domains of the full length coding sequences are represented in the available DNA 
sequences. The Bats, however, are predicted from a fully assembled genome and 
more confident statements can be made as to their domain structure. In every case 
the Bats are formed of a tandem canonical repeat array flanked by two degenerate 
N-terminal repeats and one degenerate C-terminal repeat. In addition there is a 17 or 
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18 amino acid Non repetitive region forming the complete NTR. There are thus no 
long stretches of NTR and CTR in the Bats to mediate the translocation, and 
transcriptional activation functions of TALEs. The same seems to be true for the 
MOrTLs, though again caution must be taken here. These contrasts suggest 
differences in functional domain composition and biological function between TALE-
like groups. 
(b)  DNA binding properties 
Is there conservation of the TALE code in the face of non-BSR polymorphisms? 
As described above, the TALE code is a reliable means to predict TALE target 
sequences or design dTALEs for a target of choice. Knowing the BSR composition 
of a particular TALE is typically enough to know all there is to know about its base 
preference. Yet could the simplicity of the TALE code simply reflect the lack of 
sequence diversity at non-BSR positions? Boch & Bonas created a sequence logo 
by pooling repeats from 113 TALEs from across the xanthomonads (Figure 2.1) and 
found that only positions 4, 12, 13 and 32 show any considerable polymorphism.  
Figure 2.1: A sequence logo of TALE repeats based on 113 TALEs 
 
Canonical repeat sequences of 113 TALEs were aligned by Boch & Bonas to create 
this sequence logo (Annual Reviews, 2010). Repeat positions are individually 
coloured. Alternative residues are stacked and the total height for each stack is 
correlated to the percentage conservation at that position across the aligned 
repeats. The BSR is the most variable position. Postions 4, 12 and 32 are variable to 
the extent that two alternative residues commonly occupy those positions.  
It has been demonstrated that non-BSR residues can influence the activity and to a 
lesser extent the specificity of TALE repeats. As mentioned already position 12 is a 
naturally variable residue in TALE repeats and is generally referred to as co-
determinant of base preference despite clear evidence to the contrary. Studies 
analyzing all possible combinations of residues 12 and 13 found that residue 12 
seems to regulate activity to a much greater extent than specificity (29, 30). Few 
natural polymorphisms occur beyond this and studies are therefore lacking.  
As mentioned, TALE and RipTAL repeats differ at a number of positions. Additionally 
RipTAL repeat arrays show far greater diversity in terms of inter-repeat non-BSR 
polymorphisms (Figures 1.3 and 1.4). The consensus repeats of TALEs and RipTALs 
are still conserved at just over half of all repeat positions (Figure 1.8B). Yet when 
including the Bat and MOrTL consensus repeats the polymorphism outweighs the 
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conservation (Figure 1.8B). It is thus a major aim of my work to understand the 
impact this has on DNA binding properties. Is the TALE code conserved among 
TALE-likes and if so do non-BSR polymorphisms exert any influence? 
How will differences in the non-canonical repeats affect DNA-binding? 
In addition to the canonical repeats there are reasons to suspect differences in DNA 
binding properties arising from differences in the non-canonical repeats. Most 
relevant are the N-terminal non-canonical repeats, which, in TALEs, work as the 
nucleation point for DNA target site recognition (31) contributing decisively to DNA 
binding (25) and also mediating the fixed T0 preference (57). N-terminal non-
canonical repeats with similar sequences to those of TALEs are discernible in the 
RipTALs. The same cannot be said of the Bats, though non-canonical repeats N and 
C-terminal of the canonical repeats can be identified. In the MOrTLs it is not clear if 
the full gene sequences are available but based on the information at hand non-
canonical repeats are presented but do not resemble those of TALEs. The impact of 
these repeats, particular the N-terminal non-canonical repeats is addressed for each 
of these groups in the articles in section 2. 
2.2 Unifying and defining features of the TALE-likes  
Question two: What are the unifying features of TALE-likes and which of these could 
be said to be defining? 
The term TALE-like has been used only rarely till now and when used it is used 
inconsistently. The RipTALs have been referred to as TALE-likes or simply as the 
TALEs of R. solanacearum (58, 59). The Bat proteins have received little attention in 
the literature till now. Thus the term TALE-like in the current literature is a vaguely 
defined measure of sequence similarity not a precisely defined protein family. Prior to 
any functional characterizations or structural predictions, the term just means 
sequence-similar to TALEs.  
2.3 What is known about TALE evolution? 
Question three: Can we gain insights into TALE-like evolution from the comparison of 
TALE-like protein sequences? 
Although my work has focused on a few representatives of each group, at the 
protein level, and is therefore ill designed for evolutionary enquiry, some interesting 
observations were made in the course of study. Therefore I consider it relevant to 
review the most germane research regarding TALE evolution to date, particularly to 
provide some context of the current assumptions within the field as to the 
evolutionary processes shaping the BSR composition diversity of TALEs.  
Gene copy number differs between strains and Tn3 transposons may be involved 
By comparing the TALE phylogeny of Ferreira et al. to a Xanthomonas phylogeny 
based on whole genomes (60), it appears that TALEs are a basal feature of the genus 
and have diverged with the major clades within the genus. In general the TALEs of 
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rice infecting (X. oryzae) and non-rice-infecting xanthomonads show different 
patterns of diversity. The rice infecting strains tend to bear TALEs in an excess of 15 
per strain. In addition TALEs of X. oryzae pv oryzae, though not X. oryzae pv 
oryzicola, strains tend to be arranged in tandem gene repeats flanked by transposon 
inverted repeats sequences (11, 61). The two may well be linked since not only are 
TALE genes in many cases flanked by Tn3 transposon inverted repeat sequences, 
but these are flanked by 5 bp direct repeats, an indicator of a transposon event (61). 
However, that X. oryzae pv oryzicola strains also bear TALE genes in multicopy 
without evidence of transposition speaks against this.  
In the non-rice-infecting strains TALEs are often plasmid localized (61) The 
significance of this for TALE evolution and distribution has not been studied. 
However, it is known that xanthomonads can transfer plasmids between strains (62) 
so plasmid localized TALEs may be mobile, at least among closely related strains.  
TALE repeat domain evolution involves repeat deletion, and repeat recombination 
In an experimental set-up selecting for mutants of X. oryzae pv oryzae TALE AvrXa7 
Yang et al. (39) were able to recover TALE mutants with deletions of large sections of 
canonical repeats, replicating a previous finding of Yang and Gabriel, 1995 (63) for X. 
citri TALE PthA. They  also found evidence of repeat recombination between AvrXa7 
and some other TALE gene from the genome of this strain.  
Potential molecular mechanisms allowing for changes in repeat number and 
composition in TALE genes include intra-genic recombination, inter-genic 
recombination and replication slippage. Ferreira et al. prefer the latter without 
providing supporting evidence for this (61) and it is clear from Yang et al. that 
recombinatorial processes can also direct TALE repeat domain evolution (39). 
 
2.4 New frontiers in TALE technology 
Question four: Could TALE-likes be used to make novel contributions to TALE 
technology? 
TALE technology is the use of TALE-derived molecular tools to carry out desired 
functions. This requires modification of natural TALEs to create the appropriate tools. 
This of course involves the assembly of dTALEs with different BSRs and also testing 
different NTR/CTR truncations coupled to domain fusions. Furthermore, TALE gene 
codon optimization and the use of non-natural promoters and terminators could also 
qualify. I will not devote further space here to dTALE assembly or domain fusions, 
but rather look toward what the current challenges in TALE engineering. In order to 
make judgments on the logical next steps for TALE technology it is important to 
mention the recently arrived rival system: CRISPR/Cas9.  
RNA-binding protein Cas9, together with a guide RNA supplied from a CRISPR 
locus, form a sequence specific DNA binding complex based on Watson-Crick base 
pairing (64). The specificity of the system can be reprogrammed simply by modifying 
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the 20 bp spacer region of the guide RNA gene, which makes CRISPR/Cas9 an 
incredibly simple and therefore attractive system. This system was adapted from 
bacterium Streptococus pyogenes but is widespread among prokaryotes. The 
natural Cas9 protein acts a DNA endonuclease, allowing the complex to carry out its 
function of identifying and destroying viral DNA within the cell. Endonuclease 
defective versions have been created and additional domains fused to Cas9 to adapt 
CRISPR/Cas9 for use as a targeted transcription factor for example (65).   
Considering the efficacy and simplicity of the CRISPR/Cas9 it is worth questioning 
what the value is of continuing to use TALE technology. Indeed the initially identified 
drawbacks of the CRISPR/Cas9 platform have indeed been largely overcome 
already. Two limitations that we identified previously (7) are that guide RNA 
expression is typically driven by constitutive Pol I promoters and therefore can’t be 
regulated, and the Cas9 protein will accept any guide RNA expressed in the cell, 
limiting orthogonal construct deployment. It has now been shown that guide RNAs 
can be expressed from pol II promoters if they are flanked by ribozymes to remove 5’ 
and 3’ caps which would lead to nuclear export of the guide RNA (66). Also, several 
Cas9 proteins from different bacterial species, each with their own specific guide 
RNA upstream recognition sequence requirements have been characterized (67). It is 
therefore possible to have several sets of orthogonal Cas9s and guide RNAs in one 
system. In addition using RNA scaffolds allows specific functional domains to be 
linked to specific guide RNAs (68). Therefore, by now the available regulatory nodes 
for CRISPR/Cas9 are diverse and unlikely to be a real limitation for implementation, 
even for complex applications. 
The more serious drawback of the CRISPR/Cas9 system is that the DNA binding 
interface cannot be easily modified. The number of possible binding interactions is 
limited to Watson-crick base pairing. By contrast there are 20 natural amino acids 
which could occupy the BSR position of a TALE repeat, as well as the commonly 
occurring GSL repeats, missing the BSR residue (7). In addition polymorphisms at 
other positions may be modified to alter the protein-DNA interface, which has been 
demonstrated at least for position 12 (30). This could prove advantageous in certain 
applications where the precise adjustment of affinity and specificity between protein 
and DNA partner (7) is desirable. It could also be possible to make dTALEs targeting 
the same target sequence with different binding strengths. Such a library of dTALEs 
for a single DNA element could be advantageous in synthetic biology in particular, 
where they could be used as modular resistor elements of varying strength in 
synthetic genetic circuitry, as has already been partially demonstrated (69). 
The other advantage of the dTALE system is the potential to design repeat arrays 
with very low mismatch tolerance. A comparison to CRISPR/Cas9 found that TALE 
repeat arrays had lower mismatch tolerance (65). In addition using less common 
BSRs and non-naturally occurring residues at 12 allowed the creation of dTALEs 
with even lower mismatch tolerance than a standard dTALE, without compromising 
on-target activity (30). Such engineering options are not open to the CRISPR/Cas9 
sequence, where base-pairing properties and target length are fixed, and till now 
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studies have found that the off-target activity of CRISPR/Cas9 in complex genomes 
is too high to be useful for applications such as gene therapy, requiring high fidelity 
targeting (70). Another study found that using two modified CRISPR/Cas9 nickases 
(analogous to a TALEN pair) reduced off-target activity to the same level as a TALEN 
pair within a human cell targeted cleavage set-up (40). However, for applications 
such as transcriptional modification, where single dTALEs and not pairs are used, 
the potentially greater targeting stringency could make dTALEs the more attractive 
tool.  
The possibility of higher-fidelity, tunable targeting with TALEs may provide an 
advantage in the areas of gene therapy and synthetic biology. In the former case off-
target mutations must be minimized. In the later case synthetic genetic circuitry 
requires a toolbox of tunable transcriptional regulators which can function 
orthologously in a synthetic system, which has been demonstrated for dTALEs (71). 
If, as I believe, the future of applied TALE technology lies in synthetic biology and 
high fidelity targeting applications, then certain engineering goals can be outlined. I 
think that more attention should be paid to the repeat-DNA interface, modulating it 
through the careful selection of BSR and non-BSR polymorphisms. This could allow 
fine-tuned control of DNA binding domain properties by modifying the protein-DNA 
interface. The exploration of non-BSR polymorphisms may also aide in the creation 
of dTALEs with even higher sequence specificity without compromising activity; the 
main issue for high fidelity applications such as gene therapy.  
Finally, an unresolved problem of TALE technology, relevant to all applications, is 
that TALE genes seem to be rather unstable. Specifically repeats are lost over time, 
with the magnitude of the effect dependent on the particular cell environment or 
delivery system (72, 73). Repeat loss could totally inactivate the dTALE or lead to 
novel target specificities if the loss is small in scale. This would be devastating for 
gene therapy, where high fidelity is required; and for synthetic biology applications 
where dTALEs might need to be stably expressed in a synthetic biological system 
potentially indefinitely. It may be possible to alleviate this problem by reducing 
average pairwise repeat similarity at the DNA level. Only so much can be achieved 
with alternative codon usage and thus studies into the potential for modifying repeat 
amino acid sequence without impairing activity would be desirable. 
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3 Breaking the DNA-binding code of Ralstonia solanacearum TAL 
effectors provides new possibilities to generate plant resistance genes 
against bacterial wilt disease   
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Summary
! Ralstonia solanacearum is a devastating bacterial phytopathogen with a broad host range.
Ralstonia solanacearum injected effector proteins (Rips) are key to the successful invasion of
host plants. We have characterized Brg11(hrpB-regulated 11), the first identified member of a
class of Rips with high sequence similarity to the transcription activator-like (TAL) effectors of
Xanthomonas spp., collectively termed RipTALs.
! Fluorescence microscopy of in planta expressed RipTALs showed nuclear localization.
Domain swaps between Brg11 and Xanthomonas TAL effector (TALE) AvrBs3 (avirulence
protein triggering Bs3 resistance) showed the functional interchangeability of DNA-binding
and transcriptional activation domains. PCR was used to determine the sequence of brg11 ho-
mologs from strains infecting phylogenetically diverse host plants.
! Brg11 localizes to the nucleus and activates promoters containing a matching effector-bind-
ing element (EBE). Brg11 and homologs preferentially activate promoters containing EBEs
with a 5′ terminal guanine, contrasting with the TALE preference for a 5′ thymine.
! Brg11 and other RipTALs probably promote disease through the transcriptional activation
of host genes. Brg11 and the majority of homologs identified in this study were shown to acti-
vate similar or identical target sequences, in contrast to TALEs, which generally show highly
diverse target preferences. This information provides new options for the engineering of
plants resistant to R. solanacearum.
Introduction
Ralstonia solanacearum is the causal agent of the crop diseases
most commonly referred to as bacterial wilt (Genin, 2010).
Known for its broad host range, this pathogen infects many
economically important crop and ornamental species, including
solanaceous crops potato, tomato, tobacco, pepper and auber-
gine) but also nonsolanaceous dicots (geranium and peanut) and
monocots (ginger and banana). Endemic in much of Asia and the
Americas (Elphinstone, 2005), R. solanacearum is also considered
a quarantine pest in the European Union (EU) as well as a
potential bioterrorism agent in the USA (Lambert, 2002).
A range of type III effectors are known to be translocated into
plant host cells by R. solanacearum and contribute to the extraordi-
narily broad host range of this plant pathogen (Genin & Boucher,
2004; Remenant et al., 2010). Here we provide a molecular char-
acterization of the R. solanacearum type III effector Brg11 (hrpB-
regulated 11; strain GMI1000; Cunnac et al., 2004), previously
also designated RSc1815 (Ralstonia solanacearum chromosomal
gene 1815; Salanoubat et al., 2002) or Ralstonia transcription
activator-like (TAL)-like 2 (RTL2; Li et al., 2013), as well as
homologs from diverse strains of R. solanacearum, including
Hpx17 (hrpB-dependent expression 17; strain RS1000; Mukaiha-
ra et al., 2010). Brg11 was the first identified member of this class
of effectors, notable for their sequence similarity to the transcrip-
tion activator-like effectors (TALEs) of Xanthomonas spp. and thus
termed Ralstonia injected protein TALs (RipTALs).
Members of the Xanthomonas TALE family share a common
modular architecture: an N-terminal type III secretion signal
marking TALEs for translocation from the pathogen into the
host cell, C-terminal nuclear localization signals (NLSs), tan-
demly arranged repeats that facilitate sequence-specific DNA
binding at promoters of target genes and a C-terminal transcrip-
tional activation domain (AD) that induces transcription of the
target gene (Bogdanove et al., 2010). Distinct TALEs vary pre-
dominately in their DNA-binding specificity, allowing them to
target diverse genes within the host genome. Examples of TALEs
and corresponding target genes include the well-studied AvrBs3
protein of Xanthomonas campestris pv. vesicatoria (Xcv; also
referred to as X. euvesicatoria or X. axonopodis pv. vesicatoria
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(Vauterin et al., 1995; Jones et al., 2004)), which is believed to
promote disease by transcriptional activation of the pepper
UPA20 (upregulated by AvrBs3, gene 20) gene (Kay et al.,
2007) but also triggers defense in pepper genotypes that contain
the matching resistance (R) gene Bs3 (Bacterial spot R gene 3;
R€omer et al., 2007).
TALE DNA-binding repeats are typically 33–35 amino acids
long and, within a given TALE, inter-repeat polymorphism is
found predominantly in positions 12 and 13, the repeat variable
diresidue (RVD). It was found, through analysis of TALE target
boxes within promoters, that there is a simple code linking RVDs
and target sequences (Boch et al., 2009; Moscou & Bogdanove,
2009). Each repeat binds a single DNA base and the amino acids
occupying the RVD determine base specificity. This ‘TALE code’
can be used to create designer TALEs (dTALEs) with desired
DNA-binding specificities (Bogdanove & Voytas, 2011). As
made clear by the elucidation of the crystal structures of TALEs
bound to DNA (Deng et al., 2012; Mak et al., 2012), the binding
domain forms a right-handed superhelix around the DNA, track-
ing along the sense strand, with each repeat making contact with
a single DNA base. Contact occurs between the DNA base and
TALE repeat residue 13, while residue 12 of each repeat forms a
stabilizing hydrogen bond with residue 8 of the same repeat
(Bochtler, 2012).
As has previously been noted, the R. solanacearum Brg11 pro-
tein shares 40% homology with the Xanthomonas TALE protein
AvrBs3 (Schornack et al., 2006) and possesses a central region of
tandemly arranged 35-amino acid repeats, with each repeat bear-
ing an average similarity of 55% to the repeats of AvrBs3. For
this reason, Brg11 was annotated as a putative TALE within the
GMI1000 genome (Salanoubat et al., 2002). Subsequently homo-
logs have been detected by PCR in over 300 R. solanacearum
strains (Heuer et al., 2007). However, despite their prevalence,
the functional characterization of these proteins, beyond evidence
of type III delivery and nuclear localization (Mukaihara et al.,
2010; Li et al., 2013), remains minimal. Mutant GMI1000
derivatives lacking this effector showed reduced virulence relative
to the wild-type strain in aubergine (Macho et al., 2010), demon-
strating that Brg11 contributes to pathogenicity.
We report here on the functional characterization of the
RipTAL Brg11, showing that it contains functional NLSs, and a
C-terminal AD. Furthermore, while RipTAL RVDs have previ-
ously been tested in the context of Xanthomonas TALE repeats
(Streubel et al., 2012) and a RipTAL consensus repeat (Li et al.,
2013), we show here for the first time predicted target sequences
that are transcriptionally activated by wild-type RipTALs
in planta. We demonstrate that repeats of the RipTAL Brg11 rec-
ognize DNA in a manner analogous to that of TALEs, with a
code governed by the RVDs of consecutive repeats. In addition,
however, non-RVD residues, which are highly variable in Rip-
TALs but not TALEs, have a significant impact on the DNA rec-
ognition properties of repeats. Furthermore, Brg11 is functional
only when the binding box is preceded by a 5′ guanine (G0), in
contrast to TALEs which have a preference for a 5′ thymine (T0).
Homologs of Brg11 from strains of R. solanacearum isolated from
phylogenetically diverse host plants have > 98% homology to
Brg11 and most are identical to Brg11 in repeat composition and
DNA specificity.
Materials and Methods
Bacterial strains and growth conditions
Escherichia coli TOP10 and DB3.1 (Life Technologies, Carlsbad,
CA, USA) were cultivated at 37°C in LB (Lysogeny Broth) and
Agrobacterium tumefaciens GV3101 pMP90 (Koncz & Schell,
1986) at 30°C in YEB (Yeast Extract Broth) medium.
Plant material
Nicotiana benthamiana plants were grown in a glasshouse at 60–
70% humidity, at 22°C during the day (16-h light) and 18°C at
night. Six- to eight-wk-old plants were used for inoculation.
Generation of brg11 and hpx17 pENTR-D constructs
Using TOPO-BluntII-hpx17 (T. Mukaihara, Research Institute
for Biological Sciences, Okayama, Japan) as a template we ampli-
fied hpx17 with the primers brg11_CACC-ATG and brg11_
no-stop (Supporting Information Table S1) and cloned the PCR
product into pENTR-D (Life Technologies), generating pENTR-
D_hpx17 containing wild-type hpx17. To create an ENTRY clone
for brg11, the XhoI/Bgl II fragment of pCDN2.1_brg11 contain-
ing brg11 (S. Genin, Laboratoire des Interactions Plantes-Micro-
organismes, Castanet-Tolosan, France) was cloned into the XhoI/
Bgl II-cleaved pENTR-D_hpx17.
Creation of hpx17 truncations and NLSmutants
NLS mutations and domain truncations were made to hpx17 in
pENTR-D via site- directed PCR mutagenesis utilizing Phusion
polymerase (New England Biolabs, Beverly, MA, USA) with its
GC buffer and PCR additive PreCES-I (Ralser et al., 2006). NLSI
(sequenceHRKR)was replaced with a singleHindIII site (resulting
sequence QAYW) via PCR mutagenesis with primers brg11_mut-
NLSI_fwd and brg11_mut-NLSI_HindIIIrev (Table S1); NLSII
(sequence RRKR) was replaced with a single BamHI site (resulting
sequence PDPW) with primers brg11_mut-NLSII_BamHIfwd
and brg11_mut-NLSII_rev (Table S1). hpx17-DN-Drep was cre-
ated with the removal of N-terminal- and repeat region-encoding
sequences with the primers hpx17_Cterm_fwd and
hpx17_Cterm_rev (Table S1), and hpx-17-Drep-DC with
hpx17_Nterm_fwd and hpx17_Nterm-rev (Table S1). Nucleotide
sequences for all hpx17 derivatives are displayed in Fig. S2.
Creation of C- and N-terminal AvrBs3/Brg11 chimeras
To generate the C-terminal chimera (CTC) and the DAD deriva-
tive, a fragment encoding the C-terminus of Brg11 (brg11C919-
1245), and flanked by BsaI sites, was amplified using the primers
listed in Table S1. As a template, a brg11 full-length gene, codon
optimized for in planta expression (synthesized by GenScript;
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Piscataway, NJ, USA), was used. The primers CTC-DAD Fwd
and Rev (Table S1) were used to remove the 3′-most 35 codons
to create CTC-DAD. The CTC and CTC-DAD were each com-
bined with a BsaI site-flanked fragment encoding the N-terminus
of AvrBs3 into a modified pENTR-D derivative containing BsaI
sites and a chloramphenicol acetyltransferase (cat)-ccdB cassette
via BsaI cut-ligation.
N-terminal Brg11/AvrBs3 chimeras were created by replacing
repeats –1 and 0 of AvrBs3 with the corresponding Brg11 region
(N-terminal chimera 1 (NTC1)) or by replacing the complete
N-terminus of AvrBs3 with that of Brg11 (NTC2) (Fig. S8).
Both chimeras were generated by PCR mutagenesis with the
primers listed in Table S1. As templates, wild-type avrBs3 as well
as brg11 codon optimized for in planta expression (synthesized
by GenScript) were used. Together with the avrBs3 fragment
encoding the C-terminus, the generated NTC fragments were
cloned in a modified pENTR-D derivative containing BsaI sites
and a cat-ccdB cassette via Bsa I cut-ligation (see above). In each
case, BpiI sites between the N- and C-terminal encoding regions
allowed the integration of the avrBs3 repeats via BpiI cut-ligation
(according to Morbitzer et al., 2011). All chimeras were recom-
bined into the T-DNA binary vector pGWB641 (Nakamura
et al., 2010) via LR recombination (Life Technologies).
Creation of dTALEEBE Brg11 and derivatives containing
contiguous Brg11 repeats
Binding domains of dTALEEBE Brg11 and derivatives were assem-
bled as described in Morbitzer et al. (2011), using either the
TALE repeat modules previously described or repeat modules
encoding the repeats of Brg11 (Fig. S7) synthesized using Gen-
Script. All constructs were recombined into the T-DNA binary
vector pGWB641 (Nakamura et al., 2010) via LR recombination
(Life Technologies).
Creation of AvrBs3-Brg11 derivatives and promoter
constructs used in the trimer test
The previously described Bs3 promoter derivatives containing
three cytosines (Cs), guanines (Gs) or thymines (Ts) instead of
three adenines (As) within the upregulated by TALE (UPT )AvrBs3
box of the Bs3 promoter (R€omer et al., 2007; Morbitzer et al.,
2010) were cloned upstream of the uidA (GUS ) reporter gene
into the T-DNA vector pGWB3* via BsaI cut-ligation. pGWB3*
was generated by LR recombination of a small linker fragment
containing two BsaI sites with CACC and AAGG overhangs into
the pGWB3 vector (Nakagawa et al., 2007). A cat-ccdB cassette
was then cloned into the modified pGWB3 vector using an AgeI
restriction site within the linker fragment resulting in pGWB3*.
Binding domains of all avrBs3 derivatives used in the trimer
test were assembled via BsaI cut-ligation of TALE repeats match-
ing the RVD composition of avrBs3, as described in Morbitzer
et al. (2011), along with trimers of brg11-derived repeats synthe-
sized (synthesized by GenScript) with the codon usage of
Xanthomonas campestris pv. vesicatoria (Fig. S5). Binding
domains assembled in this fashion were cloned into a pENTR-D
derivative containing fragments of avrBs3 encoding the N- and
the C-terminal parts of the TALE via BpiI cut-ligation (according
to Morbitzer et al., 2011). avrBs3 derivatives were transferred
into the T-DNA binary vector pGWB641 (Nakamura et al.,
2010) via LR recombination (Life Technologies).
Creation of target promoters for Brg11 and its homologs
The predicted RipTAL binding box was introduced in each case
via PCR mutagenesis in place of the UPTAvrBs3 box in the Bs3
promoter (R€omer et al., 2007). In the case of EBEBrg11, the for-
ward primer Bs3pEBE Brg11 Fwd was used in combination with
the reverse primers Bs3pEBE Brg11 A0 for A0, Bs3pEBE Brg11 C0 for
C0, Bs3pEBE Brg11 G0 for G0 and Bs3pEBE Brg11 T0 for T0 (Table
S1). Equivalent primers were used to introduce binding boxes for
RipTALI-6, -9, -11 and -14 (Table S1). As a template, a pUC57
(GenScript) derivative was used containing a 360-bp fragment of
the pepper Bs3 promoter. The promoter constructs were cloned
via BsaI cut-ligation into the T-DNA vector pGWB3*.
Isolation and sequencing of brg11 homologs
Genomic DNA was isolated from Ralstonia solanacearum (Smith
1896) (Yabuuchi et al., 1995) strains as follows: cell pellets of 30-
ml overnight cultures were resuspended in 50 mM Tris-HCl
(pH 8), 50 mM EDTA (pH 8.0), 0.5% (v/v) Tween 20 and 0.5%
(v/v) Triton X-100 buffer containing RNAse A (0.02% (w/v)),
lysozym (0.27% (w/v)) and protease (0.5 AU) (Qiagen). DNA
extraction and precipitation were carried out as described previ-
ously (Grover et al., 2012) and the pellet was redissolved in
0.1 TE (Tris EDTA) (pH 8.0). Amplification of RipTALs from
genomic DNA was carried out with Phusion polymerase (New
England BioLabs), the PCR additive preCES-I (Ralser et al.,
2006) and the primers brg11_CACC-ATG and brg11_no-stop
(Table S1). The PCR products were sequenced using the primers
listed in Table S1. Furthermore, the PCR products for RipTALI-
1 to -3 and RipTALI-5 to -7 were cloned and sequenced in the
vector pENTR-D (Life Technologies). RipTALI-9, -11 and -14
were PCR-amplified from genomic DNA using primers inF Rip-
TALIs F and R (Table S1) and cloned via inFusion (Clontech,
Palo Alto, CA, USA) into a pENTR-Brg11 digested with XhoI
and Bgl II. Subsequent sequencing showed an identical result to
the original PCR product sequencing results for these homologs.
All constructs were recombined into pGWB641 (Nakamura
et al., 2010) via LR recombination (Life Technologies).
Agrobacterium tumefaciens-mediated transient transfor-
mation of N. benthamiana plants and GUS assays
For subcellular localization and GUS assays, A. tumefaciens strains
were grown overnight in YEB medium containing rifampicin and
kanamycin (each 100 lg ml!1; for pGWB3-, pGWB3*- and
pGWB5-containing strains) or rifampicin and spectinomycin
(each 100 lg ml!1; for pGWB641-containing strains), collected
by centrifugation, resuspended in inoculation medium (10 mM
MgCl2, 5 mM MES, pH 5.3, and 150 lM acetosyringone), and
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adjusted to an optical density at 600 nm (OD600nm) of 0.8. For
localization studies, equal amounts of A. tumefaciens strains con-
taining brg11, hpx17 or its derivatives as green fluorescent protein
(GFP) fusions and the silencing inhibitor p19 (Voinnet et al.,
2003) were mixed and inoculated into N. benthamiana leaves by
blunt-end syringe infiltration. For GUS assays, equal amounts of
A. tumefaciens strains containing 35S-promoter-driven RipTAL
genes, avrBs3 or avrBs3/brg11 chimeras and Bs3 promoter con-
structs containing corresponding binding boxes fused to the
reporter gene uidA (GUS) were mixed before inoculation. GUS
staining was carried out as described previously (Strauß et al.,
2012). Wherever shown in the figures, stained leaf discs were
selected as representative for results obtained in at least two inde-
pendent experiments each including three separate plants. For
quantification of GUS activity, two leaf discs were taken from each
of three separate plants, pooled and homogenized in a tissue lyzer.
Two hundred micromole GUS extraction buffer (50 mM sodium
phosphate (pH 7), 10 mM DTT, 10 mM EDTA, 0.1%
N-lauryl-sarcosine, 0.1% Triton-X100, and 19 protease inhibitor
cocktail (Roche; complete mini, EDTA-free)) was then added and
quantification of GUS activity carried out as described previously
(Kay et al., 2007). Samples for each time-point were taken in
duplicate with a plate reader (TECAN, Maennedorf, Switzerland)
and averaged, and pmol 4-MU min!1 lg!1 protein extract values
were calculated and averaged for the three biological replicates.
Microscopy
For subcellular localization, brg11, hpx17 and derivatives were
cloned into pGWB5 (Nakagawa et al., 2007) by LR recombina-
tion (Life Technologies) creating C-terminal GFP fusions, trans-
formed into A. tumefaciens, and transiently expressed in
N. benthamiana leaves as already described in the section
‘Agrobacterium tumefaciens mediated transformation of N.
benthamiana plants and GUS assays’. Two to 3 d post inocula-
tion, epidermal cells of N. benthamiana were inspected with a
confocal laser-scanning microscope (TCS SP5; Leica Micro-
systems, Bensheim, Germany) equipped with a Leica HCX PL
APO 209 water immersion objective. Images were processed
using the Leica AF software and IMAGEJ (Schneider et al., 2012).
Results
RipTALs Brg11 and Hpx17 are nuclear localized, with
contributions from N- and C-terminal regions
Brg11 has previously been shown to localize to the plant nucleus
(Li et al., 2013). Having confirmed the nuclear localization of
Brg11 in leaves of N. benthamiana (Fig. 1a) and demonstrated
that Hpx17 also localizes to the nucleus (Fig. 1b), we tested trun-
cation and mutation variants to identify the corresponding NLSs
within these proteins. AvrBs3 is known to possess two functional
C-terminal NLSs whose removal prevents nuclear localization
(Van den Ackerveken et al., 1996). Sequence comparisons identi-
fied similar motifs in the C-terminus of Brg11 and Hpx17 (Figs
S1–S3), yet mutation of these potential NLSs in Hpx17 did not
impair nuclear localization (mut-NLS; Fig. 1c). For this analysis
hpx17 was used as it lacks the vast majority of the repeats and is
therefore more amenable to PCR-based modifications. NLS pre-
diction software (e.g. NLSTRADAMUS; Nguyen Ba et al., 2009)
identified an additional putative NLS in the N-terminal domain
of Brg11 and Hpx17 (Figs S1, S2) and, consistent with this pre-
diction, removal of the N-terminal and repeat domains in
addition to the aforementioned mutations led to nuclear and
cytoplasmic localizations (Hpx17-DN-Drep-mut-NLS; Fig. 1d).
The same truncation without removal of the C-terminal NLSs
was not sufficient to ablate nuclear localization (Hpx17-DN-
Drep; Fig. 1e), indicating that it is not simply the lower molecular
weight that allows passive diffusion into and out of the nucleus.
The N-terminus of Hpx17 alone (Hpx17-Drep-DC) localizes
exclusively to the nucleus (Fig. 1f). These observations show that
N- and C-terminal sequences within Hpx17 contribute in a func-
tionally redundant manner to nuclear localization. Given that
Brg11 and Hpx17 are almost identical in the N- and C-terminal
nonrepeat regions (Figs S1, S2), it is likely that the same
sequences contribute to the nuclear targeting of Brg11 (Fig. 1a).
TheC-terminusof Brg11 contains a functional eukaryoticAD
Key to the disease-promoting function of TALEs is their ability to
activate plant promoters (Bogdanove et al., 2010). In the case of
the TALE AvrBs3, an AD is found in the far C-terminus (Szurek
et al., 2001; Figs S1, S3a). Prediction software (Piskacek et al.,
2007) identified a eukaryotic nine-amino acid transactivation
domain in the C-terminal-most nine amino acids of Brg11 (Figs 1,
S3). We thus created a construct encoding a CTC in which the C-
terminal 295 amino acids of AvrBs3 were replaced with the equiva-
lent region of Brg11 (Fig. S3b) and tested its ability to activate the
pepper Bs3 promoter (Bs3p), which contains a well-characterized
AvrBs3 binding box (R€omer et al., 2009). The 35S-promoter-
driven avrBs3 or CTC and a Bs3p-uidA reporter were co-delivered
via A. tumefaciens intoN. benthamiana leaves and GUS assays were
performed (Fig. 2). In this assay, blue staining of leaf discs is caused
by expression of the GUS reporter and indicates TALE-mediated
promoter activation.The CTC chimera was indeed able to activate
the GUS reporter, indicating the presence of a functional AD in
the C-terminal region of Brg11 (Fig. 2). The stronger reporter acti-
vation observed with AvrBs3 as compared with the chimeric pro-
tein may indicate a functional difference in the strength of the
activation domains of AvrBs3 and Brg11. Alternatively, the Brg11
AD performs suboptimally in the chimeric context. We also tested
a truncation variant of the chimera that lacks 33 amino acids at its
C-terminus, including the predicted activation domain (CTC-
DAD; Fig. S3b). CTC-DADdid not activateBs3p (Fig. 2), indicat-
ing that the predicted Brg11 AD is necessary to the predicted func-
tion of Brg11 as a transcriptional activator.
The repeats of Brg11 mediate sequence-specific DNA
recognition with an RVD code similar to that of TALEs
Having ascertained that Brg11 localizes to the nucleus and pos-
sesses a functional AD, we sought to determine if its central
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Fig. 1 Subcellular localization of Ralstonia
injected protein transcription activator-like
(RipTAL) proteins and deletion derivatives in
Nicotiana benthamiana leaf cells. Leaves
were coinfiltrated with Agrobacterium
tumefaciens strains transformed with
pGWB5 T-DNA vectors containing DNA
sequences under control of the constitutive
cauliflower mosaic virus 35S promoter
encoding C-terminal GFP fusion proteins of
(a) Brg11, (b) Hpx17 (hrpB-dependent
expression 17), (c) Hpx17 with both
C-terminal nuclear localization signals (NLSs)
mutated (mut-NLS), (d) the Hpx17
C-terminal region with putative NLSs
mutated (DN-Drep-mut-NLS), (e) the Hpx17
C-terminal region (DN-Drep), and (f) the
Hpx17 N-terminal region (Drep-DC). In all
cases an A. tumefaciens transformant
containing a 35S-promoter-driven p19 gene
that encodes a viral silencing suppressor was
coinfiltrated. Leaf discs were harvested 2–3 d
after inoculation and imaged using a
confocal laser-scanning microscope. Bars,
50 lm. Cartoon representations of RipTALs
are shown next to the corresponding
microscope pictures: ellipses indicate putative
DNA-interacting repeats; a semicircle (Brg11)
indicates a putative transcriptional activation
domain; rectangles indicate confirmed or
putative NLSs.
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repeat domain also mediates sequence-specific DNA binding
and, if so, whether a code operates similar to that of TALEs. The
key features of the TALE code are the one-to-one repeat to DNA
base relationship, and the determination of base specificity by the
RVDs (Boch et al., 2009; Moscou & Bogdanove, 2009). While
an alignment of all the core repeats of AvrBs3 (Fig. S4) shows
that inter-repeat polymorphisms are limited to the RVDs and
few other residues, polymorphisms between Brg11 repeats are
not restricted to the RVDs and are far higher in frequency (Fig.
S4). In light of the many non-RVD polymorphisms among
Brg11 repeats, we tested the DNA recognition properties of each
repeat individually. To do so, we utilized a system, herein
referred to as the trimer test, adapted from a previous study
(Morbitzer et al., 2010) where Brg11-derived test repeats are set
into the repeat array of AvrBs3 (Fig. S5). In AvrBs3, repeats 5–7
are occupied by three repeats with the RVD NI, corresponding
to a run of three adenines in the AvrBs3 target box within the Bs3
promoter (referred to as Bs3p3xA; R€omer et al., 2007). In the tri-
mer test, AvrBs3 repeats 5–7 were replaced by three identical,
tandemly arranged repeats of Brg11 (Fig. S5). To determine base
specificity of each of the AvrBs3-embedded Brg11 repeats, the
three adenines in the AvrBs3 target site of the Bs3 promoter were
replaced by three guanines (Bs3p3xG), thymines (Bs3p3xT) or cyto-
sines (Bs3p3xC) and these promoter derivatives were fused
upstream of a uidA reporter gene. Subsequently we tested each of
the AvrBs3 derivatives for their ability to activate each of the four
distinct promoter constructs. 35S-promoter-driven genes encod-
ing the AvrBs3 derivatives were co-delivered together with each
of the four distinct promoter-reporter constructs into
N. benthamiana leaves via A. tumefaciens-mediated T-DNA trans-
fer, and GUS activity was quantified 48 h post infiltration. This
process was carried out for each of the 16 core repeats of Brg11.
Repeats 8 and 11, identical in all positions at the amino acid level
(Fig. S4), were tested as one construct (referred to as repeat 8/11).
As specificity controls for this assay, we included trimers of
Xanthomonas TALE repeats with RVDs HD, NG, NN or NK.
The results show that in each case at least one reporter construct
was activated (Fig. 3, Table S2). In most cases, the RVD code for
Brg11 repeats matched expectations based on known TALE
repeat specificities, although some notable exceptions were dis-
covered (summarized in Table 1): RVDs NT and NH showed
more relaxed base specificity than previously reported for the
same RVDs in TALE repeats (Streubel et al., 2012), while NK
showed the same base specificity but higher activity (activation of
Bs3p3xG with derivatives of Brg11 NK repeats 2 and 9 was 15–18
times higher than for corresponding TALE-derived NK repeats;
Fig. 3). Overall, however, our data suggest that base specificity of
Brg11 repeats is determined by repeat residues 12 and 13, as is
the case for Xanthomonas TALE repeats. To confirm this, we
reciprocally exchanged the RVDs of Brg11 repeats with clearly
contrasting specificities, 8/11 (RVD HD; pairs preferentially to
cytosine) and 12 (RVD SH; pairs preferentially to guanine). As
would be expected if the RVDs determine specificity, we
observed a reciprocal switch in DNA recognition specificities in
the trimer test (Fig. S6).
In order to investigate whether differences in reporter activation
by derivatives bearing repeats with the same RVD could be attrib-
uted to specific non-RVD residues, we compared repeats 10 and
8/11. The derivative bearing the repeat 10 trimer gave 25 times
poorer activation of the Bs3p3xC reporter compared with repeat 8/
11 (Fig. 3, Table S2), which shares the same RVD. Alignment of
these repeats showed that they differ at three residues (Fig. 4). Of
these polymorphic residues, the asparagine in position 16 is found
only in repeat 10, while all other Brg11 repeats have lysine at this
position (Fig. S4). Analysis in the trimer test found that replacing
the asparagine at position 16 of repeat 10 with lysine (defined as
repeat 10 N16K) led to reporter activation to the same level as that
recorded for repeat 8/11 (Fig. 4). The converse mutation (defined
as repeat 8/11 K16N), while not abolishing activity entirely, did
render 8/11 K16N much weaker in its activation of the reporter as
compared with the wild-type (Fig. 4). In summary, our data sup-
port the conclusion that non-RVD residues can have a profound
effect on the DNA recognition capabilities of repeats.
The N-terminus of Brg11 mediates recognition of a G0 base
necessary for activation of a promoter bearing the Brg11
target box
Based on results obtained for each repeat in isolation, we pre-
dicted a 16-bp effector-binding element (EBE) for Brg11
(Fig. 3), which we inserted in place of the AvrBs3 binding site in
the Bs3 promoter (Bs3pEBE Brg11) upstream of a uidA reporter
AvrBs3
CTC
Brg11
A T A T AT A A C C T A A C C A T C
UPT AvrBs3
CTC-ǻAD
33 AA truncation
Fig. 2 Transcriptional activation of uidA reporter gene constructs by
AvrBs3 (avirulence protein triggering Bs3 resistance)and derivatives
bearing C-terminal regions of Brg11 (hrpB-regulated gene 11). Gene
constructs encoding the depicted proteins were co-delivered into
Nicotiana benthamiana leaves via Agrobacterium tumefaciens-mediated
T-DNA transfer along with a pepper Bs3 (Bacterial spot R gene 3)
promoter fragment, bearing an AvrBs3 target box (UPTAvrBs3), upstream of
a uidA reporter gene. Leaf discs were harvested 26 h post infiltration and
stained for GUS activity. Brg11 serves as a negative control for background
reporter activity. In the C-terminal chimera (CTC), the C-terminal-most
295 amino acids of AvrBs3 were replaced with the equivalent region of
Brg11 (Supporting Information Fig. S3). CTC-DAD is identical to the CTC
but lacks the C-terminal-most 35 amino acids, including the predicted
transcriptional activation domain (AD) (Fig. S1). Cartoon representations
of AvrBs3, Brg11 and chimeras are shown next to the corresponding leaf
discs: blue, AvrBs3-derived domains; yellow/orange/red, Brg11 domains;
polygons (AvrBs3) or ellipses (Brg11), repeats; a triangle (AvrBs3) or
semicircle (Brg11), a confirmed or putative transcriptional AD; rectangles,
confirmed or putative nuclear localization signals. The UPTAvrBs3 sequence
is shown at the top of the figure with the 5′ thymine shown as a white
letter with a black frame.
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gene. Agrobacterium tumefaciens-mediated transformation of N.
benthamiana leaves with a 35S-promoter-driven brg11 in combi-
nation with the Bs3pEBE Brg11 promoter, however, led to no acti-
vation above background level (Fig. 5). A dTALE designed to
bind the Brg11 EBE (dTALEEBE Brg11) did, however, activate
Bs3pEBE Brg11 (Fig. 5), thereby demonstrating that the reporter
construct was functional. In order to confirm that the repeats of
the Brg11 core binding domain could successfully recognize the
predicted EBEBrg11, we tested the entire binding domain of
Brg11 as contiguous blocks of five to six repeats each embedded
into the binding domain of dTALEEBE Brg11 (Fig. S7). Chimeras
containing these Brg11 repeat blocks were found to be functional
to a level comparable to the positive control dTALEEBE Brg11
(Fig. 5), suggesting that the lack of reporter activation by Brg11
was attributable not to the core binding repeats but rather to
some other region(s) of the protein. We postulated that an as yet
undefined, strict base preference, mediated by putative N-termi-
nal degenerate repeats, analogous to those of TALEs (Bochtler,
2012), made Brg11 incompatible with the predicted target
sequence. To investigate whether the Brg11 N-terminal domain
contributes to DNA recognition specificity, we created two
NTCs for which either repeats 0 and !1 (NTC1) or the entire
N-terminus (NTC2) of AvrBs3 was replaced with the equivalent
sequence from Brg11 (Fig. S8). The in planta functionality of the
Brg11-AvrBs3 chimeras was then tested, against Bs3p (T0) and
three derivatives with a 5′ terminal adenine (A0), cytosine (C0) or
guanine (G0) upstream of uidA. Both chimeras, NTC1 and
NTC2 displayed a strong preference for G0, activating other pro-
moters very weakly or not at all (Fig. 6). Thus, the N-terminal
regions of Brg11 and Xanthomonas TALEs both contribute to
DNA recognition but differ with respect to their base specificity.
Accordingly, A0, G0 and C0 derivatives of Bs3pEBE Brg11 were
created. Brg11 and dTALEEBE Brg11 were then tested against each
of these promoters in addition to the original T0 version with
AvrBs3 as a negative control (Fig. 7). Indeed, Brg11 activated the
G0 promoter, and only this promoter (Fig. 7). dTALEEBE Brg11
was able to activate all promoters irrespective of the identity of
the N0 base (Fig. 7). The lack of preference for T0 in this dTALE
is possibly a result of the high affinity across the rest of the core
repeats where every RVD is paired with its best match base. This
is not the case for AvrBs3 and the UPTAvrBs3 (Fig. 6) box, where
some RVDs are mismatched, which might explain why in this
TALE-EBE combination the N-terminal TALE repeats exert a
stronger discriminating effect than is the case for dTALEEBE Brg11
Table 1 DNA recognition properties of Brg11 repeat variable diresidues
(RVDs)
RVD
Best
match
Additional
match(es)
Differences in activity compared with
same RVD in TALE repeats
NT A G/C Additional C nucleotide recognition1
NK G – Stronger reporter activation 2
SH G – Stronger reporter activation1
NH G A/C Less specific 1,3
NG T A/C/G Additional G nucleotide recognition
NP A T/C/G Different best match nucleotide 1
HD C – Repeats 10 and 16, weaker reporter
activation 2
HN G A –
SN G A Stronger reporter activation1
Results are according to Fig. 3 and Table S2.
1Streubel et al. (2012).
2Comparison to transcription activator-like effector (TALE) repeat controls
in this study.
3Cong et al. (2012).
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Fig. 3 Analysis of the base specificity of Brg11 (hrpB-regulated gene 11)
repeats using the trimer test. AvrBs3 (avirulence protein triggering Bs3
resistance) derivatives, bearing a trimer of identical Brg11 repeats,
were co-delivered into Nicotiana benthamiana leaves via Agrobacterium
tumefaciens-mediated T-DNA transfer along with a uidA reporter gene
that is under transcriptional control of the pepper Bs3 (Bacterial spot R
gene 3) promoter or derivatives thereof. The AvrBs3 target site in the Bs3
promoter contains three adenines (3xA) at the position corresponding to
the Brg11 trimer embedded in AvrBs3. In the Bs3 promoter derivatives,
the three adenines were replaced with three guanines (3xG), cytosines
(3xC) or thymines (3xT). Leaf discs were harvested 48 h post infiltration,
total protein was extracted and GUS activity was quantified. GUS activity
is given in picomoles 4-MUmin!1 lg!1 protein. The size of the bar
indicates the level of GUS activity. The color of the bars indicates the
reporter construct used (yellow for 3xA, blue for 3xG, orange for 3xC and
green for 3xT). The reporter with the highest GUS activity is shown above
the x-axis, and the results for any other activated reporters are shown
below this line. Data shown are based on three biological replicates.
Standard errors are indicated. Results are shown for each repeat in order of
appearance in the polypeptide. Brg11 repeats, displayed as ovals, are
shown in order of appearance in the polypeptide as a guide and repeat
numbers are given underneath accordingly. The Brg11 target sequence
that was predicted and experimentally studied is displayed in black font
below the repeat numbers. Repeats with different repeat variable
diresidues (RVDs) are displayed in distinct colors. Trimers of AvrBs3-
derived repeats bearing NK, NN, HD or NG as the RVD are shown on the
right-hand side as specificity controls and cartoon representations of the
corresponding repeats, shown as colored polygons, are given. The same
color code is used for these repeats as for the Brg11 repeats. Results for
AvrBs3Brg11 rep8/11 are duplicated in the figure (see repeat positions 8 and
11) as this construct was used to test both repeats 8 and 11 of Brg11,
which are identical at the amino acid level. The data corresponding to the
graphical display of this figure given in Table S2.
! 2013 The Authors
New Phytologist! 2013 New Phytologist Trust
New Phytologist (2013) 199: 773–786
www.newphytologist.com
New
Phytologist Research 779
and the matching EBE Brg11. This accords with a recent finding
that a dTALE perfectly matching UPTAvrBs3 showed less N0 dis-
crimination than the wild-type AvrBs3 (Meckler et al., 2013).
Brg11 homologs isolated from strains infecting diverse
hosts target identical or similar DNA sequences
TALEs from Xanthomonas strains infecting diverse hosts (e.g.
pepper (Capsicum sp.) and rice (Oryza sativa)) show high
conservation in N- and C-terminal nonrepeat regions and within
the repeats at non-RVD positions but are highly diverse with
respect to repeat number and RVD composition (Schornack
et al., 2006; Boch & Bonas, 2010), thus targeting distinct nucleo-
tide sequences. We studied RipTALs from different
R. solanacearum strains (Table S3) in order to learn more about
the natural diversity of these effectors and how they compare to
TALEs in this respect. The selected strains have been previously
analyzed for possession of TALE homologs via PCR (Heuer et al.,
wt rep10 LSTAQVVAIASHDGGNQALEAVGTQLVALRAAPYA
LSTAQVVAIASHDGGKQALEAVGTQLVALRAAPYA
LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA
LSTEQVVAIASHDGGNQALEAVGAQLVALRAAPYA
3xA 3xC
rep10 N16K
wt rep8/11
rep8/11 K16N
Fig. 4 Functional impact of an asparagine versus lysine polymorphism at the non-repeat variable diresidue (RVD) repeat position 16. The alignment shows
differences between the Brg11 (hrpB-regulated 11) wild-type (wt) repeats 10 and 8/11. Polymorphic residues are highlighted with black letters on a white
background. Of these, position 16 (indicated with a red triangle) has been exchanged for the corresponding residue found in the other repeat in each case
(rep10 N16K; rep8/11 K16N). RVDs are highlighted in orange font. The functionality of the repeat derivatives was defined using the trimer test as
described in Fig. 3, except that Nicotiana benthamiana leaf discs were stained to visualize reporter activity. The intensity of the staining corresponds to
promoter activity and is used as a proxy indicator of binding at the promoter.
dTALEEBE Brg11
1–5
6–10
10–16
Brg11
6 10
NN NN NN NN NINNNNNN NN NG NG HDHDHDHDNI NN
1 5 11 16
NT NK HN HN HN HN NG HD HD HD SH NP NH SN HDNK
A G G G GT G T C G C C G T G G C
EBE Brg11
Fig. 5 Functional analysis of Brg11 (hrpB-regulated 11) repeat subarrays. The AvrBs3 (avirulence protein triggering Bs3 resistance) binding site in the Bs3
promoter was replaced by the predicted Brg11 binding site (effector-binding element (EBE)Brg11) preceded by a 5′-terminal thymine to allow activation by a
matching designer transcription activator-like effector (dTALEEBE Brg11). We also generated genes encoding dTALEEBE Brg11 derivatives, depicted on the left,
in which the first five (1–5), the second five or the last six (11–16) repeats of dTALEEBE Brg11 were replaced by corresponding brg11 repeat subarrays. 35S-
promoter-driven dTALEEBE Brg11, brg11 and the above-described dTALEEBE Brg11 derivatives were cotransformed into Nicotiana benthamiana leaves via
Agrobacterium tumefaciens-mediated T-DNA delivery, along with a uidA reporter gene that was downstream of the Bs3 promoter derivative containing
the predicted EBEBrg11 box. Leaf discs were harvested 48 h post infiltration and stained to visualize GUS reporter activity. The predicted EBEBrg11 box is
displayed underneath the repeats of Brg11 in black letters. The nucleotide 5′ of the box is shown by a white letter with a black frame. Cartoon
representations that display the domain architecture of the studied proteins are shown next to the corresponding leaf disc: the blue horizontal bar and the
colored polygons represent dTALEEBE Brg11 and its repeats. The yellow horizontal bar and the colored ellipses represent Brg11 and its repeats. Repeats
framed with a bold outline indicate Brg11 repeats embedded into dTALEEBE Brg11. A triangle (dTALEEBE Brg11) or semicircle (Brg11) indicates a confirmed or
putative transcriptional activation domain; rectangles indicate confirmed or putative nuclear localization signals. Colors of repeats (ellipses for Brg11
repeats or polygons for TALE repeats) correspond to different residues at position 13 of each repeat. Gray bars are used to demarcate repeats 1–5, 6–10
and 11–16.
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2007) and the amplicons subsequently analyzed via restriction-
based fingerprinting. From that strain collection, representative
members were selected covering 10 out of 13 AluI restriction pro-
files (Table S3). All strains in this study are members of
R. solanacearum phylotype I, and corresponding RipTALs were
named RipTALI-X, where the Roman numeral ‘I’ indicates strain
phylotype and X is an Arabic numeral denoting the given homo-
log (Figs 8, S9, S10, Table S3). After PCR amplification and
sequencing of homologs, alignments were made of translation
products (Fig. S10), and polymorphisms with a potential impact
AvrBs3
NCT1
NCT2
Brg11
234231
300297
UPT AvrBs3
QWSG
QRSG
A T A T A A A C C T A A C C A T C
A0 G0 C0 T0
N0
Fig. 6 Functional analysis of the N-terminal region of Brg11 (hrpB-regulated 11). N-terminal chimeras (NTCs) were created either bearing the full Brg11 N-
terminal region (residues 1–354) in place of the corresponding AvrBs3 (avirulence protein triggering Bs3 resistance) region (NTC2) or where only repeats 0
and –1 were replaced (NTC1). AvrBs3, Brg11, NTC1 and NTC2 were tested for their ability to activate either the Bs3 promoter which contains a thymine at
the 5′ terminus of the AvrBs3 target site (T0) or derivatives that contain a guanine (G0), cytosine (C0) or adenine (A0) at the corresponding position. These
promoter-uidA fusions were co-transformed along with 35S-promoter-driven genes encoding the proteins depicted on the left in Nicotiana benthamiana
leaf tissue via Agrobacterium tumefaciens-mediated transient transformation. Leaf discs were harvested after 48 h and stained to visualize promoter
activity. Amino acid sequences for the tryptophan (W) in repeat -1 that was shown to interact with T0 (Mak et al.; 2012) are shown along with
surrounding residues for AvrBs3 and the corresponding region for Brg11 inside ellipses, with positions inside the polypeptide indicated with numbers. Blue,
AvrBs3-derived sequences; yellow, orange and red, Brg11-derived sequences.
Brg11 
dTALE EBE Brg11
AvrBs3
EBE Brg11 
NT NK HN HN HN HN NG HD HD HD SH NP NH SN HDNK
A G G G G G T C G C C G T G G C
NN NN NN NN NINNNNNN NN NG NG HDHDHDHDNI NN
HD NG NI NI NI HDHD NG HDHD HD NG HDNS NSNSNG
A
A0 G0 C0 T0N0
Fig. 7 Testing of Brg11 (hrpB-regulated 11) target boxes preceded by distinct 5′ bases. The AvrBs3 (avirulence protein triggering Bs3 resistance) binding
site in the Bs3 promoter was replaced by the predicted Brg11 binding site (effector-binding element (EBE)Brg11) preceded by a 5′-terminal adenine (A0),
guanine (G0), cytosine (C0) or thymine (T0). 35S-promoter-driven genes encoding AvrBs3, Brg11 or designer transcription activator-like effector
(dTALE)EBE Brg11 were each cotransformed along with the four Bs3 promoter derivatives driving a uidA reporter into Nicotiana benthamiana leaves via
Agrobacterium tumefaciens-mediated transient transformation. Leaf discs were harvested 48 h post infiltration and stained to visualize reporter activity.
The sequence of EBEBrg11 is displayed in black font above the repeats of Brg11. A white letter with a black frame shows the zero base in each promoter.
Cartoon representations that display the domain architecture of the given protein are shown next to the corresponding leaf disc: blue horizontal bar and
colored polygons, AvrBs3 and its repeats; yellow horizontal bar and the colored elipses, Brg11 and its repeats; triangle (AvrBs3) or semicircle (Brg11), a
confirmed or putative transcriptional activation domain; rectangles, confirmed or putative nuclear localization signals. Repeats (ellipses for Brg11 repeats or
polygons for TALE repeats) with the same repeat variable diresidues (RVDs) are displayed in the same color.
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NT NK HN HN HN HN NG HD HD HD SH NP NH SN HDNK
NT NK HN HN HN HN NG HD HD HD SH NP NH SN YHNK NH
HD
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EBE Brg11
G0
NT NK HN HN HN NN NG HD HD HD SH NP NH SN HDNK
NT NK HN HN HN QN NG HD HD HD SH HDNK
01 02 03 04 05 06 07 08 09 10 11 12 13 14 15 16
NT NK HN HN HN NG HD HD HD NP NP H SN HDNK N
(d) EBE Brg11
EBE RipTALI-9
EBE RipTALI-11
EBE RipTALI-6
EBE RipTALI-14
...ttatGAGGGGGTCGCCGTGGCaatcac...
...ttatGAGGGGGTCGCCGTGGGCaatcac...
...ttatGAGGGGGTCGCCGCaatcac...
...ttatGAGGGGGTGCCGTGGCaatcac...
...ttatGAGGGGTCGCCTTGGCaatcac...
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Fig. 8 Repeat variable diresidue (RVD) composition and target specificity of Ralstonia injected protein transcription activator-likes (RipTALs) isolated from
distinct strains of Ralstonia solanacearum. (a) Cartoon representations (left) indicate the RVD composition deduced from PCR-amplified RipTALs
(designation given on the right). Note that, where multiple RipTALs are listed next to one structure, these RipTALs have an identical composition of RVDs
but differ in their amino acid sequence in other residues (see Figs S9, S10). Ellipses, the repeats of the core binding domain; semicircle, a putative
transcriptional activation domain; rectangles, putative nuclear localization signals. Repeat positions are indicated below the core repeats of Brg11, (hrpB-
regulated 11) with gray and white stripes showing the beginning and end of each repeat, respectively. Colors of repeats correspond to RVDs. RVD residues
differing from their Brg11 equivalents are indicated with red letters with a yellow frame. Brackets indicate deletions with respect to Brg11. The ellipse that is
framed with a dashed line indicates a repeat that probably occurred by duplication of an adjacent repeat. The predicted target sequence of Brg11 is
displayed in black font above the repeats of Brg11. A white letter with a black frame shows the G0 found to be preferentially activated by the Brg11 N-
terminus. (b) Four RipTALs with a predicted binding element identical to that of Brg11 were tested alongside Brg11 for their ability to activate pepper Bs3
promoter (Bs3p) derivatives bearing effector-binding element (EBE)Brg11 with an A0, G0, C0 or T0 upstream of a uidA reporter gene. (c) Four RipTALs with a
predicted binding element differing from that of Brg11 were tested for their ability to activate Bs3p derivatives bearing G0 EBEs for Brg11 and each of the
four other homologs. Two groups of EBEs for which the corresponding RipTALs seem to have cross-reactivity are indicated with gray boxes. 35S-driven
genes encoding the RipTALs were coinfiltrated along with the promoter constructs into Nicotiana benthamiana leaves via Agrobacterium tumefaciens-
mediated transient transformation. Leaf discs were harvested 48 h post infiltration and stained to visualize reporter activity. Names of RipTALs functionally
tested in (b) and (c) are underlined in (a). A sequence comparison of the EBEs used in (c) is shown in (d). In each case the EBE, including the G encoded by
the zero position, is shown in bold font, uppercase letters. Lowercase letters indicate the Bs3p context in which the distinct EBEs were embedded. White
lettering on a black background indicates identical bases between at least two EBEs.
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on the predicted DNA target sites are shown in Fig. 8(a). Non-
RVD polymorphisms facilitated correct alignment of RipTAL
repeat domains even when mutations were discovered in the
RVDs.
Similar to TALEs, an overall conservation of > 97% was found
between different RipTAL proteins when repeat number poly-
morphisms were excluded (Fig. S10). Polymorphisms were dis-
tributed across N- and C-terminal and repeat regions but, in
contrast to TALEs, the studied RipTALs showed a rather limited
range of polymorphisms with respect to their RVD composition:
eight of 15 newly isolated RipTALs showed not only an identical
number of repeats, but also the same RVD composition as
Brg11; two of 15 RipTALs showed the same number of repeats
as Hpx17; four of 15 homologs showed a similar repeat domain
to Brg11 but, relative to Brg11, seemed to have either lost repeats
(RipTALI-14, deletion of repeat 4; RipTALI-6, deletion of
repeat 8; RipTALI-11, deletion of repeats 13–15) or gained a
repeat (RipTALI-9, repeat 14 possibly duplicated) (Fig. 8a).
Given that the majority share their repeat architecture with
Brg11, homologs with distinct architecture are possibly deriva-
tives of a Brg11-like progenitor. We also observed that some Rip-
TALs, compared with Brg11, contained substitutions in one or
both RVD residues of certain repeats. For example, RipTALI-2
and -11 contain NN and QN RVDs, respectively, in their sixth
repeat where Brg11 has an HN RVD (Figs 8a, S10). TALEs bind
DNA via repeat residue 13 (Bochtler, 2012) and thus the
observed RVD variations in residue 12 of repeat 6 probably have
no significant impact on the base specificity of these repeats. By
contrast, repeat 11 of RipTALI-14 and repeat 17 of RipTALI-9
both showed variation in repeat residue 13 (Fig. 8a), suggesting a
change in base specificity for these repeats relative to their puta-
tive progenitor repeat in Brg11.
The lack of RVD polymorphisms between Brg11 and homo-
logs with an identical number of repeats suggests that these Rip-
TALs would bind to identical DNA targets. Indeed, when a
subset of these were tested in GUS reporter assays, RipTALI-1, -
3 and -7, differing at many non-RVD residues but identical in
repeat number and RVD composition (Figs 8a, S10), were all
found to be able to activate Bs3pEBE Brg11 (Fig. 8b). Furthermore,
like Brg11, they were only able to activate the Bs3pEBE Brg11 with
a G0 (Fig. 8b). Additionally, RipTALI-2, which contains an
RVD polymorphism in residue 12 of the sixth repeat, also acti-
vated Bs3pEBE Brg11, as anticipated (Fig. 8b). While RipTALI-5
and -8, like Hpx17, would be predicted to bind any guan-
ine-cytosine dinucleotide, of which there are two within
EBEBrg11, TALEs bearing only one to three repeats are unable to
activate target promoters (Boch et al., 2009). Consistent with
this, RipTALI-5 was unable to activate any of the Bs3pEBE Brg11
reporters (Fig. 8b). RipTALs I-6, -9, -11 and -14 have predicted
target boxes differing from that of Brg11 (Fig. 8d) and were
tested against Bs3p derivatives bearing corresponding G0 EBEs
(Bs3p EBE RipTALI-X; Figs 8c, d). Each promoter was activated to
the highest level by its corresponding RipTAL, although the
strength of staining indicated differences in activity even between
the optimal RipTAL-promoter pairs (Fig. 8c). We also observed
some cross-reactivity where EBEs had high sequence similarity.
EBERipTALI-14 differs in only three positions from EBERipTALI-6
and was activated by both RipTALI-6 and -14, although to dif-
fering degrees. Surprisingly, the converse was not observed
(Fig. 8c). Brg11 and RipTALI-9 were able to activate promoters
bearing each other’s EBEs to similar levels, which is unsurprising
as these target sites differ from one another by only one nucleo-
tide in each case (Fig. 8c,d). Both RipTALs were also able to
weakly activate EBERipTALI-11, with which each has three mis-
matches in the 3′ end, and RipTALI-11 likewise showed some
cross-reactivity with EBEBrg11 and EBERipTALI-9 (Figs 8c, d).
RipTALs I-6, -9, -11 and -14 were also tested for their N0
preferences (Fig. S11), and in each case the G0 reporter was the
most strongly activated, although in the case of RipTALI-6 and -
9 there was some activation of the A0 reporter, indicating a
relaxed specificity. This difference in base specificity, however,
could not be correlated to any specific amino acid polymor-
phisms shared between these homologs.
Discussion
We have been able to demonstrate an overall functional similarity
between TALEs and RipTALs. RipTALs Brg11 and Hpx17, like
TALEs, localize to the nucleus (Fig. 1) and bear a functional C-ter-
minal AD (Fig. 2). The repeats of Brg11 were shown to mediate
one-to-one base-specific DNA recognition with a code determined
by RVDs (Fig. 3) very similar to that of Xanthomonas TALEs.
Indeed, the Brg11 target sequence used in this study is among
those previously predicted from analysis of Brg11 RVDs inside a
TALE repeat scaffold (Fig. S12; Streubel et al., 2012). This sug-
gests that the scaffold formed by the tandem arranged repeats is
similar in TALE and RipTAL proteins. As Brg11 has been shown
to promote virulence in the interaction with eggplant (Solanum
melongena; Macho et al., 2010), it is conceivable that Brg11
contributes to disease similarly to Xanthomonas TALEs by tran-
scriptional activation of host susceptibility genes. The now
known DNA base preferences of Brg11 and other RipTALs will
simplify the identification of potential susceptibility genes in the
host.
The functional characterization of RipTALs provides useful
information for the optimization of existing TALE-based DNA-
binding domains. While RipTAL RVDs have already been used
within the context of dTALE repeat arrays (Streubel et al., 2012)
and arrays of identical repeats based on one consensus RipTAL
repeat (Li et al., 2013), the functional impact of non-RVD resi-
dues in combination with specific RVDs remains unexploited.
Non-RVD polymorphisms are rare among TALEs (Boch &
Bonas, 2010) but abundant in RipTAL repeats (Fig. S4), repre-
senting a valuable resource for the optimization of TALE-based
DNA-binding modules.
In the case of repeats 10 and 8/11, we were able to demon-
strate the functional impact of a specific non-RVD polymor-
phism (Fig. 4), but further inferences can be made based on data
from the trimer test (Fig. 3, Table S2). For example, we found
that the RVD NK in Brg11 repeats 2 and 9 gave 15–18 times
stronger reporter activation than was the case for NK in a TALE
repeat (Fig. 3, Table S2). The observed functional differences are
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probably attributable to the nine residues common to Brg11
repeats 2 and 9, and not found in TALE repeats (Fig. S13). Fur-
ther examples are repeats 3–6 of Brg11, all possessing HN RVDs
and differing from each other at only four non-RVD positions
(Fig. S4). Pronounced differences in both the level of activity
(Fig. 3, Table S2) and specificity were detected for derivatives
bearing trimers of these repeats. These data support the conclu-
sion that non-RVD polymorphisms can have profound effects on
both repeat activity and specificity, and that further analysis of
RipTALs from across the R. solanacearum species complex may
reveal further examples of use to those working with TALE-based
DNA-binding domains.
The successful engineering of a TALE derivative that specifi-
cally activates a reporter with a target box preceded by a G nucle-
otide (NTC1 and NTC2; Fig. 6) is also of relevance to those
working with TALE-based custom DNA-binding modules. All
known TALEs show a preference for a T0, while sequences with
G0 are generally poorly activated (e.g. AvrBs3; Fig. 6). dTALEs
bearing Brg11 N-terminal regions may be of use to those wishing
to create DNA-binding domains for GC-rich regions where the
requirement for a T0 can be constraining. Moreover, the high
base specificity for targets with a G0, which we observed for the
RipTAL N-terminal DNA-binding domain (Fig. 6), may allow
for the construction of custom TALEs with higher specificity
than previously attainable.
The sequencing of brg11 homologs from phylotype I
R. solanacearum strains, in combination with functional data,
provides insights into the evolution of the encoded RipTALs.
Xanthomonas TALEs are highly flexible with respect to repeat
number and RVD composition, and even closely related strains
target identical host genes via repeat arrays with distinct binding
specificities. One such example is the rice gene Os11N3, which is
transcriptionally activated by the distinct Xanthomonas oryzae pv.
oryzae TALEs PthXo3 (pathogenicity Xanthomonas oryzae 3),
AvrXa7 (avirulence protein triggering Xa7 resistance) (strains
PXO61 and PXO86, respectively; Antony et al., 2010) and TalC
(strain BAI3; Yu et al., 2011). Notably, each TALE targeting the
Os11N3 promoter has a unique binding site, suggesting conver-
gent evolution. In marked contrast, the majority of RipTALs in
this study, isolated from geographically diverse locations and
phylogenetically diverse hosts (Table S3), have the same pre-
dicted DNA target site (Fig 8). This suggests that RipTALs, in
contrast to TALEs, target sequences that are conserved even in
phylogenetically diverse host genomes. Alternatively, RipTALs
may be functional in only a few host species that have matching
RipTAL-binding sites.
Our study also provides a first glimpse into the mechanisms
that drive evolution of RipTALs. The few differences in RipTAL
RVD composition identified in this study are a result only of
loss, duplication or mutations of individual repeats. By contrast,
genes encoding TALE repeat arrays are highly variable in their
RVD composition and seem to evolve diversity by inter- and
intragenic recombination (Yang et al., 2005), allowing for major
rearrangements of the repeat array. Thus, the mechanistic princi-
ples in TALE and RipTAL evolution might be fundamentally
different.
Insights into the molecular mechanisms of RipTAL activity
could also be of value for plant breeding purposes. Ralstonia
solanacearum is a devastating pathogen and the few well-defined
instances of genetic resistance to this disease are limited to certain
bacterial strains or host plants, such as the effector PopP2
(Pseudomonas outer protein P2), eliciting a resistance response
in A. thaliana but with restricted distribution among
R. solanacearum strains (Genin, 2010). By contrast, a number of
plant R genes that mediate resistance to Xanthomonas via recogni-
tion of TALEs have been isolated, with transcriptional activation
of R gene promoters being the most common mechanism
(Bogdanove et al., 2010; Strauß et al., 2012). Knowledge of
RipTAL-binding preferences can assist in the identification or
creation of transcriptionally activated R genes conferring resis-
tance to R. solanacearum. Plant germplasm collections can be
screened for resistance responses induced by RipTALs. The pre-
dicted binding sequence can then be used in combination with
transcriptomics to rapidly isolate the R gene responsible, as
recently described for the identification of an R gene from pepper
which is activated by and mediates recognition of the Xcv TAL
effector AvrBs4 (Strauß et al., 2012). Alternatively, RipTAL-
binding sites could be inserted upstream of known executor type
R genes (Bogdanove et al., 2010) that provide a defense response
upon transcriptional activation. We also envision that multiple
RipTAL-binding sites could be inserted into one promoter that
would be activated by and confer resistance to strains bearing
RipTAL homologs with distinct target sequences (Morbitzer
et al., 2010; Hummel et al., 2012). In summary, the elucidation
of the RipTAL code provides new possibilities for classical as well
as molecular breeding of wilt-resistant crop plants.
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ABSTRACT
The tandem repeats of transcription activator like
effectors (TALEs) mediate sequence-specific DNA
binding using a simple code. Naturally, TALEs are
injected by Xanthomonas bacteria into plant cells to
manipulate the host transcriptome. In the laboratory
TALE DNA binding domains are reprogrammed and
used to target a fused functional domain to a ge-
nomic locus of choice. Research into the natural di-
versity of TALE-like proteins may provide resources
for the further improvement of current TALE technol-
ogy. Here we describe TALE-like proteins from the
endosymbiotic bacterium Burkholderia rhizoxinica,
termed Bat proteins. Bat repeat domains mediate
sequence-specific DNA binding with the same code
as TALEs, despite less than 40% sequence identity.
We show that Bat proteins can be adapted for use
as transcription factors and nucleases and that se-
quence preferences can be reprogrammed. Unlike
TALEs, the core repeats of each Bat protein are highly
polymorphic. This feature allowed us to explore alter-
native strategies for the design of custom Bat repeat
arrays, providing novel insights into the functional
relevance of non-RVD residues. The Bat proteins of-
fer fertile grounds for research into the creation of
improved programmable DNA-binding proteins and
comparative insights into TALE-like evolution.
INTRODUCTION
When the DNA binding code of transcription activator like
effectors (TALEs) was published in 2009 (1,2), a doorway
was opened for researchers to build custom DNA-binding
proteins. In nature, TALE proteins are injected by mem-
bers of the plant pathogenic bacterial genus Xanthomonas
into host cells. They act as eukaryotic transcription fac-
tors, inducing expression of targeted host genes that pro-
mote bacterial disease. This relies on a set of functional
domains within the protein (3). Upon injection into host
cells, nuclear localisation signals (NLSs) target TALEs to
the plant nucleus. There the central domain of the protein,
composed of tandem-arranged repeats, mediates sequence-
speci!c binding to the promoters of target genes. A C-
terminal transcriptional activation domain (AD) mediates
promoter activation. The unique repeat array, mediating in-
teraction of TALEs with DNA, has received great atten-
tion in the past years. Functional arrays are typically com-
posed of 10–30 repeats, each 33–35 amino acids in length
(3). Within repeats, variation is almost exclusively limited
to positions 12 and 13, termed the repeat variable di-residue
(RVD; 2). One repeat binds one base with speci!city deter-
mined by the RVD. The TALE code refers to this 1-to-1
correlation and the base preferences de!ned by the distinct
RVDs, providing a simple guide for users. By modifying re-
peat number and RVD composition users can design cus-
tom TALE repeat arrays that target nucleotide sequences
of desired length and base composition.
Since the inter-repeat polymorphisms of TALE repeat ar-
rays are almost solely limited to the RVDs, reprogramming
of base speci!city is straightforward. As a consequence of
the almost identical amino acid composition, each TALE
repeat forms a near identical structure irrespective of its po-
sition in the array (4,5). Accordingly, each repeat is com-
petent to make almost exactly the same inter-repeat in-
teractions regardless of the residues occupying the RVD
positions (4,5). Thus, changes to repeat number or posi-
tion do not perturb the network of inter-repeat interactions
that stabilize the superhelical structure formed by tandem-
arranged repeats. This allows each repeat to be treated as a
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functionally independent module and isolates the RVD as
the only position within the repeat of interest to the user.
Functional domains of choice can be fused to the TALE
DNA binding domain and targeted to a prede!ned DNA
sequence. By now TALE-activators, repressors and nucle-
ases have been used extensively (6) andmore recently TALE
fusions mediating targeted epigenetic modi!cations have
also been described (7–9).
Work on the TALE-like proteins of Ralstonia
solanacearum, termed RipTALs, has revealed that they too
act as eukaryotic transcription factors and that RipTAL
target speci!city is linked to RVDs as in TALEs (10).
Comparative analysis of TALE and RipTAL repeat arrays
also revealed functional differences, due to non-RVD
polymorphisms, which could be used to improve custom
TALE repeat arrays. Considering the ever-increasing use of
TALEs across fundamental and applied biology, it seems
sensible to further explore the natural diversity of this
protein class in order to identify new functional features of
bene!t to users.
Burkholderia rhizoxinica is an obligate endosymbiotic
bacterium of the fungal plant pathogen Rhizopus mi-
crosporus (11). The genome of B. rhizoxinica strain HKI
0454 has been sequenced (12) and among the predicted pro-
teins are three with similarity to TALEs that we have termed
Bat (Burkholderia TALE-like) proteins. The gene encod-
ing the predicted Bat1 protein (Uniprot E5AV36, Gen-
Bank RBRH 01844) is located on megaplasmid pBRH01
while the predicted Bat2 (Uniprot E5AW45, GenBank
RBRH 01776) and Bat3 proteins (Uniprot E5AW43, Gen-
Bank RBRH 01777) are encoded on neighbouring, non-
overlapping open reading frames within plasmid pBRH02.
Evidence for DNA binding activity and use as a pro-
grammable DNA binding domain has been demonstrated
recently for Bat1 (alternatively designated BurrH; 13,14).
We investigated DNA binding properties of the three Bat
proteins, showing that Bat2 as well as Bat1 binds DNAwith
the same code as TALEs. We quanti!ed the interaction of
Bat1 with its predicted target DNA bearing the four pos-
sible zero bases and found that, unlike TALEs and Rip-
TALs, Bat1 has no sequence preference at this position.
Bat proteins share limited sequence identity with TALEs
and also show greater inter-repeat diversity than TALEs or
the recently described RipTALs. However, alignments be-
tween repeats of these different proteins reveal a core set
of conserved residues that might be of use to identify fur-
ther members of this class. We show that the Bat proteins
can be used as modular DNA binding domains to medi-
ate targeted transcriptional activation or site-directedDNA
cleavage. However, in contrast to TALEs, no two repeats of
any Bat proteins are identical, with inter-repeat similarity
dropping below 50% in some cases. Because of this alter-
native approaches are possible for the customisation of the
DNA binding repeats. We explored two options: exchang-
ing whole repeats along with their RVDs or exchanging
RVDs only. We found that while one strategy seems prefer-
able, both are viable. In the process we gained evidence to
suggest that polymorphisms at non-RVD positions affect
binding domain function. Our observations suggest that the
Bat proteins may offer a more compact alternative to the
TALE platform for programmable DNA binding.
MATERIALS AND METHODS
Assembly of Bat1 and TALE expression constructs
Genes encoding the three Bat proteins were synthesized
with Escherichia coli codon usage (GenScript) in sepa-
rate BsaI-site "anked subunits (Supplementary Figure S4).
For E. coli protein production, these modules were as-
sembled via BsaI cut-ligation into a pENTR/D-TOPO
(Life Technologies) derivative bearing BsaI sites (overlaps
CACC-AAGG) within the LR recombination sites, cre-
ated using primers listed in Supplementary Table S2. The
genes were then transferred into pDEST-17 (Life Tech-
nologies). For human cell transfection and in vitro cleav-
age assays bat encodingmodules were assembled along with
BsaI-site-"anked modules encoding HA-NLS and NLS-
3xFLAG-VP64 AD domains (acBat1, human cell reporter)
or 3xHA/HA-NLS and HA-FokI (in vitro cleavage). Se-
quences are in Supplementary Figure S5. These were as-
sembled into a modi!ed pVAX vector (Life Technolo-
gies) with combined Cytomegalovirus (CMV)/Sp6 pro-
moter and BsaI sites (AATG-GCTT), details and sequences
for mutational primers given in Supplementary Table S2.
The acBat1 truncation derivatives tested in Figure 5 were
carried out using polymerase chain reaction (PCR) on the
individual synthesized blocks of Bat1 prior to assembly, us-
ing the primers listed in Supplementary Table S2. To cre-
ate the acBat1 derivatives tested in Figure 6 modi!ed as-
sembly blocks were synthesized with the same codon usage
as wild-type acbat1 (GenScript). To create the pSOX2 tar-
geted dBats tested in Figure 7, a DNA fragment encoding
the N- and C-terminal non-core-repeat sections of Bat1 was
synthesized with the same codon usage as wild-type acbat1
(GenScript; Supplementary Figure S11) and assembled into
the pVAX vector along with HA-NLS, NLS-3xFLAG-
VP64 constructs. The repeats were ordered as two blocks
for each dBat (Supplementary Figure S11) and added into
the expression vector between N- and C-terminally encod-
ing regions via BpiI cut-ligation.
The repeat domains of dTALEBat1mimic and dTALESOX2
were created using a previously described method (15). The
assembly of dTALEBat1mimic required modi!cations to the
toolkit. These included a novel level 2 vector, pUC57-CD-
DEST, to allow assembly of more than 17 core repeats. This
was created using PCR mutagenesis of pUC57 to insert
the BsaI sites using primers listed in Supplementary Table
S2. Repeats 4 NT, 5B NN, 4 ND, 7C NT, 1C NR, 3 ND,
7D NS and D 12 N* were created via PCR mutagenesis on
described repeat modules (15) or ampli!cation from the re-
peats of avrbs3 using the primers listed in Supplementary
Table S2.
dTALEUPT AvrBs3 3x Bat1 rep2/6/8 /17 were created as previ-
ously described (10) with trimers synthesized by GenScript
with the sequences listed in Supplementary Figure S14,
while dTALEUPT AvrBs3 3x NI/NN/NG were created with the
aforementioned TALE assembly toolkit (15). Repeat do-
mains were assembled into pENTR-D-TALE !rep BpiI-
AC (15) and then dTALEs transferred into T-DNA binary
vector pGWB641 (16) via LR recombination (Life Tech-
nologies).
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Protein puri!cation
Genes encoding the three N-terminally His tagged Bat pro-
teins (Supplementary Figures S4 and S5) were expressed in
E. coli Rosetta (DE31) pLaqI (Novagen) as previously de-
scribed (17). In short, cells were induced at 30◦Cwith IPTG
for 3 h. After puri!cation from cell lysate via TALON resin
(Clontech), proteins were dialysed against storage buffer
(480 mMKCl, 1.6 mMEDTA, 1 mMDTT, 12 mMTris-Cl,
pH 7.5; Slide-A-Lyzer, Thermo Scienti!c) and concentrated
(Amicon Ultra, Millipore).
Electrophoretic mobility shift assay
Equal amounts of 100 !M 5’ Cy5 labelled forward strand
and unlabelled reverse strand oligonucleotides (Metabion)
were mixed 1:4 with annealing buffer (TALE storage buffer
without DTT or SodiumAzide). After heating to 100◦C for
10 min the mixture was allowed to cool to room tempera-
ture, then diluted 1/20 in annealing buffer. 2 !l of 1 !M
Bat protein was mixed with 16 !l electrophoretic mobility
shift assay (EMSA) buffer (15 mMTris-Cl, 75 mMKCl, 2.5
mM DTT, 0.063% NP-40, 62.5 ng/!l dI.dC, 0.125 mg/ml
BSA, 6.25% glycerol, 6.25 mM MgCl, 0.125 mM EDTA)
and incubated 5 min at room temperature. 2 !l of target
DNA were added followed by a further 30 min incubation.
Total binding reactions were run on a 6% native polyacry-
lamide TBE-gel for 1 h at 100V, 4◦C. Cy5 labelled DNAwas
visualized with the FMBIO III Multi View (Hitachi).
Microscale thermophoresis
Binding af!nity was measured using the Monolith NT.115
from Nanotemper Technologies. Bat1 was labelled with
the protein labelling kit RED (Nanotemper) according to
the manufacturer’s instructions. Differing concentrations
of unlabelled Bat1 target DNA (prepared as above) were
incubated with 100 nM Bat1 protein in microscale ther-
mophoresis (MST) buffer (Tris 20 mM [pH 7.4], NaCl 150
mM, 10 mM MgCl2 and 0.05% Tween). Samples were
loaded into NT.115 Hydrophilic Capillaries. Measurements
were performed at room temperature, using 40% LED
and 20% IR-laser power. Data analysis and Kd calcula-
tions were performed using Nanotemper Analysis software,
v.1.4.17 and Origin 9.1.
Assembly of target plasmids in vivo and in vitro reporters
For the analysis of reporter activation in human cells target
sites were assembled into a BsaI-digested pUC57 derivative
with BsaI sites (TAGA-GGAT) preceding a minimal CMV
promoter followed by a dsEGFP reporter gene (18; Sup-
plementary Figure S6). Target sites were introduced as an-
nealed primers (Metabion, annealing as for EMSAs), with
matching four base pair overlaps, and were ligated into the
BsaI cleaved vectors.
To create the target for the in vitro cleavage assay, BEBat1
was introduced into the transcriptionally silent Capsicum
annuum Bs3 promoter, previously cloned into pUC57, via
mutagenesis PCR (see Supplementary Table S2 for primers
and Supplementary Figure S6 for target sequences). The
Bs3 promoter derivatives used in Figure 8 were delivered in
modi!ed binary vector pGWB3* upstream of a uidA (GUS)
reporter gene as previously described (10).
Transfection of HEK293T cells
HEK293T cells were grown in Dulbecco’s modi!ed Eagle’s
medium––high glucose (Sigma-Aldrich) supplementedwith
10% FBS (Sigma-Aldrich), penicillin (100 U/ml) and strep-
tomycin (100 !g/ml) in a 10% CO2 atmosphere. 5 × 105
cells were transiently transfected using Fugene (Promega)
according to the manufacturer’s instructions. Cells were
transfected with 3 !g of Bat/TALE expression vector and
300 ng of the dsEGFP reporter plasmid.
Immunohistochemistry and microscopy
For microscopic analysis HEK293T cells were mounted
on poly-L-lysine coated glass slides. Forty-eight hours af-
ter transfection, the cells were !xed with 4% formalde-
hyde in phosphate buffered saline (PBS) for 10 min. Af-
ter permeabilisation with 0.5% Triton X-100 for 10 min,
the cells were incubated with 3% bovine serum albumin
(BSA) in PBS for 30 min. After 1 h incubation with the
primary antibody (1/200 diluted mouse monoclonal an-
tibody ANTI-FLAG M2 (Sigma-Aldrich) in PBS supple-
mented with 0.05% Tween-20 (PBS-T) and 3% BSA), cells
were washed three times with PBS-T. Cells were then incu-
bated with 1/600 Alexa Fluor 594 rabbit Anti-Mouse IgG
(Invitrogen) in PBS-T with 3% BSA for 1 h. After wash-
ing three times with PBS-T, nuclei were counterstained with
4,6-diamidino-2-phenylindole (DAPI) and stored in 90%
Glycerol in PBSwith 0.25%DABCO. Images were acquired
and processed using a Leica TCS SP5 confocal microscope
equippedwith anHCXPLAPOCS63x 1.2Water objective.
Images were processed using Leica AF and ImageJ (14).
FACS analysis of transfected HEK293T cells
Flow cytometry measurements of GFP and Alexa Fluor
594 were performed with a Becton-Dickinson FACS-Aria
II. HEK293T cells were harvested, pelleted by centrifuga-
tion at 500 x g for 5 min at room temperature and gently
washed with PBS. Cells were !xed with 4% formaldehyde
in PBS for 10 min, pelleted by centrifugation at 500 x g
for 5 min and permeabilized with 0.5% Triton X-100 for 10
min. After pelleting, the cells were incubated in 3% BSA for
30 min and then with mouse monoclonal antibody ANTI-
FLAG M2 (Sigma-Aldrich, 1/100 dilution in PBS-T with
3% BSA) for 1 h. Subsequently, the cells were pelleted and
washed three times with PBS-T and incubated with Alexa
Fluor 594 rabbit anti-mouse IgG (Invitrogen, 1/500 dilu-
tion with PBS-T with 3% BSA) for 1 h. The cells were then
pelleted and washed three times with PBS-T, stored in 500
!l PBS and analysed with FACS. Data were analysed using
FlowJo V 10.0.6 (Tree Star). dsEGFP values for cells with
above-threshold (Supplementary Figure S13) Alexa Fluor
594 "uorescence were used in Figures 3, 5–7.
In vitro nuclease assay
bat1-FokI and TALE-FokI genes were expressed in vitro
using the Sp6 Quick coupled Transcription/Translation
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system (Promega) as per manufacturer’s instructions. Tar-
get DNA was PCR ampli!ed from the previously assem-
bled Bs3p derivatives using primers listed in Supplemen-
tary Table S2 and puri!ed (GeneJET Gel extraction and
DNA clean up Microkit, Life Technologies). Two hun-
dred nanogram of PCR product was incubated with 5 !l
transcription/translation product for 3 h at 37◦C in cleav-
age buffer (1x restriction enzyme buffer 4, New England
Biosciences, 1 ml/ml BSA, 500 nM NaCl). Reactions were
terminated by heating to 60◦C and DNA was separated
(with kit as above). One hundred nanogram of DNA pu-
ri!ed from the cleavage reaction was run on a 2% agarose
gel. DNAwas visualized via ethidium bromide staining un-
der UV light. Size estimation was made in comparison to
a standard ladder (GeneRuler 100 bp plus, Fermentas) and
band intensities were measured with ImageJ (14).
GUS assays
dTALE or reporter constructs were transformed into
Agrobacterium tumefaciens (GV3101) via electroporation.
Strains were grown overnight in YEB medium containing
rifampicin and kanamycin (each 100 !g/ml; for pGWB3*
containing strains) or rifampicin and spectinomycin (each
100 !g/ml; for pGWB641 containing strains), collected
by centrifugation, resuspended in inoculation medium (10
mMMgCl2, 5 mMMES, pH 5.3, 150 !M acetosyringone)
and adjusted to an OD600nm of 0.8. For GUS assays equal
amounts ofA. tumefaciens strains containing 35S-promoter
driven dTALE genes and reporter constructs containing
corresponding binding boxes fused to the reporter gene
uidA (GUS) weremixed prior to inoculation. Leaf tissuewas
harvested after 48 h and GUS quanti!cation was carried
out as described (10).
RESULTS
Three TALE-like proteins are encoded in the genome of B.
rhizoxinica strain HKI-0454
The Bat polypeptides are formed entirely of repetitive se-
quences with similarity to those of TALEs (Figures 1A,
Supplementary Figures S1 and S2), excluding 17–18 amino
acids at the very N-terminus (non-repetitive N-terminal do-
main; NND). This contrasts from all known TALEs and
RipTALs, which possess N-terminal and C-terminal non-
repetitive domains of between 100 and 300 amino acids each
(Supplementary Figure S2) that are crucial to transloca-
tion and their in planta function as transcriptional activa-
tors (3,10). The Bat proteins can be divided into a set of core
repeats all >45% identical to each other at the amino acid
level and cryptic repeats not reaching this threshold (Figure
1B, Supplementary Figures S1 and S3; alignments gener-
ated with Clusal Omega 19,20). Core repeats are so named
as they form the central, and largest, section of the studied
polypeptides. Bat1, Bat2 and Bat3 have 20, 26 and 6 core
repeats, respectively. The core repeats are framed by two N-
terminal (−1, 0) and one C-terminal (+1) cryptic repeat in
each Bat protein. The sequence identities of the various do-
mains of the Bat proteins to each other are given in Supple-
mentary Table S1.
Figure 1. Sequence-based comparison of TALE-like proteins. (A) Com-
parison of TALE (AvrBs3) and Bat architecture. The lengths of all do-
mains are drawn to the indicated scale, except the dashes representing core
repeats. TALE domains are shown in blue and Bat domains in purple.
Rectangles indicate the N-terminal non-repetitive domain of each while a
triangle indicates the non-repetitive C-terminal domain of TALEs includ-
ing the transcriptional AD. Ovals represent core repeats, hexagons repre-
sent cryptic repeats (repeat number is indicated above). (B) Alignment of
Bat1 core repeats, generated with Clustal Omega and Boxshade. Repeats
are shown in order of appearance in the polypeptide. Repeat numbers are
given on the left and positions within the repeat, including the RVD (in-
dicated by an orange bar) above. (C) A consensus repeat generated from
this alignment is compared to similarly generated consensus repeats from
Bat2, Bat3, Brg11 (RipTAL) and AvrBs3 (TALE). From these a set of 10
hyper-conserved residues termed the consensus TALE-like repeat (CTR)
was generated. The RVD positions are excluded from this. Repeat residues
previously identi!ed as involved in stabilising intra-molecular interactions
from structural studies in TALEs (4) are highlighted with red lettering in
the AvrBs3 consensus repeat, while the residues forming the !rst and sec-
ond alpha helices (4) are underlined.
Consensus core repeats were deduced for each of the three
Bat proteins (Figure 1B and Supplementary Figures S3).
Bat1, 2 and 3 consensus repeats are 73–94% identical (Fig-
ure 1C, Supplementary Table S1). Each of the three Bat
core repeat consensus sequences is less than 40% identi-
cal to equivalent consensus repeats of AvrBs3 and Brg11
(AvrBs3 from X. campestris pv. vesicatoria and Brg11 from
R. solanacearum GMI1000 are used here as the represen-
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Figure 2. In vitro interaction studies of Bat proteins with predicted DNA
targets. (A) Electrophoretic mobility shift assays were carried out for Bat1,
2 and 3 using 5’Cy5 labelled double-stranded DNA, bearing target se-
quences deduced from the TALE code. Each protein (100 nM) was tested
against each target DNA (10 nM). Cy5 !uorescence was visualized af-
ter running through a native polyacrylamide gel. A shifted band, running
slower on the gel, indicates the protein–DNA complex. (B) The interac-
tion between Bat1 and its target (BEBat1) was quanti"ed using microscale
thermophoresis. The !uorescence ratio over the thermophoretic jump is
shown on the y-axis against DNA concentration. Standard deviation for
four repetitions is indicated.Measurements were made with 40%LED and
20% laser power. The dark grey line indicates the Kd "t. (C) This was re-
peated for BE Bat1 derivatives bearing A (grey bar), C ("lled stripes) or G
(spotted) at the zero position. The Kd was calculated in each case and is
shown compared to that with BEBat1 (T0, empty bar).
Figure 3. A Bat1 derived transcriptional activator (acBat1) is functional
in a human cell reporter assay. (A) Schematic drawing showing the do-
main composition of acBat1. NLSs (yellow bars), a 3xFLAG tag (red cres-
cent line) and a VP64 AD (green triangle) were fused onto Bat1 (purple)
via !exible linkers (orange). This was introduced into HEK293T cells via
transfection alongside a DNA reporter (grey) bearing BE Bat1 (purple) up-
stream of a dsEGFP coding sequence (green). Transcriptional activation
of the reporter (green arrow) follows binding to BE Bat1, leading to produc-
tion of dsEGFP protein (green star). acBat1 is detected via the 3xFLAG
epitope with use of an Alexa Fluor 594 labelled secondary antibody. (B)
Alexa Fluor 594, dsEGFP and DAPI !uorescence are shown for trans-
fected cells. acBat1 is compared to derivatives lacking AD (acBat1!AD)
or NLSs (acBat1!NLSs) and to a dTALE created with the same NLSs
and AD and with the same core repeat number and RVD composition as
Bat1 (dTALEBat1mimic). The scale bar indicates 10 !m. (C) FACS analysis
was used to quantify dsEGFP !uorescence for transfected cells express-
ing acBat1,!AD derivative or dTALEBat1mimic as well as cells transfected
with the reporter only. dsEGFP values are shown for the whole population
(curves) as well as boxplots showing fold changes in !uorescence intensity
compared to the reporter control. Boxplot whiskers represent the 2.5% and
97.5% data limits.Median values are written next to or inside each box plot
and shown graphically with thick black lines.
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Figure 4. In vitro assessment of Bat1-FokI nuclease activity. Bat1- and
TALE-FokI fusion proteins were expressed in vitro and equal volumes
of transcription-translation product were incubated with a puri!ed PCR
product bearing two copies of BEBat1 in reverse complement, separated
by 5–19 base pairs. A target with a control sequence replacing the Bat1
target boxes was also used. After 3 h incubation at 37◦C DNA was puri-
!ed from the nuclease reactions and run on a 2% agarose gel to discrimi-
nate cleaved and uncleaved DNA (indicated with arrows and illustrations
on left side). Cleavage ef!cacy was calculated from the ratio of cleaved to
uncleaved DNA band intensities in each lane with ImageJ (14). Full and
striped bars indicate activities of the Bat1-FokI and TALEN constructs
respectively. ND = none detected.
tative TALE and RipTAL, respectively). The Bat proteins
thus form a highly diverged subgroup of the protein class
referred to throughout this publication as ‘TALE-likes’ to
mean TALEs, RipTALs and Bat proteins. Despite the high
sequence diversity of repeats among TALE-like proteins, 10
residues are conserved in almost all TALE-like repeats and
formwhat we term the ‘consensus TALE-like repeat’ (CTR;
Figure 1C). The CTR includes residues clustering around
the RVD as well as other residues, such as V22 and L29,
able to form stabilising intra-molecular bonds in the crys-
tal structure of DNA-bound TALE dHAX3 (Figure 1C; 4).
Given their sequence conservation, the CTR residues are
likely to make key contributions to the structure and func-
tion of the TALE repeat.
Bat1 and 2 mediate sequence-speci!c DNA binding with a
code matching the TALE code
TALEs and RipTALs mediate sequence-speci!c DNA
recognition with each core repeat recognising one DNA
base and speci!city determined by RVDs (the TALE code).
We tested whether Bat proteins function similarly. In Bat
proteins inter-repeat variability is not limited to the RVDs
(positions 12 and 13), in fact position 12 varies very little
and the diversity peaks between positions 23–30 (Figure 1B
and Supplementary Figure S3). However, we continue to re-
fer to positions 12 and 13 in Bat repeats as the RVD for con-
sistency. The base speci!cities of most RVDs found in the
Bat proteins are known from studies on TALEs and Rip-
TALs allowing us to predict target sequences in each case.
The single NR repeat (RVDs and their corresponding re-
peats are referred to with the single letter amino-acid code
throughout) of Bat1 and the three repeats of Bat2 lacking
both RVD residues were paired to Guanine and Thymine,
based on presumed molecular similarities to NK and N*
repeats, respectively.
Genes encoding His-tagged versions of the three Bat pro-
teins were synthesized, expressed in E. coli (see Supplemen-
tary Figures S4 and S5 for sequences), puri!ed and assayed
for binding capabilities in EMSAs against their predicted
binding elements (BEBat1, BEBat2 and BEBat3) (Figure 2A;
sequences in Supplementary Figure S6). Bat1 and 2 both
produced clear shifts in combination with their predicted
targetDNAs only (Figure 2A). Bat3, which has only six core
repeats, was unable to produce a clear shift with any of the
target DNAs (Figure 2A). Previous tests with TALEs have
shown little activity with TALEs possessing fewer than 10
core repeats (1). It thus seems likely that Bat3 is either non-
functional as aDNA-binding protein ormediates veryweak
interactions, not detectable in this assay.
Bat1 and 2, those displaying DNA binding with a clear
sequence preference, are more similar to each other than ei-
ther is to Bat3 (Supplementary Table S1). The Bat1 and 2
consensus core repeats are 94% identical. Considering the
close homology of Bat1 and 2, DNA binding properties are
likely conserved and only Bat1 was further characterized.
Bat1 binds its predicted target with an af!nity within the up-
per boundary of TALE–DNA interactions and without base
discrimination at the zero position
MST experiments were carried out to measure the bind-
ing strength of Bat1 with BEBat1. We found a disassociation
constant (Kd) of 132 nM (Figure 2B). Af!nities of TALEs
with their target DNAs have been measured at 0.3 to>1000
nM (17), depending on the RVD composition. Yet, stronger
interactions than that shown in Figure 2B are thought to
be necessary for the in vivo function of TALEs. For exam-
ple, the interaction of TALE AvrBs4 with its target site in
the promoter of the pepper Bs4C resistance gene was previ-
ously measured by MST to have a Kd of 18.1 nM while the
interaction with the homologous sequence from the non-
activated bs4C allele had a Kd of 181.5 nM (21). Given
that the af!nity of Bat1 to BEBat1 is similar to the af!nity
of AvrBs4 to the non-activated bs4C allele, it is too low to
suggest a strong interaction when assuming near-identical
physiological conditions. This assumption may not be valid
as, for example, the concentration of Bat proteins at the na-
tive site of action may differ from that of TALEs on de-
livery by Xanthomonas bacteria. Alternatively, BEBat1 may
not represent the optimal binding sequence or additional
endogenous factors may promote interaction in vivo.
BEBat1 was created in accordance with the TALE require-
ment for a thymine at the zero position (T0 preference).
However, the RipTALs do not share the T0 preference and
instead activate only G0 targets (10). Therefore, we carried
out further MST experiments with the different N0, bases
to clarify whether the T0 preference holds for Bat1 or if an-
other base is preferred. We found that in fact no signi!cant
differences were seen in the Kds of the different N0 base
target DNAs (Figure 2C and Supplementary Figure S7 and
Table S3). This accords with the results of Juillerat et al. (22)
using an in vivo reporter system. All further experiments
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Figure 5. Functional analysis of acBat1 repeat truncations. Tests were carried out as described (Figure 3). Flow cytometry measurements of dsEGFP
!uorescence are displayed as population distributions (top) or box plots (centre). Distinct colour codes are used throughout the whole "gure and correspond
to indicated constructs. Boxplots show fold changes in !uorescence intensity compared to the reporter control with whiskers representing the 2.5% and
97.5% data limits.Median values are written next to or inside each box plot and shown graphically as thick black lines. Cartoon representations of the tested
truncations are shown below. Dashed lines with scissors indicate "xed (black) and variable (coloured) truncation points. Bat repeats and fused domains of
acBat1 are represented as in Figure 3A. (A) Within the repeats grey or purple indicate truncated or retained regions, respectively. (B) N- (!NTD) or C-
(!CTD) terminal truncations were tested. NND is the short non-repetitive N-terminal domain at the N-terminus of Bat1.
were carried out using T0 targets to allow optimal condi-
tions for comparison to TALE controls.
The fusion of NLSs andAD are suf!cient to convert Bat1 into
a targeted transcription factor in human cells and in planta
Having demonstrated that Bat1 binds its predicted target se-
quence in vitro, we developed a Bat1 derivative to function
in vivo as a transcriptional activator and tested this with re-
porter assays. A Bat1 transcriptional activator (acBat1) was
created through translational fusion of a viral NLS and a
VP64 AD. A 3xFLAG epitope tag between NLS and VP64
domain (Supplementary Figure S5) allowed for antibody-
based protein detection using an Alexa Fluor 594-tagged
secondary antibody. We measured the ability of acBat1 to
activate a dsEGFP-based reporter gene (18) in human cells
(HEK293T; Figure 3A). A custom TALE-activator con-
struct was tested in parallel. Termed dTALEBat1mimic, it has
the same repeat number and RVD composition as Bat1 and
the same fused domains (Figure 3A, Supplementary Fig-
ures S5 and S8). Immunostaining showed that the acBat1
and dTALEBat1mimic both localized to the nucleus, while
acBat1-!NLS, lacking the NLSs, did not localize to the
nucleus. This demonstrates that NLSs must be added to
Bat1 in order to target it to the nucleus in human cells
(Figure 3B). dsEGFP expression in cells expressing acBat1
showed that it is able to activate the reporter. By contrast,
cells expressing a derivative lacking the AD (acBat1-!AD)
showed onlyAlexa Fluor 594 !uorescence, but did not show
dsEGFP !uorescence indicating that the reporter was not
activated (Figure 3B). Fusion of an AD is thus necessary to
convert Bat1 into a functional transcriptional activator in
human cells.
acBat1 induced the reporter 5-fold, while the
dTALEBat1mimic induced the reporter 20-fold (Figure
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Figure 6. Functional analysis of designer (d)Bat constructs generated by RVD (A) or repeat switch (B). dBats were tested using !ow cytometry with a
transcriptional activation reporter as described (Figure 3). dsEGFP !uorescence values are displayed as population distributions (top) or boxplots (centre).
dsEGFP values are normalized to the reporter only control (Supplementary Figure S13), which was BEBat1 for all constructs except RVD switch 1 and 2
(Supplementary Figure S6). Boxplots show fold changes in !uorescence intensity compared to the reporter control with whiskers representing the 2.5%
and 97.5% data limits. Median values are written next to or inside each box plot and shown graphically as thick black lines. dBat design is outlined below
in each case. Coloured boxes indicate the repeats (ovals) modi"ed in a given dBat. In the case of the RVD switch (A) modi"ed repeats are highlighted with
darker grey. RVDs are shown and colour coded by type. Arrows indicate the rearrangement of RVDs between repeats. In the case of the repeat switch (B)
repeats are coloured to indicate that each has a unique set of non-RVD residues. Arrows indicate movement of whole repeats within the array.
3C). This may indicate that dTALEBat1mimic has a higher
af"nity for BEBat1 than acBat1 does. Alternatively, the
activity of the C-terminally fused VP64 AD may be
differentially affected by the architecture of each fusion
protein.
To study functionality of acBat1 in planta, a correspond-
ing T-DNA construct was delivered via A. tumefaciens into
Nicotiana benthamiana leaves. In this assay, constitutively
expressed acBat1 activated a co-delivered uidA reporter
gene downstream of a promoter bearing BEBat1 (Supple-
mentary Figure S9). In analogy to the results observed in
human cells, the dTALEBat1mimic control was able to acti-
vate the reporter in plant cells to 3-fold higher levels than
acBat1. In sum, we were able to show that acBat1 can tran-
scriptionally activate a promoter with its target sequence in
both human and plant cells.
Fusion of a FokI domain to the C-terminus of Bat1 creates a
sequence-speci!c DNA nuclease
The most common approach for the creation of TALE-
nucleases (TALENs) is a C-terminal translational fusion to
a FokI endonuclease domain. Since the FokI endonuclease
is active only as a dimer, interaction of two FokI domains
is achieved by placing neighbouring TALEN target sites on
opposite strands in reverse orientation promoting interac-
tion of the FokI monomers after DNA binding. The FokI
dimer catalyses formation of a double-strand break in the
DNA spacer region between the two TALEN target sites.
We created an analogous architecture using Bat1 to con-
fer DNA binding speci"city and compared its activity in an
in vitro cleavage assay against the corresponding TALEN
(dTALEBat1mimic-FokI; sequences given in Supplementary
Figure S5). As target DNA we used a PCR product bear-
ing two copies of BEBat1 in reverse orientation on oppo-
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Figure 7. Functional analysis of designer (d)Bat constructs targeting
the human SOX2 promoter. dBats were tested using !ow cytometry with
a transcriptional activation reporter as described (Figure 3). Population
curves for dsGFP !uorescence are shown (top) as well as boxplots of !u-
orescence intensities (bottom) compared to the reporter control (logarith-
mic scale). Boxplots show fold changes in !uorescence intensity compared
to the reporter control with whiskers representing the 2.5% and 97.5%
data limits. Median values are written next to each box plot and shown
graphically as thick black lines. Two dBats, designed based on the RVD
(dBatSOX2 RVD switch) or repeat switch (dBatSOX2 repeat switch), and an equiv-
alent dTALE were tested.
site strands. We generated derivatives differing only in the
length of the DNA spacer separating the targets (Supple-
mentary Figure S6) in order to determine the spacing be-
tween the two target sites that would result in the highest
activity of the Bat-FokI fusion proteins. As a negative con-
trol, we tested a template with a control sequence instead of
the Bat1 target sites.
Bat1-FokI and dTALEBat1mimic-FokI were expressed in
vitro and equal volumes of reaction product were incubated
with the target DNA. After 3 h at 37◦C the DNA was size
fractionated on a 2% agarose gel (Figure 4). Both Bat1
and TALE nucleases were able to cleave the target con-
structs. By contrast, the controls lacking target sites were
not cleaved, indicating that Bat1-FokI, like the TALEN,
is target speci"c in its DNA cleavage. The highest ef"cacy
shown by Bat1-FokI was 35% cleavage (11 bp spacer) while
dTALEBat1mimic-FokI had amaximum ef"cacy of 86% cleav-
age (19 bp spacer; Figure 4). That dTALEBat1mimic-FokI
showed greater !exibility with respect to spacer length may
relate to the previously optimized architecture employed
(18). TALEN architecture is known to play a decisive role
in spacer preference (23). Similarly, alternative Bat1 trunca-
tions or peptide linkers might allow for the creation of Bat1
nucleases with greater !exibility in spacer length.
Figure 8. Functional analysis of Bat1 repeats within the context of a
TALE repeat array. Trimers of identical Bat1 repeats or TALE repeats
with the same RVDs as the Bat1 repeats were embedded into the repeat
domain of the 17-repeat TALE AvrBs3 that targets the pepper Bs3 pro-
moter (Bs3p). Repeats 5–7 (3xRVD NI in AvrBs3) where replaced either
by TALE repeat trimers with the RVDs NN or NG or by trimers of Bat1
repeats 2, 6, 8 and 17. This is shown in cartoon form with dTALE re-
gions shown in light grey with the trimer of Bat1 repeats or dTALE re-
peats shown as white ovals. The grey rectangle and triangle indicate the
native N- and C-terminal regions of AvrBs3, respectively. RVDs are given
in each case and the matching bases in the target box underneath. The
resulting chimeras (striped bars) were tested for their ability to activate
a Bs3p derivative bearing the matching binding site upstream of a uidA
(GUS) reporter gene and compared to non-chimeric dTALEs ("lled bars)
with the same RVDs. Dashed lines separate groups of constructs all with
the same RVDs and tested against the same reporter. Barred lines indicate
standard deviation. Two-tailed t-tests were used to compare chimeric and
non-chimeric dTALEs for each reporter. A double asterisk indicates a P-
value of below 0.02 and n.s. indicates a P-value of above 0.05.
The paradigm underlying the modi!cation of core and cryptic
TALE repeats cannot be applied to Bat1
In both natural (3) and custom TALEs, the number of core
repeats is !exible, within a certain range. The number and
position of cryptic N- and C-terminal repeats are typically
in!exible, though alternative repeat −1 modules have re-
cently been described (24,25). We tested acBat1 deletion
derivatives to test if this paradigm applies to Bat1.
First, we tested variants of acBat1 lacking 2 (!18–20),
4 (!16–20), 6 (!14–20) or 8 (!12–20) core repeats (Figure
5A and Supplementary Figure S10). The later half of repeat
20 and repeat +1 were retained in each case. These trunca-
tions were tested against the BEBat1 reporter and produced
varied levels of reporter activation (Figure 5A). acBat1-
!18–20 was able to activate the reporter more than 2-fold,
corresponding to 40% activity of wild-type acBat1. The
other truncation derivatives were unable to activate the re-
porter to levels above background. If we assume that each
repeat contributes a certain amount of af"nity to the Bat1–
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BEBat1 interaction then fewer than 17 repeats may simply
be insuf!cient for an interaction strong enough to lead to
reporter activation. This is in accordance with results from
TALE repeat arrays showing that a certain number of core
repeats are necessary for downstream reporter gene acti-
vation (1). Alternatively, the novel interface formed within
the last repeat in each truncation derivative may create un-
favourable intramolecular interactions, reducing protein ac-
tivity. This explanation would not apply to TALEs where
repeats are near identical and repeat order does not change
the interface between repeats. Given the numerous non-
RVD polymorphisms between Bat1 repeats, deletion or in-
sertion of core repeats will always create novel repeat inter-
faces and should be experimentally validated before use in
downstream applications.
We next tested acBat1 derivatives where the 82 residues
N-terminal of core repeat 1 (acBat1!NTD; lacking repeats
0 and −1), or the 30 residues C-terminal of core repeat
20 (acBat1!CTD, lacking repeat +1) were deleted (Figure
5B and Supplementary Figure S10). Whilst acBat1!NTD
showed a modest reduction in activity (56% of acBat1),
acBat1!CTDwas barely able to activate the reporter above
background (Figure 5B). This does not match expectations
based on TALEswhere only the cryptic N- but not the cryp-
tic C-terminal repeats are essential for DNA binding (26).
By contrast, our results suggest that the cryptic C-terminal
Bat1 repeat +1, in contrast to the corresponding cryptic
TALE repeat +1, makes an unexpectedly strong contribu-
tion to activity and thus should be retained for the creation
of active Bat1-based transcriptional activators.
Despite high inter-repeat diversity designer Bat1 proteins
(dBats) with wild-type levels of activity can be assembled
The non-RVD residues of Bat1 repeats are highly polymor-
phic. This provides a means to study the functional rel-
evance of non-RVD polymorphism in the native Bat1 as
well as being relevant for the creation of Bat1 derivatives
with novel speci!city (dBats). We hypothesize that non-
RVD polymorphisms may have two functionally relevant,
non-mutually-exclusive, effects. (i) The formation of unique
but functionally equivalent repeat interfaces that stabilize
the superhelical structure formed by tandem-arranged re-
peats (4,5) (superstructural hypothesis). (ii) The creation of
unique scaffolds optimized for the native RVD residues in
each case (RVD scaffold hypothesis).
We used two different dBat designmethods to test our hy-
potheses. These are the repeat switch and the RVD switch.
Sequences of the dBats created can be found in Supplemen-
tary Figure S11. In the repeat switch whole repeats, includ-
ing their native RVDs, were exchanged. This creates new
interfaces between repeats but leaves RVDs in their native
repeat context. If the superstructural hypothesis is correct
then the repeat switch is likely to modify evolved repeat in-
terfaces possibly yielding less active DNA-binding proteins.
In the RVD switch it is only the RVDs that are changed
while all non-RVDs remain unchanged. This design will not
change repeat interfaces but will place RVDs in non-native
repeat scaffolds. If the RVD scaffold hypothesis is correct
then the RVD switch will reduce activity due to RVDs be-
ing sub-optimally oriented in relation to the paired DNA
bases.
RVD composition and target sequence are key parame-
ters determining af!nity of TALE–DNA interactions and
these were kept constant in our dBat tests as far as possi-
ble. For the repeat switch tests, we exchanged repeats with
RVDs paired to the same base in BEBat1 allowing the wild-
type target construct to be used in each case. For the RVD
switch constructs, where possible we exchanged RVDs with
the same target base (dBat RVD switch 3 and 4) and tested
these constructs against BEBat1. Where this was not possi-
ble exchanges were made between repeats in close proxim-
ity to one another to reduce any in"uence from an N- to
C-terminal polarity effect as known for TALEs (17,27–29).
These were then tested against BEBat1 derivatives with the
appropriate minormodi!cations in base composition. Thus
any differences we see in activity are likely to be linked to
effects arising from manipulation of repeats and not to dif-
ferences in RVD composition or target sequence.
We found that despite the minor modi!cations in each
case the different dBat constructsmediated strikingly varied
levels of reporter activation. Of the four RVD switch con-
structs two were superior in activation level compared to
acBat1 (2.9x and 1.4x relative to acBat1; Figure 6A). The
other two dBat derivatives were slightly reduced in their ac-
tivity as compared to acBat1 (0.56x and 0.72x relative to
acBat1; Figure 6A). Overall, the impact on activity of the
RVD switch constructs showed no single trend with some
superior and some inferior to the wild type. Of the four re-
peat switch constructs none reached the activation level of
acBat1 (Figure 6B). Notably, dBat repeat switch 3, in which
core repeats 11 and 12 were exchanged, was unable to in-
duce the reporter above background levels. Thus the repeat
switch constructs all showed reduced activity compared to
the wild type, and some dramatically so.
These data support that inter-repeat interfaces are unique
and optimized (superstructural hypothesis) though whether
the same is true for RVD scaffolds is not clear. That the
RVD switch constructs performed differentially suggests
that RVD scaffold can have a functional impact. However,
the natural scaffold does not seem to be the optimal one in
every case.
Custom dBats can be created to target a novel, user-de!ned
sequence
We next tested whether the Bat1 repeat array could be fully
customized to target a sequence of interest. Based on the
two alternative strategies described above, dBatSOX2-RVD
switch and dBatSOX2-repeat switch were created to activate
a dsEGFP reporter driven from a minimal CMV promoter
containing a binding element taken from the human SOX2
promoter (Supplementary Figures S6, S8 and S11 for pro-
tein and reporter sequences). The SOX2 protein prevents
determination in human neural stem cells and has previ-
ously been a target for dTALE studies (30). Both dBat re-
peat arrays were limited to 18 repeats instead of the wild-
type 20 to bring them in line with the length of custom
TALE repeat arrays commonly produced with our toolkit
(15). The same NLS and VP64 fusions were used as for the
assays displayed in Figure 3A. Both dBats were able to ac-
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tivate the reporter to similar levels (Figure 7) suggesting
that both the RVD and repeat switch strategies can yield
successful constructs. dBatSOX2-repeat switchmediated 4.8x
reporter activation and thus was slightly more active than
the dBatSOX2-RVD switch (4.4x reporter activation). How-
ever, as seen previously (Figure 6), results can be surpris-
ingly varied even between very similar dBat constructs and
any potential design should be tested !rst in a reporter sys-
tem before further application. Cross-reactivity assays test-
ing the SOX2 dBats on the BEBat1 reporter showed that they
were unable to activate the non-target reporter above back-
ground (Supplementary Figure S12) indicating that target
speci!city is maintained in the dBats. Further work on the
creation of Bat1-based arrays and fusion proteins may im-
prove activity levels. In conclusion, wewere successfully able
to reprogram the Bat1 protein for the creation of transcrip-
tional activators with novel speci!city.
TALE-Bat1 chimeras show varied activity but may be a
means to harness the sequence diversity of Bat1 repeats
While the activation achieved with the SOX2 dBats was
encouraging a custom TALE-activator for the SOX2 pro-
moter (dTALESOX2) activated the reporter more than 200-
fold (Figure 7). It may be possible to improve the activation
levels achieved with dBats through further work on con-
struct design and indeed Bat1 nuclease activities matching
the corresponding activities of corresponding TALE nucle-
ases were previously reported (22). However, another pos-
sibility is to create chimeric proteins to combine desirable
features of both the Bat and TALE repeat scaffold.
We tested the principle of creating TALE-Bat chimeric re-
peat domains utilising a simple assay approach previously
used in our lab to test chimeric TALE-RipTAL repeat ar-
rays (10). Three identical copies of different Bat repeats were
used to replace three repeats in a dTALE targeting the pep-
per Bs3 promoter (Bs3p). These were then tested in planta
against a reporter construct bearing a Bs3p fragment up-
stream of a uidA (GUS) gene. Three different reporters were
used with triple A, G or T at the position that should be
bound by the inserted Bat repeats in order to test repeats
with different RVDs. In each case comparison was made
to a dTALE assembled using only TALE repeats with the
same RVD as the Bat repeats. As with earlier dBat tests
we found strikingly different results for different constructs
(Figure 8).
dTALEAvrBs3 3xBat1 rep2, a dTALE bearing three copies of
Bat1 repeat 2 (RVD NI) at the test positions, gave a sig-
ni!cantly weaker induction of the reporter compared to
the control with TALE repeats only (dTALE AvrBs3 3xNI).
dTALEAvrBs3 3xBat1 rep8 (RVD NN) was barely able to elicit
any detectable activation, unlike its TALE repeat equivalent
(dTALEAvrBs3 3xNN). In contrast, dTALEAvrBs3 3x Bat1 rep6
(RVDNI) and dTALEAvrBs3 3xBat1 rep17 (RVDNG) activated
their reporters to a level not signi!cantly different from the
TALE repeat control constructs. It is not possible to clarify
whether differences in functionality arise from performance
differences betweenBat or TALE repeats in their native con-
!rmations or if the differences arise due to the formation
of novel and likely unfavourable inter-repeat interactions
in these chimeric constructs (see superstructural hypothesis
above). The functionality of any potential chimeric binding
domain is likely to depend on both the particular repeats
utilized and their arrangement within the repeat domain.
However, we have demonstrated that such chimeric repeat
domains containing some Bat1 repeats can be functional to
the same level as TALE repeat equivalents paving the way
for further development and applied uses.
DISCUSSION
The Bat proteins, together with the TALEs and RipTALs,
form the TALE-like protein class. Like the other TALE-
likes, Bat proteins mediate sequence-speci!c DNA binding
with speci!city predicted from the established TALE code.
This functional similarity likely correlates to a structural
similarity since DNA recognition proceeding via the TALE
code relies on a particular structure that places position 13
of each repeat in close proximity to a single DNAbase (4,5).
Indeed modelling the structure of Bat1 based on the known
structure of TALE Pthxo1 binding to its target DNA (5)
suggests that the whole Bat1 polypeptide would form a se-
quence aligning closely to the TALE core repeat domain
(Supplementary Figure S15).
Comparison of the core repeats of distinct TALE-likes
enabled us to de!ne a set of conserved residues, the CTR,
as a unifying feature of the TALE-like proteins (Figure 1C).
TheCTRcould be a useful tool to scan databases for further
TALE-likes. In addition, the conservation of CTR residues
suggests that they have an important functional relevance.
Intriguingly, the CTR residues do not include some repeat
residues such as K16, which have been shown to provide
a large contribution to non-base-speci!c DNA binding, or
H33, suggested as key to stabilisation of the TALE repeat
(31). Conversely, some CTR residues such as L29 cannot
currently be linked to a certain key function. Thus, inves-
tigation of the TALE-likes provides an interesting window
into the opportunities for and constraints on sequence di-
versi!cation whilst maintaining protein function.
We have demonstrated that the Bat1 protein itself can be
taken as a targeting module for transcriptional activation
(Figure 3) and nuclease function (Figure 4). The repeat ar-
ray can also be reprogrammed to target a sequence of in-
terest (Figure 7). Unlike the reprogramming of TALEs, al-
ternative design strategies must be considered to generate
Bat1 repeat arrays with desired base speci!city and we have
successfully employed two conceptually distinct design ap-
proaches (Figure 6). However, Bat1 and derivative fusion
proteins were outperformed by equivalent TALE fusions
(Figures 3, 4 and 7). This may relate to the relatively low
af!nity of Bat1 for BEBat1 (Figure 2B) compared to known
af!nities of TALEs for their natural target boxes. However,
the TALE platform has been optimized over several years.
The creation of high activity TALE-nucleases, in particular,
has been a focus of many labs. Thus, with further work to
improve activity, the Bat platform may prove a more com-
pact alternative to TALEs for targeted DNA binding with-
out any zero base preference to be taken into account (Fig-
ure 2C). Alternatively, Bat repeats could be assembled along
with TALE repeats to create chimeric DNA-binding pro-
teins with novel properties. At the very least the inclusion
of some Bat repeats into TALE repeat arrays would lower
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sequence identity between repeats, useful for some cloning
strategies, and possibly alleviating the previously reported
problem of recombinatorial repeat loss (32). That Bat1 re-
peats can be integrated into a dTALE whilst retaining func-
tionality is shown in Figure 8, but since no two Bat1 re-
peats are identical, so too must each Bat1-TALE chimera
be treated as novel and requiring experimental validation
before further use.
Functionally relevant differences between TALEs and
Bat proteins were discovered upon attempting to modify
the repeat domain. Bat1 showed surprisingly little tolerance
to reductions in repeat number below 18 repeats (Figure
5A). These results seem to be in agreement with analysis
of TALE proteins where a minimum number of repeats was
needed to achieve in vivo function (1). The conclusion that
has been drawn from such analysis is that each TALE repeat
contributes something towards af!nity and that a certain
number of repeats are required to achieve the af!nity nec-
essary for in vivo function. However, the situation for Bat
proteins is more complex. Due to the numerous non-RVD
polymorphisms between each repeat (Figure 1B), a novel in-
terface is formed when truncations are made within the re-
peat domain and these could have functionally deleterious
consequences. Indeed the results of rearrangements within
the repeat domain (Figure 6B) suggest that this is so.
A further difference between Bat1 and TALEs is the rel-
ative impact of truncations of the N- and C-terminal cryp-
tic repeats. The N-terminal cryptic repeats of TALEs make
a decisive contribution to DNA af!nity such that their re-
moval fully ablates DNA binding (26). By contrast, the lim-
ited evidence available suggests that the C-terminal cryp-
tic repeats of TALEs contribute little to af!nity and speci-
!city. This includes the independently observed (17,27–29)
N- to C-terminal reduction along the binding domain of
contribution to base speci!city. In addition, TALE fusion
proteins with truncations in C-terminal cryptic repeat +2
(Supplementary Figure S2) are active (18) suggesting that
any af!nity contribution is not decisive. Thus in TALEs
the N-terminal cryptic repeats seem to contribute more to
DNAbinding than theC-terminal cryptic repeats. This con-
trasts to our !ndings based on truncations of the N- and
C-terminal cryptic repeats of acBat1. We found that the N-
terminal truncation had a modest impact on reporter ac-
tivation and did not contribute to speci!city (Figures 2C,
5B and Supplementary Figure S7 and Table S3), whilst the
truncation of the single C-terminal cryptic repeats almost
entirely ablated activity (Figure 5B). This repeat may be
important for DNA binding and the high proportion of
positively charged residues (8/30; Supplementary Figure
S1) is in agreement with a possible contribution to inter-
action with the negatively charged DNA phosphate back-
bone. Sequence comparison of the cryptic repeats of Bats
and AvrBs3 (see Supplementary Figures S1 and S2) showed
that the 0 repeats share a few residues (L1, L7 and K8) not
found in theCTR (Figure 1C) but no such unique conserved
residues can be found among the -1 or +1 repeats. Together
with the results shown in Figure 5B it appears that, at both
the sequence and functional level, at least the cryptic re-
peats -1 and +1 of Bats and TALEs are likely to be non-
homologous.
Through the exploration of dBat assembly strategies,
we gained insights into the functional signi!cance of Bat1
non-RVD polymorphisms. These polymorphisms provided
amolecular handle to question differentmodels. The results
of these experiments are possibly speci!c to Bat proteins but
most likely are relevant to the non-RVD polymorphisms of
other TALE-like proteins. The RVD switch constructs (Fig-
ure 6A) tested the importance of the RVD scaffold formed
by all the non-RVD residues of a repeat, while the repeat
switch constructs tested the importance of inter-repeat in-
teractions (Figure 6B). We found that all repeat switch con-
structs were less active than the wild type (Figure 6B). This
supports the hypothesis that the non-RVD polymorphisms
of adjacent Bat1 repeats lead to the formation of unique
but functionally equivalent interfaces between repeats. Our
model for the structure of Bat1 bound toDNA suggests that
unique bonds are indeed formed between varied residues
of Bat1 repeats (Supplementary Table S4). Perturbation of
these possibly co-evolved residues would likely impair pro-
tein function. The performances of the RVD-switch con-
structs (Figure 6A) were mixed, with some activating the re-
porter better than the wild-type acBat1. This speaks against
the idea that each repeat scaffold has co-evolved with its
RVD for optimal activity. The data do, however, support
previous !ndings from RipTALs (10) and TALEs (33) that
certain non-RVDpolymorphisms can have profound effects
on repeat activity. These effects can be negative or positive
and must be investigated individually. The quantity of non-
RVD polymorphisms in Bat1 repeats compared to TALEs
(3) or RipTALs (10) thus complicates the creation of de-
signer DNA binding domains but also represents an as yet
unexploited pool of potentially bene!cial repeat variants.
Comparing the diversity of Bat and TALE repeats also
raises evolutionary questions. The consensus core repeats or
TALEs and Bats are less than 40% conserved (Figure 1C) at
the sequence level, but at the functional level Bat and TALE
repeats are apparently very similar. This shows that the se-
quence composition of TALE-like repeats is not heavily
constrained by functional requirements. If most polymor-
phisms are functionally equivalent we would expect that,
over time, inter-repeat polymorphisms would accumulate.
The high levels of inter-repeat polymorphism in the Bat pro-
teins (Figure 1B and Supplementary Figure S3) are con-
sistent with this assumption. What is surprising is the rel-
ative sequence uniformity of TALE repeats. This suggests
that TALE repeats are under the in"uence of a selective
pressure to maintain sequence conservation, not felt by Bat
proteins. However, while the non-RVDs of each TALE re-
peat are highly uniform the RVD composition and repeat
number are highly diverse (3). These observations may be
mutually explanatory. It is known that repeat regions of
TALE genes can evolve via intra- and inter-molecular re-
combination (34,35). It may be, therefore, that the sequence
conservation between individual TALE repeats promotes
this recombination and subsequent diversi!cation of repeat
number and RVD composition. This property may be pos-
itively selected for in TALE genes. These assumptions and
hypotheses require further testing, but comparison to non-
XanthomonasTALE-likes will likely prove a helpful one. In-
deed the RipTALs, which show intermediate sequence di-
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versity and limited structural diversity (10), provide an in-
teresting third group for comparison.
We have shown that the Bat proteins are a highly di-
vergent subgroup within a class referred to as the TALE-
likes, which they help to de!ne. Moreover, Bat speci!city
can be programmed with a code matching to known TALE
and RipTAL repeat speci!city (Figure 2A). Bat proteins
thus represent an alternative platform for programmable
sequence-speci!cDNA targeting. In addition, the highly di-
verse Bat repeats may prove a valuable reservoir for novel
residue combinations with bene!cial properties. More than
this they provide an out-group for comparative analysis into
function and evolution ofRipTALs andTALEs. Further re-
search into the Bat proteins is thus likely to reap rewards for
both fundamental and applied research.
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Abstract**!Transcription! ActivatorOLike! Effectors! (TALEs)! of! Xanthomonas! bacteria! are!programmable! DNA! binding! proteins! with! unprecedented! target! specificity.!Efforts! have! been! made! to! engineer! TALE! DNAObinding! repeats! with! novel!properties,!but!are!made!difficult!by!the!very!limited!pool!of!known!TALE!repeat!sequence!variations.!More!sequenceOdiverse!TALEOlike!proteins!are!known!from!
Ralstonia,solanacearum!(RipTALs)!and!Burkholderia,rhizoxinica!(Bats),!but!their!repeats!are!conserved!with!those!of!TALEs!around!the!DNAObinding!residue.!We!have! assessed! the! structure! and! DNAObinding! properties! of! repeats! of! novel!marineOorganism! TALEOlike! proteins! (MOrTLs),! the! first! to! date! of! nonOterrestrial!origin.!We!found!that!they!function!analogously!to,!and!are!compatible!with,! TALE! and! Bat! repeats! despite! low! sequence! similarity! around! the! base!specifying!residue!(BSR).!MOrTL!repeat!sequences!could!be!used!in!the!future!to!augment!existing!TALEOtechnology.!Repeat!residues!around!the!BSR!were!found!to!be!conserved!within!but!not!between!TALEOlike!groups,!and!in!fact!only!three!residues!spread!around!the!repeat!are!highly!conserved!across!all!groups.!This!conserved! motif! could! prove! useful! as! an! identifier! for! future! TALEOlikes.!Additionally,!comparing!MOrTL!repeats!with!those!of!other!TALEOlikes!suggests!a!common!evolutionary!origin!for!the!TALEs,!RipTALs!and!Bats.!!
Introduction:*!TALEs! are! effector! proteins! injected! by! plant! pathogenic! bacteria! of! the! genus!
Xanthomonas!into!host!plants!where!they!mimic!eukaryotic!transcription!factors!(1).!An!array!of!DNAObinding!repeats!mediate!TALEOpromoter!interaction!and!an!acidic! activation! domain! at! the! COterminus! of! the! protein! mediates! host! gene!expression.!TALEs!hijack! the!host’s! transcriptional!machinery!(2,!3)! to!activate!plant!genes!beneficial!to!the!pathogen.!!!
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It!was! the!2009!publication! (4,!5)!of! the!TALE!code! for! sequenceOspecific!DNA!binding! that! launched! these!proteins! into! the! limelight.!The! code! in! its! refined!form!describes! the!base!preferences!of!each!possible!residue!at!repeat!position!13!(base!specifying!residue;!BSR)!(6).!Each!repeat!pairs!with!one!base,!generally!without! interference! from! adjacent! repeats.! With! this! information! one! can!predict! the! DNA! binding! element! (BE)! for! any! given! TALE! and! what! is! more,!design! a! TALE! to! match! any! DNA! sequence! of! interest.! Designer! (d)OTALE!DNAObinding!domains,! coupled! to! a! functional!domain!of! choice!are! invaluable!tools! for! precision! manipulation! of! genome! (7),! transcriptome! (8)! and! even!epigenome!(9).!!One! of! the! potential! advantages! of! the! TALE! system! over! the! alternative!CRISPR/Cas9!system!is!that!TALE!repeat!arrays!are!highly!flexible!with!respect!to!the! length!and!sequence!composition!of!the!desired!target!site.!Furthermore!BSRs!bind!their!cognate!bases!with!a!range!of!different!affinities!and!specificities!as! inferred! from! reproducible! effects! on! the! binding! properties! of! arrays!containing! such! repeats! (10).! This! diversity! of!molecular! interactions! found! in!TALEs! contrasts! with! the! restricted! WatsonOCrick! base! pairing! of! the!CRISPR/Cas9! platform.! The! diversity! of! base! recognition! characteristics! found!among!BSRs!offers!the!possibility!of!creating!finely!tuned!DNAObinding!proteins.!This! possibility! could! be! particularly! useful! in! synthetic! biology! where! parts!libraries! covering! a! range! of! parameter! values! for! a! property! of! interest! are!highly!desirable.!A! library!of!dTALEs!with!a! range!of!binding! strengths! for! the!same!DNA!element!could!be!useful!for!creating!synthetic!genetic!circuitry.!!!The!range!of!DNAObinding!properties!mediated!by!TALE!repeats!might!be!further!expanded! by! exploiting! nonOBSR! polymorphisms.! Till! now,! the! only! nonOBSR!position! to! receive! much! attention! for! TALE! repeat! engineering! has! been! the!neighbouring!residue!12!(commonly!referred!to!together!with!position!13!as!the!RVD! (5)).! By! now! all! 400! possible! RVDs! have! been! assessed! for! interaction!strength! and! specificity! (11,! 12).! This! confirmed! that! residue! 13! is! the! major!baseOspecificity!determinant!but!some!residue!12!polymorphisms!were!found!to!affect!DNA!recognition!properties,!supporting!a!role!for!nonOBSR!polymorphisms!in! defining! the! DNA! recognition! properties! of! TALE! repeats.! ! Furthermore,!repeat! arrays! with! novel! RVDs! were! found! to! outcompete! those! based! on!commonly!occurring!RVDs,!displaying!increased!onOtarget!and!reduced!offOtarget!activity! (11).!However,!nonOBSR!polymorphisms!beyond!position!12!are!scarce!in! natural! TALEs,! and! the! studies! examining! the! functional! impact! of! this!diversity! are! similarly! scarce.! Only! 18! nonORVD! polymorphisms! are! found!between! the! full! repeat! arrays! of! TALEs! AvrBs3! and! AvrBs4,! and!when! these!were! exchanged! en! masse! they! were! found! to! have! no! significant! functional!impact!on!reporter!gene!activation!(8).!Another!study!found!that!TALE!nuclease!repeat!arrays!formed!of!repeats!differing!from!one!another!at!residues!4!and!32!had! slightly! enhanced! activity! in, vivo! compared! to! similar! constructs!made! of!fully! identical! repeat! arrays! (13).! Overall,! however,! the! paucity! of! natural!diversity! among! TALE! proteins! limits! the! raw! material! available! for! repeat!engineering.!!!
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TALEs! are! distributed! widely! among! Xanthomonas! species! but! sequence!diversity!is!very!low!(14).!TALEOlike!proteins!from!other!bacterial!groups!offer!a!far! greater! pool! of! sequence! diversity.! An! effector! protein! called! Brg11,! 41%!identical! to! AvrBs3, ,! is! produced! by! plant! pathogen! Ralstonia, solanacearum,!strain! GMI1000! (15).! Further! brg11,homologs! were! later! identified! in! a! large!number!of!R.,solanacearum!strains!(16,!17).!These!proteins!are!termed!RipTALs!(Ralstonia! injected! protein! TALEOlike).! In! 2013! we! and! others! published!molecular!characterisations!of!these!RipTAL!proteins!(16,!18)!showing!that!they!function!analogously! to!TALEs!as!plant! transcription! factors.!TALE!and!RipTAL!repeats! are! polymorphic! at! numerous! positions! and,! in! addition,! the!polymorphism!among!RipTAL!repeats!is!greater!than!that!among!TALE!repeats.!We!looked!at!the!DNA!recognition!properties!of!each!of!the!repeats!of!Brg11!and!found!differences!in!reporter!activation!strength!even!when!comparing!repeats!with! identical!BSRs! (16).!This!suggested!an! impact!on!repeatODNA! interactions!from! nonOBSR! polymorphisms.! RipTAL! repeats! could! be! useful! as! a! pool! of!natural!sequence!diversity!for!TALE!repeat!engineering.!!The!pool!of!sequence!polymorphisms!amongst! functionally!validated!TALEOlike!repeats! was! further! expanded! by! the! molecular! characterisation! of! TALEOlike!proteins! from! bacterium! Burkholderia, rhizoxinica, (19–21).! We! demonstrated,!that!two!of!these!proteins,!Bat1!and!Bat2,!bind!DNA!with!a!sequence!specificity!matching!the!TALE!code!(19).!Furthermore,!the!solved!crystal!structures!of!Bat1!(21)!and!AvrBs3!are!strikingly!similar.!The!structure!of!individual!repeats!is!also!highly!conserved!between!TALEs!and!Bats!with!BSRs! in!a! loop!between!paired!αOhelices.! This! high! structural! similarity! is! remarkable! given! only! 32%! amino!acid!sequence!similarity!across!the!repeat!region.!Since!TALE!and!Bat!repeats!are!functionally! compatible! (19)! the! pool! of! available! sequences! for! TALE! repeat!redesign!is!greatly!enlarged!by!the!Bats.!!However,! residues! clustered! around! the! BSR! (positions! 7! to! 19)! are! largely!invariant! across! all! known!TALEs,!RipTALs!and!Bats! (19).!The! conservation!of!these!residues!not!just!between!but!also!within!these!groups!of!TALEOlikes!and!their!position!next!to!the!binding!base!suggests!that!these!residues!are!important!for! repeat! structure.! It! seems! conceivable! that! residues! adjacent! to! the! BSRs!have!a!major!impact!on!the!placement!of!the!BSR!with!respect!to!the!paired!base.!Accordingly,! these!residues!may!also!be! those!most! interesting! for!engineering!attempts!aimed!at!changing!DNA!binding!properties.!!!We!describe!here!molecular!characterisations!of! two!novel!proteins!with!weak!sequence! similarity! to! TALEs! predicted! from! marine! bacterial! metagenomics!data! (22,! 23).! We! refer! to! these! predicted! proteins! as! MOrTL1! and! MOrTL2!(Marine!Organism!TALEOLikes)! to! reflect! the!very! limited! information!we!have!regarding! their! provenance.! We! show! that! repeats! of! both! MOrTLs! mediate!sequenceOspecific! DNA! binding! in! accordance! with! the! TALE! code.! To! gain!information!on!the!structure!of!MOrTL1!and!MOrTL2!we!built!homology!models!that! were! subsequently! analysed! using!molecular! dynamics! (MD)! simulations.!The! final!models!show!a!striking!structural!similarity! to!TALE!and!Bat!repeats.!Yet! MOrTL! repeats! bear! sequence! motifs! unknown! from! TALEs,! RipTALs! and!Bats.!The!MOrTLs!are!as!distant!from!one!another!at!the!sequence!level!as!they!
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are!from!any!of!the!other!TALEOlikes.!Furthermore,!sequence!similarity!between!TALEs!and!both!MOrTLs! is! low,!even! in! the!otherwise!highly!conserved!region!around!the!BSR.!This!all!makes!the!MOrTLs!a!fascinating!addition!to!the!growing!family!of!TALEOlikes!and!the!pool!of!functionally!validated!repeat!sequences!for!TALE!repeat!reOengineering.!!
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*
Materials*and*Methods*! !
MOrTL*construct*creation*Genes!encoding!EBN1909!and!ECG96326,! codon!optimized! for!E.,coli! and!with!additional! 5’! and! 3’! BsaI! recognition! sites,! were! synthesized! (GenScript).!Sequences!in!Figure!S1.!Genes!were!cloned!into!a!modified!pENTR!DOTOPO!(Life!Technologies)!vector!rendered!Golden!Gate!compatible!with!the!replacement!of!the!native!gateway!cassette!and!Att!sites!with!a!gateway!cassette!flanked!by!BsaI!recognition!sites!with!the!digestOoverhangs!TATGOGGTG.!!To!create!Bat1!chimeras!5Omer!subunits!of! the!synthesized!MOrTL!genes!were!PCR! amplified! with! the! primers! listed! in! Table! S2! bearing! BsaI! sites!corresponding!to!Block!2!of!the!previously!described!Bat1!cloning!system!(19).!The!MOrTL!blocks,!along!with!Bat1!blocks!1!and!3O5,!were!assembled!into!either!pENTR! or! pBT102*! CACCOAAGG! (see! below)! via! BsaI! cutOligation.! Chimera!sequences!are!given!in!the!supplementary!material.!!To!create!TALE!chimeras!5Omer!subunits!of!the!synthesized!MOrTL!genes!were!PCR! amplified! with! the! primers! listed! in! Table! S2! bearing! BsaI! sites!corresponding! to! the! 5B! level! 2! repeat! blocks! of! the! designer! TALE! assembly!toolkit! as!previously!described! (24)!but!using!Level! 2! vectors!pUC57OA5ODEST!and! pUC57O5BODEST! instead! of! pUC57OABODEST,! to! allow! different! A5! and! 5B!repeat!blocks!to!be!combined.!A5!and!BC!Blocks!to!target!BEBat1!were!made!with!the!same!TALE!toolkit.!A5,!5B!and!BC!blocks!were!assembled!together!via!BpiI!cutOligation! into! pENTR! 3xHAOTALE! N/CO3xFlagONLSOSTOP! (19)! or! pBT102*!TALE!Δ356/+90OGFP!(See!below).!
*
Protein*expression*and*purification*Genes! were! transferred! from! pENTR! into! pDESTO17! using! the! Gateway!recombinase! system!(Life!Technologies).!Proteins!were!expressed!and!purified!as!previously!described!(19).!In!short,!E.,coli!Rosetta!cells!were!induced!at!30°C!with! a! final! concentration! of! 0.1! mM! IPTG! for! 3! h.! HisOtagged! proteins! were!purified!by! affinity! chromatography!with! an!ÄKTA!Protein!Purification! System!(GE!Life!Sciences)!using!a!HisTrap!TALON!crude!column!(GE!Life!Science).!!
EMSAs*EMSAs!were! performed! as! described! previously! (19).! Complementary! pairs! of!labelled! or! corresponding! unlabelled! oligonucleotides! were! annealed.! Binding!reactions!contained!1!pmol!of! labelled!probe,!0!pmol,!25!pmol,!50!pmol!or!200!pmol!of!unlabelled!probe!and,!if!not!otherwise!stated,!4!pmol!of!protein.!Binding!reactions!were!incubated!at!room!temperature!for!30!mins!and!resolved!on!a!6%!native! polyacrylamide! Gel! for! one! hour! at! 100! V,! 4°C.! Labelled! DNA! was!visualized!with!a!Typhoon!FLA!9500!(GE!healthcare).!
*
E.#coli*repressor*reporter*system*The! repressor! reporter! system! we! used! is! an! adaptation! of! the! TALEObased!bacterial! NOT! gate! created! by! Politz! et, al., (25),! who! kindly! provided! us! with!
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plasmids!pCherry!(mCherry!reporter)!and!the!TALE!expression!plasmid!pBT102!with!a!designer!TALE!they!created!to!target!the!Lac!operon!cloned!inside.!!pCherry!was!modified!by!the!insertion!of!target!boxes!3’!of!the!Lac!Operon!(see!Figures! S6! and! S7)! via! PCR! amplification! of! the!whole! plasmid,! using! primers!listed! in! Table! S2.! The! sequences! of! the! promoter! derivatives! created! can! be!found!in!Figure!S7.!!We! created! a! goldenOgate! compatible! version! of! the! E., coli! TALE! expression!vector! pBT102.! This!was! done! by! PCR! amplifying! the! backbone! of! the! vector,!excluding! the! TALE! gene,! and! ligating! this! together! with! a! PCR! amplicon! of! a!gateway!cassette!flanked!by!BsaI!recognition!sites!with!overhangs!5’!TATG!–!3’!GGTG! (pBT102*! TATGOGWOGGTG;! Figure! S6)! or! 5’! CACCO! 3’! AAGG! (pBT102*!CACCOGWOAAGG).!pBT102*!TATGOGWOGGTG!was!then!made!into!a!level!3!dTALE!vector!through!the!addition!of!several!subunits!via!BsaIOcutligation,!5’!to!3’:!Δ356,
TALE, NDterminal, region,, +90, TALE, CDterminal, region,! gfp, (pBT102*! TALE!Δ356/+90OGFP;!see!Figure!S8).!!The! assay! was! carried! out! by! coOtransforming! 0.25! µl! of! pCherry! and! 0.5! µl!plasmids!into!25!µl!of!chemically!competent!E.,coli!Top10!cells!and!plating!onto!LB! Agar! plates! containing! 12.5! µg/ml! Kanamycin,! 50! µg/ml! Ampicillin! and!0.1mM!IPTG.!The!IPTG!was!added!to!prevent!interference!from!the!endogenous!lac!inhibitor!since!pCherry!has!a!lac!operator.!Plates!were!incubated!36!hours!at!37°C!to!achieve!stationary!phase!colonies.!Single!colonies!were!then!picked!into!150! µl! of! liquid! LB! medium! with! the! same! antibiotic/IPTG! concentrations! as!above,! in! wells! of! a! 96! well! Greiner! plate! with! black! sides! but! a! transparent!bottom!(Vision!plate,!4ttitude).!Cultures!were!shaken!3.5!hours!at!37°C,!180!rpm.!OD! 600! was! measured! in! a! plate! reader! (TECAN)! as! well! as! mCherry!fluorescence! with! the! following! parameters:! Excitation! 587! nm,! Emission! 610!nm,!bandwidth!±!12nm,!Gain!90,!ZOposition!6300!µm.!!Fluorescence! data!were! divided! by!OD600! to! correct! for! bacterial! density! and!these! values!were! used! as! inputs! for! the! generation! of! boxplots! in!RStudio! (v.!0.98.501).!
*
Structure*modelling*Homology! models! of! Bat1M1! 6O10! and! Bat1M2! 6O10! were! built! using! Schrödinger!Prime! (version!3.5;! Schrödinger,! LLC,!New!York,!NY,!2014).! For!both! chimeras!we! used! PDB! entry! 4cja! as! template! structure! for! modelling! the! protein.! The!template! DNA! structures! were! mutated! in, silico! using! the! software! package!3DNA!(version!2.1)!(26)!in!order!to!match!the!optimal!bases!for!both!constructs!and!merged!into!the!homology!models.!To!investigate!the!quality!and!reliability!of!the!generated!models!we!conducted!MD!simulations!of!both!models!using!the!software!package!GROMACS!(version!4.6.7)!(27).!The!protocol!that!was!applied!to! both! models! used! the! CHARMM27! allOatom! force! field! (version! 2.0)! with!CMAP(28,!29)!and!TIP3P!as!the!water!model.!In!order!to!neutralize!the!solvated!systems!water!molecules!were! replaced!by! sodium!as! counterOions! to! adjust! a!zero!net!charge.!The!models!were!energy!minimized!in!two!steps!using!steepest!descent!and!subsequent!conjugate!gradient.!A!total!of!50!ns!were!simulated!for!
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each!system!with!a!time!step!of!2!fs.!Neighbour!searching!was!performed!every!10!steps.!The!PME!algorithm!was!used!for!electrostatic! interactions!with!a!cutOoff! of! 1!nm.!A! reciprocal! grid!of! 72! x!64! x!72! cells!was!used!with!4th! order!BOspline!interpolation.!A!single!cutOoff!of!1!was!used!for!van!der!Waals!interactions.!Temperature! coupling! was! done! with! the! vOrescale! algorithm,! while! the!Berendsen!algorithm!was!used!for!pressure!coupling.!The!results!were!analysed!using! tools! from! the! GROMACS! package.! Figures! and! videos! were! generated!using!VMD(30)!(version!1.9.2)!and!R!(R!Core!Team:!A!language!and!environment!for!statistical!computing.!2013.!http://www.rOproject.org).!Potential!energy!and!RMSD!plots!are!shown!in!Figures!S10!and!S9.!Input!files!and!parameter!settings!for! both! simulations! given! in! supplementary! data! files! 3O7.! PDB! files!with! the!final! frames! of! each! MD! simulation! with! and! without! solvent! molecules! are!provided!as!supplementary!data!files!8O10.!!
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*
Results**
*
MOrTL1*and*MOrTL2*are*predicted*proteins*from*a*marine*metagenomics*
database*The! term!MOrTLs! is! throughout! used! to! refer! to! two! predicted! proteins! from!marine!microbial!genomic!DNA,!sequenced!as!part!of!the!Global!Ocean!Sampling!Expedition! (22).!Host! organisms!bearing! the!MOrTLs! sequences!were! sampled!from!the!Gulf!of!Mexico/Yucatan!Channel!and!are!most!likely!bacterial!based!on!size!filtration!of!the!biological!material!that!was!used!for!recovery!of!DNA!(0.1!to!0.8!micron)! (22,!23).!MOrTL!1!and!2!are!encoded!on! two!separate!contigs!and!each!contig!bears!an!additional!repeat!protein!ORF.!Further!details!can!be!found!in! Figure! S1;!MOrTL1! is! synonymous!with!GenBank!protein! ID!ECG96326! and!MOrTL2!with! EBN91409.! These! sequences! have! been! previously! suggested! to!encode!modular!DNA!binding! repeats! (20)!but!no! functional! analysis!has!been!reported!till!now.!!Both!predicted!MOrTL!proteins!are! tandemOrepeat!arrays,!with!each!repeat!33!amino! acids! in! length! (Figure! 1).! However,! comparing! consensus! repeat!sequences! (Figure! S2)! shows! that! MOrTLs! 1! and! 2! are! as! diverged! from! one!another!as!they!are!from!all!other!TALEOlike!groups.!We!therefore!analysed!both!MOrTL1!and!2!because!their!repeats!differ!considerably!at!the!sequence!level.!!!
Database*sequences*are*likely*incomplete*MOrTL1!is!formed!of!8!repeats,!and!MOrTL2!of!10!repeats!(Figure!1b).!Thus,!the!number! of! repeats! in! both!MOrTLs! is! fewer! than! in! any! functionallyOvalidated!natural!TALEOlike!protein!examined! to!date.! In!addition,! it!has!been!shown! for!TALEs! and! Bats! that! sequence! divergent! repeats! in! the! NO! and/or! COterminal!region!of!the!protein!make!a!decisive!contribution!to!DNA!binding!(19,!31).!Such!sequences!may!also!exist!in!the!fullOlength!MOrTL!proteins!but!are!not!found!in!the!DNA!sequences!available.!Indeed!CDSs!of!both!MOrTLs!1!and!2!begin!in!what!appears!to!be!the!middle!of!a!repeat!(Figures!S1d!and!S1h)!supporting!this!idea.!We! therefore!considered! it! likely! that! the! reference!sequences!would!not!yield!functional!proteins.!We!nevertheless!had!genes!encoding!the!predicted!MOrTLs!1! and! 2! synthesized.! We! were! able! to! express! and! purify! MOrTL1! from!
Escherichia, coli,! while! MOrTL2! formed! protein! aggregates! preventing!purification! (Figure! S3a).! MOrTL1!was! tested! in! electrophoretic! mobility! shift!assays! (EMSAs)! at! a! range! of! concentrations! against! a! fluorescently! labelled!oligonucleotide! probe! bearing! a! predicted!DNA!binding! element! (BE;!BEMOrTL1;!Figure!1)!based!on!the!TALE!code!(Table!S1).!A!shift!was!detectable!only!with!a!MOrTL1! concentration! of! 822! nM! or! greater! (Figure! S3b).! Such! weak! DNA!binding!is!inconsistent!with!expectations!based!on!other!TALEOlikes!(19,!32).!In!addition! laddering! was! observed! in! the! gel! shift! indicating! the! formation! of!higher! order! proteinODNA! complexes! (Figure! S3b)! again! inconsistent! with!TALEOlikes,! which! bind! their! targets! in! a! 1OtoO1! ratio! with! high! sequence!specificity.!!As! previously! mentioned,! both! MOrTLs! 1! and! 2! are! found! in! contigs! with!additional,!highly!similar,!MOrTL!ORFs!immediately!upstream!(Figures!S1b!and!
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S1f),! suggestive! of! a! larger! but! incompletely! sequenced! repeat! protein! in! each!case.! The! unexpectedly! weak! and!multiOspecies! binding! behaviour! of! MOrTL1!may! be! the! result! of!working!with! a! protein! fragment! only,! since! array! length!and! NO! and! COterminal! degenerate! repeats! are! known! to! be! crucial! for! high!affinity!DNA!binding!in!other!TALEOlikes!(4,!16,!19).!Since!it!has!been!shown!for!other! TALEOlikes! that! in! many! cases! repeats! can! be! rearranged! without!impairing!function!(19,!21),!we!created!a!fusion!protein!combining!the!repeats!of!both! reads! from! EN814823.1! (EBN19408DMOrTL2;, Figure! S4).! We! had! the!
EBN19408DMOrTL2! fusion! gene! synthesized! but! were! once! again! unable! to!obtain!soluble!protein!from!E.,coli,preventing!functional!analysis.!!
MOrTL*repeats*embedded*in*Bat*and*TALE*repeat*domains*bind*predicted*
BEs*in#vitro*and*in#vivo*We!next!decided!to!explore!a!repeat!domain!chimera!approach!that!has!proved!highly! informative! in! the! past! for! the! functional! analysis! of! Bat! and! RipTAL!repeats!(16,!19).!We!tested!blocks!of! five!repeats! from!the!central!part!of!each!MOrTL!embedded!within!the!repeat!domain!of!Bat1!at!positions!6O10!(Bat1M1!6O10!and! Bat1M2! 6O10;! Figure! 2a)! or! in! a! dTALE! designed! to! target! the! same! DNA!sequence! as! Bat1! (dTALEOBat1,! dTALEOBat1M1! 6O10,! dTALEOBat1M2! 6O10).! The!MOrTL! repeats! used! for! each! of! these! chimeras! are! depicted! in! Figure! 1.! We!assembled!genes! encoding! the!desired! chimeras! and!expressed! them! in!E.,coli.!Proteins!were!purified!and!tested!in!EMSAs!against!predicted!BEs.!In!each!case!the! integrated!MOrTL!repeats!differ! in! their!BSR!composition! from!the!Bat1!or!dTALE! repeats! they! replace,! which! should! lead! to! a! modified! DNA! sequence!preference.!Cognate!binding!elements!were!predicted!based!on! the!established!TALE! code! (Table! S1).! Previous! work! has! shown! that! even! one! or! two!mismatches!can!have!a!serious!effect!on!DNA!binding!of!TALE!likes!(16,!20,!33).!Thus! if! the! chimeras! containing! five!MOrTL! repeats!mediate! clear! 1OtoO1! DNA!binding! with! their! predicted! BEs! this! strongly! supports! the! hypothesis! that!MOrTL!repeats!are!actually!binding!their!cognate!DNA!bases!in!the!BEs.!This!is!indeed!what!we!observed.!Clear!single!shifts,!of!similar!intensity,!were!observed!for! every! chimeric! and! nonOchimeric! TALEOlike! at! 200!nM!with! its! cognate! BE!(Figures!2b!and!2c).!!To!study!DNA!recognition!properties!of!MOrTL!repeats!in,vivo!we!also!developed!an! E., coliObased! repressor! reporter.! This! system! was! an! adaptation! of! a!previously!described!TALEObased!bacterial!NOT!gate!(25).!In!this!system!binding!of!a!TALEOlike!protein!at!a!predicted!BE!inserted!into!a!constitutively!active!Trc!promoter! inhibits! expression! of! the! downstream! fluorophore! (mCherry).! Thus!reduction! in! fluorescence! levels! should! directly! relate! to! the! strength! of! the!interaction!between!the!given!BE!and!the!tested!TALEOlike!protein.!!In! this! assay! mcherry! reporter! plasmid! and! TALE! expression! plasmid! are!coOtransformed!into!E.,coli.!Expression!of!both!TALE!and!mCherry!is!driven!from!synthetic!constitutive!promoters.!A!lac!operator!sequence!(LacO)!is!contained!in!the! Trc, promoter,! which! drives!mcherry, expression.! In! the! original! system! a!dTALE!made! to! bind! this! operon! (dTALEOLacO)! shuts! off!mCherry! expression.!We!modified! this! set!up!by! inserting!an!additional!BE!of! choice! just!3’!of!LacO!(see!Fig.!S6).!The!TALE!expression!plasmid!was!also!modified!to!allow!insertion!
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of!a!bat1,!dTALEDbat1,or,MOrTLDchimera,gene.!Repression! is!measured!relative!to!a!negative!control!plasmid!(gfp)!and!is!used!as!a!proxy!for!DNA!binding.!The!setOup! is! illustrated! in! Figure! 3a.!We! found! that! Bat1M1!6O10!and! Bat1M2!6O10,! the!Bat1!derivatives!bearing!five!MOrTL!repeats,!were!able!to!repress!their!cognate!reporters! to! levels! similar! to! that! of!wild! type! Bat1! (Figure! 3b).! Similarly,! the!TALEOMOrTL1! chimera,! dTALEOBat1M1!6O10,! performed!well,! able! to!mediate! an!11.6Ofold!repression!of!its!target!reporter,!compared!to!9.5Ofold!for!dTALEOBat1!wild! type! (Figure! 3c).! However,! dTALEOBat1M2!6O10! was! only! able! to!mediate! a!weak! repression,! 1.6Ofold! relative! to! the! GFP! control.! Overall,! however,! the!strong!repression!observed!for!three!out!of!four!tested!chimeras!corroborate!the!
in,vitro!binding!data,!supporting!the!hypothesis!that!MOrTL!repeats!function!as!TALEOlike!DNA!binding!repeats!with!the!expected!properties.!!The! poor! performance! of! dTALEOBat1M2!6O10! in! the! in, vivo! assay! (Figure! 3c)! is!seemingly! inconsistent!with! the! results! of! the! in, vitro! EMSA! approach! (Figure!2c).! This!may,! however,! relate! to! fundamental! differences! in! the! nature! of! the!two! approaches.! In! the!EMSA! approach! the! protein! is! added! in! fourfold!molar!excess!to!the!perfectOmatch!(onOtarget)!probe!DNA,!whilst!in!the!in,vivo!approach!the!matching!DNA!binding!element!is!just!one!of!millions!of!potential!DNA!target!sites! within! the! bacterial! cell.! Thus! a! certain! degree! of! sequence! specificity! is!necessary!to!see!any!repression!using!the!in,vivo,approach.!Thus!if!the!sequence!specificity! of! the! protein! is! low! we! might! expect! a! poor! performance! in! the!repressor!assay!due!to!offOtarget!binding,!while!the!EMSA!is!still!expected!to!give!a! clear! shift! since! competing! offOtargets! are! absent! in! this! assay.! Thus! the!differences!we! see! for! dTALEOBat1M2!6O10!in! the! in, vitro! and! in, vivo! assays!may!relate!to!differences!in!specificity,!as!discussed!below.!!
Off$target*binding*tests*confirm*sequence*specificity*in#vitro*and*in#vivo*To! carry! out! EMSA! competition! assays! we! designed! offOtarget! BEs! using! the!TALEOcode! (Table! S1)! to! test! if! the! MOrTL! repeats! conform! to! the! sequence!specificity! expectations! of! TALEOlike! repeats.! Only! bases! 6O10! in! the! BEs!(corresponding!to!MOrTL!repeats!in!the!chimeras)!were!altered,!while!all!others!were! kept! identical.! We! chose! the! least! favoured! base! in! each! case! for!corresponding!BEs:!G!used!for!Gly!at!the!BSR!and!T!used!for!Arg,!Asp!or!Ile!at!the!BSR.!GGTTG!(BEBat1OGGTTG)!was!used! for!all! constructs!except!dTALEOBat1M2!6O10,!for! which! the! offOtarget! sequence! is! TTGGT! (BEBat1OTTGGT).! In! the! EMSA!competition!assays!the!labelled!onOtarget!probe!is!mixed!with!an!excess!of!either!onO! or! offOtarget! competitor!DNA! to! study! sequence! specificity! of! proteinODNA!interactions.!If!MOrTL!repeats!are!indeed!sequenceOspecific!in!their!DNA!binding,!an! excess! of! the! onOtarget! competitor! should! outcompete! the! onOtarget! probe,!leading!to!a!loss!of!shifted!signal!while!an!excess!of!offOtarget!competitor!should!have!a!less!pronounced!impact!on!probeOprotein!interaction.!As!seen!in!Figure!4!this!was!indeed!observed!in!every!case!except!for!dTALEOBat1M2!6O10!(Figure!4e).!Quantifications!of!the!intensity!of!shifted!and!free!probe!for!these!gels!are!shown!in!Figure!S5.!In!the!case!of!dTALEOBat1M2!6O10!the!onO!and!offOtarget!competition!assays! gave! very! similar! levels! of! shift! depletion! indicating! poor! sequence!specificity!of! the!chimeric!protein.!This!observation! is!consistent!with!the!poor!performance! of! this! chimeric! protein! in! the! in, vivo! reporter! (see! above).! In!addition!Bat1M1!6O10!and!Bat1M2!6O10!(Figures!4a!and!4b;!S5)!showed!some!limited!
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shift!depletion!with! the!offOtarget!DNA.!This!was!however! far!weaker! than! the!depletion!seen! in!combination!with! the!onOtarget!DNA.!However,! in! the!case!of!Bat1! the! shift! band! (Figure! 4c;! S5),! was! hardly! reduced! in! intensity! even! in!presence!of!200Ofold!excess!of!offOtarget!competitor!DNA.!It!may!be!that,!at!least!in! this!specific!chimeric!context,!MOrTL!repeats!are!slightly! less!discriminating!in!their!DNAObinding!sequence!specificity!than!Bat1!repeats.!!
in, vivo! assays! confirmed! that! reporters! bearing! offOtarget! boxes! were! not!repressed!by!the!tested!DNA!binding!proteins!(Figure!6).!This!confirms!that!the!strong! repression! seen! in! onOtarget! boxes! (Figure! 3)! is! dependent! on! the! five!MOrTLs! repeats! pairing! baseOspecifically! with! the! five! cognate! nucleotides! of!their!BEs.!Overall!these!data!show!that!MOrTL!repeats!are!able!to!mediate!DNA!binding!in!accordance!with!the!TALE!code.!!
Functional*conservation*is*likely*a*consequence*of*structural*conservation*We!were!able!to!show!that!MOrTL1!and!2!repeats!mediate!DNA!binding!with!a!sequence!specificity!matching! the!TALE!code!when!embedded! in!a!Bat1!repeat!array.! The! same! could! be! confirmed! for!MOrTL1! in! a! TALE! repeat! array.! DNA!binding!properties!are! thus!conserved!among!repeats!of!TALEs,!RipTALs,!Bats,!MOrTL1! and! MOrTL2.! They! are! also! functionally! interchangeable! as! we! have!shown! in! this! study! and! previous! studies! showing! that! chimeric! TALE! repeat!arrays! containing! RipTAL! and! Bat! repeats! are! functional! (16,! 19).!We! suggest!that!this!functional!conservation!justifies!the!use!of!the!term!TALEOlikes!to!refer!to!proteins!bearing!a!tandem!array!of!33O35!amino!acid!repeats!mediating!1OtoO1!DNA! binding! with! position! 13! determining! DNA! binding! specificity! at! least!largely! in! accordance! with! the! conserved! TALE! code.! This! functional!conservation!is!suggestive!also!of!a!structural!conservation!allowing!each!repeat!to! contact! a! single! nucleotide! and! for! position! 13! to! mediate! base! specific!interactions.! Yet! the! sequence! similarity! between! TALEOlike! repeats! can! be!below!40%!(Figure!S2).!Structural!conservation!can!hardly!be!taken!for!granted!for!such!dissimilar!proteins.!!There! is! however,! already! evidence! in! support! of! a! high! degree! of! structural!similarity!among!TALEs!and!Bats.!Crystal!structures!for!Bat1,!with!and!without!its! DNA! target,! have! been! solved! (21)! and! are! very! similar! to! analogous!structures! for! TALEs! PthXo1,! AvrBs3! and! dTALE!dHax3! (34–36).! All! examples!possess!the!same!super!helical!structure!that!contracts!tightly!around!the!BOform!DNA! double! helix.! Additionally,! position! 13! residues! are! located! in! loops! that!point! into! the!major! groove! of! the! target! DNA.! Assuming! these! features! form!structural!prerequisites!for!the!DNAObinding!properties!of!TALEOlikes,!we!expect!the!MOrTL! repeats,! for!which! no! experimentally! derived! structure! is! available!yet,! to! adopt! a! similar! structure.! To! support! this! hypothesis,! we! generated!models! of! the! functionally! validated! chimeras! Bat1M1!6O10! and! Bat1M2!6O10.! Both!models!show!structural!properties!similar! to! those!described!earlier! for!TALEOlike! repeats! (Figure! 6;! supplementary! data! files! 1O2).! While! these! homology!models!resulted!in!a!plausible!protein!structure,!they!do!not!provide!functional!information.!To!get!information!about!the!stability!of!the!predicted!proteinODNA!interaction! interfaces! over! time! we! conducted! molecular! dynamics! (MD)!simulations! of! the! MOrTL! homology! models! bound! to! DNA.! Both! simulations!
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revealed! highly! stable! complexes! between! the! proteins! and! their! target! DNA,!seen! in! the! values! for! atomic! distances! between! protein! and! DNA! partners!(Figure!S9)!and!potential!free!energy!of!the!complexes!(Figure!S10).!Measuring!baseOBSR!distances!during!MD!simulations!showed!that!interactions!were!stable!and!comparable!for!Bat1!and!MOrTL!repeats!(Tables!S3!and!S4).!This! is! in! line!with!our! in,vitro! and! in,vivo!DNAObinding!data.! Taken! together,! it! seems! likely!that,! despite! amino! acid! sequence! similarities! below! 40%,! repeats! of! TALEs,!RipTALs,! Bats,! MOrTL1! and! MOrTL2,! adopt! similar! structures,! facilitating! a!conserved! DNAObinding! mechanism.! We! suggest! therefore! that! the! TALEOlike!designation! should!not! refer! to!proteins! conforming! to!a!particular!aminoOacid!sequence! but! to! any! proteins! bearing! a! repeat! array! conserved! with! those! of!TALEs!both!functionally!and!structurally.!!!
MOrTL*repeats*differ*from*all*other*TALE$likes*in*residues*around*the*BSR**The!structural!similarities!between!TALEOlike!repeats!are!surprising!considering!the!low!sequence!similarity.!To!illustrate!the!variation!among!TALEOlike!repeats!we!created!amino!acid!alignments!of!core!repeats!from!representatives!of!each!TALEOlike! group! so! far! described! (13! TALEs,! 5! RipTALs,! Bat1/Bat2! and! both!MOrTLs;! Figure! 7;! see! Table! S5! for! list! of! TALEOlikes! used).! These! alignments!show! first! that! TALE! repeats! are! somewhat! exceptional! for! their! very! low!sequence!diversity.!In!all!other!TALEOlike!groups!more!than!one!third!of!repeat!positions! are! highly! polymorphic.! More! specifically! TALEs! are! highly!polymorphic!only!at!five!positions:!4,!12,!13,!32!and!35.!Bat!and!RipTAL!repeats,!in!contrast,!are!polymorphic!across!much!of!the!long!helix!(positions!15O32)!and!interOrepeat!loop!(positions!33O2)!regions.!!Percentage! conservation! at! each! repeat! position!was! calculated! separately! for!each! TALEOlike! group.!We! then! took! the! average! conservation! for! each! repeat!position! across! the! five! TALEOlike! groups,! thus! giving! equal! weight! to! the!conservation!found!in!each!of!TALEs,!RipTALs,!Bats,!MOrTL1!and!MOrTL2.!This!average!withinOgroup! conservation! is! shown! in! the! line! graph! underneath! the!alignments! (Figure! 7b)! With! the! exception! of! residue! 12! and! the! BSR,!conservation! is! 90%! or!more! across! residues! 5O20.! The! conservation! of! these!residues! is! logical! considering! their! proximity! to! the! crucial! BSR! position! (see!Figure!6).!!!Examining! the! sequences! for! each! TALEOlike! group! reveals! that! some! of! these!residues!are!conserved!not!just!within!but!also!between!groups.!Between!TALEs,!RipTALs!and!Bats!there!is!almost!no!polymorphism!at!positions!7,!9,!10,!14,!15!and!17O19.!This!is!limiting!for!repeat!engineering!efforts!because!these!residues!cluster! around! the! BSR! and! are! therefore! especially! likely! to! exert! significant!influence! over!DNA! binding! properties.! Furthermore,! any! effort! to! use! natural!diversity! to! create! sequenceOdiverse! TALEOlikes! less! prone! to! repeat!recombination!(37,!38)!will!be!held!back!by!the!lack!of!sequence!diversity!in!this!region.!!Repeats! of!MOrTL1! and! 2,! however,! have! a! number! of! residues! in! this! region!around! the! BSR! not! found! in! repeats! of! any! other! TALEOlike! (Figure! 7a;! red!lettering).!At!positions,!10,!15,!and!17O19!there!is!little!to!no!sequence!diversity!
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among!TALEOlikes!except! that! found! in!MOrTLs!1!and!2.!Thus!MOrTLs!1!and!2!make!a!substantial!contribution!to!the!sequence!diversity!of!TALEOlike!repeats!in!residues!around!the!BSR;!a!contribution!that!may!prove!crucial!for!future!efforts!to!engineer!TALEOlike!repeat!arrays.!!
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Discussion!!We!have!been!able!to!show!that!repeats!from!MOrTL1!and!2!(Figure!1)!recognise!DNA!with!a!sequence!specificity!matching!the!TALEOcode!(Figures!2O5),!despite!more! than! 60%! of! residues! differing! from! previously! characterised! TALEOlike!repeats!on!average!(Figure!S2).!Blocks!of!five!MOrTL!repeats,!embedded!in!Bat1!or! designer! TALE! repeat! arrays,! were! competent! to! discriminate!TALEOcodeOpredicted! onOtarget! BEs! (Figures! 2b,! 2c,! and! 3),! from! offOtarget!sequences! (Figures! 4! and! 5).! Sequence! specificity! was! highly! stringent! for! all!tested!constructs!except!for!dTALEOBat1M2!6O10.!The!superior!performance!of!the!Bat1OMOrTL2! chimera! compared! to! the! dTALEOMOrTL2! chimera! suggests!functional!differences!in!the!MOrTL2!repeats!used!for!the!two!chimeras,!or!some!functional! interference!between! the!given!TALE!and!MOrTL2! repeats.! Since!all!onOtarget! and! mismatch! sequences! were! predicted! based! on! the! TALEOcode!(Table!S1)!our!results!overall!suggest!that!the!MOrTL!repeats!within!the!tested!chimeras! were! able! to! mediate! DNA! recognition! with! a! sequence! specificity!matching!that!of!previously!characterised!TALEOlikes.!!!Based! on! previous! knowledge! of! TALEOlike! repeatODNA! interactions! our!observations!strongly!suggest!direct!binding!of!the!cognate!DNA!bases!by!MOrTL!repeats.!An!alternative!explanation!is!that!the!MOrTL!repeats!passively!tolerate!onOtarget! bases! but! sterically! clash! with! offOtarget! bases,! similar! to! the! GSL!repeats! of! some!TALEs! (6,! 35).!However,! such!TALE! repeats! are! relatively!unOdiscriminating!(39),!inconsistent!with!our!observation!of!high!stringency!of!DNA!target! recognition! for! TALEO! and! Bat1OMOrTL! chimeras! (Figures! 4! and! 5).!Furthermore,!homology!models!combined!with!MD!analysis!suggest!that!MOrTL!and!Bat1!repeats!are!conserved!in!overall!structure!(Figures!6,!S9!and!S10)!and!in!proximity!between!BSRs!and!cognate!bases!(Tables!S3!and!S4).!Our! findings!support!the!hypothesis!that!despite!low!sequence!similarity!the!repeat!arrays!of!TALEs,! RipTALs,! Bats! and! both! MOrTLs! are! able! to! bind! DNA! with! a! largely!conserved!mechanism.!!The! repeats! of! MOrTLs! 1! and! 2! substantially! increase! the! total! variability! of!TALEOlike!repeats!(Figure!7).!Because!MOrTL!repeats!have!unique!sequences!in!the!otherwise!highly!conserved!BSR!cluster!of!residues!(Figure!7a;!red!lettering)!they! represent! a! qualitatively! different! variabilityOcontribution! from! that! of! all!other!functionally!validated!groups.!As!we!have!demonstrated,!MOrTL1!repeats!seem!to!be!readily!compatible!with!TALE!and!Bat!repeats!whilst!MOrTL2!repeats!are!at!least!compatible!with!Bat!repeats!(Figures!2O4).!This!suggests!that!MOrTL!repeats!or!repeat!subdomains!can!be!combined!with!other!TALEOlike!repeats!for!the!creation!of!novel!TALEOlike!repeat!arrays.!The!sequence!diversity!of!MOrTL!repeats!thus!presents!a!unique!and!potentially!valuable!contribution!to!the!pool!of!available!sequences!for!TALEOrepeat!engineering.!!Even!without!using!MOrTL!repeats!directly!in!engineered!TALEOlike!repeats!the!comparison! of! TALEOlike! repeat! sequences! may! improve! understanding! of!TALEOlike! repeat! structure! and! its! relation! to! DNA! binding! properties.! This!improved!understanding!will!in!turn!benefit!TALE!repeat!engineering!efforts.!Till!
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now! descriptions! of! the! roles! of! different! TALE! or! TALEOlike! repeat! residues,!apart!from!the!RVD,!have!come!only!from!predictions!based!on!structural!models!(21,!34,!35).!Hypotheses!about!residue!roles!remain!largely!untested!in!a!wet!lab!setting! though! molecular! dynamics! simulations! have! provided! some! insights!(40).!Using!data!from!the!natural!experiment!of!evolution!can!help!answer!some!questions! or! provide! a! starting! point! for! hypothesis! testing,! complementing!other! methods.! For! example,! positively! charged! residues! Lys16! and! Gln17! of!TALE! repeats! have! been! suggested! to! form! an! electropositive! stripe! along! the!TALE!superhelix!and!to!form!hydrogen!bonds!to!the!phosphate!backbone!of!the!DNA! (34).! In! Bat! and!MOrTL! repeats,! position! 16! is! generally! occupied! by! an!uncharged! residue! speaking! against! the! importance! of! Lys16! for! repeat! array!function,! unless! the! effect! is! elsewhere! compensated.! Gln17! in! contrast! is!conserved!across!all!groups,!except!for!MOrTL2!where!a!Lysine!is!found!at!this!position.! This! would! support! an! important! role! for! the! electropositive! strip!formed! from!positive! residues!at!position!17!only.!To! take!another!example,! it!seems! logical! that! the! highly! conserved! double! Glycine! at! positions! 14O15! in!TALEs,!RipTALs,!Bats! and!MOrTL2! is!necessary! for! the! flexibility!of! the! repeat!loop.! MOrTL1! repeats! have! either! Alanine! or! Serine! at! position! 15;! does! this!effect! flexibility!of! the!BSR! loop!and!consequently! the! interaction!between!BSR!and!base?!Other!positions!are!surprisingly!conserved.!Leu29!is!one!of!only!three!residues!highly! conserved!between! all! the!TALEOlike! groups.! Till! now! the! only!function!attributed!to!this!residue!is!a!role!in!hydrophobic!interactions!that!bring!together! neighbouring! repeats! as! the! TALE! structure! contracts! upon! DNA!binding! (21),! yet! other! hydrophobic! residues! seem! not! to! be! tolerated! at! this!position.! Since!MOrTL! repeats! are! polymorphic! at! otherwise! highly! conserved!positions! in! all! other! TALEOlikes! they! may! be! especially! useful! for! such!comparative! approaches! to! understanding! the! interplay! of! sequence,! structure!and!function!in!the!TALEOlike!repeat.!!MOrTL1! and! 2! also! make! useful! outgroups! for! asking! questions! about! the!evolutionary! history! of! other! TALEOlikes.! As! mentioned! previously! TALE! and!RipTAL! repeats! are! conserved! at!many! positions,!while! the! Bats! show! greater!sequence! divergence.! However! some! residues! around! the! BSR! are! conserved!among!TALE,!RipTAL!and!Bat!repeats!(Figure!7).!So!far!it!has!remained!an!open!question!as!to!whether!these!sequence!similarities!are!an! indicator!of!common!evolutionary! origin! or! are! rather! the! result! of! convergent! evolution! of! similar!proteins!with!a!constrained!sequenceOstructure!space.!The!diversity!of!MOrTL1!repeat! sequences! in! this! region! shows! that! several! alternative! sequences! are!tolerated!within!this!structure.!Therefore,!that!the!TALEs,!RipTALs!and!Bats!are!conserved! in! this! region! suggests! that! the! share! a! common! ancestor.! Another!insight!can!be!gained! from!comparing!the! level!of!diversity! found!among!TALE!repeats!to!those!of!other!TALEOlikes.!RipTAL,!Bat!and!MOrTL!repeats!are!highly!diverse!across!much!of!the!longOhelix!and!interOrepeat!loop!region,!while!there!is!little! repeat! diversity!when! comparing! repeats! of! all! known!TALEs! (Figure! 7).!Furthmore,! there! is! almost! no! nonORVD! repeat! polymorphism! between! the!repeats! of! any! single! TALE! repeat! array! (for! example,! compare! repeat! array!alignments! of! TALE! AvrBs3! and! RipTAL! Brg11,! Figure! S12).! The! majority! of!sequence! diversity! among! TALE! repeat! comes! from! positions! polymorphic!between! repeat! arrays! but! conserved!within! each!particular! array,! contrasting!
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with! the! other! TALEOlikes.! The! withinOarray! sequence! conservation! of! TALE!repeats! could! be! the! result! of! a! selective! pressure! against! sequence!diversification.!Such!hypotheses!required!further!investigation!and!we!hope!that!the! MOrTLs! will! prove! useful! as! an! outgroup! for! future! studies! into!sequenceOfunction!relations!and!into!the!evolution!of!the!TALEOlikes.!!Considering!the!full!sequence!diversity!of!TALEOlike!repeats!may!even!assist!with!the! identification! of! future! functional! homologs! and,! through! these,! novel!evolutionary! insights.! Whilst! TALE! repeats! are! highly! conserved! across! most!positions!only!three!residues!are!conserved!across!all!TALEOlike!groups!(Figure!7b,! yellow! shaded):! Val7,! Gly14! and! Leu29.! That! these! positions! are! so! highly!conserved! suggests! functional! importance! as! discussed! above,! but! in! addition!these! conserved! residues! allow! us! to! provide! a! broad! sequence! definition! of!TALEOlike!repeats!as!conforming!to!the!motif!X6VX6GX13LX4O6.!This!motif!may!be!useful!as!a!basis!for!identifying!additional!TALEOlikes!from!genome!sequences.!!By!demonstrating!that!MOrTL!repeats!mediate!the!same!DNA!binding!behaviour!as!other!TALEOlike!repeats!(Figures!2O4)!we!have!gained!insights!into!the!nature!of!the!whole!TALEOlike!family!and!we!hope!this!will!enable!further!research!into!the!distribution!and!functions!of!these!fascinating!DNA!binding!proteins.!!!
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Figure 1
Amino acid sequences and cartoon graphics of predicted proteins MOrTL1 (ECG96326) and 
MOrTL2 (EBN19409). (a) The amino acid sequences are given as a series of aligned tandem repeats 
prepared with Boxshade. Repeat positions 10, 20 and 33 are indicated above each alignment as is 
residue 13, designated BSR based on our assumption that this is the base specifying residue.  Core 
repeats are numbered down the left-hand side in each case, excluding those repeats less than 50% 
identical to the consensus, shown below. (b) Cartoon representations of the two proteins with core 
repeats (dark blue polygons) ordered N to C terminal with BSRs indicated (white font). Predicted 
binding bases are indicated under repeats, with predictions made using the TALE code. The MOrTL 
repeats used for chimera creation are indicated with grey shading (Bat1 chimeras) or a dashed-line box 
(dTALE chimeras). 
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Figure 2
Bat1-MOrTL and TALE-MOrTL chimera 
proteins bind predicted target sequences in 
vitro. (a) Schematic display of chimeras containing 
!ve MOrTL1 or MOrTL2 repeats (dark blue polygons) 
in place of repeats 6-10 of Bat1 or dTALE-Bat1 (grey 
ovals). BSRs of the Bat1 repeats are given in each 
case, with an asterisk (*) for repeat 20 of Bat1 which 
lacks an amino acid at position 13, in reference to 
the consensus sequence. Where dTALEBat1 BSRs 
di"er from Bat1 they are given above the dotted line 
in the relevant repeat. The last three repeats of Bat1 
are outlined with dashes to re#ect that dTALE-Bat1 
is three repeats shorter.  Binding elements (BEs) for 
each TALE-like chimera were predicted using the 
TALE code and are given below the cartoon display 
with dots indicating identical bases.  Circles (°) 
indicate BEs used for more than one protein (BEBat1 
for Bat1 and dTALE-Bat1; BEBat1 M1 6-10 for Bat1M1 6-10 
and dTALE-Bat1M1 6-10. Electrophoretic mobility shift 
assays (b, c) were carried out using 5' Cy5-labelled 
double-stranded DNA probes at a ϐ
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An in vivo  ϐ      Ǥ ȋȌ Schematic 
display of repressor assay: mCherry reporter (red symbols) and expression plasmids encoding TALE-likes are 
co-transformed into E. coli. TALE-like chimeras consist of TALE/Bat-repeats (grey ovals) and MOrTL-repeats (dark 
blue ovals). If the TALE-like is able to bind the given BE and repress the mCherry promoter (DNA black, BE grey/dark 
blue rectangle) this is observed as a reduction in mCherry !uorescence (red cherries).  A dTALE that binds the Lac 
Operon (LacO) within the mCherry promoter provides a positive control for each reporter (BE shown with orange 
box). (b) Box and whisker plots showing mCherry !uorescence values for Bat1, Bat1M1 610 and Bat1ʹ͸ǦͳͲtested 
against reporters bearing corresponding BEs (designation across the top of each plot), normalized to cell density 
(OD600) and compared to positive (LacO TALE) and negative (GFP) control expression plasmids. Fold repression, 
based on median values, and p-values of a 2-tailed t-test with unequal variances comparing test and GFP samples 
are given in the top left corner of each plot. (c) dTALE-Bat1 and its two MOrTL chimera derivatives tested in the 
same system. Bat1 and dTALE-Bat1 have the same binding elements, as do Bat1M1 610 and dTALE-Bat1M1 610, so the 
same reporters are used for these constructs and the corresponding data for LacO and GFP are shown in both sets 
of box and whisker plots. N=16 in every case. 
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. Puri!ed protein was incubated with 5 nM 5’ Cy5 labelled double-stranded DNA probes. For the 
competition tests, the concentration of unlabelled competitor DNA was 25-200x that of the labelled 
probe. The o"-target sequence was designed to bear mismatch bases for repeats 6-10 of each 
construct based on the TALE code (BEBat1 TTGGT for dTALE-Bat1ʹ ͸ǦͳͲ   and BEBat1 GGTTG for all other 
constructs). Proteins used were (a) Bat1M1 6-10, (b) Bat1ʹ ͸ǦͳͲ, (c) Bat1, (d) dTALE-Bat1M1 6-10, (e) 
dTALE-Bat1ʹ͸ǦͳͲ and (f) dTALE-Bat1. In each case the designation of the protein used is underlined, 
the probe italicized and the competitor bold and italicized. DNA-protein complexes and free probes 
are indicated with asterisks (*) and tildes (~), respectively. Plus/minus symbols indicate presence or 
absence of the respective DNA or protein. 
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Figure 5
Bat1- and TALE-MOrTL chimeras do not activate off-target reporters in vivo. O!-target 
reporters were created with mismatch bases for repeats 6-10 of each construct based on the TALE 
code. These were tested against cognate TALE-likes and chimeras: (a) BEBat1 GGTTG , all constructs except 
dTALE-Bat1ʹ ͸ǦͳͲ, (b) BEBat1 TTGGT with dTALE-Bat1ʹ ͸ǦͳͲǤ Box and whisker plots show mCherry 
"uorescence values normalized to cell density (OD600) and compared to positive (LacO TALE) and 
negative (GFP) control expression plasmids for each reporter tested against all relevant TALE-likes and 
chimeras. N=16 in every case.
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In silico    ͳǦ       
correspond to known TALE-like structures. ͳM1 6-10 (a) ͳʹ͸ǦͳͲ (b) 
Ͷ in 
silicoǤ Single snapshots of the models bound 
to DNA (purple) are shown. Bat1 repeats are shown in grey. MOrTL repeats are highlighted in dark blue. 
Models are orientated with the N-terminus of each protein in the bottom left corner.
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  Ǥ (a) Repeat alignments and corresponding sequence logo were made from 
representative core repeat arrays from each TALE-like group characterized so far, using CLC Main 
Workbench 7. In the sequence logo the total height in each column correlates to conservation at that 
position. Repeat positions are indicated above the sequence logos. Dark blue arrows indicate likely 
alpha-helical regions based on crystal structures of TALE and Bat repeat arrays. Residues unique to 
MOrTL1/MOrTL2 at positions 5-19 are highlighted with red lettering. A yellow background highlights 
residues conserved across all TALE-like core repeats. (b) Graph shows within-group sequence 
conservation at each position, averaged across the !ve groups. Conservation ηͻͲΨȋǦȌ
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6 Discussion 
 
6.1 Overview  
The molecular characterization of RipTAL proteins (Chapter 3) was undertaken to reveal the role these 
proteins might play in bacterial wilt disease and to assist future efforts to breed or engineer resistance 
to bacterial wilt. It had been assumed by many that the RipTALs and TALEs function similarly, and 
particularly that RipTAL repeats, like those of TALEs, bind DNA in a sequence specific manner like 
TALE repeats (74). However so many positions are polymorphic between TALE and RipTAL repeats 
(Figure 1.8B) and between individual RipTAL repeats (Figure 1.7), that we considered such an 
assumption inadvisable. Therefore, each repeat was tested individually for base preference, but in 
each case results corresponded to results for TALE repeats with the same RVDs (3: Figure 3). The 
TALE code was indeed broadly conserved between TALEs and RipTALs. This code was thus taken as 
an assumption for further work, and found to hold for canonical repeats of Bat1, Bat2, MOrTL1 and 
MOrTL2 (chapters 3 and 4). This was surprising considering the sequence identities for canonical 
repeats of the different groups dropping well below 40% in many cases. Together this work provides 
evidence of functional conformity in the face of considerable sequence diversity. 
With that said some notable differences were found in the DNA recognition properties of different 
TALE-likes. Non-BSR polymorphisms were found to have some impact on the DNA recognition 
properties of canonical repeats (3: Figures 3, 4 and S9) as well as on inter-repeat compatibility (4: 
Figure 5). TALEs require a T0, RipTALs a G0 (3: Figure 7) and Bat1 no preference at all (2.2: Figure 2). 
These and related observations are highly relevant for future work on TALE technology.  
In addition, conformity stops at the canonical repeats with domain structure dividing the TALE-likes 
into at least two groups: the TALEs and RipTALs as contrasting with the Bats, MOrTL1 and MOrTL2. 
Comparing each group to the TALEs reveals that the TALE-like canonical repeat can be considered as 
a functionally equivalent domain in all groups though if it is homologous or the result of convergent 
evolution is unresolved. The canonical TALE-like repeat is, however, the only unifying feature of the 
TALE-likes.  
 
6.2 Placing this work into the context of similar studies 
 
In the case of both the RipTALs and Bats, molecular characterizations were published just prior to 
those presented in this thesis. Here I briefly outline those publications and how they compare to the 
findings presented in this thesis. These are discussed here before continuing on to address the 
questions posed in the introduction, so that conclusions can be placed into their appropriate context.  
 
Characterization and DNA-binding specificities of Ralstonia TAL-Like effectors. Lixin Li et al., July 2013 
(75)  
 
The findings of this paper somewhat corroborated our own, but differ markedly in places, probably 
because they used a very different approach for DNA recognition analysis. The RipTALs (here 
designated RTLs) that they worked with were chimeric derivatives bearing native non-canonical-repeat 
regions and arrays composed of tandemly arranged consensus repeats, or with these consensus 
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repeats embedded into TALE Hax3 in place of its canonical repeats. They showed that the consensus 
repeats flanked by native RipTAL regions localize to the nucleus. They were also able to show that 
consensus RipTAL repeats embedded in a Hax3 backbone activate reporters with predicted EBEs. 
They also modified the RVDs of the consensus repeats and tested specificity by using these chimeras 
to challenge reporters bearing different EBEs.  In some cases their findings match our own: Asp 
repeats activate the C reporter only; Asn the A and G reporters. In other cases their results differ most 
strikingly Pro repeats activate all except for the T reporter, in their system. These differences may 
indicate the importance of non-BSR polymorphisms and/or repeat array context effects: they tested 
full arrays of consensus repeats, whereas we tested trimers of natural Brg11 repeats embedded in a 
TALE.  
 
They were unable to show reporter activation by any full-length native RipTAL nor did they show 
activation by any of the consensus repeat arrays embedded in RipTAL non-canonical-repeat domains. 
Possibly such attempts were made but the G0 preference of RipTALs (3: Figure 7) was not taken into 
account. They did in fact question the zero base specificity but used a RipTAL consensus repeat array 
embedded into a Hax3 backbone, including the Hax3 N-terminal non-canonical repeats. 
Unsurprisingly they discovered that T0 is preferred.  
         
 
Additional publications covering a molecular characterization of Bat1: Stella et al., January 2014 (76); 
Juillerat et al., January 2014 (56); Stella et al., May 2014 (77) 
 
Three publications in quick succession came in 2014 from a collaboration of biomedical technology 
company Cellectis and the Spanish National Cancer Research Centre. Together they present a 
reasonably comprehensive report of Bat1-DNA binding interactions, and a number of demonstrations 
of the potential of Bat1 to act as a programmable DNA binding protein. Overall their findings agree 
with and complement our own. Bat1 is referred to in these publications as BurrH, or BuD when 
referring only to the canonical repeats.  
 
The first of these publications reported the crystallization of Bat1 without presenting a structure (76). 
However it included an EMSA with Bat1 against predicted target sequence 5’-
TTAAGAGAAGCAAATACGTTAA-3’. The italicized bases indicate cognate bases of the canonical 
repeats of Bat1, with the only base differing from BEBat1 (4: Figure 1) underlined.  
 
The second paper presented a further molecular characterization of Bat1 and explored the possibility 
of using Bat1 to create designer nucleases (56). They created Bat1-FokI fusions and demonstrated 
their function with a yeast single strand annealing reporter bearing two inverted repeats of BEBat1. They 
also tested versions of this reporter with all possible bases at positions 0, -1 and -2, finding no activity 
differences. This corroborates and extends our own finding that Bat1, unlike TALEs and RipTALs, has 
no fixed zero base preference, and that Bat1-FokI fusions function analogously to TALENs (4: Figure 
4). 
 
They then continued to test Bat1 nucleases in human cell culture targeted at endogenes, a necessary 
step if such nucleases are to be considered as an alternative for TALENs.  
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As part of their nuclease studies they created a designer repeat array of Bat1 by modifying BSRs only. 
That this approach proved successful supports our suggestion that the RVD-switch approach (4: 
Figure 5) is a good approach for modifying Bat1 repeat specificity.  
 
The last of these publications provided not only a crystal structure for the Bat1-DNA complex but also, 
more fine-grained DNA binding analysis and a further exploration of designer nucleases (77).  
 
Using isothermal calorimetry they tested the binding interactions of Bat1 and different species of 
nucleic acid single-stranded (ss) and double-stranded (ds) DNA and RNA, and combinations thereof 
bearing BEBat1. Of the tested species they found that the Bat1-dsDNA interaction gave the strongest 
affinity (Kd=25nM). The next best binding partner was a +DNA/-RNA duplex with an affinity half as 
strong as that for dsDNA. ssDNA, +RNA/-DNA, and also the random sequence DNAs they tested 
yielded no or extremely weak binding interactions. This all accords with a similar finding for TALEs 
(78), yet again demonstrating the analogous DNA binding properties of TALEs and Bats.  
 
Binding kinetics were also addressed. They found first that AvrBs3 showed a twofold faster 
dissociation rate from its target DNA than Bat1 from its target. It would be interesting to know if this 
can be generalized for Bat vs. TALE DNA interactions. A study utilizing in-vivo fluorescence 
measurements after bleaching to estimate dissociation times for TALE-DNA interactions found that 
signal remained after over 7 minutes, indicating an extraordinarily stable interaction (32). Could Bat-
DNA interactions be more stable still?  
 
Importantly in this article they present a crystal structure of Bat1, alone and bound to its DNA target. 
They were able to resolve a structure for the whole protein and revealed a continuous solenoid of 
helix-turn-helix repeat structures. The super helix and individual repeat structures are highly 
reminiscent of the solved TALE crystal structures (15, 16) and our own structural prediction of Bat1 (4: 
Figure S15). Just as for TALEs, they found that, upon binding, the whole array contracts longitudinally 
to more closely match the pitch of B-form DNA.  
 
One difference they uncovered was that two electropositive stripes run along the Bat1 repeat array, 
formed by Lys8 and Gln17 of each of repeats 1-18. This allows for an electrostatic interaction with the 
backbone phosphates of the + and – strands. TALE repeat arrays display only a single electropositive 
stripe (16).  
 
A very striking observation was that the Arg BSR of repeat 13, in their structure, does not interact with 
the cognate T in the +strand of their target DNA. Instead they suggest interactions with two 
neighbouring bases in the –strand. This BSR-base pairing is the only one that differs from our BEBat1. 
We used a G at this position in accordance with findings from TALEs that Arg at the BSR position 
should pair best with G (29). Further molecular investigation isolating the binding contribution of repeat 
13, and Arg repeats in general, would be beneficial in this case.  
 
After addressing the structure of Bat1 they returned to the topic of Bat1 derived nucleases. In a yeast-
based nuclease assay dBat-nucleases with BSRs for the EBEAvrBs3 showed greater target sequence 
stringency in their activity compared to TALENs. Two base pair mismatches were enough to ablate 
activity almost completely for the dBat-nucleases, whereas the TALENs performed comparably to the 
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on-target pairing. This exciting finding deserves to be tested further, in different systems and with a 
range of dBats and dTALEs, to see if the principle can be generalized.  
 
6.3 Addressing the goals of this work 
As set out in chapter 2, there are three main questions underlying the work presented in this 
dissertation: 
1. To what extent do TALE-likes conform to the established TALE paradigm in terms of domain 
structure and function? 
2. What are the defining features of TALE-likes? 
3. What can be inferred about TALE-like evolution from the comparison of TALE-likes?  
4. Can TALE-likes augment TALE technology?  
6.3.1 Partial conformity to the TALE paradigm 
a) Domain structure and biological function 
TALEs and RipTALs act in planta as transcription factors 
Investigations were launched into the molecular properties of the RipTALs with a suspicion that these 
proteins, like TALEs, function in planta as sequence specific transcription factors. We were able to 
confirm that RipTALs do indeed function in this manner, localizing to the nucleus (3: Figure 1) and 
inducing expression of reporter genes bearing a cognate EBE (3: Figure 8).  
Despite this functional similarity details of biological activity differ somewhat between TALEs and 
RipTALs. For instance we found that nuclear localization of RipTALs is mediated by signals in both the 
NTR and CTR (3: Figure 1). There are motifs in the RipTAL CTR corresponding to the TALE annotated 
NLSs, whereas the predicted NLSs in the RipTAL NTR (3: Figure S2) have no equivalent in the TALE 
NTR. The activation domains of TALEs and RipTALs are sequence related and functionally 
interchangeable. We were able to demonstrate not only that RipTALs function in planta as 
transcriptional activators (3: Figures 8 and 9), but also that the predicted RipTAL AD could functionally 
replace the AD of AvrBs3. Yet this chimeric protein gave a weaker activation of the reporter than found 
for wild type AvrBs3 (3: CTC, Figure 2). This may suggest that the activation domain of Brg11 
mediates weaker gene induction, but may just as well indicate a structural incompatibility arising 
during the fusion of the Brg11 CTR to the binding domain and NTR of AvrBs3. Information is lacking 
on the levels to which RipTALs are able to activate host genes in a natural situation. It would also be 
interesting to know if the observed ability of TALEs to induce novel transcriptional start sites (79) holds 
for RipTALs. Homologous domains are found in the TALEs and RipTALs and they mediate similar but 
not necessarily identical functions. 
Characterizing RipTAL functional domains was the first step in the long-term goal of this work was to 
understand the role these proteins play in bacterial wilt disease. They have been shown to contribute 
to bacterial growth in a competition assay in eggplant leaf tissue (48). RipTALs thus seem to fit the 
TALE paradigm closely. Yet TALEs differ greatly in their target sequences even between closely 
related strains (61) suggesting a co-evolution between host and pathogen, also mirrored in the SWEET 
gene targeting TALEs and corresponding promoter polymorphisms in rice (33). Contrastingly the 
phylotype I R. solanacearum strains studied as part of 
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host plants and most shared the same repeat array composition as Brg11 (3: Figure 9A). Even where 
differences were found, most were single repeat loss or gain and such RipTALs showed cross-
reactivity on each other’s target EBEs (3: Figure 9C). This speaks against a continuous co-evolution 
between RipTALs and hosts. It is also puzzling that the arrays of RipTALs are so conserved and their 
hosts so divergent. Are they in fact only relevant in certain hosts? Do they target a hyper-conserved 
promoter, or a commonly occurring promoter motif? There are also reasons to suspect different types 
of sequences targeted by TALEs and RipTALs, since the target sequences of all RipTALs we studied 
are GC rich, unlike TALEs which commonly target AT rich TATA elements of plant promoters. GC rich 
elements can be found in plant promoters, such as ethylene response elements (80), but there is 
reason at least to expect differences in what promoter elements are targeted by TALEs and RipTALs. 
To address these questions transcriptomic studies should be carried out using wild type and RipTAL 
knock out strains on a range of host plants.  
Bats are sequence-specific DNA binding proteins but no further functional domains identified, and 
even less can be said of the biological functions of the MOrTLs. 
Bats and MOrTLs do not carry out the same biological roles as TALEs. They are not delivered by plant 
pathogenic bacteria to induce virulence associated host genes. Bats are found in endosymbiotic 
bacteria within a fungus and the MOrTLs with their marine provenance cannot be associated with 
terrestrial disease causing plant pathogens. Furthermore, in the case of the Bats where we have a 
reliable idea of gene structure there is no evidence for the existence of the functional domains 
necessary for TALEs, and RipTALs, to act as in planta transcriptional activators. It is possible that 
Bats, like the toxin rhizoxin, are delivered by B. rhizoxinica to its fungal host to be further secreted into 
the plant host. However, nuclear localization signals are not predicted for this protein and it does not 
nuclear localize in human cells (4: Figure 3). Furthermore there is no functional eukaryotic AD as 
inferred from reporter assays in human cells and in planta (4: Figures 3 and S9). We were later able to 
show that Bat1 works as a transcriptional repressor in E. coli (5: Figure 4), which suggests, at least, 
that it could act as a transcriptional regulator inside the bacteria themselves. Yet merely because such 
an activity is possible does not make it likely. Also feasible is an unpredicted functional domain or a 
binding partner in the natural situation, mediating an as yet unknown function after DNA binding. Data 
on the expression and localization of Bats within the natural system would provide first clues. As for 
the MOrTLs, their biological roles remain completely mysterious, as is the case for so much about the 
marine pico-plankton. DNA binding repeats are the only proven functional domains of the Bats and 
MOrTLs and the only basis for assumptions on their biological roles. They might function as 
transcriptional repressors, but this is only one possibility. It would be intriguing to know whether the 
Bats and MOrTLs are rare and esoteric or just the first representatives of a larger group of bacterial 
TALE-like proteins with an as yet unknown functional importance. 
A clear demarcation appears between the TALEs and RipTALs on one side, and the Bats and MOrTLs 
on the other. The RipTALs broadly match the TALE paradigm in respect to functional domains. Are the 
disease associated TALE-likes, the TALEs and RipTALs, one element of a larger protein group?  
b) DNA binding properties 
Canonical repeats 
Despite the apparent disunity of domain structure between the TALE-likes there is one functional 
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domain, which is strikingly conserved: the canonical repeat. Observed repeat sequence similarity 
inspired my doctoral work but I found that, as well as sequence similarity, TALE-like canonical repeats 
also display a striking functional conservation.  
The TALE code is conserved across canonical repeats of all TALE-likes 
TALE-like repeat sequence diversity is considerable (5: Figure 7) but the code linking BSRs and bases 
holds across all TALE-like canonical repeat domains so far investigated. Yet non-BSR polymorphisms 
are not totally without an effect on DNA binding properties. First I will summarize the experimental 
basis for the assertion that the TALE code based on BSRs is consistent across all TALE-like groups. 
The base preferences of individual Brg11 repeats were tested in AvrBs3 derivatives bearing three 
identical copies of individual Brg11 repeats (3: Figure 3). These were tested against reporters bearing 
the four possible bases at the cognate EBE position. Despite the non-BSR polymorphisms between 
TALE and RipTAL repeats results were consistent with the known BSR preferences of TALEs: Asp-C, 
Gly-T, Asn-G/A, Lys-G, Thr – A/G, Pro-A/T (29, 30). The results of this investigation were then used to 
predict a binding element for Brg11 (EBEBrg11 ), which was indeed recognized by Brg11 in planta (3: 
Figure 7). This showed that the results of the trimer test held true for repeats in their native context. 
The results of the trimer test were also used to successfully design EBEs for seven other RipTALs with 
canonical repeat arrays differing in repeat number or BSR composition from Brg11 (3: Figure 9). These 
reporter assays form the basis of the statement that the TALE code is conserved between TALEs and 
RipTALs.  
In the case of the Bats and MOrTLs the conservation of the code was taken as an assumption to 
design binding elements. These were then shown to be recognized in vitro  (4: Figure 2, 5: Figure 2). 
Off-target oligonucleotides and reporters were not bound by the cognate TALE-likes confirming 
sequence specificity (4: Figure 2; 5: Figure 4). Additionally, in the case of the Bats, dBats with modified 
BSRs were created and shown to function in combination with BEs derived from the TALE code (4: 
Figure 6A; (56, 77)). It is therefore reasonable to affirm that the binding properties of Bat and MOrTL 
repeats conform to the TALE code. 
The conservation of the TALE code strongly suggests structural similarity. That the interactions 
between BSRs and bases are broadly conserved suggests that repeats all form a similar helix-turn-
helix structure with the BSR interpolated into the DNA double helix to make close contacts to DNA 
bases. It is conceivable that multiple distinct structures are able to achieve the same DNA recognition 
behavior. But in such a case we would not expect repeat arrays from different TALE-like groups to be 
inter-compatible. Yet in this thesis RipTAL-TALE (3: Figure 3), Bat-TALE (4: Figure 8), MOrTL-Bat and 
MOrTL-TALE (5 Figure 2) repeat mixtures have all been demonstrated to be functional. Thus the 
functional data regarding DNA recognition strongly supports a conserved structure. More convincing 
than this are the actual solved crystal structures of Bat1 with or without its DNA partner (77) strongly 
resembling TALE crystal structures, both the super helical arrangement of repeats and the repeats 
themselves. In both cases the repeat array contracts to closely match the turn of B-form DNA, tracing 
the major groove. This allows the BSRs of each repeat to come into close enough contact with the 
base to form hydrogen bonds or van der Waals interactions, depending on the particular pairing. Our 
structural models of MOrTL repeat blocks embedded in the Bat1 repeat array show the same overall 
structure (5 Figure 6). This is hardly surprising in itself as the sequence was modeled onto the known 
Bat1 structure, but molecular dynamics simulations showed that this structure is highly stable, 
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showing that MOrTL repeats can at least stably adopt this confirmation when embedded into a TALE-
like repeat array (5 Figures S9 and S10). Combined with the functional observations, the available 
structures and models make a compelling case for a common structure for TALE-like canonical repeat 
arrays supporting a conserved BSR code.  
Non-BSR polymorphisms affect interaction strength for the preferred target base and inter-repeat 
compatibility but not base preference 
Whilst the dominant finding of this thesis as regards the TALE code is that the code is reliably 
conserved there are important caveats. Some of these, such as the impact of repeat position within 
the array, have already been addressed in chapter 1.3. What has been very little addressed till now in 
the literature is the functional impact of non-BSR polymorphisms on the properties of canonical TALE 
repeats. This is because only positions 12 and 13 are substantially variable in TALEs. The natural 
experiment of TALE-likes provides a convenient tool since one is immediately provided with a whole 
set of repeats of different sequence but at least broadly the same functionality.  
Non-BSRs seem to impact the overall strength of the repeat-DNA interaction, with no major effect on 
base preference. For example, we found that the two Lys repeats of Brg11 both mediate several-fold 
higher activation of a cognate reporter than equivalent AvrBs3 repeats, when embedded in a dTALE 
(3: Figures 3 and S13). Yet all are highly specific for the G-reporter. This functional impact most likely 
arises from the impact of one, several or all of the 9 residues conserved between the Brg11 Lys 
repeats, which are not found in AvrBs3 repeats. In addition, we found that Brg11 Asp repeats 10 and 
8/11 both activate only the C-reporter in the trimer test as expected, but differed in the strength of the 
activation. The TALE derivative with the repeat 10 trimer was barely able to activate the reporter above 
background, while repeat 8/11 activated the C-reporter more than the equivalent TALE Asp repeat 
control (3: Figure 3). We demonstrated that this was linked to a single Asn in repeat 10, occupied by a 
Lys residue in all other repeats (3: Figure 5). The activities and specificities of a few Bat repeats were 
assessed in the trimer test (4: Figure 8). These results suggest that non-BSRs impacting on DNA 
binding non-sequence specifically, either by interacting with the DNA backbone or impacting the 
positioning of the BSR loop or the conformation of the whole repeat array. This may have implications 
for TALE technology as explored in 3.2.4.   
Another idea, explored in chapter 4: Figure 6, is that non-BSR polymorphisms have co-evolved with 
BSRs. If this is true then Bat repeat arrays should function best when only the native BSR of each 
repeat is used. In two of the four dBats we tested, re-arranging BSRs did have a slight negative 
impact on reporter activation. Numerous Bat1 derivatives, where BSRs only were modified, have been 
reported by Juillerat et al., (56) and Stella et al., (77) and shown to function well. Non-BSR 
polymorphisms do not seem to co-evolve with BSRs based on the available evidence. 
Obviously the observed polymorphisms may simply arise through evolutionary drift. It is the most 
striking of my observations that the sequence polymorphisms between TALE-like repeats seem to 
matter so little. Certain constraints are however clearly in place on the TALE-like repeat sequence 
space. Two alpha-helical regions of particular length, a short BSR loop and a longer flexible inter-
repeat loop impose constraints on which sequences could form a TALE-like repeat. Furthermore, 
residues around the BSR conserved within groups and largely within groups too (5: Figure 7) possibly 
due to the necessity of preserving certain inter-repeat interaction across the array. Yet such 
constraints still leave an ample sequence space from which residues could be arbitrarily selected 
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during evolution. Further study on the functional impact of non-BSR polymorphisms will help to tease 
apart the roles of selection and drift in shaping the pattern of sequence diversity seen in TALE-like 
canonical repeats.  
Non-canonical repeats 
The canonical repeat arrays of TALEs, RipTALs, and Bats are all framed by non-canonical repeats. Yet 
while the non-canonical repeats of TALEs and RipTALs seem to be homologous those of Bats are 
non-homologous and functionally distinct.  
N-terminal non-canonical repeat regions of TALEs and RipTALs are homologous and functionally 
analogous 
Sequence comparisons and functional analyses suggest that the N-terminal non-canonical repeats of 
TALEs and RipTALs are homologous and functionally equivalent. Comparing the amino acid 
sequences of the known TALE repeats -3 to 0 with the equivalent region of Brg11 (Figure 3) suggests 
homology. Furthermore, we were able to show that this region in TALEs can be replaced with the 
equivalent stretch from Brg11 without compromising function (3: Figure 6). The one clear functional 
effect of this domain swap was a shift away from the canonical T0 preference of TALEs to a G0 
preference. This was also confirmed to hold for wild type Brg11 (3: Figure 8) and all other RipTALs 
tested (3: Figures 9 and S11), though two showed some activation of the A0 reporter (RipTALI-6 and 
RipTALI-9). The T0 binding of TALEs has been shown to be directly mediated by Trp232, with co-
ordination by several other residues in repeat -1 (15, 57). In Brg11 an Arginine residue occupies the 
position equivalent to Trp232 (3: Figure 6). This may underlie the observed base preference switch, 
especially since engineered TALE derivatives with a Trp232Arg mutation displayed a G0 preference 
(57). This would suggest that broadly the same structural conformation is adopted by TALE and 
RipTAL repeats 0 and -1. Overall, it seems that the N-terminal non-canonical repeats of TALEs and 
RipTALs are homologous, functionally conserved domains.  
 
The C-terminal non-canonical repeats of TALEs seem to be unimportant for DNA binding but it is not 
known if this holds true for those of RipTALs 
Two C-terminal non-canonical repeats can be identified immediately following the canonical repeats of 
TALEs and RipTALs based on weak sequence similarity to canonical repeats (3: Figures S1). Little is 
known about the function or structure of TALE or RipTAL repeats +1 and +2 so only tentative 
statements can be made. Repeat +1 has been shown to exert a sequence preference in accordance 
with the TALE code (21). However, one study found that the N-terminal (canonical) portion of repeat 
+1 can be deleted without impairing reporter activation abilities (81). Repeat +2 can be truncated from 
the binding domain component of a TALE nuclease without impairing function (82). In addition repeat 
+2 of TALEs harbors a predicted basic leucine zipper motif (12) but one study into the functional 
importance of this motif for in planta activity concluded that it had no impact based on reporter assays 
with derivatives bearing mutations in this region (58).The C-terminal non-canonical repeats of TALEs 
clearly await further research but it can already be concluded that any impact on DNA binding is 
minimal. This contrasts with what we found for Bat1 repeat +1, described below.  
N- and C-terminal non-canonical repeats of Bats are important for DNA-binding  
Bat1-3 all display a similar N-terminal domain structure. In each case two non-canonical repeats 
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precede the canonical repeats. As in TALEs and RipTALs, repeat 0 lacks a predicted BSR loop but 
repeat -1 possesses one. But here end the similarities. Bat N-terminal non-canonical repeats share no 
derived sequence features with those of TALEs. Instead they are sequence related to the canonical 
repeats of Bats. This suggests that the N-terminal non-canonical repeat domains of Bats and 
TALEs/RipTALs are likely not homologous but may have each independently derived from canonical 
repeat sequences of the respective groups. Furthermore, there is no zero base preference for Bat1 (4: 
Figure 2; (56)). In addition, truncation of these repeats from a designer Bat transcriptional activator 
impaired but did not totally ablate activity (4: Figure 5B), in contrast to equivalent truncations in 
dTALEs (25). Overall, the N-terminal non-canonical repeat domains of Bats are non-homologous to 
and functionally distinct from those of TALEs/RipTALs, though they do contribute to DNA interactions.  
Bat proteins also have a C-terminal non-canonical repeat (repeat +1), bearing many positively charged 
Lys, His and Arg residues, setting it apart from the canonical repeats. Truncation of repeat +1 from 
acBat1 led to a more dramatic decrease in activity than the N-terminal non-canonical-repeat domain 
truncation (4: Figure 5B). Structural, sequence and functional observations are consistent with repeat 
+1 of Bat1 making an important contribution to non-sequence-specific DNA binding and that this 
domain has no functional equivalent in TALEs and RipTALs.  
6.3.2 A unifying definition of the TALE-likes 
The TALEs, RipTALs, Bats, MOrTL1 and MOrTL2 are described throughout this thesis as TALE-likes. 
The definition of the term TALE-likes has never been formally addressed in the literature, and the term 
itself has been used sporadically and inconsistently. It has been used to describe the RipTALs in both 
molecular characterization papers (3, (75)).  I have used it to refer to Bats and MOrTLs (chapters 3 and 
4). It has also been used in a review on TALEs to include RipTALs and Bats (83). Yet in the same 
review these proteins are simply referred to as Ralstonia or Burkholderia TALEs, or nonclassical TALE 
homologs. A working definition of TALE-likes is clearly desirable to allow for more consistency in the 
literature.  
An array of repeats conforming structurally and functionally to those of TALEs is the unifying and 
defining feature of the TALE-likes 
Far more features unite the TALEs and RipTALs than unite these two groups to the Bats and MOrTLs. 
In addition the evolutionary relationships between Bats, MOrTLs and TALEs/RipTALS are still highly 
unclear (see below). How then to define the TALE-likes?  
I would assign TALE-like status based solely on the repeat array because it is the only conserved 
domain between TALEs/RipTALs, Bats and MOrTLs, and the most pertinent feature of TALEs to the 
majority of the research community. The TALE-like canonical repeat domain is an array consisting of 
tandemly arranged 33-35 amino acid repeats. These repeats consist of two alpha helices, a BSR loop 
and an inter-repeat loop. These repeats are likely to be highly polymorphic at position 13 but highly 
conserved around this position (5: Figure 7). Deviation from any of these guidelines would be 
inconsistent with a functional TALE-like repeat array. 
Structural studies carried out on TALEs and Bat1 (15, 16, 77) revealed that the repeat arrays and 
individual repeats form similar structures. Molecular dynamics simulations that we carried out on 
modeled structures of Bat1-MOrTL repeat chimeras (5: Figure 6) also suggest that repeats of MOrTL1 
and MOrLT2 can form stable structures resembling TALE and Bat repeats. No structures are available 
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for RipTAL repeats but considering the higher sequence similarity these have to TALE repeats 
anything other than the by now familiar structure would be highly surprising. Since structure and 
function are clearly related the two together form the working definition of the canonical repeats which 
define the TALE-likes.  
It is not practical to provide a consensus sequence definition TALE repeat due to the sequence 
diversity present among and within groups (5: Figure 7). As explored in chapter 5, only three residues 
are conserved across all TALE-like repeats (X6VX6GX13LX4<6). This could be useful as a pattern to 
identify future TALE-likes. Yet using full repeat arrays of TALEs, RipTALs, Bats, MOrTL1 and MOrTL2 
separately is likely to provide a more comprehensive and reliable search template.  
With this in mind, I would suggest keeping TALE-likes as an informal collective term for any proteins 
bearing a repeat array conforming to the structure and function of the TALE canonical repeat array. 
This covers all proteins studied in this thesis, but excludes, for example, pentatricopeptide repeat 
(PPR) proteins. Such proteins display tandem arrays of 35 amino acid repeats, like RipTALs and some 
TALEs and these repeats form two alpha-helices with two loop regions, similar to the canonical TALE-
like repeat structure. They have been explicitly compared to TALEs (84) and have even been asserted 
to belong to the same superfamily of proteins (24). Yet PPRs bind ssRNA, one of the nucleic acid 
species which cannot be bound by TALEs or Bats (78, 77). Moreover the TALE code cannot be 
applied to PPR-RNA interactions. Nor is there any clear sequence similarity between known PPRs and 
TALE-likes (84). The term TALE-like, based on canonical repeats mediating DNA binding conforming 
to the TALE code provides a practical definition with sufficient precision to exclude proteins with 
apparently similar domain structure.  
6.3.3 Insights into TALE and TALE-like evolution 
The key observations made to date regarding TALE evolution were outlined in 2.3. Briefly, TALE genes 
are found in multi-copy in X. oryzae strains, and in X. oryzae pv oryzae strains are mostly flanked by 
inverted repeats indicative of Tn3 transposition; in many non-oryzae strains they are plasmid localized 
(61). TALE repeats are highly uniform in sequence, but repeat arrays are diverse in respect to repeat 
number, BSR composition and thus diverse with respect to their DNA targets (Figure 1.5). 
Despite functional similarities what we know of the evolutionary history of the RipTALs contrasts with 
that of TALEs 
RipTALs do not fit this paradigm in any respect. When present they are generally found in single copy, 
with the exception of banana infecting strain Molk2 (two copies). Xanthomonas strains bearing TALEs 
in single copy generally carry them on episomes (61), whereas RipTALs are borne within the bi-partite 
genome of R. solanacearum strains. In addition, our analysis of Phylotype I R. solanacearum strains 
found that repeat array polymorphisms between orthologs are mostly single repeat losses or 
duplications (3: Figure 9). The other major isoform is the Hpx17-like lacking all repeats but one. TALEs 
seem to display an evolutionary dynamism, likely made possible by mechanisms of intra- and 
intergenic recombination (85). Such mechanisms in turn likely rely on the high sequence identity of 
TALE repeats. In contrast, RipTALs show little repeat array diversity across the whole species 
complex, but the sequences of individual repeats differ greatly from one another. Thus the rates of 
inter and intra genic recombination thought to allow TALEs to achieve their astonishing BSR diversity 
(Figure 1.5) may be far lower for RipTALs. There may thus be a mechanistic connection between 
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individual repeat sequence identity on one hand, and evolutionary dynamism of repeat arrays on the 
other. The molecular characterization of RipTAL function and diversity described in chapter 3 has 
provided hints into RipTAL and TALE evolution allowing the formulation of testable hypotheses. 
Despite their unusual provenance the Bats are likely to be homologs of the TALEs and RipTALs 
The Bats are known only from a single strain of a single Burkholderia species. Genome sequences for 
47 Burkholderia genomes are available on NCBI but only B. rhizoxinica has so far been found to bear 
TALE-likes. Thus the evolutionary provenance of the Bats is somewhat puzzling. In particular it is 
unclear if they have arisen independently of the TALEs and RipTALs. To approach an answer to this it 
is necessary to address the MOrTLs. Though both MOrTLs were isolated from bacteria occupying 
similar marine environments the two MOrTLs differ from one another at the sequence level as much as 
they do from each of the other TALE-like groups (Figure 1.5). Like the Bats their repeats are 33 amino 
acids long, and from the available sequence data it seems, based on the admittedly limited data 
available, that they lack large non-repeat domains, like the Bats (5: Figure 7). MOrTL 1 and 2 repeats 
are polymorphic at certain positions with respect to the TALEs, RipTALs and the Bats too. That is to 
say that certain residues at certain positions are found consistently in TALE, RipTAL and Bat repeats 
but in repeats of MOrTL 1 and/or MOrTL2 some other residue is found there. Common sequence 
features, where alternatives are demonstrably possible within the structural and functional constrains, 
are an indication of common evolutionary origins. The residues in question are Ala10, Gly15, Gln17, 
Ala18 and Leu19. 5 residues out of 33-35 cannot be taken as a definitive proof but is at least an 
indication. Chance convergence cannot be excluded, especially if the structure and function or 
MOrTL1 or MOrTL2 repeats differ in some subtle way that relaxes some sequence constraint on them. 
And even if the canonical repeats of TALEs/RipTALs and Bats share a common ancestor, that 
ancestor may have been a single helix-turn-helix domain, co-opted twice independently to form a long 
array of sequence-specific DNA binding repeats. I hope that in the coming years further TALE-likes are 
discovered, which shed some further light on these questions. Till then the available evidence can be 
taken to draw a tentative conclusion that the DNA-binding domains of Bats, TALEs and RipTALs are 
homologous.  
6.3.4 Practical and conceptual contributions to TALE technology 
 TALEs, RipTALs and Bats, with the addition of MOrTL repeats represent alternative protein platforms 
for sequence specific DNA binding. Furthermore, having shown that dTALEs bearing non-
Xanthomonas TALE-likes are in most cases functional, this paves the way for chimeric TALE-like 
arrays. I envision three primary ways in which these findings could be used to augment existing TALE 
technology: chimeric repeat arrays due to lower inter-repeat sequence similarity are less likely to 
undergo rearrangements, dBats as a replacement for dTALEs, and finally exploiting repeat 
polymorphisms to create a library of arrays with the same target sequence but different affinities. I will 
explore each in turn.  
TALE-like repeats could be used to stabilize repetitive stretches in TALE genes 
TALE genes are unstable in some systems (72, 73). Whole repeat arrays are lost due to presumed 
intragenic recombination. This property has been noticed when the instability is so drastic that it 
completely prevents application, yet it may be a far more widespread phenomenon than 
acknowledged. It may be that organisms or populations stably transformed with TALEs will over time 
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become genetic mosaics bearing a mixture of intact and compromised TALE genes. Such an outcome 
would stand in the way of any application requiring stable and continuously active TALEs. These could 
include gene therapy and synthetic genetic circuits operating within modified organisms (e.g. (71, 86)). 
In 2013 a team at Harvard Medical School created “reTALEs” by using alternative codon usage to 
prevent identical nucleotide strings longer than 11 bp occurring anywhere within the repeat arrays (87). 
reTALEs were functional in lentiviral delivery vectors, which had been found to be incompatible with 
standard dTALEs (72) suggesting that this was sufficient to stabilize the genes. Using the sequence 
diversity of TALE-like repeats is an easy way to further reduce the sequence similarity of TALE genes, 
and therefore improve stability.  
dBats could be used as an alternative to dTALEs 
An alternative to creating sequence diverse dTALE arrays is to use the naturally sequence diverse 
Bat1 repeat array as a scaffold. As explored in 4: Figure 6, there are two approaches for 
reprogramming the Bat1 repeat array to create dBats: the repeat switch and the RVD (BSR) switch. 
The first of these was hypothesized to lead to steric clashes caused by repeat polymorphisms in 
neighboring repeats. In accordance with this all repeat-switch constructs displayed reduced activity 
relative to the wild-type (4: Figure 6A). Similarly we hypothesized that BSRs and non-BSRs might co-
evolve such that BSRs will not be properly positioned relative to the base in a non-native setting. Yet 
the BSR-switch constructs performed better than the analogous repeat switch constructs (4: Figure 
6B) and others have successfully created several dBats using this approach (56, 77). This suggests 
that the creation of dBats by using the native repeat array of Bat1 and modifying BSRs could be a 
straightforward and reliable approach akin to dTALE assembly. What then are the advantages of such 
a system? As well as the intimated stability improvement, another advantage of the dBat system is the 
more compact DNA-binding domain: fewer non-canonical repeats and each repeat one amino acid 
shorter. In addition, the findings of Stella et al. suggest that dBats could be more sequence specific 
than dTALEs (77). If this were found to be a general principle this would give a clear advantage to the 
dBat scaffold over the dTALE. Conversely, we found that the Bat1-BEBat1 interaction is rather weak (4: 
Figure 2) and again if this is a general principle, perhaps related to the fewer non-canonical repeats 
this could be disadvantageous. Also disadvantageous is the extra research that would be necessary to 
establish dBats as a dTALE replacement. Over the last five years a number of excellent studies have a 
systematically tested different TALE domain truncations and fusions (26, 42, 82, 88) and quantified the 
overall interaction strength and sequence specific of dTALE repeat arrays with different BSR 
compositions (21, 22, 29, 30). It is perhaps unrealistic, given the rising star of the CRISPR/Cas9 
system, to expect these investments to be repeated for a system that is directly analogous to the 
dTALE system. 
TALE-like non-BSR polymorphisms could be used to fine tune the TALE repeat 
Finally, TALE-like repeat diversity could be used on a smaller-scale to alter the DNA recognition and 
interaction properties of TALE repeats. Miller et al. have shown that residue 12 polymorphisms, have a 
profound on interaction strength (30). Similarly, we found drastic differences in inferred DNA 
interaction properties between TALE and RipTAL repeats or between individual RipTAL repeats that 
seem to be due to non-BSR polymorphisms (3: Figures 5 and S13). Testing the total theoretical 
sequence space of the TALE repeat would entail functional tests on 2034 constructs, and a random 
walk is likely to lead mostly through non-functional constructs. The natural experiment of TALE-like 
repeat diversity can be taken as a more limited raw material for TALE repeat engineering. The benefit 
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of such an approach would be the possibility of designing libraries of dTALEs with not only different 
target sequences but also those with differing affinities for the same target sequence. In synthetic 
biology such libraries would be useful to be able to create analogous circuits with different outputs or 
to regulate flow through different regulatory pathways. As described above this would again require 
further heavy research investments. Yet the product would be something qualitatively different from 
anything achieved or achievable till now.  
 
7 Concluding remarks  
 
In the introduction I painted a vision of plant disease research working together with green 
biotechnology to increase the output and reliability of agricultural production for the coming centuries. 
Of course reality is forever reminding us of its nuances and contingencies. Knowing this I had no 
illusion of providing some panacea for global food security with my work characterising TALE-like 
proteins. What I hoped to achieve at the outset, and what I have done together with others, is to lay 
out the groundwork for future efforts from which tangible rewards might be reaped.  
This groundwork is twofold. Firstly, for the role of RipTALs in plant disease. Our molecular 
characterisation of native RipTAL proteins, showed that they function as sequence specific 
transcription factors in planta. All the functional domains of TALEs seem to be conserved with 
RipTALs, suggesting that RipTALs, like TALEs contribute to plant disease by activating host S-genes. 
If this information can be used to identify such S-genes, then this can be used to better understand 
bacterial wilt disease and to inform resistance-breeding programmes.  
Secondly, by showing that canonical repeats are analogous and in most cases functionally compatible 
among TALE-like groups this may lay out a path to the next generation of TALE technology. With the 
advent of CRISPR/Cas9 the future for TALE-technology will lie in high-fidelity applications, and the 
creation of parts libraries for synthetic biology. These applications could benefit from the introduction 
of TALE-like repeat sequences by improving and diversifying DNA binding properties of canonical 
repeats by exploiting non-BSR polymorphisms, and by increasing the genetic stability of TALE genes.  
Finally, the characterisations of Bats and MOrTLs have unexpectedly revealed that the TALE-likes 
might be a larger group than previously thought. Whether or not all TALE-likes have arisen from a 
common ancestor they clearly carry out biological roles beyond that of effectors inducing host gene 
induction. TALE-likes lacking translocation signals or ADs may regulate bacterial transcription by 
acting as repressors, or mediating functions through as yet unknown binding partners. As with all 
research, observation leads to new directions of inquiry, and I eagerly await further marine bacterial 
genomics projects to learn if the MOrTLs are widely distributed. As in the early days of ocean 
exploration, there are no maps to guide us.  
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Supplementary Information  
Figures  
S1 Annotated sequences of Brg11 and AvrBs3. 
S2 Amino acid sequences of Hpx17 and corresponding truncation derivatives used in 
subcellular localisation studies. 
S3 Alignment of C-terminal regions of AvrBs3 and Brg11 (a) and the sequence of the 
C-terminal chimera CTC (b). 
S4 Alignments of Brg11 and AvrBs3 core repeats. 
S5 Representative amino acid sequences used in the “trimer test”. 
S6 Reciprocal exchange of RVDs between Brg11 repeats 12 and 8/11 leading to 
exchange of DNA recognition specificity.  
S7 Nucleotide sequences of brg11 repeats used to assemble three identical, tandem-
arranged repeat blocks that were tested in the context of dTALEEBE Brg11. 
S8 Alignment of N-terminal regions AvrBs3 and Brg11 regions (a) and sequence of 
chimeras NTC1 and NTC2 (b). 
S9 Individual amino acid sequences of RipTALs analysed in this study.  
S10 Amino acid sequence alignment of RipTALs analysed in this study.   
S11 Zero base preferences of RipTALI-6, -9, -11 and -14.  
S12 Comparison of predicted Brg11 binding sequences from this study and from 
Streubel et al., 2012. 
S13 Alignment of Brg11 repeats 2 and 9 and a consensus AvrBs3 repeat. 
Tables 
Supplementary Table 1: Sequences of primers used in this study. 
Supplementary Table 2: Origin of RipTALs analysed in this study. 
Supplementary Table 3: GUS activities as determined in the trimer test and shown in 
Figure 3. 
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Supplementary Figure 1 
Annotated sequences of Brg11 and AvrBs3. N-terminal and C-terminal non-repeat 
regions and the central repeat array are displayed in separate paragraphs but are part 
of contiguous polypeptides. Consecutive repeats are numbered (left side). The repeats 
0 and -1 constitute the N-terminal, 1-17 the core and +1 and +2 the C-terminal 
repeats. The RVDs (residues at repeat positions 12 and 13) are marked as boldface 
black letters on grey background. Previously predicted monopartite nuclear 
localization signals (NLSs; consensus K-K/R-X-K/R, Chelsky et al., 1989) of AvrBs3 
shown to be relevant for protein function are highlighted in blue background (Van den 
Ackerveken et al., 1996), corresponding sequences in Brg11 are highlighted in green 
background (see also Fig. S3a). Further NLS sequences not tested here were predicted 
by NLStradamus (Nguyen et al., 2009) and cNLS Mapper (Kosugi et al., 2009) and 
are shown in boldface, blue font. Only those predicted NLSs that were experimentally 
tested are indicated as red rectangles in cartoon representations of Brg11 and 
homologs in Figs 1-2, 5-8 and S10. The annotated acidic activation domain of AvrBs3 
(Szurek et al., 2001) and a predicted nine amino acid transactivation domain in Brg11 
are underlined. 
>Brg11 (from R. solanacearum strain GMI1000; GenBank NP_519936.1) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGDGGLAHLHRRLAVGYAEDTPRTEA
RSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPAVSSPRFSAGSSAAITDPFPSLPPTPVLY
AMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIASACPQAFASPPRAPRS
ARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSREQIRKLKQESLSEIAKYHTT
LTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQY GERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAHLLDLRGVPYA 
 6 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGNQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LNTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQIVAIASHDGGKPALEAVWAKLPVLRGAPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQASHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQATRPALLRLLSSVGVT
EIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGSPGMAGQSACS
PHRKRPAETAIAPRSIRRSPNNAGQPSEPWPDQLAWLQRRKRTARSHIRADSAASVPANLHL
GTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPDPGTPTSADLASFEAEPFGVG
PLDFHLDWLLQILET 
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>AvrBs3 (from Xanthomonas campestris pv. vesicatoria strain 71-21; GenBank 
CAA34257.1) 
MDPIRSRTPSPARELLPGPQPDGVQPTADRGVSPPAGGPLDGLPARRTMSRTRLPSPPAPSP
AFSAGSFSDLLRQFDPSLFNTSLFDSLPPFGAHHTEAATGEWDEVQSGLRAADAPPPTMRVA
VTAARPPRAKPAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH
GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKR GGVTAVEAVHAWRNALTGAPLN 
 1 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3 LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
17 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACL GGRPALDAVKKGLPHAPALIKRT 
NRRIPERTSHRVADHAQVVRVLGFFQCHSHPAQAFDDAMTQFGMSRHGLLQLFRRVGVTELE
ARSGTLPPASQRWDRILQASGMKRAKPSPTSTQTPDQASLHAFADSLERDLDAPSPMHEGDQ
TRASSRKRSRSDRAVTGPSAQQSFEVRVPEQRDALHLPLSWRVKRPRTSIGGGLPDPGTPTA
ADLAASSTVMREQDEDPFAGAADDFPAFNEEELAWLMELLPQ!
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Supplementary Figure 2 
Amino acid sequences of Hpx17 and corresponding truncation derivatives used in 
subcellular localisation studies (Fig. 1). N-terminal, repeat and C-terminal regions of 
Hpx17 (a) and its derivatives (b - e) are displayed in distinct paragraphs but are part of 
contiguous polpypeptides. Consecutive repeats are numbered (left side). Repeats 0 
and -1 constitute the N-terminal, 1 the core and +1 and +2 the C-terminal repeats. The 
RVD is marked in boldface black font on grey background. Putative NLSs (see also  
in Brg11 Figs S1, S3) are highlighted in green background, corresponding NLS 
mutations in red background. Further, not experimentally tested NLSs predicted by 
NLStradamus (Nguyen et al., 2009) and cNLS Mapper (Kosugi et al., 2009) are 
shown in boldface, blue font. Only those predicted NLSs that were experimentally 
tested are indicated as red rectangles in cartoon representations of Brg11 and 
homologs in Figs 1-2, 5-8 and S10. Below each amino acid sequence the 
corresponding nucleotide sequence is shown. Dashes (-) indicate amino acids in 
repeat +2 that have not been integrated in the given constructs (d and e). 
(a) Sequence of Hpx17 
>Hpx17 (from R. solanacearum strain RS1000; GenBank BAD42396.1) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDTPRTGA
RSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPFSSLPPTPVLY
AMARELKALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIASACPQAFASPPRAPRS
ARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSREQIRKLKQESLSEIAKYHTT
LTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQY GERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLSSVGVT
EIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGSPGMAGQSACS
PHRKRPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQRRKRTARSHIRADSAASVPANLHL
GTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPDPGTPTSAASFEAEPFGVGPL
DFHLDWLLQILEA 
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>hpx17 
ATGAGAATAGGCAAATCAAGCGGTTGGTTGAACGAGTCCGTGTCTCTTGAATATGAACACGT
GTCCCCACCGACACGGCCTCGAGACACCCGTCGCCGGCCTCGCGCCGCTAGCGACGGCGGGC
TCGCGCATCTGCATCGCCGGCTCGCGGTCGGCTACGCGGAGGACACGCCGAGAACCGGGGCT
CGGTCTCCGGCGCCGCGCCGCCCGCTCCCTGTGGCACCTGCATCCGCACCGCCTGCACCGTC
CCTCGTTCCGGAACCCCCTATGCCGGTCAGCCTTCCTGTCGTATCGAGCCCGCGCTTCTCTG
CCGGCAGCTCGGCAGCCATCACCGATCCTTTTTCGAGCCTTCCGCCCACGCCCGTGCTGTAT
GCGATGGCTCGCGAACTGAAGGCGCTGTCCGACGCTACCTGGCAGCCAGCCGTACCGTTGCC
CGCCGAGCCGCCTACTGATGCGCGGCGCGGCAACACGGTATTTGACGAAGCGTCTGCATCAT
CGCCGGTGATCGCCTCTGCCTGCCCTCAAGCGTTTGCCAGCCCACCGCGAGCACCGCGCTCG
GCGCGAGCCCGCAGGGCTCGGACAGGCGGTGATGCTTGGCCGGCCCCGACTTTTCTTAGCCG
CCCCTCGTCATCCCGCATCGGCCGTGACGTGTTCGGGAAACTGGTCGCACTCGGCTATTCCC
GTGAGCAGATCCGGAAGCTCAAGCAGGAGAGCCTGAGCGAAATTGCGAAGTATCACACCACC
TTGACAGGACAAGGGTTCACGCACGCCGACATCTGCCGGATCAGCCGCAGACGGCAGTCGCT
CCGGGTGGTCGCCAGGAACTACCCGGAGTTGGCTGCGGCGCTCCCTGAGCTGACCAGGGCCC
ACATCGTGGACATCGCTCGGCAGCGATCGGGCGACTTGGCGCTGCAAGCGCTGCTACCCGTG
GCGACCGCACTGACAGCGGCCCCCCTGAGATTGAGCGCCTCGCAAATCGCGACCGTTGCGCA
GTACGGCGAGCGGCCGGCCATCCAGGCCCTTTATCGGCTGCGCCGGAAGCTCACGCGAGCAC
CGCTGCATCTCACACCGCAGCAGGTGGTGGCCATCGCCAGCCACGATGGCGGTAAACCGGCG
CTGGAAGCGGTCTGGGCGAAATTGCCGGTATTGCGCGGGGTGCCCTATGCGCTGAGCACCGC
GCAAGTGGTGGCCATTGCCTGCATCAGTGGCCAGCAGGCGCTGGAGGCAATCGAGGCGCACA
TGCCTACATTGCGCCAAGCCCCCCACAGCCTGAGTCCCGAGCGGGTGGCGGCGATCGCGTGC
ATCGGCGGCCGATCAGCCGTGGAGGCCGTCAGGCAGGGGTTGCCGGTGAAGGCGATCCGGCG
GATACGGCGCGAGAAAGCCCCTGTAGCCGGGCCGCCACCAGCCTCTCTTGGCCCAACCCCGC
AGGAACTCGTGGCGGTCCTGCATTTCTTCCGTGCACATCAGCAGCCCAGACAGGCCTTTGTC
GACGCACTGGCAGCGTTCCAGACCACCAGACCGGCACTGTTGAGGTTGCTCAGCAGTGTTGG
GGTCACAGAAATCGAGGCGCTCGGCGGCACGATCCCCGACGCCACCGAGCGCTGGCAGCGCC
TGCTTGGCCGGCTGGGCTTCAGGCCGGCAACCGGCGCTGCCGCGCCTTCGCCTGATTCCCTG
CAAGGGTTCGCCCAGTCACTTGAGCGCACGCTCGGGTCTCCCGGTATGGCAGGGCAATCGGC
TTGCTCACCACATCGCAAGCGGCCTGCCGAGACGGCCATCGCACCGCGGTCGATACGACGCA
GACCCAACAATGCGGGCCAACCCTCCGAGCCATGGCCCGATCAACTGGCATGGCTCCAACGC
AGGAAACGTACCGCTCGTTCGCACATACGGGCCGATTCGGCGGCAAGCGTGCCGGCAAATCT
CCACTTGGGCACGCGAGCCCAGTTCACGCCAGATCGTCTTCGGGCCGAACCGGGACCCATCA
TGCAGGCTCACACATCGCCGGCATCGGTCAGCTTCGGTTCTCACGTTGCTTTCGAGCCTGGC
CTGCCGGACCCCGGTACGCCCACCTCAGCAGATCTTGCATCGTTCGAGGCTGAGCCGTTCGG
CGTCGGGCCGCTTGATTTCCACCTCGACTGGCTTCTGCAAATATTGGAAGCG 
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(b) Sequence of Hpx17-mut-NLSI/II 
>Hpx17-mut-NLSI/II 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDTPRTGA
RSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPFSSLPPTPVLY
AMARELKALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIASACPQAFASPPRAPRS
ARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSREQIRKLKQESLSEIAKYHTT
LTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
Repeat -1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
Repeat  0 LSASQIATVAQY GERPAIQALYRLRRKLTRAPLH 
Repeat  1 LTPQQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
Repeat +1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
Repeat +2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLSSVGVT
EIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGSPGMAGQSACS
PQAYWPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQPDPWTARSHIRADSAASVPANLHL
GTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPDPGTPTSADLASFEAEPFGVG
PLDFHLDWLLQILEA 
>hpx17-mut-NLSI/II 
ATGAGAATAGGCAAATCAAGCGGTTGGTTGAACGAGTCCGTGTCTCTTGAATATGAACACGT
GTCCCCACCGACACGGCCTCGAGACACCCGTCGCCGGCCTCGCGCCGCTAGCGACGGCGGGC
TCGCGCATCTGCATCGCCGGCTCGCGGTCGGCTACGCGGAGGACACGCCGAGAACCGGGGCT
CGGTCTCCGGCGCCGCGCCGCCCGCTCCCTGTGGCACCTGCATCCGCACCGCCTGCACCGTC
CCTCGTTCCGGAACCCCCTATGCCGGTCAGCCTTCCTGTCGTATCGAGCCCGCGCTTCTCTG
CCGGCAGCTCGGCAGCCATCACCGATCCTTTTTCGAGCCTTCCGCCCACGCCCGTGCTGTAT
GCGATGGCTCGCGAACTGAAGGCGCTGTCCGACGCTACCTGGCAGCCAGCCGTACCGTTGCC
CGCCGAGCCGCCTACTGATGCGCGGCGCGGCAACACGGTATTTGACGAAGCGTCTGCATCAT
CGCCGGTGATCGCCTCTGCCTGCCCTCAAGCGTTTGCCAGCCCACCGCGAGCACCGCGCTCG
GCGCGAGCCCGCAGGGCTCGGACAGGCGGTGATGCTTGGCCGGCCCCGACTTTTCTTAGCCG
CCCCTCGTCATCCCGCATCGGCCGTGACGTGTTCGGGAAACTGGTCGCACTCGGCTATTCCC
GTGAGCAGATCCGGAAGCTCAAGCAGGAGAGCCTGAGCGAAATTGCGAAGTATCACACCACC
TTGACAGGACAAGGGTTCACGCACGCCGACATCTGCCGGATCAGCCGCAGACGGCAGTCGCT
CCGGGTGGTCGCCAGGAACTACCCGGAGTTGGCTGCGGCGCTCCCTGAGCTGACCAGGGCCC
ACATCGTGGACATCGCTCGGCAGCGATCGGGCGACTTGGCGCTGCAAGCGCTGCTACCCGTG
GCGACCGCACTGACAGCGGCCCCCCTGAGATTGAGCGCCTCGCAAATCGCGACCGTTGCGCA
GTACGGCGAGCGGCCGGCCATCCAGGCCCTTTATCGGCTGCGCCGGAAGCTCACGCGAGCAC
CGCTGCATGGGTTGCCGGTGAAGGCGATCCGGCGGATACGGCGCGAGAAAGCCCCTGTAGCC
GGGCCGCCACCAGCCTCTCTTGGCCCAACCCCGCAGGAACTCGTGGCGGTCCTGCATTTCTT
CCGTGCACATCAGCAGCCCAGACAGGCCTTTGTCGACGCACTGGCAGCGTTCCAGACCACCA
GACCGGCACTGTTGAGGTTGCTCAGCAGTGTTGGGGTCACAGAAATCGAGGCGCTCGGCGGC
ACGATCCCCGACGCCACCGAGCGCTGGCAGCGCCTGCTTGGCCGGCTGGGCTTCAGGCCGGC
AACCGGCGCTGCCGCGCCTTCGCCTGATTCCCTGCAAGGGTTCGCCCAGTCACTTGAGCGCA
CGCTCGGGTCTCCCGGTATGGCAGGGCAATCGGCTTGCTCACCACAAGCTTACTGGCCTGCC
GAGACGGCCATCGCACCGCGGTCGATACGACGCAGACCCAACAATGCGGGCCAACCCTCCGA
GCCATGGCCCGATCAACTGGCATGGCTCCAACCGGATCCATGGACCGCTCGTTCGCACATAC
GGGCCGATTCGGCGGCAAGCGTGCCGGCAAATCTCCACTTGGGCACGCGAGCCCAGTTCACG
CCAGATCGTCTTCGGGCCGAACCGGGACCCATCATGCAGGCTCACACATCGCCGGCATCGGT
CAGCTTCGGTTCTCACGTTGCTTTCGAGCCTGGCCTGCCGGACCCCGGTACGCCCACCTCAG
CAGATCTTGCATCGTTCGAGGCTGAGCCGTTCGGCGTCGGGCCGCTTGATTTCCACCTCGAC
TGGCTTCTGCAAATATTGGAAGCG 
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(c) Sequence of Hpx17-Δrep-ΔC 
>Hpx17-Δrep-ΔC 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDTPRTGA
RSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPFSSLPPTPVLY
AMARELKALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIASACPQAFASPPRAPRS
ARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSREQIRKLKQESLSEIAKYHTT
LTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQY GERPAIQALYRLRRKLTRAPLH 
   LTPQ 
>hpx17-Δrep-ΔC 
ATGAGAATAGGCAAATCAAGCGGTTGGTTGAACGAGTCCGTGTCTCTTGAATATGAACACGT
GTCCCCACCGACACGGCCTCGAGACACCCGTCGCCGGCCTCGCGCCGCTAGCGACGGCGGGC
TCGCGCATCTGCATCGCCGGCTCGCGGTCGGCTACGCGGAGGACACGCCGAGAACCGGGGCT
CGGTCTCCGGCGCCGCGCCGCCCGCTCCCTGTGGCACCTGCATCCGCACCGCCTGCACCGTC
CCTCGTTCCGGAACCCCCTATGCCGGTCAGCCTTCCTGTCGTATCGAGCCCGCGCTTCTCTG
CCGGCAGCTCGGCAGCCATCACCGATCCTTTTTCGAGCCTTCCGCCCACGCCCGTGCTGTAT
GCGATGGCTCGCGAACTGAAGGCGCTGTCCGACGCTACCTGGCAGCCAGCCGTACCGTTGCC
CGCCGAGCCGCCTACTGATGCGCGGCGCGGCAACACGGTATTTGACGAAGCGTCTGCATCAT
CGCCGGTGATCGCCTCTGCCTGCCCTCAAGCGTTTGCCAGCCCACCGCGAGCACCGCGCTCG
GCGCGAGCCCGCAGGGCTCGGACAGGCGGTGATGCTTGGCCGGCCCCGACTTTTCTTAGCCG
CCCCTCGTCATCCCGCATCGGCCGTGACGTGTTCGGGAAACTGGTCGCACTCGGCTATTCCC
GTGAGCAGATCCGGAAGCTCAAGCAGGAGAGCCTGAGCGAAATTGCGAAGTATCACACCACC
TTGACAGGACAAGGGTTCACGCACGCCGACATCTGCCGGATCAGCCGCAGACGGCAGTCGCT
CCGGGTGGTCGCCAGGAACTACCCGGAGTTGGCTGCGGCGCTCCCTGAGCTGACCAGGGCCC
ACATCGTGGACATCGCTCGGCAGCGATCGGGCGACTTGGCGCTGCAAGCGCTGCTACCCGTG
GCGACCGCACTGACAGCGGCCCCCCTGAGATTGAGCGCCTCGCAAATCGCGACCGTTGCGCA
GTACGGCGAGCGGCCGGCCATCCAGGCCCTTTATCGGCTGCGCCGGAAGCTCACGCGAGCAC
CGCTGCATCTCACACCGCAG 
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(d) Sequence of Hpx17-ΔN-Δrep 
>Hpx17-ΔN-Δrep 
Repeat +2 M------------------------LPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLSSVGVT
EIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGSPGMAGQSACS
PHRKRPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQRRKRTARSHIRADSAASVPANLHL
GTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPDPGTPTSADLASFEAEPFGVG
PLDFHLDWLLQILEA 
>hpx17-ΔN-Δrep 
ATGTTGCCGGTGAAGGCGATCCGGCGGATACGGCGCGAGAAAGCCCCTGTAGCCGGGCCGCC
ACCAGCCTCTCTTGGCCCAACCCCGCAGGAACTCGTGGCGGTCCTGCATTTCTTCCGTGCAC
ATCAGCAGCCCAGACAGGCCTTTGTCGACGCACTGGCAGCGTTCCAGACCACCAGACCGGCA
CTGTTGAGGTTGCTCAGCAGTGTTGGGGTCACAGAAATCGAGGCGCTCGGCGGCACGATCCC
CGACGCCACCGAGCGCTGGCAGCGCCTGCTTGGCCGGCTGGGCTTCAGGCCGGCAACCGGCG
CTGCCGCGCCTTCGCCTGATTCCCTGCAAGGGTTCGCCCAGTCACTTGAGCGCACGCTCGGG
TCTCCCGGTATGGCAGGGCAATCGGCTTGCTCACCACATCGCAAGCGGCCTGCCGAGACGGC
CATCGCACCGCGGTCGATACGACGCAGACCCAACAATGCGGGCCAACCCTCCGAGCCATGGC
CCGATCAACTGGCATGGCTCCAACGCAGGAAACGTACCGCTCGTTCGCACATACGGGCCGAT
TCGGCGGCAAGCGTGCCGGCAAATCTCCACTTGGGCACGCGAGCCCAGTTCACGCCAGATCG
TCTTCGGGCCGAACCGGGACCCATCATGCAGGCTCACACATCGCCGGCATCGGTCAGCTTCG
GTTCTCACGTTGCTTTCGAGCCTGGCCTGCCGGACCCCGGTACGCCCACCTCAGCAGATCTT
GCATCGTTCGAGGCTGAGCCGTTCGGCGTCGGGCCGCTTGATTTCCACCTCGACTGGCTTCT
GCAAATATTGGAAGCG 
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(e) Sequence of Hpx17-ΔN-Δrep-mutNLSI/II 
>Hpx17-ΔN-Δrep-mut-NLSI/II 
+2 M------------------------LPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLSSVGVT
EIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGSPGMAGQSACS
PQAYWPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQPDPWTARSHIRADSAASVPANLHL
GTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPDPGTPTSADLASFEAEPFGVG
PLDFHLDWLLQILEA 
>hpx17-ΔN-Δrep-mut-NLSI/II 
ATGTTGCCGGTGAAGGCGATCCGGCGGATACGGCGCGAGAAAGCCCCTGTAGCCGGGCCGCC
ACCAGCCTCTCTTGGCCCAACCCCGCAGGAACTCGTGGCGGTCCTGCATTTCTTCCGTGCAC
ATCAGCAGCCCAGACAGGCCTTTGTCGACGCACTGGCAGCGTTCCAGACCACCAGACCGGCA
CTGTTGAGGTTGCTCAGCAGTGTTGGGGTCACAGAAATCGAGGCGCTCGGCGGCACGATCCC
CGACGCCACCGAGCGCTGGCAGCGCCTGCTTGGCCGGCTGGGCTTCAGGCCGGCAACCGGCG
CTGCCGCGCCTTCGCCTGATTCCCTGCAAGGGTTCGCCCAGTCACTTGAGCGCACGCTCGGG
TCTCCCGGTATGGCAGGGCAATCGGCTTGCTCACCACAAGCTTACTGGCCTGCCGAGACGGC
CATCGCACCGCGGTCGATACGACGCAGACCCAACAATGCGGGCCAACCCTCCGAGCCATGGC
CCGATCAACTGGCATGGCTCCAACCGGATCCATGGACCGCTCGTTCGCACATACGGGCCGAT
TCGGCGGCAAGCGTGCCGGCAAATCTCCACTTGGGCACGCGAGCCCAGTTCACGCCAGATCG
TCTTCGGGCCGAACCGGGACCCATCATGCAGGCTCACACATCGCCGGCATCGGTCAGCTTCG
GTTCTCACGTTGCTTTCGAGCCTGGCCTGCCGGACCCCGGTACGCCCACCTCAGCAGATCTT
GCATCGTTCGAGGCTGAGCCGTTCGGCGTCGGGCCGCTTGATTTCCACCTCGACTGGCTTCT
GCAAATATTGGAAGCG 
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Supplementary Figure 3 
Alignment of C-terminal regions of AvrBs3 and Brg11 (a) and the sequences of the 
C-terminal chimeras CTC and CTC-ΔAD (b). 
(a) Alignment of the C-termini of AvrBs3 (AvrBs3_C) and Brg11 (Brg11_C). The 
alignment was constructed with ClustalW and Boxshade. Amino acids that are 
identical between the repeat units are displayed as white letters on black background. 
The fusion points for the creation of the C-terminal chimera is indicated with a red 
triangle. NLSs (for Brg11 those experimentally tested; Fig. 1) are highlighted in bold, 
italic font. The previously annotated acidic activation domain of AvrBs3 (Szurek et 
al., 2001) and a predicted nine amino acid transactivation domain in Brg11 are shown 
in lower case letters (see also Fig. S1). 
 
AvrBs3_C  867 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAALTNDHLVALACLGGRPALDAVKKGL 
Brg11_C   915 LSTAQVVAIACISG-QQALEAIEAHMPTLRQASHSLSPERVAAIACIGGRSAVEAVRQGL 
 
 
AvrBs3_C  927 PHAPALIKRTNRR--IPERTSHRVADHAQVVRVLGFFQCHSHPAQAFDDAMTQFGMSRHG 
Brg11_C   974 PVKAIRRIRREKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQATRPA 
 
 
AvrBs3_C  985 LLQLFRRVGVTELEARSGTLPPASQRWDRILQASGMKRAKPSPTSTQTPDQASLHAFADS 
Brg11_C  1034 LLRLLSSVGVTEIEALGGTIPDATERWQRLLGRLGFR----PATGAAAPSPDSLQGFAQS 
 
 
AvrBs3_C 1045 LERDLDAPSPMHEGDQTRASSRKRSRSDRAVTGPSAQQSFEVRVPEQRDALHLPLSWRVK 
Brg11_C  1090 LERTLGSPGMAGQS----ACSPHRKRPAETAIAPRSIRRSPNNAGQPSEPWPDQLAWLQR 
 
 
AvrBs3_C 1105 RPRTSIGGGLPDPGTPTAADLAASSTVMReqd---------------------------- 
Brg11_C  1146 RKRTARSHIRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFE 
 
 
AvrBs3_C 1137 ---edpfagaaddfpafnee---------elawlmellpq 
Brg11_C  1206 PGLPDPGTPTSADLASFEAEPFGVGPLDFhldwllqilet 
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(b)! Annotated amino sequence of the C-terminal chimera (CTC). The sequence 
corresponding to AvrBs3 is shown in regular font, the Brg11 part is shown in 
boldface, italic font (for annotation of AvrBs3 and Brg11, see Fig. S1). The predicted 
transactivation domain of Brg11 is underlined. The sequences lacking from the 
CTC-ΔAD construct are indicated with green highlighting. Below the amino acid 
sequence the nucleotide sequence of the chimera is given starting with repeat 17 of 
avrBs3. To generate the chimera a brg11 derivative codon optimized for in planta 
expression (sbrg11, synthesised by GenScript) was used. 
>CTC 
MDPIRSRTPSPARELLPGPQPDGVQPTADRGVSPPAGGPLDGLPARRTMSRTRLPSPPAPSP
AFSAGSFSDLLRQFDPSLFNTSLFDSLPPFGAHHTEAATGEWDEVQSGLRAADAPPPTMRVA
VTAARPPRAKPAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH
GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKR GGVTAVEAVHAWRNALTGAPLN 
 1 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3 LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
17 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
+1 LTPQQVVAIACISGQQALEAIEAHMPTLRQASHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQATRPALLRLLSSVGVT
EIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGSPGMAGQSACS
PHRKRPAETAIAPRSIRRSPNNAGQPSEPWPDQLAWLQRRKRTARSHIRADSAASVPANLHL
GTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPDPGTPTSADLASFEAEPFGVG
PLDFHLDWLLQILET 
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>CTC 
…(avrBs3 17th repeat)CTGACCCCGCAGCAGGTGGTGGCCATCGCCAGCCATGATGG
CGGCAAGCAGGCGCTGGAGACGGTGCAGGCGCTGTTGCCGGTGCTGTGCCAGGCCCATGGCC
TGACCCCCCAGCAAGTCGTTGCAATCGCT(sbrg11!)TGCATCTCCGGTCAACAAGCTCTG
GAGGCAATTGAAGCCCACATGCCAACTCTTAGACAGGCATCACATAGTCTTTCTCCTGAGAG
GGTTGCCGCTATTGCTTGTATTGGAGGAAGAAGTGCAGTTGAGGCTGTTAGGCAAGGTCTGC
CAGTGAAGGCTATTAGAAGAATAAGAAGGGAGAAGGCCCCCGTTGCTGGACCACCACCAGCA
TCACTTGGTCCAACACCTCAAGAGCTTGTAGCAGTTTTACACTTCTTCAGGGCTCACCAACA
GCCAAGACAGGCTTTTGTGGATGCACTAGCTGCATTTCAGGCAACTCGTCCTGCACTACTTA
GGCTACTTAGTTCTGTGGGAGTCACAGAGATAGAGGCTTTGGGCGGTACTATTCCAGACGCA
ACTGAAAGATGGCAGAGGTTGTTAGGAAGGCTTGGCTTTAGACCTGCAACTGGGGCTGCTGC
TCCATCTCCTGATTCCTTGCAAGGTTTCGCTCAATCTCTAGAACGTACACTTGGTTCACCAG
GAATGGCAGGTCAATCTGCATGTTCCCCACATAGGAAGAGGCCAGCTGAAACTGCTATCGCT
CCAAGGAGTATCAGGAGGTCCCCTAATAATGCTGGACAGCCTTCAGAGCCTTGGCCAGACCA
GCTGGCTTGGCTACAAAGGAGGAAACGAACAGCTCGTAGCCATATTAGGGCTGATTCTGCAG
CTTCTGTGCCAGCTAATCTCCATCTTGGTACAAGGGCACAATTTACTCCTGATAGGTTGAGA
GCAGAACCTGGACCCATTATGCAAGCACATACATCTCCTGCATCTGTTTCCTTCGGATCACA
CGTTGCATTTGAACCTGGTCTACCTGATCCAGGAACTCCTACTTCAGCAGATCTTGCTTCTT
TCGAGGCTGAACCATTCGGAGTGGGTCCATTGGACTTTCATCTGGACTGGCTCCTCCAAATT
CTTGAAACA 
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Supplementary Figure 4 
Alignments of Brg11 and AvrBs3 core repeats. Alignments were constructed with 
ClustalW and Boxshade. Amino acids that are identical between the repeat units are 
displayed as white letters on black background. The RVDs are highlighted in bold-
italic font. The asparagine (n) in position 16 (displayed in lower case font) is found 
only in repeat 10, while all other Brg11 repeats have lysine (k) at this position. 
Numbers above the sequence (read from top to bottom; 5, 10, 15, 20, 25, 30, 35) 
indicate the position of the given amino acid within the repeat.!
Brg11 
                11111111112222222222333333 
       12345678901234567890123456789012345 
 1     LTPQQVVAIASNTGGkRALEAVCVQLPVLRAAPYR 
 2     LSTEQVVAIASNKGGkQALEAVKAHLLDLLGAPYV 
 3     LDTEQVVAIASHNGGkQALEAVKADLLDLRGAPYA 
 4     LSTEQVVAIASHNGGkQALEAVKADLLELRGAPYA 
 5     LSTEQVVAIASHNGGkQALEAVKAHLLDLRGVPYA 
 6     LSTEQVVAIASHNGGkQALEAVKAQLLDLRGAPYA 
 7     LSTAQVVAIASNGGGkQALEGIGEQLLKLRTAPYG 
 8     LSTEQVVAIASHDGGkQALEAVGAQLVALRAAPYA 
 9     LSTEQVVAIASNKGGkQALEAVKAQLLELRGAPYA 
10     LSTAQVVAIASHDGGnQALEAVGTQLVALRAAPYA 
11     LSTEQVVAIASHDGGkQALEAVGAQLVALRAAPYA 
12     LNTEQVVAIASSHGGkQALEAVRALFPDLRAAPYA 
13     LSTAQLVAIASNPGGkQALEAVRALFRELRAAPYA 
14     LSTEQVVAIASNHGGkQALEAVRALFRGLRAAPYG 
15     LSTAQVVAIASSNGGkQALEAVWALLPVLRATPYD 
16     LNTAQIVAIASHDGGkPALEAVWAKLPVLRGAPYA!
AvrBs3 
                1111111111222222222233333 
       1234567890123456789012345678901234 
 1     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2     LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3     LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4     LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5     LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 6     LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 7     LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 8     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10     LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11     LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12     LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16     LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
17     LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
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Supplementary Figure 5 
Representative amino acid sequences used in the trimer test. (a) The amino acid 
sequence for Brg11 repeat 1 as a trimer is shown in bold font. The central repeat of 
the trimer is underlined to allow each repeat to be identified. Flanking sequences 
correspond to the amino acid sequences of AvrBs3. Below the amino acid sequence 
the corresponding nucleotide sequence is shown. Terminal BpiI recognition sites, 
indicated in lower case letter, facilitate compatibility with the TALE binding domain 
assembly toolkit (Morbitzer et al., 2011). In (b) the Brg11 trimer for repeat 1 
(boldface black font) is shown in the context of the TALE AvrBs3. N-terminal, repeat 
and C-terminal regions of AvrBs3 are separated from each other. The repeats are 
numbered. The repeats 0 and -1 constitute the N-terminal, 1-17 the core and +1 and 
+2 the C-terminal repeats. 
(a) 
>Brg11 repeat 1 trimer 
EDAETVQRLLPVLCQAHGLTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYRLTPQQVVAI
ASNTGGKRALEAVCVQLPVLRAAPYRLTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYRL
TPEQVVAIASQS 
>brg11 repeat 1 trimer 
gaagacGCTGAGACGGTGCAGCGCCTGCTGCCGGTGCTGTGCCAGGCCCATGGCCTGACCCC
GCAGCAGGTGGTGGCGATCGCGTCGAACACCGGCGGCAAGCGCGCCCTGGAAGCGGTGTGCG
TGCAATTACCGGTGCTGCGCGCCGCGCCGTACCGTTTAACTCCTCAGCAGGTGGTGGCCATC
GCGAGCAACACCGGCGGCAAGCGCGCCCTGGAGGCGGTGTGCGTGCAACTTCCGGTGCTGCG
CGCGGCCCCGTACCGTTTAACTCCCCAACAAGTGGTGGCCATCGCCTCGAATACCGGCGGCA
AGCGTGCGCTGGAGGCCGTGTGCGTGCAGCTGCCGGTGCTGCGCGCCGCCCCGTATCGCCTG
ACCCCGGAACAGGTGGTGGCCATCGCAAGCCAgtcttc 
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(b) 
>Brg11 repeat 1 trimer embedded in the AvrBs3 repeat array 
MDPIRSRTPSPARELLPGPQPDGVQPTADRGVSPPAGGPLDGLPARRTMSRTRLPSPPAPSP
AFSAGSFSDLLRQFDPSLFNTSLFDSLPPFGAHHTEAATGEWDEVQSGLRAADAPPPTMRVA
VTAARPPRAKPAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH
GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKR GGVTAVEAVHAWRNALTGAPLN 
 1 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3 LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 6 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 7 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 8 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
17 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACLGGRPALDAVKKGLPHAPALIKRT 
 
NRRIPERTSHRVADHAQVVRVLGFFQCHSHPAQAFDDAMTQFGMSRHGLLQLFRRVGVTELE
ARSGTLPPASQRWDRILQASGMKRAKPSPTSTQTPDQASLHAFADSLERDLDAPSPMHEGDQ
TRASSRKRSRSDRAVTGPSAQQSFEVRVPEQRDALHLPLSWRVKRPRTSIGGGLPDPGTPTA
ADLAASSTVMREQDEDPFAGAADDFPAFNEEELAWLMELLPQ 
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Supplementary Figure 6 
Reciprocal exchange of RVDs between Brg11 repeats 12 and 8/11 leading to 
exchange of DNA recognition specificity. RVDs were swapped between repeats 12 
and 8/11 of Brg11 and these novel repeats tested again in the trimer test to clarify the 
importance of RVDs in the base specificity of Brg11 repeats. The novel repeats are 
defined as Brg11 repeat 8/11 SH and Brg11 repeat 12 HD, with WT used to identify 
the wild-type repeats in each case. An alignment (Clustal Omega; Boxshade) of the 
wild-type and chimeric repeats is shown in (a). Orange font is used to indicate the 
RVDs. Amino acid positions are indicated with numbers above the corresponding 
positions in the alignment (read from top to bottom 1, 11, 21, 31). Trimers consisting 
of three identical copies of each repeat were created and embedded into TALE 
AvrBs3, replacing repeats 5-7, in the wild-type AvrBs3 a trimer of repeats bearing the 
RVD NI. 35S-promoter driven genes encoding AvrBs3-embedded Brg11 repeats were 
co-delivered into N. benthamiana leaves via A. tumefaciens mediated T-DNA transfer 
along with an uidA reporter gene that is either under transcriptional control of the Bs3 
promoter (3xA) or of a derivative containing a triple guanine (3xG), cytosine (3xC) or 
thymine (3xT) at the position corresponding to the repeat trimer. Leaf discs were 
harvested forty-eight hours post-infiltration and stained to visualise reporter activity. 
The intensity of the staining corresponds to promoter activity and is used as a proxy 
indicator of binding at the promoter. Results are shown in (b). The repeat tested is 
indicated above the column of leaf discs in each case. The promoter derivate used is 
indicated with the abbreviation ‘3xN’ in each row.  
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Supplementary Figure 7 
 
Nucleotide sequences of brg11 repeats used to assemble three identical, tandem-
arranged repeat blocks that were tested in the context of dTALEEBE Brg11 (Fig. 5). BsaI 
sites used to assemble the repeats are distinguished with lower case letters. 
>brg11 repeat A1 
ggtctcTTACGCCGCAGCAGGTGGTGGCCATTGCCAGCAACACTGGCGGCAAGCGGGCGTTG
GAGGCGGTCTGTGTGCAATTGCCCGTGCTGCGCGCGGCCCCCTATAGAgagacc 
>brg11 repeat 2 
ggtctcTATAGACTGAGCACCGAGCAGGTGGTGGCGATCGCCAGCAACAAAGGCGGCAAACA
GGCGCTGGAGGCGGTCAAGGCGCACCTGCTGGATCTGCTCGGGGCACCCTATGTGAgagacc 
>brg11 repeat 3 
ggtctcTTGTGCTCGACACCGAGCAAGTCGTGGCCATTGCCAGCCACAATGGCGGCAAGCAG
GCACTGGAGGCGGTCAAGGCGGACCTGCTGGATTTGCGCGGAGCACCCTAgagacc 
>brg11 repeat 4 
ggtctcTCCCTATGCGTTGAGTACCGAGCAAGTCGTGGCCATTGCCAGCCACAATGGCGGCA
AACAGGCACTGGAGGCGGTCAAGGCGGACCTGCTGGAACTGCGCGGAGAgagacc 
>brg11 repeat 5 
ggtctCTGGAGCACCCTATGCGTTGAGTACCGAGCAGGTGGTGGCCATCGCCAGCCACAATG
GCGGCAAGCAGGCTCTGAgagacc 
>brg11 repeat 6 
ggtctcTTCTGGAAGCGGTCAAGGCGCACCTGCTGGATCTGCGTGGAGTGCCCTATGCGTTG
AGTACCGAGCAAGTCGTGGCCATCGCCAGCCACAATGGCGGCAAACAGGCGCTGGAGGCGGT
CAAGGCACAACAgagacc 
>brg11 repeat 7 
ggtctcTCAACTGCTGGATCTGCGCGGAGCACCCTATGCGTTGAGTACCGCCCAGGTGGTCG
CCATCGCCAGTAACGGCGGCGGCAAACAGGCGCTGGAGGGGATTGGCGAACAGCTGCTGAAA
CTGCGGACTGCACCCTATGGGAgagacc 
>brg11 repeat 8 
ggtctcTTGGGCTGAGTACCGAGCAGGTGGTCGCCATCGCCAGCCATGATGGCGGCAAACAA
GCGTTGGAAGCGGTCGGTGCGCAGTTGGTGGCACTGCGCAgagacc 
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>brg11 repeat 9 
ggtctcTGCGCGCGGCGCCTTATGCGCTGAGCACCGAGCAGGTGGTGGCCATCGCCAGCAAC
AAGGGTGGCAAGCAGGCACTGGAGGCGGTCAAGGCGCAACTGCTGGAGAgagacc 
>brg11 repeat 10B N16K 
ggtctcTGGAGCTGCGCGGAGCACCCTATGCGTTGAGTACCGCCCAGGTGGTCGCCATCGCC
AGCCATGATGGCGGCAAGCAAGCACTGGAAGCGGTCGGTACGCAGTTGGTGGCGCTGCGCGC
GGCGCCTTATGCGCTGAGCACCGAGCAGGTGGTAGCGAgagacc 
>brg11 repeat 11B 
ggtctctAGCGATCGCCAGTCATGATGGCGGCAAACAGGCATTGGAAGCGGTCGGGGCGCAG
TTGGTGGCGCTGCGCGCAGCGCCTTATGCGCTGAACAgagacc 
>brg11 repeat 12 
ggtctcTGAACACCGAGCAGGTGGTGGCCATCGCCAGCAGCCATGGCGGCAAACAGGCGCTG
GAGGCGGTCCGGGCACTGTTTCCGGATCTGCGCGCGGCGCCTTATGCGCTGAGTACCAgaga
cc 
>brg11 repeat 13 
ggtctcTTACCGCGCAACTGGTGGCCATCGCCAGCAACCCTGGCGGCAAACAAGCGCTGGAG
GCAGTCCGGGCACTGTTTCGGGAGCTGCGGGCGGCGCCCTATGAgagacc 
>brg11 repeat 14 
ggtctcTTATGCGTTGAGCACCGAGCAAGTGGTAGCCATCGCCAGCAACCATGGCGGCAAAC
AGGCGCTGGAGGCCGTCCGGGCACTGTTTCGGGGTCTGCGAGCCGCGCCTTACGGAAgagac
c 
>brg11 repeat 15/16 
ggtctcTCGGACTCAGTACCGCGCAGGTGGTGGCCATCGCGAGCAGTAATGGCGGCAAACAG
GCGCTGGAGGCGGTCTGGGCGCTGCTACCGGTGTTGCGCGCCACACCCTACGATCTGAATAC
CGCGCAGATCGTGGCCATCGCCAGCCATGATGGGGGCAgagacc 
de Lange et al. Breaking the Ralstonia TALE code  -  SUPPLEMENT  ! ! ! !! 19 
Supplementary Figure 8 
Alignment of N-terminal regions AvrBs3 and Brg11 regions (a) and sequence of 
chimeras NTC1 and NTC2 (b). 
(a) Comparison of the N-terminal regions of AvrBs3 and Brg11, including repeats 0 
and -1. The alignment was constructed with ClustalW and Boxshade. Amino acids 
that are identical between the repeat units are displayed as white letters on black 
background. Red triangles indicate the breakpoints for the creation of N-terminal 
chimera 1 (NTC1, see also Fig. S8b). Red font is used to highlight tryptophan 232 of 
AvrBs3 and the corresponding arginine of Brg11. 
 
AvrBs3_N    1 --------------------------------------------------------MDPI 
Brg11_N     1 MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGDGGLAHLHRRLAVGYAEDTPRT 
 
 
AvrBs3_N    5 RSRTPSPARELLPGPQPDGVQPTADRGVSPPAGGPLDGLPARRTMSRTRLPSPP------ 
Brg11_N    61 EARSPAPRRPLPVAPA-------------------------SAPPAPSLVPEPPMPVSLP 
 
 
AvrBs3_N   59 -APSPAFSAGSFSDLLRQFDPSLFNTSLFDSLPP---------------FGAHH-TEAAT 
Brg11_N    96 AVSSPRFSAGSSAAITDPF-PSLPPTPVLYAMARELEALSDATWQPAVPLPAEPPTDARR 
 
 
AvrBs3_N  102 GE--WD-------EVQSGLRAADAPPPTMRVAVTAARPP---RAKPAPRRRAAQPSDASP 
Brg11_N   155 GNTVFDEASASSPVIASACPQAFASPPRAPRSARARRARTGGDAWPAPT-FLSRPSSSRI 
 
 
AvrBs3_N  150 AAQV--DLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVA 
Brg11_N   214 GRDVFGKLVALGYSREQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVA 
 
 
AvrBs3_N  208 VKYQDMIAALPEATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQLDTGQLLKIAKRG 
Brg11_N   274 RNYPELAAALPELTRAHIVDIARQRSGDLALQALLPVATALTAAPLRLSASQIATVAQYG 
 
 
AvrBs3_N  268 GVTAVEAVHAWRNALTGAPLN 
Brg11_N   334 ERPAIQALYRLRRKLTRAPLH 
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(b) Annotated amino sequences of the N-terminal chimeras NTC1 and NTC2. The 
sequences corresponding to AvrBs3 are shown in regular font, the Brg11 parts are 
shown in boldface, italics font (for annotation of AvrBs3 and Brg11 see Fig. S1). 
While NTC1 contains only a part of the Brg11 N terminus, chimera NTC2 contains 
the complete Brg11 N terminus, including repeats 0 and -1. Below each amino acid 
sequence the corresponding nucleotide sequence is given from the start codon up to 
and including the first repeat of the avrBs3 core binding domain. 
>NTC1 
MDPIRSRTPSPARELLPGPQPDGVQPTADRGVSPPAGGPLDGLPARRTMSRTRLPSPPAPSP
AFSAGSFSDLLRQFDPSLFNTSLFDSLPPFGAHHTEAATGEWDEVQSGLRAADAPPPTMRVA
VTAARPPRAKPAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH
GFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQY GERPAIQALYRLRRKLTGAPLN 
 1 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3 LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
17 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACL GGRPALDAVKKGLPHAPALIKRT 
NRRIPERTSHRVADHAQVVRVLGFFQCHSHPAQAFDDAMTQFGMSRHGLLQLFRRVGVTELE
ARSGTLPPASQRWDRILQASGMKRAKPSPTSTQTPDQASLHAFADSLERDLDAPSPMHEGDQ
TRASSRKRSRSDRAVTGPSAQQSFEVRVPEQRDALHLPLSWRVKRPRTSIGGGLPDPGTPTA
ADLAASSTVMREQDEDPFAGAADDFPAFNEEELAWLMELLPQ 
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>NTC1 
(avrBs3)ATGGATCCCATTCGTTCGCGCACACCAAGTCCTGCCCGCGAGCTTCTGCCCGGA
CCCCAACCCGATGGGGTTCAGCCGACTGCAGATCGTGGGGTGTCTCCGCCTGCCGGCGGCCC
CCTGGATGGCTTGCCCGCTCGGCGGACGATGTCCCGGACCCGGCTGCCATCTCCCCCTGCCC
CCTCACCTGCGTTCTCGGCGGGCAGCTTCAGTGACCTGTTACGTCAGTTCGATCCGTCACTT
TTTAATACATCGCTTTTTGATTCATTGCCTCCCTTCGGCGCTCACCATACAGAGGCTGCCAC
AGGCGAGTGGGATGAGGTGCAATCGGGTCTGCGGGCAGCCGACGCCCCCCCACCCACCATGC
GCGTGGCTGTCACTGCCGCGCGGCCGCCGCGCGCCAAGCCGGCGCCGCGACGACGTGCTGCG
CAACCCTCCGACGCTTCGCCGGCCGCGCAGGTGGATCTACGCACGCTCGGCTACAGCCAGCA
GCAACAGGAGAAGATCAAACCGAAGGTTCGTTCGACAGTGGCGCAGCACCACGAGGCACTGG
TCGGCCATGGGTTTACACATGCC(brg11!)GATATATGTCGAATTTCTAGGAGAAGACAAA
GCCTTCGAGTAGTCGCTCGTAATTACCCTGAACTGGCAGCAGCTCTACCAGAATTGACTAGA
GCACATATCGTGGATATTGCAAGACAAAGGTCTGGAGATTTGGCATTACAAGCACTTCTCCC
TGTGGCAACAGCTCTCACAGCTGCACCTTTGAGGCTTTCTGCTAGCCAAATCGCTACAGTCG
CACAATATGGTGAGAGGCCAGCTATCCAAGCACTTTATAGACTTCGAAGGAAACTGACG(av
rBs3 GAPLN Repeat 1 !)GGTGCCCCCCTGAACCTTACGCCGGAGCAGGTGGTGGCCA
TCGCCAGCCACGATGGCGGCAAGCAGGCGCTGGAGACGGTGCAGCGGCTGTTGCCGGTGCTG
TGCCAGGCCCATGGC... 
 
>NTC2 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGDGGLAHLHRRLAVGYAEDTPRTEA
RSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPAVSSPRFSAGSSAAITDPFPSLPPTPVLY
AMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIASACPQAFASPPRAPRS
ARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSREQIRKLKQESLSEIAKYHTT
LTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQY GERPAIQALYRLRRKLTRAPLH 
 1 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3 LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
17 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACL GGRPALDAVKKGLPHAPALIKRT 
NRRIPERTSHRVADHAQVVRVLGFFQCHSHPAQAFDDAMTQFGMSRHGLLQLFRRVGVTELE
ARSGTLPPASQRWDRILQASGMKRAKPSPTSTQTPDQASLHAFADSLERDLDAPSPMHEGDQ
TRASSRKRSRSDRAVTGPSAQQSFEVRVPEQRDALHLPLSWRVKRPRTSIGGGLPDPGTPTA
ADLAASSTVMREQDEDPFAGAADDFPAFNEEELAWLMELLPQ 
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>NTC2 
(brg11)ATGAGAATTGGCAAGTCCTCAGGATGGTTAAATGAATCTGTGTCATTAGAATATG
AACATGTGTCACCACCAACTAGGCCTCGAGATACTCGAAGGCGACCTAGGGCAGCTGGAGAT
GGAGGTCTTGCACATTTGCACAGGAGGTTAGCTGTGGGCTATGCAGAGGATACTCCAAGAAC
CGAAGCTAGGAGTCCAGCTCCACGTAGGCCTCTTCCAGTGGCTCCAGCAAGCGCACCTCCAG
CTCCATCACTTGTTCCAGAGCCACCAATGCCAGTCTCCCTTCCCGCTGTTAGTTCTCCACGT
TTTAGCGCTGGTAGTAGTGCCGCTATCACAGATCCTTTTCCTTCACTTCCTCCAACACCAGT
GTTATATGCTATGGCTAGAGAGTTGGAGGCATTAAGTGACGCTACTTGGCAGCCAGCAGTGC
CATTACCTGCCGAGCCACCTACTGATGCAAGGAGAGGCAACACAGTTTTTGACGAAGCATCT
GCATCATCTCCAGTTATTGCATCCGCTTGCCCACAGGCTTTCGCTTCACCACCAAGAGCACC
TCGATCTGCTAGAGCTAGAAGAGCTAGGACAGGCGGAGATGCATGGCCAGCTCCTACTTTTC
TCAGCAGACCAAGCTCTTCTAGGATTGGTAGAGATGTATTTGGAAAGCTAGTCGCACTCGGG
TATAGTAGGGAACAGATCAGAAAGTTGAAACAAGAGTCTCTTTCTGAAATAGCAAAGTACCA
TACCACACTCACCGGTCAAGGATTCACCCATGCCGATATATGTCGAATTTCTAGGAGAAGAC
AAAGCCTTCGAGTAGTCGCTCGTAATTACCCTGAACTGGCAGCAGCTCTACCAGAATTGACT
AGAGCACATATCGTGGATATTGCAAGACAAAGGTCTGGAGATTTGGCATTACAAGCACTTCT
CCCTGTGGCAACAGCTCTCACAGCTGCACCTTTGAGGCTTTCTGCTAGCCAAATCGCTACAG
TCGCACAATATGGTGAGAGGCCAGCTATCCAAGCACTTTATAGACTTCGAAGGAAACTTACT
AGAGCCCCTCTTCAC(avrBs3 Repeat 1 !)CTTACGCCGGAGCAGGTGGTGGCCATCG
CCAGCCACGATGGCGGCAAGCAGGCGCTGGAGACGGTGCAGCGGCTGTTGCCGGTGCTGTGC
CAGGCCCATGGC... 
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Supplementary Figure 9 
Amino acid sequences of RipTALs (RipTALI-1 – RipTALI-15; Table S2) analysed in 
this study. N-terminal, repeat and C-terminal regions are separated from each other. 
The repeats are numbered. The repeats 0 and -1 constitute the N-terminal repeats and 
+1 and +2 the C-terminal repeats. The RVDs are marked as boldface black letters on 
grey background. RVDs that differ from that ones found in Brg11 are shown in 
boldface blue letters. For amplification of the RipTALs the primers brg11-CACC-
ATG and brg11-no stop (Table S1) were used. Therefore all RipTALs are sequence 
identical in the corresponding N- and C-terminal amino acid sequences. The 
sequences can be found at NCBI under the GenBank accession numbers KC405066-
KC405080. 
>RipTALI-1 (from R. solanacearum strain JS53; GenBank KC405066) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRSPPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPSEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKADLLDLRGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 6 LSTAQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGKQALEAAGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LSTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTPADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-2 (from R. solanacearum strain HB53; GenBank KC405067) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRSLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPSEPPTDTRRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQLRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
+2 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 6 LSTEQVVAIASNNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGKQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LSTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAIRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAVASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQVVAIASHDGGKPALEAVWAKLPVLRGVPYE 
+1 LSTAQVVAIACISGQQALEVIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRSPNNAGQPFEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTSADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-3 (from R. solanacearum strain GX53; GenBank KC405068) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGGGGLAHLPRRLAVGYAEDT
PRTGARSPAPRRSLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
PSLPPTPVLDAMTRELEALSDATWQPAVPLPSEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFAHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLLGAPYV 
 4 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 5 LSTEQVVAIASHNGGKLALEAVKAHLLDLRGAPYA 
 6 LSTEQVVAIASHNGGKQALEAVKTQLLELRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGKQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LSTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIQ 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRSPNNAGQPFEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTPADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-4 (from R. solanacearum strain GX55; GenBank KC405069) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRSLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAHLLELRGAPYA 
 6 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIAGHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGKQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LSTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAIRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRSPNNAGQPFEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTPADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-5 (from R. solanacearum strain HN515; GenBank KC405070) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
SSLPPTPVLYAMARELKALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
HGTPTPADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-6 (from R. solanacearum strain GD52; GenBank KC405071) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRSPPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPSEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAHLLDLRGAPYA 
 6 LSTAQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLRKLRTAPYG 
 8 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
 9 LSTAQVVAIASHDGGKQALEAVGTQLVALRAAPYA 
10 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
11 LSTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
12 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
13 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
14 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
15 LNTAQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTSADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-7 (from R. solanacearum strain FJ41; GenBank KC405072) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGDGGLAHLHRRLAVGYAEDT
PRTEARSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPAVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAHLLDLRGVPYA 
 6 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGNQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LNTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQIVAIASHDGGKPALEAVWAKLPVLRGAPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR  
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQATRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRSPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTSADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-8 (from R. solanacearum strain SD58; GenBank KC405073) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
SSLPPTPVLYAMARELKALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTSADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-9 (from R. solanacearum strain UW360; GenBank KC405074; a 
partial sequence that does not cover the complete repeat array has been 
deposited as EF435034) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGGGGLAHLHRRLAVDYAEDT
PRTGARSPAPRRPLPVAPASTPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
SSLPPTPVLYAMARELEALSDATWQPAVPLPSEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 6 LSTAQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGKQALEAAGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LSTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRELRAAPYA 
15 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
16 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
17 LNTAQVVAIASHYGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLKS
PGMAGQSACSPHRKRPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTSADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-10 (from R. solanacearum strain UW148; GenBank KC405075) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGDGGLAHLHRRLAVGYAEDT
PRTEARSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPAVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAHLLDLRGVPYA 
 6 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGNQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LNTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQIVAIASHDGGKPALEAVWAKLPVLRGAPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQATRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRSPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTSADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-11 (from R. solanacearum strain GX526; GenBank KC405076) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRSLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 6 LSTAQVVAIASQNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGKQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LSTEQVVAIASSHGGKQALEAVRALLPVLRATPYD 
13 LNTAQVVAIASHDGGKPALEAVRAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTSADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-12 (from R. solanacearum strain GX528; GenBank KC405077) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGFAEDT
PRTGARSPAPRRSLPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAHLLELRGAPYA 
 6 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIAGHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGKQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LSTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAIRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRSPNNAGQPFEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTPADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-13 (from R. solanacearum strain GZ522; GenBank KC405078) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGGGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRPLPVAPASAPPAPSLVPEPAMPVSLPVVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAQLLELRGAPYA 
 6 LSTEQVVAIASHNGSKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSAAQVVAIASHDGGKQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LSTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAIRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQVVAIASHDGGKPALEAVWAKLPVLRGVPYE 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRSPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGAIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTSADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-14 (from R. solanacearum strain GD45; GenBank KC405079) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGGGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRPLPVAPASAPPAPSLVPEPAMPVSLPVVSSPRFSAGSSAAITDPF
PSIPPTPVLYAMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKAHLLDLRGVPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 6 LSTAQVVAIAGNGGGKQALEGIGEQLLKLRTAPYG 
 7 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 8 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
 9 LSTAQVVAIASHDGGNQALEAVGTQLVALRAAPYA 
10 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
11 LNTEQVVAIASNPGGKQALEAVRALFPDLRAAPYA 
12 LSTAQLVAIASNPGGKQALEAIRALFRELRAAPYA 
13 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
14 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
15 LNTAQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKVPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRSPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTSADLASFEAEPFGVGPLDFHLDWLLQILET 
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>RipTALI-15 (from R. solanacearum strain ICPM11110; GenBank KC405080) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAASDGGLAHLHRRLAVGYAEDT
PRTGARSPAPRRSPPVAPASAPPAPSLVPEPPMPVSLPVVSSPRFSAGSSAAITDPF
PSLPPTPVLYAMARELEALSDATWQPAVPLPSEPPTDARRGNTVFDEASASSPVIAS
ACPQAFASPPRAPRSARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSR
EQIRKLKQESLSEIAKYHTTLTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQYGERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKADLLDLRGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 6 LSTAQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGKQALEAAGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LSTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQVVAIASHDGGKPALEAVWAKLPVLRGVPYA 
+1 LSTAQVVAIACISGQQALEAIEAHMPTLRQAPHS 
+2 LSPERVAAIACIGGRSAVEAVRQGLPVKAIRRIR 
REKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQTTRPALLRLLS
SVGVTEIEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGS
PGMAGQSACSPHRKRPAETAIAPRSIRRRPNNAGQPSEPWPDQLAWLQRRKRTARSH
IRADSAASVPANLHLGTRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPD
PGTPTPADLASFEAEPFGVGPLDFHLDWLLQILET 
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Supplementary Figure 10 
Alignment of all RipTALs analysed in this study. Only polymorphic positions are 
displayed. Amino acid position relative to Brg11 is indicated with numbers above the 
relevant column, to be read vertically (from the far left 27, 28, 29, 38 etc.). The amino 
acids found in Brg11 are distinguished in each case with bold font. Dashes indicate 
positions occupied by the identical amino acid as that found in Brg11. White boxes 
indicate that the equivalent position is missing from a certain RipTAL.  
A colour code is used to distinguish the predicted structural regions of each 
polypeptide. Yellow corresponds to N- and C-terminal regions and all other colours to 
individual repeats of the repeat domain. Repeats bearing identical RVDs in Brg11 are 
identically coloured. White lines divide sequences corresponding to separate repeats. 
Grey horizontal bars and written descriptions below the alignment indicate sequences 
corresponding to the N-terminus, repeats and C-terminus of each RipTAL, while 
black lines and numbers below the alignment indicate the positions of individual 
repeats as they occur within the repeat region of Brg11. Where polymorphisms occur 
within the repeat region the relative position within the single repeat is indicated with 
numbers, to be read horizontally, above the appropriate column. Polymorphisms in 
the RVD positions (12 and 13) are highlighted with red lettering. A black triangle in 
between repeats 13 and 15 in the row corresponding to RipTALI-9 indicates the 
complete duplication of repeat 14, relative to Brg11, in this RipTAL.  
A cartoon representation of Brg11 is shown below the alignment for reference. 
Ellipses indicate the repeats of the core binding domain; a red semi-circle indicates a 
putative transcriptional activation domain; red rectangles indicate putative nuclear 
localisation signals. Colouring for the N- and C-terminal and repeat regions is the 
same as in the alignment. Numbers above the ellipses indicate the position of the 
respective repeat within the repeat domain.  
 
 
 
 
 
 
 
 
de Lange et al. Breaking the Ralstonia TALE code  -  SUPPLEMENT  ! ! ! !! 39 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
de Lange et al. Breaking the Ralstonia TALE code  -  SUPPLEMENT  ! ! ! !! 40 
Supplementary Figure 11 
Zero base preferences of RipTALI-6, -9, -11 and -14. These four RipTALs were 
tested for ability to activate Bs3p promoter derivatives bearing their own predicted 
EBEs with an A0, G0, C0 or T0 upstream of an uidA reporter gene. 35-S driven genes 
encoding the RipTALs were confiltrated along with the promoter constructs into N. 
benthamiana leaves via A. tumefaciens-mediated transient transformation. Leaf discs 
were harvested forty-eight hours post-infiltration and stained to visualise reporter 
activity. Sequences of the EBEs used are shown on the right in each case. White 
letters with a black border indicate the nucleotide occupying the zero position in each 
case. The RipTAL tested against each promoter is indicated on the left.  
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Supplementary Figure 12 
Comparison of predicted Brg11 binding sequences from this study and from Streubel 
et al., 2012. Numbers indicate repeats of the Brg11 core binding domain and the 
corresponding predicted binding partners are displayed in columns underneath as 
black letters on a grey background. A black line divides sequences from the two 
studies. In each case the row of letters closest to the line indicates the best predicted 
match and then alternative matches are displayed, in order of preference, extending 
above (this study) or below (Streubel et al., 2012) the nucleotides of the best match 
sequence. Bold font is used to indicate the sequence used for EBEBrg11 throughout this 
study.  
de Lange et al. Breaking the Ralstonia TALE code  -  SUPPLEMENT  ! ! ! !! 42 
Supplementary Figure 13 
Alignment of Brg11 repeats 2 and 9 and a consensus AvrBs3 repeat. The repeats are 
displayed with NK as the RVD (orange font). Residues common to Brg11 repeats 2 
and 9 and not found in an equivalent AvrBs3 repeat are shown in blue font. The 
alignment was constructed with ClustalW and Boxshade. 
Brg11 repeat 2    LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
Brg11 repeat 9    LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
TALE NK repeat    LTPEQVVAIASNKGGKQALETVQRLLPVLCQAHG- 
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Supplementary Tables 
 
Table S1: Primers used in this study.  
Name of Primer Application Sequence 
brg11-CACC-ATG Creation of hpx17 and brg11 
pENTR-D constructs 
CAC CAT GAG AAT AGG CAA ATC 
AAG CGG TTG GTT GAA C 
brg11-no Stop Creation of hpx17 and brg11 
pENTR-D constructs 
CGT TTC CAA TAT TTG CAG AAG 
CCA GTC G 
brg11_mut-
NLSI_fwd 
Mutation of putative hpx17 
nuclear localisation signals 
CCT GCC GAG ACG GCC ATC GCA 
CCG C 
brg11_mut-
NLSI_HindIIIrev 
Mutation of putative hpx17 
nuclear localisation signals 
CCA GTA AGC TTG TGG TGA GCA 
AGC CGA TTG CC 
brg11_mut-
NLSII_BamHIfwd 
Mutation of putative hpx17 
nuclear localisation signals 
CCG GAT CCA TGG ACC GCT CGT 
TCG CAC ATA CG 
brg11_mut-
NLSII_rev 
Mutation of putative hpx17 
nuclear localisation signals 
TTG GAG CCA TGC CAG TTG AT 
hpx17_Cterm_fwd Truncation of hpx17 for 
localisation studies 
TTG CCGGTG AAG GCG ATC CGG 
hpx17_Cterm_rev Truncation of hpx17 for 
localisation studies 
CAT GGT GAA GGG GGC GGC CGC 
hpx17_Nterm_fwd Truncation of hpx17 for 
localisation studies 
AAG GGT GGG CGC GCC GAC CCA 
hpx17_Nterm-rev Truncation of hpx17 for 
localisation studies 
CTG CGG TGT GAG ATG CAG CGG 
TGC 
avrbs3 
NtermCACCFwd 
Subcloning of full avrbs3 N-
terminal encoding fragment 
GGT CTC TCA CCA TGG ATC CCA 
TTC GTT CGC GCA C 
avrbs3 
NtermATAARev 
Subcloning of full avrbs3 N-
terminal encoding fragment 
GGT CTC ATT ATG GGA AGA CCG 
CGT AAG GTT CAG GGG G 
sBrg11 CTC Fwd 1 First round of PCR for the 
subcloning of the CTC region of 
brg11 C-terminal encoding 
fragment 
CAG CAA GTC GTT GCA ATC GCT 
TGC ATC TCC 
sBrg11 CTC Fwd 2 Second round of PCR for the 
subcloning of the CTC region of 
brg11 C-terminal encoding 
fragment 
GGT CTC TAT AAG GGA AGA AGA 
CCC ACC CCA GCA AGT CGT TGC 
sBrg11 CTC Rev 1  First round of PCR for the 
subcloning of the CTC region of 
brg11 C-terminal encoding 
fragment 
AAG AAT TTG GAG GAG CCA GTC 
CAG ATG AAA GTC CAA TGG ACC 
CAC TCC G 
sBrg11 CTC Rev 2 Second round of PCR for the 
subcloning of the CTC region of 
brg11 C-terminal encoding 
fragment 
GGT CTC ACC TTT GTT TCA AGA 
ATT TGG AGG AGC CAG TC 
sBrg11 CTC-ΔAD 
Rev 
Subcloning C-terminal region of 
brg11 lacking C-terminal most 
35 codons 
TCC TGG ATC AGG TAG ACC AGG 
TTC AAA TGC 
 
sBrg11 CTC- ΔAD 
Fwd 
Subcloning C-terminal region of 
brg11 lacking C-terminal most 
35 codons 
AAG GTG AGA CCC CTG CAT GCA 
AGC 
 
sBrg11 780 Fwd Subcloning brg11 rep0 and -1 
for NTC1 
CAT GCC GAT ATA TGT CGA ATT TC 
sBrg11 1040 Rev Subcloning brg11 rep0 and -1 
for NTC1 
TTT CCT TCG AAG TCT ATA AAG 
TGC 
AvrBs3 LTG Fwd Removal of rep0 and -1 from 
avrbs3 N-terminal encoding 
region for NTC1 and removal of 
full N-terminal encoding region 
for NTC2 
CTG ACG GGT GCC CCC CTG 
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Table S1: Primers used in this study.  
Name of Primer Application Sequence 
AvrBs3 VGH Rev Removal of avrbs3 rep0 and -1 
for NTC1 
TGT AAA CCC ATG GCC GAC C 
 
AvrBs3 BsaI CACC 
Rev 
Removal of avrbs3 full N-
terminal encoding region for 
NTC2 
CAC GGT GAG AGA CCA AAG G 
 
sBrg11 Nterm ATG 
Fwd 
Subcloning of brg11 N-terminal 
encoding fragment for NTC2 
GGT CTC TCA CCA TGA GAA TTG 
GCA AGT CC 
sBrg11 
NtermBsaIBpiI Rev 
Subcloning of brg11 N-terminal 
encoding fragment for NTC2 
GGT CTC ATT ATG GGA AGA CTT 
CAG GTG AAG AGG GGC TCT AG 
sBrg11 Nterm TACG 
Fwd 
Addition of BpiI site at 3’ of 
subcloned brg11 N-terminal 
encoding fragment for 
compatibility with golden-gate 
assembly method  
CGA AGT CTT CCC ATA ATG AG 
sBrg11 Nterm TACG 
Rev 
Addition of BpiI site at 3’ of 
subcloned brg11 N-terminal 
encoding fragment for 
compatibility with golden-gate 
assembly method 
TAA GGT GAA GAG GGG CTC TAG 
Bs3pEBE Brg11 Fwd Introducing Brg11 target box 
into the Bs3 promoter in place 
of UPTAvrBs3 
GTG GCA ATC ACA ACT TCA AGT 
TAT CAT C 
 
Bs3pEBE Brg11 A0 Introducing Brg11 target box 
with an A0 into the Bs3 
promoter in place of UPTAvrBs3 
GGC GAC CCC CTT ATA AAA TTG 
GTC AG 
 
Bs3pEBE Brg11 G0   Introducing Brg11 target box 
with a G0 into the Bs3 promoter 
in place of UPTAvrBs3 
GGC GAC CCC CTC ATA AAA TTG 
GTC AG 
 
Bs3pEBE Brg11 C0 Introducing Brg11 target box 
with a C0 into the Bs3 promoter 
in place of UPTAvrBs3 
GGC GAC CCC CTG ATA AAA TTG 
GTC AG 
 
Bs3pEBE Brg11 T0   Introducing Brg11 target box 
with a T0 into the Bs3 promoter 
in place of UPTAvrBs3 
GGC GAC CCC CTA ATA AAA TTG 
GTC AG 
 
brg11_tow_prom_01 Primers used to sequence 
RipTAL homologs 
GTG AGA TGC AGC GGT GCT CGC 
GTG AG 
brg11_tow_stop_01 Primers used to sequence 
RipTAL homologs 
CGG TGA AGG CGA TCC GGC GGA 
TAC 
Hpx17N-termrev Primers used to sequence 
RipTAL homologs 
CGC TCG CCG TAC TGC GCA ACG 
Hpx17C-termfwd Primers used to sequence 
RipTAL homologs 
GCC GCC ACC AGC CTC TCT TGG 
Hpx17N- termIIfwd Primers used to sequence 
RipTAL homologs 
GAT CGC CTC TGC CTG CCC TCA 
AGC 
Hpx17C- termIIfwd Primers used to sequence 
RipTAL homologs 
CCA TCG CAC CGC GGT CGA TAC G 
Hpx17N- termIIrev Primers used to sequence 
RipTAL homologs 
GCT TGA GGG CAG GCA GAG GCG 
ATC 
Hpx17C- termIIrev Primers used to sequence 
RipTAL homologs 
CGT ATC GAC CGC GGT GCG ATG G 
Repeat region Seq 
Fwda) 
Primers used to sequence 
RipTAL homologs 
CGC TGC ATC TGA CAC CGC AGC 
AGG T 
Repeat region Seq 
Reva) 
Primers used to sequence 
RipTAL homologs 
CCT TCA CCG GCA ACC CCT GCC 
TGA C 
brg11 rep12 Seq Primers used to sequence 
RipTAL homologs 
ATA AGG CGC CGC GCG CAG ATC 
CGG 
brg11_rep07_unique- Primers used to sequence CAG GCG CTG GAG GGG ATT GGC 
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Table S1: Primers used in this study.  
Name of Primer Application Sequence 
seq RipTAL homologs GA 
brg11 rep17 Seq Primers used to sequence 
RipTAL homologs 
CTT GGC GCA ATG TGG GCA TGT GC 
inF RipTALIs Fwd Primers used to amplify 
RipTALI-9, -11 and -14 
TCC ACC GAC ACG GCC TCG A 
inF RipTALIs Rev Primers used to amplify 
RipTALI-9, -11 and -14 
GCC TCG AAC GAT GCA AGA TCT G 
Bs3p EBERipTALI-6 
Fwd 
Introducing RipTALI-6 target 
box into the Bs3 promoter in 
place of UPTAvrBs3 
GCA ATC ACA ACT TCA AGT TAT 
CAT C 
 
Bs3p EBERipTALI-9 
Fwd 
Introducing RipTALI-9 target 
box into the Bs3 promoter in 
place of UPTAvrBs3 
GTG GGC AAT CAC AAC TTC AAG 
TTA TCA TC 
 
Bs3p EBERipTALI-11 
Fwd 
Introducing RipTALI-11 target 
box into the Bs3 promoter in 
place of UPTAvrBs3 
GCA ATC ACA ACT TCA AGT TAT 
CATC 
 
Bs3p EBERipTALI-14 
Fwd 
Introducing RipTALI-14 target 
box into the Bs3 promoter in 
place of UPTAvrBs3 
TTG GCA ATC ACA ACT TCA AGT 
TAT CAT C 
 
Bs3p EBERipTALI-6 
A0Rev 
Introducing RipTALI-6 target 
box with an A0 into the Bs3 
promoter in place of UPTAvrBs3 
GGC ACC CCC TTA TAA AAT TGG 
TCA G 
 
Bs3p EBERipTALI-6 
G0Rev 
Introducing RipTALI-6 target 
box with a G0 into the Bs3 
promoter in place of UPTAvrBs3 
GGC ACC CCC TCA TAA AAT TGG 
TCA G 
 
Bs3p EBERipTALI-6 
C0Rev 
Introducing RipTALI-6 target 
box with a C0 into the Bs3 
promoter in place of UPTAvrBs3 
GGC GAC CCC TGA TAA AAT TGG 
TCA G 
 
Bs3p EBERipTALI-6 
T0Rev 
Introducing RipTALI-6 target 
box with a T0 into the Bs3 
promoter in place of UPTAvrBs3 
GGC GAC CCC TAA TAA AAT TGG 
TCA G 
 
Bs3p EBERipTALI-14 
A0Rev 
Introducing RipTALI-14 target 
box with an A0 into the Bs3 
promoter in place of UPTAvrBs3 
GGC GAC CCC TTA TAA AAT TGG 
TCA G 
 
Bs3p EBERipTALI-14 
G0Rev 
Introducing RipTALI-14 target 
box with a G0 into the Bs3 
promoter in place of UPTAvrBs3 
GGC GAC CCC TCA TAA AAT TGG 
TCA G 
 
Bs3p EBERipTALI-14 
C0Rev 
Introducing RipTALI-14 target 
box with a C0 into the Bs3 
promoter in place of UPTAvrBs3 
GGC GAC CCC TGA TAA AAT TGG 
TCA G 
 
Bs3p EBERipTALI-14 
T0Rev 
Introducing RipTALI-14 target 
box with a T0 into the Bs3 
promoter in place of UPTAvrBs3 
GGC GAC CCC TAA TAA AAT TGG 
TCA G 
 
a) Described in Heuer et al., 2007. 
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Table S2: Origin of RipTALs analysed in this study. 
RipTAL repeat 
no. 
Strain 
(source) 
Pa) 
AluI 
typeb) 
Host plant a) 
(family) 
Geographic 
origin a) 
RipTALI-1 16 JS53 I 
d5 
Capsicum annuum 
(Solanaceae) 
China 
RipTALI-2 16 HB53 I 
d3 
Capsicum annuum 
(Solanaceae)  
China 
RipTALI-3 16 GX53 I 
d3 
Capsicum annuum  
(Solanaceae) 
China 
RipTALI-4 16 GX55 I 
d1 
Capsicum annuum 
(Solanaceae)  
China 
RipTALI-5 1 HN515 I 
a 
Capsicum annuum 
(Solanaceae) 
China 
RipTALI-6 15 GD52 I 
c1 
Capsicum annuum 
(Solanaceae)  
China 
RipTALI-7 16 FJ41 I 
d4 
Capsicum annuum 
(Solanaceae)  
China 
RipTALI-8 1 SD58 I 
a 
Zingiber officinale 
(Zingiberaceae) 
China 
RipTALI-9 17 UW360 I 
e 
Morus alba 
(Moraceae)  
China 
RipTALI-10 16 UW148 I 
d4 
Rapistrum rugosum 
(Brassicaceae)  
Australia 
RipTALI-11 13 GX526 I 
b2 
Arachis hypogaea 
(Fabaceae)  
China 
RipTALI-12 16 GX528 I 
d1 
Arachis hypogaea 
(Fabaceae)  
China 
RipTALI-13 16 GZ522 I 
d7 
Nicotiana tabacum 
(Solanaceae)  
China 
RipTALI-14 15 GD45 I 
c2 
Solanum lycopersicum 
(Solanaceae)  
China 
RipTALI-15 16 ICPM11110 I 
d5 
Casuarina equisetifolia 
(Casuarinaceae) 
China 
P.: Phylotype; a) according to Heuer et al., 2007, Xue et al., 2011 and personal communication 
for RipTALI-10: A. Milling, Department of Plant Pathology, University of Wisconsin-
Madison. b) according to Heuer et al., 2007; out of a total thirteen identified AluI types: a, b1-
2, c1-2, d1-7 and e.  
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Table S3: GUS activities as determined in the trimer test and shown in Figure 3 
Trimer test repeat Bs3p 3xA Bs3p 3xG Bs3p 3xC Bs3p 3xT 
Brg11 repeat 1 2.33 ± 0.61 1.60 ± 0.51 0.70 ± 0.31 0.00 ± 0.00 
Brg11 repeat 2 0.00 ± 0.00 3.06 ± 0.79 0.00 ± 0.00 0.00 ± 0.00 
Brg11 repeat 3 0.01 ± 0.00 0.30 ± 0.03 0.00 ± 0.00 0.00 ± 0.00 
Brg11 repeat 4 1.66 ± 0.09 2.16 ± 0.30 0.00 ± 0.00 0.00 ± 0.00 
Brg11 repeat 5 0.78 ± 0.40 1.19 ± 0.11 0.00 ± 0.00 0.00 ± 0.00 
Brg11 repeat 6 4.80 ± 0.51 3.93 ± 1.11 0.08 ± 0.02 0.00 ± 0.00 
Brg11 repeat 7 0.34 ± 0.06 0.42 ± 0.36 0.42 ± 0.04 2.39 ± 0.34 
Brg11 repeat 8/11 0.00 ± 0.00 0.00 ± 0.00 1.26 ± 0.08 0.00 ± 0.00 
Brg11 repeat 9 0.00 ± 0.00 2.67 ± 1.25 0.00 ± 0.00 0.00 ± 0.00 
Brg11 repeat 10 0.00 ± 0.00 0.00 ± 0.00 0.06 ± 0.01 0.00 ± 0.00 
Brg11 repeat 12 0.06 ± 0.01 1.00 ± 0.12 0.00 ± 0.00 0.00 ± 0.00 
Brg11 repeat 13 4.07 ± 0.58 1.04 ± 0.36 1.19 ± 0.25 3.05 ± 0.29 
Brg11 repeat 14 3.49 ± 0.24 4.52 ± 0.14 2.07 ± 0.35 0.00 ± 0.00 
Brg11 repeat 15 0.84 ± 0.03 1.72 ± 0.24 0.00 ± 0.00 0.00 ± 0.00 
Brg11 repeat 16 0.00 ± 0.00 0.00 ± 0.00 0.28 ± 0.15 0.00 ± 0.00 
TALE NK repeat 0.00 ± 0.00 0.17 ± 0.06 0.00 ± 0.00 0.00 ± 0.00 
TALE HD repeat 0.00 ± 0.00 0.00 ± 0.00 0.61 ± 0.07 0.00 ± 0.00 
TALE NN repeat 5.78 ± 0.75 5.98 ± 0.83 0.00 ± 0.00 0.00 ± 0.00 
TALE NG repeat 0.51 ± 0.19 0.00 ± 0.00 0.06 ± 0.16 1.89 ± 1.00 
GUS activitys are in picomoles 4-MU per minute per µg protein. Standard error of the mean 
is given after the ± symbol in each case.Results are shown to 3 significant figures. A 
description of the trimer test approach and details of the protocol for GUS activitiy 
quantification can be found in Materials and Methods. Briefly, A. tumefaciens strains bearing 
derivatives of AvrBs3 where repeats 5-7 have been replaced with three identical copies of 
the repeats indicated in the first column, were coinfiltrated into N. benthamiana along with 
strains bearing an uidA reporter downstream of one of four Bs3p derivatives. In these 
promoter derivatives the three nucelotides corresponding to repeats 5-7 of AvrBs3, which are 
normally three adenines, have been replaced by three gunanines, cytosines or thymines to 
create Bs3p3xA, Bs3p3xG, Bs3p3xC and Bs3p3xT. Results are shown for protein extracts taken 
from leaf tissue forty-eight hours post infiltration and are averages based on three biological 
replicates.  
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Supplementary Figure 1: Annotated amino acid sequences of Bat1, Bat2 and Bat3 
Annotated sequences of the three predicted Bat proteins. Each is formed of a short 
Non-repetitive N-terminal Domain (NND) followed by an array of cryptic (-1, 0, +1) 
and core repeats (1, 2, 3…).  Consecutive repeats are numbered (left side). The RVDs 
(residues at repeat positions 12 and 13) are marked as boldface black letters on grey 
background. Blue lettering is used for the positively charged residues within repeat 
+1. 
>Bat1 (from Burkholderia rhizoxinica strain HKI-0454 plasmid pBRH01, GenBank 
NC_014718.1, RBRH_01844; Uniprot E5AV36) 
 NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
TALE-like DNA binding proteins from Burkholderia rhizoxinica - SUPPLEMENT ! 3 
>Bat2 (from Burkholderia rhizoxinica strain HKI-0454 plasmid pBRH02, GenBank 
NC_014723.1, RBRH_01776; Uniprot E5AW45) 
   NND MPATSMHQEDKQSANGLN 
-1 LSPLERIKIEKHYGGGATLAFISNQHDELAQV 
 0 LSRADILKIASYDCAAQALQAVLDCGPMLGKRG 
 1 FSRADIVRIAGNGGGAQALYSVLDVEPTLGKRG 
 2 FSQVDVVKIAG--GGAQALHTVLEIGPTLGERG 
 3 FSRGDIVTIAGNNGGAQALQAVLELEPTLRERG 
 4 FNQADIVKIAGNGGGAQALQAVLDVEPALGKRG 
 5 FSRVDIAKIAG--GGAQALQAVLGLEPTLRKRG 
 6 FHPTDIIKIAGNNGGAQALQAVLDLELMLRERG 
 7 FSQADIVKMASNIGGAQALQAVLNLEPALCERG 
 8 FSQPDIVKMAGNSGGAQALQAVLDLELAFRERG 
 9 FSQADIVKMASNIGGAQALQAVLELEPALHERG 
10 FSQANIVKMAGNSGGAQALQAVLDLELVFRERG 
11 VRQADIVKIVGNNGGAQALQAVFELEPTLRERG 
12 FNQATIVKIAANGGGAQALYSVLDVEPTLDKRG 
13 FSRVDIVKIAG--GGAQALHTAFELEPTLRKRG 
14 FNPTDIVKIAGNKGGAQALQAVLELEPALRERG 
15 FNQATIVKMAGNAGGAQALYSVLDVEPALRERG 
16 FSQPEIVKIAGNIGGAQALHTVLELEPTLHKRG 
17 FNPTDIVKIAGNSGGAQALQAVLELEPAFRERG 
18 FGQPDIVKMASNIGGAQALQAVLELEPALRERG 
19 FSQPDIVEMAGNIGGAQALQAVLELEPAFRERG 
20 FSQSDIVKIAGNIGGAQALQAVLELEPTLRESD 
21 FRQADIVNIAGNDGSTQALKAVIEHGPRLRQRG 
22 FNRASIVKIAGNSGGAQALQAVLKHGPTLDERG 
23 FNLTNIVKIAGNGGGAQALKAVIEHGPTLQQRG 
24 FNLTDIVEMAGKGGGAQALKAVLEHGPTLRQRG 
25 FNLIDIVEMASNTGGAQALKTVLEHGPTLRQRD 
26 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAL---LLERQ 
>Bat3 (from Burkholderia rhizoxinica strain HKI-0454 plasmid pBRH02 GenBank 
NC_014723.1, RBRH_01777; Uniprot E5AW45) 
   NND MPVTSVYQKDKPFGARLN 
-1 LSPFECLKIEKHSGGADALEFISNKYDALTQV 
 0 LSRADILKIACHDCAAHALQAVLDYEQVFRQRG 
 1 FARADIIKITGNGGGAQALKAVVVHGPTLNECG 
 2 FSQADIVRIADNIGGAQALKAVLEHGPTLNERD 
 3 YSGADIVKIAGNGGGARALKAVVMHGPTLCESG 
 4 YSGADIVKIASNGGGAQALEAVAMHGSTLCERG 
 5 YCRTDIAKIAGNGGGAQALKAIVMHGPTLCERG 
 6 YSRTDIVKIADNNGGAQALKAVFEHGPALTQAG 
+1 RSNEDIVNMAARTGAAGQIRKMAAQ---LSGRQ 
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Supplementary Figure 2: Annotated amino acid sequences of AvrBs3 and Brg11 
AvrBs3 and Brg11 are the first characterised TALE and RipTAL respectively (36, 
10). Annotated amino-acid sequences are given for Brg11 and AvrBs3. N-terminal 
and C-terminal non-repeat regions and the central repeat array are displayed in 
separate paragraphs but are part of contiguous polypeptides. Consecutive repeats are 
numbered (left side). Repeats can be divided into cryptic (-1, 0, +1, +2) and core (1, 2, 
3…). The RVDs (residues at repeat positions 12 and 13) are marked as boldface black 
letters on grey background.  
>AvrBs3 (from Xanthomonas campestris pv. vesicatoria strain 71-21; GenBank 
CAA34257.1) 
MDPIRSRTPSPARELLPGPQPDGVQPTADRGVSPPAGGPLDGLPARRTMSRTRLPSPPAPSP
AFSAGSFSDLLRQFDPSLFNTSLFDSLPPFGAHHTEAATGEWDEVQSGLRAADAPPPTMRVA
VTAARPPRAKPAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH
GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKR-GGVTAVEAVHAWRNALTGAPLN 
 1 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3 LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
17 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACL-GGRPALDAVKKGLPHAPALIKRT 
NRRIPERTSHRVADHAQVVRVLGFFQCHSHPAQAFDDAMTQFGMSRHGLLQLFRRVGVTELE
ARSGTLPPASQRWDRILQASGMKRAKPSPTSTQTPDQASLHAFADSLERDLDAPSPMHEGDQ
TRASSRKRSRSDRAVTGPSAQQSFEVRVPEQRDALHLPLSWRVKRPRTSIGGGLPDPGTPTA
ADLAASSTVMREQDEDPFAGAADDFPAFNEEELAWLMELLPQ  
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>Brg11 (from Ralstonia solanacearum strain GMI1000; GenBank NP_519936.1) 
MRIGKSSGWLNESVSLEYEHVSPPTRPRDTRRRPRAAGDGGLAHLHRRLAVGYAEDTPRTEA
RSPAPRRPLPVAPASAPPAPSLVPEPPMPVSLPAVSSPRFSAGSSAAITDPFPSLPPTPVLY
AMARELEALSDATWQPAVPLPAEPPTDARRGNTVFDEASASSPVIASACPQAFASPPRAPRS
ARARRARTGGDAWPAPTFLSRPSSSRIGRDVFGKLVALGYSREQIRKLKQESLSEIAKYHTT
LTGQGFTHADICRISRRRQSLRVVARNYPELAAALPE 
-1 LTRAHIVDIARQRSGDLALQALLPVATALTAAPLR 
 0 LSASQIATVAQY GERPAIQALYRLRRKLTRAPLH 
 1 LTPQQVVAIASNTGGKRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGKQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGKQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGKQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGKQALEAVKAHLLDLRGVPYA 
 6 LSTEQVVAIASHNGGKQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGKQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGKQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGNQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGKQALEAVGAQLVALRAAPYA 
12 LNTEQVVAIASSHGGKQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGKQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGKQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGKQALEAVWALLPVLRATPYD 
16 LNTAQIVAIASHDGGKPALEAVWAKLPVLRGAPYA 
+1 LSTAQVVAIACI-SGQQALEAIEAHMPTLRQASHS 
+2 LSPERVAAIACI-GGRSAVEAVRQGLPVKAIRRIRR 
EKAPVAGPPPASLGPTPQELVAVLHFFRAHQQPRQAFVDALAAFQATRPALLRLLSSVGVTE
IEALGGTIPDATERWQRLLGRLGFRPATGAAAPSPDSLQGFAQSLERTLGSPGMAGQSACSP
HRKRPAETAIAPRSIRRSPNNAGQPSEPWPDQLAWLQRRKRTARSHIRADSAASVPANLHLG
TRAQFTPDRLRAEPGPIMQAHTSPASVSFGSHVAFEPGLPDPGTPTSADLASFEAEPFGVGP
LDFHLDWLLQILET 
TALE-like DNA binding proteins from Burkholderia rhizoxinica - SUPPLEMENT ! 6 
Supplementary Figure 3: Amino acid alignments of Bat2 and Bat3 core repeats. 
Alignments of the core repeats of Bat2 and Bat3 were created in Clustal Omega (34, 
35) and Boxshade was used for formatting. White lettering on a black background 
indicates a consensus residue. Black lettering on a grey background indicates a 
residue similar to the consensus residue. Black lettering on a white background 
indicates a residue neither identical nor similar to the consensus residue. Repeats are 
shown in order of appearance in the polypeptide and numbered accordingly. The 
consensus repeat is shown below each alignment.  
>Alignment of Bat2 core repeats 
01 FSRADIVRIAGNGGGAQALYSVLDVEPTLGKRG 
02 FSQVDVVKIAG--GGAQALHTVLEIGPTLGERG 
03 FSRGDIVTIAGNNGGAQALQAVLELEPTLRERG 
04 FNQADIVKIAGNGGGAQALQAVLDVEPALGKRG 
05 FSRVDIAKIA--GGGAQALQAVLGLEPTLRKRG 
06 FHPTDIIKIAGNNGGAQALQAVLDLELMLRERG 
07 FSQADIVKMASNIGGAQALQAVLNLEPALCERG 
08 FSQPDIVKMAGNSGGAQALQAVLDLELAFRERG 
09 FSQADIVKMASNIGGAQALQAVLELEPALHERG 
10 FSQANIVKMAGNSGGAQALQAVLDLELVFRERG 
11 VRQADIVKIVGNNGGAQALQAVFELEPTLRERG 
12 FNQATIVKIAANGGGAQALYSVLDVEPTLDKRG 
13 FSRVDIVKIAG--GGAQALHTAFELEPTLRKRG 
14 FNPTDIVKIAGNKGGAQALQAVLELEPALRERG 
15 FNQATIVKMAGNAGGAQALYSVLDVEPALRERG 
16 FSQPEIVKIAGNIGGAQALHTVLELEPTLHKRG 
17 FNPTDIVKIAGNSGGAQALQAVLELEPAFRERG 
18 FGQPDIVKMASNIGGAQALQAVLELEPALRERG 
19 FSQPDIVEMAGNIGGAQALQAVLELEPAFRERG 
20 FSQSDIVKIAGNIGGAQALQAVLELEPTLRESD 
21 FRQADIVNIAGNDGSTQALKAVIEHGPRLRQRG 
22 FNRASIVKIAGNSGGAQALQAVLKHGPTLDERG 
23 FNLTNIVKIAGNGGGAQALKAVIEHGPTLQQRG 
24 FNLTDIVEMAGKGGGAQALKAVLEHGPTLRQRG 
25 FNLIDIVEMASNTGGAQALKTVLEHGPTLRQRD 
26 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
   FSQADIVKIAGNGGGAQALQAVLELEPTLRERG 
> Alignment of Bat3 core repeats 
01 FARADIIKITGNGGGAQALKAVVVHGPTLNECG 
02 FSQADIVRIADNIGGAQALKAVLEHGPTLNERD 
03 YSGADIVKIAGNGGGARALKAVVMHGPTLCESG 
04 YSGADIVKIASNGGGAQALEAVAMHGSTLCERG 
05 YCRTDIAKIAGNGGGAQALKAIVMHGPTLCERG 
06 YSRTDIVKIADNNGGAQALKAVFEHGPALTQAG 
   YSRADIVKIAGNGGGAQALKAVVMHGPTLCERG 
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Supplementary Figure 4: Nucleotide sequences of synthesised Bat1, Bat2 and Bat3 
genes 
Genes encoding the three predicted proteins were synthesised with E. coli codon 
usage (GenScript). Each was synthesised as a series of separate blocks flanked by 
BsaI sites allowing ordered assembly via BsaI cut-ligation into target vectors. BsaI 
recognition sites are underlined, while bold typeface marks the overlaps created upon 
digest.  Start and stop codons are distinguished with the use of lowercase italics.  
>Bat1 block 1 
GGTCTCTCACCatgAGCACCGCCTTCGTGGACCAAGATAAGCAAATGGCAAATCGCC
TGAACCTGTCACCGCTGGAACGTAGCAAAATTGAAAAACAATATGGCGGTGCAACCA
CGCTGGCTTTTATTAGCAACAAACAGAATGAACTGGCACAAATCCTGAGCCGTGCTG
ATATTCTGAAAATCGCGTCTTACGACTGCGCAGCACATGCACTGCAGGCTGTCCTGG
ATTGTGGCCCGATGCTGGGCAAACGCGGTTTTAGCCAGTCTGACATTGTCAAGATCG
CCGGTAACATTGGCGGTGCACAGGCACTGCAAGCAGTGCTGGATCTGGAAAGTATGC
TGGGCAAACGTGGTTTCTCCCGCGATGACATTGCGAAGATGGCCGGCAATATCGGCG
GTGCACAGACCCTGCAGGCCGTGCTGGATCTGGAATCAGCCTTTCGTGAACGCGGCT
TCTCGCAGGCCGACATTGTTAAAATCGCCGGTAACAATGGCGGTGCACAAGCTCTGT
ATAGTGTGCTGGATGTTGAACCGACCCTGGGTAAACGTGGTTTTTCACGCGCTGACA
TTGTTAAGATCGCCGGTAACACCGGCGGTGCCCAAGCACTGCACACGGTCCTGGATC
TGGAACCGGCCCTGGGCAAGCGTGGTTTCTCCCGCATTGATATCGTTAAGATCGCAG
CTAACAACGGTGGTGCTCAAGCCCTGCACGCTGTCCTGGATCTGGGTCCGACGCTGC
GCGAATGTGGGTGAGACC 
>Bat1 block 2 
GGTCTCTTGGGTTCTCGCAGGCAACCATCGCAAAAATCGCTGGCAATATCGGCGGTG
CTCAGGCTCTGCAAATGGTGCTGGATCTGGGTCCGGCTCTGGGCAAACGTGGTTTTA
GCCAGGCAACCATTGCTAAGATCGCCGGTAACATTGGCGGTGCACAGGCACTGCAAA
CGGTCCTGGATCTGGAACCGGCGCTGTGCGAACGCGGCTTCTCTCAGGCCACCATCG
CAAAAATGGCTGGTAACAATGGCGGTGCACAGGCTCTGCAAACGGTTCTGGATCTGG
AACCGGCCCTGCGTAAACGCGATTTTCGTCAGGCGGACATTATCAAGATTGCCGGTA
ATGACGGTGGCGCCCAGGCACTGCAAGCAGTGATCGAACATGGCCCGACCCTGCGCC
AACACGGTTTCAACCTGGCAGACATTGTTAAGATGGCTGGTAATATCGGTGGTGCTC
AAGCTCTGCAAGCGGTGCTGGACCTGAAGCCGGTGCTGGACGAACATGGTTTGAGAC
C 
>Bat1 block 3 
GGTCTCTGGTTTCTCTCAACCGGATATCGTCAAGATGGCGGGCAACATTGGTGGTGC
TCAAGCCCTGCAAGCCGTCCTGTCACTGGGTCCGGCGCTGCGTGAACGTGGCTTTAG
CCAGCCGGATATTGTCAAAATCGCCGGTAACACCGGCGGTGCACAGGCACTGCAAGC
AGTGCTGGATCTGGAACTGACGCTGGTTGAACATGGCTTCTCTCAACCGGACATTGT
TCGCATCACCGGTAATCGTGGCGGTGCCCAAGCTCTGCAAGCGGTGCTGGCTCTGGA
ACTGACCCTGCGTGAACGAGGATGAGACC 
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>Bat1 block 4 
GGTCTCTAGGATTTAGCCAACCGGACATCGTGAAAATCGCGGGCAATAGCGGCGGTG
CTCAAGCTCTGCAAGCGGTCCTGGATCTGGAACTGACGTTTCGTGAACGCGGCTTTA
GCCAGGCGGATATTGTCAAAATCGCCGGTAACGACGGCGGTACCCAAGCACTGCATG
CTGTGCTGGATCTGGAACGTATGCTGGGCGAACGTGGTTTCTCTCGCGCAGACATTG
TGAACGTTGCTGGCAACAATGGCGGTGCGCAGGCCCTGAAAGCCGTGCTGGAACACG
AAGCCACGCTGAATGAACGTGGCTTTAGTCGCGCAGATATTGTCAAGATCGCGGGTA
ACGGTGGCGGCGCACAAGCACTGAAGGCGGTTCTGGAACACGAAGCGACCCTGGATG
AACGCGGCTGAGACC 
>Bat1 block 5 
GGTCTCTCGGCTTTTCTCGTGCTGATATTGTCCGTATTGCGGGTAATGGTGGTGGTG
CCCAGGCTCTGAAGGCTGTGCTGGAACATGGTCCGACGCTGAACGAACGTGGCTTTA
ATCTGACCGATATTGTTGAAATGGCGGCCAACAGTGGCGGTGCACAGGCTCTGAAAG
CGGTCCTGGAACACGGCCCGACGCTGCGTCAACGTGGTCTGAGCCTGATTGACATCG
TGGAAATTGCATCTAACGGCGGTGCGCAGGCCCTGAAAGCTGTCCTGAAGTATGGTC
CGGTGCTGATGCAAGCAGGTCGTAGCAATGAAGAAATCGTGCACGTTGCCGCTCGTC
GTGGTGGTGCTGGCCGTATCCGTAAGATGGTTGCTCCGCTGCTGGAACGTCAGtagA
AGGTGAGACC 
>Bat2 block1 
GGTCTCTCACCatgCCGGCCACCTCGATGCACCAAGAAGATAAACAGTCCGCAAACG
GTCTGAACCTGAGCCCGCTGGAACGTATTAAAATTGAAAAACATTATGGCGGTGGCG
CGACCCTGGCCTTTATTAGTAACCAGCACGATGAACTGGCACAAGTGCTGAGCCGTG
CTGACATTCTGAAAATCGCCTCTTATGACTGTGCTGCTCAAGCTCTGCAAGCGGTGC
TGGACTGCGGCCCGATGCTGGGTAAACGCGGCTGAGACC 
>Bat2 block2 
GGTCTCTCGGCTTTTCCCGTGCTGATATTGTCCGTATTGCTGGTAATGGTGGTGGTG
CCCAAGCTCTGTATTCTGTCCTGGATGTTGAACCGACGCTGGGTAAACGTGGCTTTA
GCCAGGTTGATGTGGTTAAAATTGCGGGCGGTGGCGCACAAGCACTGCATACCGTCC
TGGAAATCGGTCCGACGCTGGGTGAACGTGGCTTCTCTCGCGGTGACATTGTTACCA
TCGCCGGCAACAATGGTGGCGCACAGGCTCTGCAAGCAGTTCTGGAACTGGAACCGA
CGCTGCGTGAACGCGGTTTTAACCAGGCGGATATTGTCAAAATCGCCGGTAATGGTG
GCGGTGCACAGGCACTGCAAGCAGTCCTGGATGTGGAACCGGCTCTGGGTAAACGTG
GCTTTTCCCGCGTGGACATTGCAAAAATCGCTGGCGGTGGCGCCCAAGCCCTGCAGG
CAGTTCTGGGTCTGGAACCGACCCTGCGTAAACGCGGCTTCCACCCGACGGACATTA
TCAAAATTGCGGGTAACAATGGTGGTGCCCAAGCACTGCAAGCAGTTCTGGATCTGG
AACTGATGCTGCGTGAACGCGGCTTTAGCCAGGCAGACATTGTGAAAATGGCTTCTA
ACATCGGTGGCGCCCAAGCTCTGCAAGCGGTTCTGAATCTGGAACCGGCCCTGTGCG
AACGCGGTTTCTCACAGCCGGATATCGTCAAAATGGCCGGTAACTCGGGTGGCGCCC
AAGCGCTGCAAGCAGTGCTGGATCTGGAACTGGCTTTTCGTGAACGCGGCTTCAGTC
AGGCGGACATTGTGAAAATGGCCTCCAATATCGGCGGCGCACAAGCACTGCAAGCTG
TCCTGGAACTGGAACCGGCTCTGCACGAACGCGGCTTTAGTTGAGACC 
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>Bat2 block3 
GGTCTCATAGTCAAGCAAATATCGTCAAAATGGCGGGTAATAGTGGTGGTGCCCAAG
CCCTGCAAGCGGTCCTGGATCTGGAACTGGTCTTTCGTGAACGTGGCGTGCGCCAGG
CGGATATTGTGAAAATCGTTGGTAACAATGGCGGTGCACAGGCTCTGCAAGCAGTCT
TTGAACTGGAACCGACCCTGCGTGAACGCGGCTTCAACCAGGCTACGATTGTTAAAA
TCGCAGCAAATGGCGGTGGCGCACAAGCACTGTATAGCGTCCTGGATGTGGAACCGA
CCCTGGACAAACGTGGTTTCTCTCGCGTTGATATTGTCAAAATCGCAGGTGGCGGTG
CCCAAGCTCTGCATACCGCTTTTGAACTGGAACCGACGCTGCGTAAACGCGGCTTCA
ACCCGACCGACATTGTCAAAATCGCCGGTAATAAAGGCGGTGCACAGGCACTGCAAG
CAGTGCTGGAACTGGAACCGGCTCTGCGTGAACGCGGCTTTAACCAGGCAACGATTG
TGAAAATGGCGGGTAATGCCGGCGGTGCACAAGCTCTGTACAGTGTGCTGGATGTTG
AACCGGCACTGCGTGAACGTGGTTTCTCCCAGCCGGAAATTGTTAAAATCGCCGGTA
ACATCGGCGGTGCGCAAGCCCTGCATACGGTTCTGGAGTTAGAACCGACCCTGCACA
AACGTGGCTTTAACCCGACCGATATTGTGAAAATCGCGGGTAATAGCGGCGGTGCCC
AGGCCCTGCAGGCGGTTCTGGAACTGGAACCGGCGTTTCGTGAACGCGGCTTCGGTC
AGCCGGACATTGTTAAAATGGCCAGCAATATCGGCGGTGCCCAAGCCCTGCAAGCCG
TCCTGGAACTGGAACCGGCCCTGCGTGAACGTGGTTTTAGCCAGTGAGACC 
>Bat2 block4 
GGTCTCTCCAGCCGGATATTGTGGAAATGGCGGGTAACATCGGCGGCGCTCAAGCCC
TGCAAGCTGTCCTGGAACTGGAACCGGCCTTTCGTGAACGCGGCTTTAGCCAGTCTG
ATATTGTTAAAATCGCGGGTAACATTGGCGGTGCACAGGCACTGCAAGCAGTTCTGG
AACTGGAACCGACCCTGCGCGAAAGCGATTTCCGTCAGGCAGACATTGTGAACATCG
CTGGCAATGACGGTTCTACCCAAGCGCTGAAAGCCGTTATTGAACATGGCCCGCGTC
TGCGCCAGCGTGGTTTTAACCGCGCGAGTATTGTCAAAATCGCCGGCAATTCCGGCG
GTGCACAGGCTCTGCAAGCAGTGCTGAAACACGGCCCGACCCTGGATGAACGTGGTT
TCAACCTGACGAATATTGTTAAAATCGCCGGTAACGGCGGTGGCGCACAGGCACTGA
AAGCTGTCATTGAACATGGCCCGACCCTGCAGCAACGCGGTTTTAATCTGACGGATA
TCGTGGAAATGGCGGGCAAAGGTGGCGGTGCACAAGCTCTGAAAGCAGTTCTGGAAC
ACGGTCCGACCCTGCGTCAGCGTGGTTTCAACCTGATTGACATCGTCGAAATGGCGT
CCAATACGGGCGGTGCGCAAGCCCTGAAAACCGTTCTGGAACATGGTCCGACGCTGC
GCCAGCGTGATCTGTCACTGATTGACATCGTGGAAATTGCATCGAATGGTGGTGCAC
AGGCTCTGAAAGCTGTCCTGAAATATGGCCCGGTGCTGATGCAGGCAGGTCGTAGCA
ATGAAGAAATCGTGCACGTTGCCGCTCGTCGTGGTGGTGCGGGCCGTATTCGTAAAA
TGGTTGCTCTGCTGCTGGAACGCCAAtaaGGTGAGACC !>Bat3!block!1!
GGTCTCTCACCATGCCGGTCACCAGCGTCTACCAAAAAGATAAACCGTTCGGCGCAC
GTCTGAACCTGAGCCCGTTTGAATGTCTGAAAATTGAAAAACATAGCGGCGGTGCGG
ATGCCCTGGAATTTATTTCTAACAAATATGACGCCCTGACCCAGGTGCTGAGTCGTG
CAGATATTCTGAAAATCGCTTGCCACGACTGTGCCGCCCACGCTCTGCAAGCTGTGC
TGGACTATGAACAAGTTTTTCGCCAACGCGGCTGAGACC !>Bat3!block!2!
GGTCTCTCGGCTTCGCTCGTGCAGATATTATTAAAATCACGGGTAACGGCGGTGGTG
CCCAAGCCCTGAAAGCAGTGGTTGTCCATGGTCCGACGCTGAACGAATGCGGTTTTT
CACAGGCGGATATTGTCCGTATCGCCGACAATATTGGCGGTGCGCAAGCCCTGAAAG
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CGGTGCTGGAACATGGCCCGACCCTGAACGAACGTGATTATTCGGGTGCAGACATTG
TGAAAATCGCTGGTAATGGCGGTGGCGCACGTGCTCTGAAAGCAGTGGTTATGCACG
GTCCGACGCTGTGTGAAAGCGGTTACTCTGGCGCGGATATTGTTAAAATCGCAAGTA
ACGGTGGCGGTGCACAGGCACTGGAAGCAGTCGCTATGCATGGTTCCACCCTGTGCG
AACGTGGCTATTGTCGCACGGACATTGCGAAAATCGCCGGCAACGGCGGTGGCGCAC
AAGCACTGAAAGCAATTGTCATGCACGGTCCGACCCTGTGTGAACGCGGCTACAGCC
GCACGGATATTGTGAAAATCGCAGACAACAATGGTGGCGCACAGGCTCTGAAAGCTG
TTTTCGAACATGGTCCGGCACTGACCCAAGCTGGCCGCAGTAACGAAGATATCGTTA
ATATGGCCGCACGCACGGGCGCAGCGGGTCAGATTCGTAAAATGGCGGCACAACTGT
CGGGTCGTCAAtaaGGTGAGACC 
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Supplementary,Figure,5:!Sequences of translational fusions for protein 
purification, transcriptional activation reporters and nuclease assay. 
Only the sequences specific to each expression construct are shown. The sequence of 
the relevant Bat protein or derivative or TALE derivative fills the position indicated. 
Epitopes used for purification or antibody binding are indicated with a red 
background. NLSs are indicated with a yellow background. Green background marks 
an activation domain and mustard-brown a nuclease domain.  
>Protein expression and purification 
MSYYHHHHHHLESTSLYKKAGSAAAPFT – Bat1, Bat2 or Bat3 coding 
sequence – STOP 
>Human cell transcriptional activation assay: Full construct 
MGYPYDVPDYASRPKKKRKVGIHAM – Bat1, dBat or dTALE coding 
sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEASGSGRADALDD
FDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLINSR – STOP 
>Human cell transcriptional activation assay: ΔAD 
MGYPYDVPDYASRPKKKRKVGIHAM – Bat1 coding sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEAS – STOP 
>Human cell transcriptional activation assay: ΔNLSs 
START – Bat1 coding sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSGRADALDDFDLDMLGSDALDD
FDLDMLGSDALDDFDLDMLGSDALDDFDLDMLINSR – STOP 
>Planta transcriptional activation assay: Full construct 
START – Bat1 or dTALE coding sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEASGSGRADALDD
FDLDMLGSDALDDFDLDMLGSDALDDFDLDMLGSDALDDFDLDMLINSR – STOP 
>Planta transcriptional activation assay: ΔAD 
START – Bat1 coding sequence - 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEAS – STOP 
>In vitro nuclease assay 
MGLINIFYPYDVPDYAGYPYDVPDYAGSYPYDVPDYAAQCSG – Bat1 coding 
sequence –  
GGQLVKSELEEKKSELRHKLKYVPHEYIELIEIARNSTQDRILEMKVMEFFMKVYGYRGKHL
GGSRKPDGAIYTVGSPIDYGVIVDTKAYSGGYNLPIGQADEMQRYVEENQTRNKHINPNEWW
KVYPSSVTEFKFLFVSGHFKGNYKAQLTRLNHITNCNGAVLSVEELLIGGEMIKAGTLTLEE
VRRKFNNGEINF 
MGYPYDVPDYASRPKKKRKVGIHAS – TALE coding sequence -  
GSQLVKSELEEKKSELRHKLKYVPHEYIELIEIARNSTQDRILEMKVMEFFMKVYGYRGKHL
GGSRKPDGAIYTVGSPIDYGVIVDTKAYSGGYNLPIGQADEMQRYVEENQTRNKHINPNEWW
KVYPSSVTEFKFLFVSGHFKGNYKAQLTRLNHITNCNGAVLSVEELLIGGEMIKAGTLTLEE
VRRKFNNGEINF 
TALE-like DNA binding proteins from Burkholderia rhizoxinica - SUPPLEMENT ! 12 
Supplementary Figure 6: Target and reporter sequences used in this study. 
Sequences of binding elements used for electrophoretic mobility shift assays (Figure 
2). Only forward strand shown, the binding element is highlighted with bold lettering 
BEBat1/BEBat1 T-0 TAGACTAAGAGAAGCAAAGACGTTATATGC!
BEBat2 TAGACTTTGTTGAAAAGTTGTAAAAACATTATATGC!
BEBat3 TAGACATAGATTATTATATTTGTAACAAGTAAATGC!
BEBat1 C-0 TAGACCAAGAGAAGCAAAGACGTTATATGC!
BEBat1 G-0 TAGACGAAGAGAAGCAAAGACGTTATATGC!
BEBat1 A-0 TAGACAAAGAGAAGCAAAGACGTTATATGC!
Sequences of reporters and binding elements used in assessments of 
transcriptional activation (Figures 3, 5-7 and S8) 
pCMV-BE-dsEGFP – transcriptional activation reporter in human cells. (Figures 3, 
5-7, S8). Green highlighting is used for the dsEGFP coding sequence and italics for 
the subsequence polyA signal. Grey highlighting for the minimal CMV promoter. The 
bold-N positions are filled by one of the four binding elements listed. 
BEBat1   AAGAGAAGCAAAGACGTTAT 
BEdBatRVDswitch1 AGAGAAAGCAAAGACGTTAT 
BEdBatRVDswitch2 AAGAGAGCAAAAGACGTTAT 
BEpSOX2  TTTATTCCCTGACAGCCCC 
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CTAGACTNNNNNNNNNNNNNNNNNNNNNATGCGGATCCACGTATGTCGAGGTAGGCG
TGTACGGTGGGAGGCCTATATAAGCAGAGCTCGTTTAGTGAACCGTCAGATCGCCTG
GAGGTACCGCCACCATGGGCTTAATTAATATAATTAATAATCCACTTAAGAATTCTT
TAAAGTGGATTATTAATTATAGGACCGGTATTACCCTGTTATCCCTAGTGAGCAAGG
GCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAA
ACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGC
TGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCG
TGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGC
AGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCT
TCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACA
CCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCC
TGGGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACA
AGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCA
GCGTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGC
TGCTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACG
AGAAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCG
GCATGGACGAGCTGTACAAGAAGCTTAGCCATGGCTTCCCGCCGGAGGTGGAGGAGC
AGGATGATGGCACGCTGCCCATGTCTTGTGCCCAGGAGAGCGGGATGGACCGTCACC
CTGCAGCCTGTGCTTCTGCTAGGATCAATGTGTAGCTAAGTAAGATCCTTCGAGCAG
ACATGATAAGATACATTGATGAGTTTGGACAAACCACAACTAGAATGCAGTGAAAAA
AATGCTTTATTTGTGAAATTTGTGATGCTATTGCTTTATTTGTAACCATTATAAGCT
GCAATAAACAAGTTAACAACAACAATTGCATTCATTTTATGTTTCAGGTTCAGGGGG
AGGTGTGGGAGGTTTTTTAAAGCAAGTAAAACCTCTACAAATGTGGTAAAA 
Bs3p-BEBat1-uidA for in planta assessment of transcriptional activation (Figure S8). 
Blue indicates the coding sequence of the uidA reporter gene, which is a part of the 
vector pGWB3* (10). BEBat1 is embedded within the pepper Bs3 promoter (italics) 
and is distinguished with bold typeface. In this construct a guanine base is paired with 
the 20th repeat of acBat1 and dTALEBat1mimic. 
TCATAGTCAAGCTAACGAAACTTATGCAAGGGAAATATGAAATTAGTATGCAAGTAA
ACTCAAAGAACTAATCATTGAACTGAAAGATCAATATATCAAAAAAAAAAAAAAAAC
AATAAAACCGTTTAACCGATAGATTAACCATTTCTGGTTCAGTTTATGGGTTAAACC
ACAATTTGCACACCCTGGTTAAACAATGAACACGTTTGCCTGACCAATTTTATTATA
TAAACCTAACCATCCTCACAACTAAGAGAAGCAAAGACGTTAGGTTCAAGTTATCAT
CCCCTTTCTCTTTTCTCCTCTTGTTCTTGTCACCCGCTAAATCTATCAAAACACAAG
TAGTCCTAGTTGCACTATATTTCAAGGGTGGGCGCGCCGACCCAGCTTTCTTGTACA
AAGTGGTTCGATCTAGAGGATCCCCGGGTGGTCAGTCCCTTATGTTACGTCCTGTAG
AAACCCCAACCCGTGAAATCAAAAAACTCGACGGCCTGTGGGCATTCAGTCTGGATC
GCGAAAACTGTGGAATTGATCAGCGTTGGTGGGAAAGCGCGTTACAAGAAAGCCGGG
CAATTGCTGTGCCAGGCAGTTTTAACGATCAGTTCGCCGATGCAGATATTCGTAATT
ATGCGGGCAACGTCTGGTATCAGCGCGAAGTCTTTATACCGAAAGGTTGGGCAGGCC
AGCGTATCGTGCTGCGTTTCGATGCGGTCACTCATTACGGCAAAGTGTGGGTCAATA
ATCAGGAAGTGATGGAGCATCAGGGCGGCTATACGCCATTTGAAGCCGATGTCACGC
CGTATGTTATTGCCGGGAAAAGTGTACGTATCACCGTTTGTGTGAACAACGAACTGA
ACTGGCAGACTATCCCGCCGGGAATGGTGATTACCGACGAAAACGGCAAGAAAAAGC
AGTCTTACTTCCATGATTTCTTTAACTATGCCGGAATCCATCGCAGCGTAATGCTCT
ACACCACGCCGAACACCTGGGTGGACGATATCACCGTGGTGACGCATGTCGCGCAAG
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ACTGTAACCACGCGTCTGTTGACTGGCAGGTGGTGGCCAATGGTGATGTCAGCGTTG
AACTGCGTGATGCGGATCAACAGGTGGTTGCAACTGGACAAGGCACTAGCGGGACTT
TGCAAGTGGTGAATCCGCACCTCTGGCAACCGGGTGAAGGTTATCTCTATGAACTGT
GCGTCACAGCCAAAAGCCAGACAGAGTGTGATATCTACCCGCTTCGCGTCGGCATCC
GGTCAGTGGCAGTGAAGGGCGAACAGTTCCTGATTAACCACAAACCGTTCTACTTTA
CTGGCTTTGGTCGTCATGAAGATGCGGACTTGCGTGGCAAAGGATTCGATAACGTGC
TGATGGTGCACGACCACGCATTAATGGACTGGATTGGGGCCAACTCCTACCGTACCT
CGCATTACCCTTACGCTGAAGAGATGCTCGACTGGGCAGATGAACATGGCATCGTGG
TGATTGATGAAACTGCTGCTGTCGGCTTTAACCTCTCTTTAGGCATTGGTTTCGAAG
CGGGCAACAAGCCGAAAGAACTGTACAGCGAAGAGGCAGTCAACGGGGAAACTCAGC
AAGCGCACTTACAGGCGATTAAAGAGCTGATAGCGCGTGACAAAAACCACCCAAGCG
TGGTGATGTGGAGTATTGCCAACGAACCGGATACCCGTCCGCAAGGTGCACGGGAAT
ATTTCGCGCCACTGGCGGAAGCAACGCGTAAACTCGACCCGACGCGTCCGATCACCT
GCGTCAATGTAATGTTCTGCGACGCTCACACCGATACCATCAGCGATCTCTTTGATG
TGCTGTGCCTGAACCGTTATTACGGATGGTATGTCCAAAGCGGCGATTTGGAAACGG
CAGAGAAGGTACTGGAAAAAGAACTTCTGGCCTGGCAGGAGAAACTGCATCAGCCGA
TTATCATCACCGAATACGGCGTGGATACGTTAGCCGGGCTGCACTCAATGTACACCG
ACATGTGGAGTGAAGAGTATCAGTGTGCATGGCTGGATATGTATCACCGCGTCTTTG
ATCGCGTCAGCGCCGTCGTCGGTGAACAGGTATGGAATTTCGCCGATTTTGCGACCT
CGCAAGGCATATTGCGCGTTGGCGGTAACAAGAAAGGGATCTTCACTCGCGACCGCA
AACCGAAGTCGGCGGCTTTTCTGCTGCAAAAACGCTGGACTGGCATGAACTTCGGTG
AAAAACCGCAGCAGGGAGGCAAACAATGA 
Sequences of the PCR templates used to create targets for the nuclease assays 
shown in Figure 4. Only the forward strand is shown. Grey highlighting shows the 
annealing sites for the amplification primers used in the PCR to create the target DNA 
for the nuclease assays. The two copies of BEBat1 in reverse orientation are underlined. 
The italicised bases are one of the five spacers listed below. The entire 
yellow-highlighted region is replaced by the given sequence in the case of the ‘no 
target’ control. 5bp!!!CTAGC!7bp!!!TCTAGAC!11bp!TACGTCTAGAC!15bp!TACGTACGTCTAGAC!19bp!AAGCTACGTACGTCTAGAC!No!target!ATTGCCACGGCGACTCTCTTG!
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GCAGCTCCCGGAGACGGTCACAGCTTGTCTGTAAGCGGATGCCGGGAGCAGACAAGC
CCGTCAGGGCGCGTCAGCGGGTGTTGGCGGGTGTCGGGGCTGGCTTAACTATGCGGC
ATCAGAGCAGATTGTACTGAGAGTGCACCATATGCGGTGTGAAATACCGCACAGATG
CGTAAGGAGAAAATACCGCATCAGGCGCCATTCGCCATTCAGGCTGCGCAACTGTTG
GGAAGGGCGATCGGTGCGGGCCTCTTCGCTATTACGCCAGCTGGCGAAAGGGGGATG
TGCTGCAAGGCGATTAAGTTGGGTAACGCCAGGGTTTTCCCAGTCACGACGTTGTAA
AACGACGGCCAGTGAATTCGAGCTCGGTACCTCGCGAATGCATCTAGATATCGGATC
CCGGGCCCGTCGACTGCAGAGGGGTCTCCCCTTGAAATATAGTGCAACTAGGACTAC
TTGTGTTTTGATAGATTTAGCGGGTGACAAGAACAAGAGGAGAAAAGAGAAAGGGGA
TGATAACTTGAATAAGAGAAGCAAAGACGTTATNNNNNNNNNNNNNATAACGTCTTT
GCTTCTCTTAGTTGTGAGGATGGTTAGGTTTATATAATAAAATTGGTCAGGCAAACG
TGTTCATTGTTTAACCAGGGTGTGCAAATTGTGGTTTAACCCATAAACTGAACCAGA
AATGGTTAATCTATCGGTTAAACGGTTTTATTGTTTTTTTTTTTTTTTGATATATTG
ATCTTTCAGTTCAATGATTAGTTCTTTGAGTTTACTTGCATACTAATTTCATATTTC
CCTTGCATAAGTTTCGTTAGCTTGACTATGAGGTGGGAGACCCCTGCATGCAAGCTT
GGCGTAATCATGGTCATAGCTGTTTCCTGTGTGAAATTGTTATCCGCTCACAATTCC
ACACAACATACGAGCCGGAAGCATAAAGTGTAAAGCCTGGGGTGCCTAATGAGTGAG
CTAAC 
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Supplementary Figure 7 – MST results for Bat1 measured against BEBat1A-0, -C-0, -G-
0, and -T-0 
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Supplementary Figure 8: Amino acid sequence of dTALEs used in this study 
Core and cryptic repeats are numbered. Grey background and bold typeface highlight 
the RVD residues. In all cases only the TALE-derived amino acids are shown. The 
sequences of fused domains are given in Figure S5. 
>dTALEBat1mimic (for transcriptional activation assays) 
   MDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH 
   GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLN 
 1 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 2 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 3 LTPEQXVAIASNNGGKQALXTVQRLLPVLCQAHG 
 4 LTPQQVVAIASNTGGKQALXTVQRLLPVLCQAHG 
 5 LTPQQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
10 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPQQVVAIASNTGGKQALETVQALLPVLCQAHG 
13 LTPQQVVAIASNRGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
18 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
19 LTPQQVVAIASNSGGKQALETVQALLPVLCQAHG 
+1 LTPQQVVAIASN-GGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACL-GGRPALDAVKKGLPHAPALIKR 
   TNRRIPERTSHRVA 
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>dTALESOX2 (for human cell transcriptional activation assay) 
MDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH 
GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLN 
 1 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 2 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 3 LTPEQXVAIASNNGGKQALXTVQRLLPVLCQAHG 
 4 LTPQQVVAIASNTGGKQALXTVQRLLPVLCQAHG 
 5 LTPQQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
10 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPQQVVAIASNTGGKQALETVQALLPVLCQAHG 
13 LTPQQVVAIASNRGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
+1 LTPQQVVAIASN-GGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACL-GGRPALDAVKKGLPHAPALIKR 
   TNRRIPERTSHRVA 
>dTALEBat1mimic (for nuclease assay) 
MAPRRRAAQPSDASPAAQVDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGH 
GFTHAHIVALSQHPAALGTVAVKYQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
 0 LDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLN 
 1 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 2 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 3 LTPEQXVAIASNNGGKQALXTVQRLLPVLCQAHG 
 4 LTPQQVVAIASNTGGKQALXTVQRLLPVLCQAHG 
 5 LTPQQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
 8 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
10 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPQQVVAIASNTGGKQALETVQALLPVLCQAHG 
13 LTPQQVVAIASNRGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASNDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
18 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
19 LTPQQVVAIASNSGGKQALETVQALLPVLCQAHG 
+1 LTPQQVVAIASN-GGRPALESIVAQLSRPDPALAA 
+2 LT 
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Supplementary Figure 9: in planta transcriptional activation mediated by acBat1. 
BEBat1 was embedded within a 360 base pair fragment of the silent pepper Bs3 
promoter, using the primers listed in Table S2. This promoter derivative was then 
inserted upstream of uidA in the binary vector pGWB3* as previously described (10).  
Bat1 and TALE derivatives were assembled via BsaI cut-ligation along with the NLSs 
and VP64 activation domain (Figure S5) into pENTR/D-TOPO (Life technologies) 
derivatives bearing BsaI sites. They were then transferred to binary vector pGWB442 
via LR recombination (Life technologies). Agrobacterium tumefaciens strains 
carrying pGWB442acBat1, pGWB442acBat1ΔAD or pGWB442dTALEBat1mimic were 
co-delivered into Nicotiana benthamiana leaves alongside a strain carrying the target 
reporter.  In addition the reporter plasmid was delivered alone as a control. The target 
reporter was a promoter bearing BEBat1 upstream of a uidA reporter gene (Figure S6). 
Leaf discs were harvested after 48 hours and GUS activity quantified (10). Results are 
shown for three biological replicates with error bars indicating standard deviation.  !
,
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Supplementary Figure 10: Amino acid sequences of all acBat1 derivatives (dBats) 
tested in figures 5 and 6.  
Dashes indicate truncated residues. Red font is used to highlight residues truncated or 
rearranged in each case. In all cases repeat numbering is used to identify repeats with 
those in the wild-type Bat1 protein. Grey background and bold typeface highlights the 
RVD residues. NND stands for non-repetitive N-terminal Domain. In all cases only 
the Bat1-derived amino-acids are shown. The sequences of fused domains are given 
in Figure S5. 
>acBat1 Δ18-20 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQ---------------- 
19 --------------------------------- 
20 -----------------ALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>acBat1 Δ16-20 
   NNDMSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQ---------------- 
17 --------------------------------- 
18 --------------------------------- 
19 ---------------------------------     
20 ------------------ALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
>acBat1 Δ14-20 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNS-------------------- 
15 --------------------------------- 
16 --------------------------------- 
17 --------------------------------- 
18 --------------------------------- 
19 ---------------------------------     
20 -------------GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>acBat1 Δ12-20 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNT-------------------- 
13 --------------------------------- 
14 --------------------------------- 
15 --------------------------------- 
16 --------------------------------- 
17 --------------------------------- 
18 --------------------------------- 
19 ---------------------------------     
20 -------------GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
>acBat1 ΔNTD 
NND  
-1  
 0   
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>acBat1 ΔCTD 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1  
>dBat RVD switch 1 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
0  LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
1  FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
2  FSRDDIAKMAGNNGGAQTLQAVLDLESAFRERG 
3  FSQADIVKIAGNIGGAQALYSVLDVEPTLGKRG 
4  FSRADIVKIAGNNGGAQALHTVLDLEPALGKRG 
5  FSRIDIVKIAANTGGAQALHAVLDLGPTLRECG 
6  FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
7  FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
8  FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
9  FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>dBat RVD switch 2 
   NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNNGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNDGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNIGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
>dBat RVD switch 3 
   NNDMSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNTGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNIGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>dBat RVD switch 4 
   NNDMSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGN-GGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASNGGGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
>dBat Repeat switch 1 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ!!!
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>dBat Repeat switch 2 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ!
>dBat Repeat switch 3 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ!
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>dBat Repeat switch 4 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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Supplementary Figure 11: Nucleotide and amino acid sequences of dBatSOX2-RVD 
switch and -repeat switch. 
Genes encoding the dBats were synthesised with E. coli codon usage (GenScript). 
One block encodes the N- and C-terminal regions including the cryptic repeats, 
separated by BpiI sites, flanked by BsaI sites. This was assembled via BsaI cut-
ligation into the pVAX destination vector. Repeats were encoded on two BpiI flanked 
modules assembled directly into the destination vector via BpiI cut-ligation. BsaI 
recognition sites are underlined and BpiI sites grey-highlighted, while bold typeface 
marks the overlaps created upon digest. 
In the amino acid sequences consecutive repeats are numbered, corresponding to the 
repeats of wild type Bat1. The RVDs (residues at repeat positions 12 and 13) are 
marked as boldface black letters on grey background. The sections encoded by the 
BsaI-flanked N- and C- terminal module are underlined.  
>Bat1 N-BpiI BpiI-C 
GGTCTCTTATGAGCACCGCCTTCGTGGACCAAGATAAGCAAATGGCAAACCGCCTGA
ACCTGTCACCGCTGGAACGTAGCAAAATTGAAAAACAATATGGCGGTGCAACCACGC
TGGCTTTTATTAGCAACAAACAGAATGAACTGGCACAAATCCTGAGCCGTGCTGATA
TTCTGAAAATCGCGTCTTACGACTGCGCAGCACATGCACTGCAGGCTGTCCTGGATT
GTGGCCCGATGCTGGGCAAACGCGGTTTTAGCTAGTCTTCTAGAAGACTAGGCGGTG
CGCAGGCCCTGAAAGCTGTCCTGAAGTATGGTCCGGTGCTGATGCAAGCAGGTCGTA
GCAATGAAGAAATCGTGCACGTTGCCGCTCGTCGTGGTGGTGCTGGCCGTATCCGTA
AGATGGTTGCTCCGCTGCTGGAACGTCAGGGTGTGAGACC 
>dBatSOX2 Repeat switch AB 
GAAGACTTTAGCCGCGCAGATATTGTCAAGATCGCGGGTAACGGTGGCGGCGCACAA
GCACTGAAGGCGGTTCTGGAACACGAAGCGACCCTGGATGAAAGCGGCTTTAGTCGC
GCAGATATTGTCAAGATCGCGGGTAACGGTGGCGGCGCACAAGCACTGAAGGCGGTT
CTGGAACACGAAGCGACCCTGGATGAAAGCGGCTTCTCCCGCGATGACATTGCGAAG
ATGGCCGGCAATATCGGCGGTGCACAGACCCTGCAGGCCGTGCTGGATCTGGAATCA
GCCTTTCGTGAACGCGGCTTTTCTCGTGCTGATATTGTCCGTATTGCGGGTAATGGT
GGTGGTGCCCAGGCTCTGAAGGCTGTGCTGGAACATGGTCCGACGCTGAACGAACGT
GGCTTTTCTCGTGCTGATATTGTCCGTATTGCGGGTAATGGTGGTGGTGCCCAGGCT
CTGAAGGCTGTGCTGGAACATGGTCCGACGCTGAACGAACGTGGCTTTCGTCAGGCG
GACATTATCAAGATTGCCGGTAATGACGGTGGCGCCCAGGCACTGCAAGCAGTGATC
GAACATGGCCCGACCCTGCGCCAACACGGTTTTAGCCAGGCGGATATTGTCAAAATC
GCCGGTAACGACGGCGGTACCCAAGCACTGCATGCTGTGCTGGATCTGGAACGTATG
CTGGGCGAACGTGGTTTTCGTCAGGCGGACATTATCAAGATTGCCGGTAATGACGGT
GGCGCCCAGGCACTGCAAGCAGTGATCGAACATGGCCCGACCCTGCGCCAACACGGT
TTTAGTCGCGCAGATATTGTCAAGATCGCGGGTAACGGTGGCGGCGCACAAGCACTG
AAGGCGGTTCTGGAACACGAAGCGACCCTGGATGAAAGCGGTTTTAGTCTTC 
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>dBatSOX2 Repeat switch BC 
GAAGACTGGTTTCTCCCGCATTGATATCGTTAAGATCGCAGCTAACAACGGTGGTGC
TCAAGCCCTGCACGCTGTCCTGGATCTGGGTCCGACGCTGCGCGAATGTGGGTTCTC
GCAGGCAACCATCGCAAAAATCGCTGGCAATATCGGCGGTGCTCAGGCTCTGCAAAT
GGTGCTGGATCTGGGTCCGGCTCTGGGCAAACGTGGTTTTAGCCAGGCGGATATTGT
CAAAATCGCCGGTAACGACGGCGGTACCCAAGCACTGCATGCTGTGCTGGATCTGGA
ACGTATGCTGGGCGAACGTGGTTTTAGCCAGTCTGACATTGTCAAGATCGCCGGTAA
CATTGGCGGTGCACAGGCACTGCAAGCAGTGCTGGATCTGGAAAGTATGCTGGGCAA
ACGTGGTTTCTCGCAGGCCGACATTGTTAAAATCGCCGGTAACAATGGCGGTGCACA
AGCTCTGTATAGTGTGCTGGATGTTGAACCGACCCTGGGTAAACGTGGTTTTCGTCA
GGCGGACATTATCAAGATTGCCGGTAATGACGGTGGCGCCCAGGCACTGCAAGCAGT
GATCGAACATGGCCCGACCCTGCGCCAACACGGTTTTAGCCAGGCGGATATTGTCAA
AATCGCCGGTAACGACGGCGGTACCCAAGCACTGCATGCTGTGCTGGATCTGGAACG
TATGCTGGGCGAACGTGGTTTTCGTCAGGCGGACATTATCAAGATTGCCGGTAATGA
CGGTGGCGCCCAGGCACTGCAAGCAGTGATCGAACATGGCCCGACCCTGCGCCAACA
CGGTTTTAGCCAGGCGGATATTGTCAAAATCGCCGGTAACGACGGCGAAGTCTTC 
>dBatSOX2 RVD switch AB 
GAAGACTTTAGCCAGTCTGACATTGTCAAGATCGCCGGTAACGGTGGCGGTGCACAG
GCACTGCAAGCAGTGCTGGATCTGGAAAGTATGCTGGGCAAACGTGGTTTCTCCCGC
GATGACATTGCGAAGATGGCCGGCAATGGTGGCGGTGCACAGACCCTGCAGGCCGTG
CTGGATCTGGAATCAGCCTTTCGTGAACGCGGCTTCTCGCAGGCCGACATTGTTAAA
ATCGCCGGTAACATTGGCGGTGCACAAGCTCTGTATAGTGTGCTGGATGTTGAACCG
ACCCTGGGTAAACGTGGTTTTTCACGCGCTGACATTGTTAAGATCGCCGGTAACGGT
GGCGGTGCCCAAGCACTGCACACGGTCCTGGATCTGGAACCGGCCCTGGGCAAGCGT
GGTTTCTCCCGCATTGATATCGTTAAGATCGCAGCTAACGGTGGTGGTGCTCAAGCC
CTGCACGCTGTCCTGGATCTGGGTCCGACGCTGCGCGAATGTGGGTTCTCGCAGGCA
ACCATCGCAAAAATCGCTGGCAATGATGGCGGTGCTCAGGCTCTGCAAATGGTGCTG
GATCTGGGTCCGGCTCTGGGCAAACGTGGTTTTAGCCAGGCAACCATTGCTAAGATC
GCCGGTAACGATGGCGGTGCACAGGCACTGCAAACGGTCCTGGATCTGGAACCGGCG
CTGTGCGAACGCGGCTTCTCTCAGGCCACCATCGCAAAAATGGCTGGTAACGATGGC
GGTGCACAGGCTCTGCAAACGGTTCTGGATCTGGAACCGGCCCTGCGTAAACGCGAT
TTTCGTCAGGCGGACATTATCAAGATTGCCGGTAATGGTGGTGGCGCCCAGGCACTG
CAAGCAGTGATCGAACATGGCCCGACCCTGCGCCAACACGGTTTTAGTCTTC 
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GAAGACTAGTTTCAACCTGGCAGACATTGTTAAGATGGCTGGTAATAATGGTGGTGC
TCAAGCTCTGCAAGCGGTGCTGGACCTGAAGCCGGTGCTGGACGAACATGGTTTCTC
TCAACCGGATATCGTCAAGATGGCGGGCAACATTGGTGGTGCTCAAGCCCTGCAAGC
CGTCCTGTCACTGGGTCCGGCGCTGCGTGAACGTGGCTTTAGCCAGCCGGATATTGT
CAAAATCGCCGGTAACGACGGCGGTGCACAGGCACTGCAAGCAGTGCTGGATCTGGA
ACTGACGCTGGTTGAACATGGCTTCTCTCAACCGGACATTGTTCGCATCACCGGTAA
TATTGGCGGTGCCCAAGCTCTGCAAGCGGTGCTGGCTCTGGAACTGACCCTGCGTGA
ACGAGGATTTAGCCAACCGGACATCGTGAAAATCGCGGGCAATAACGGCGGTGCTCA
AGCTCTGCAAGCGGTCCTGGATCTGGAACTGACGTTTCGTGAACGCGGCTTTAGCCA
GGCGGATATTGTCAAAATCGCCGGTAACGACGGCGGTACCCAAGCACTGCATGCTGT
GCTGGATCTGGAACGTATGCTGGGCGAACGTGGTTTCTCTCGCGCAGACATTGTGAA
CGTTGCTGACAACAATGGCGGTGCGCAGGCCCTGAAAGCCGTGCTGGAACACGAAGC
CACGCTGAATGAACGTGGCTTTAGTCGCGCAGATATTGTCAAGATCGCGGGTAACGA
TGGCGGCGCACAAGCACTGAAGGCGGTTCTGGAACACGAAGCGACCCTGGATGAAAG
CGGCTTTTCTCGTGCTGATATTGTCCGTATTGCGGGTAATGATGGCGAAGTCTTC 
>dBatSOX2 RVD switch 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
 1 FSQSDIVKIAGNGGGAQALQAVLDLESMLGKRG 
 2 FSRDDIAKMAGNGGGAQTLQAVLDLESAFRERG 
 3 FSQADIVKIAGNIGGAQALYSVLDVEPTLGKRG 
 4 FSRADIVKIAGNGGGAQALHTVLDLEPALGKRG 
 5 FSRIDIVKIAANGGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNDGGAQALQMVLDLGPALGKRG 
 7 FSQATIAKIAGNDGGAQALQTVLDLEPALCERG 
 8 FSQATIAKMAGNDGGAQALQTVLDLEPALRKRD 
 9 FRQADIIKIAGNGGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNNGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNDGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNIGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNNGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVADNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNDGGAQALKAVLEHEATLDESG 
18 FSRADIVRIAGNDGGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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>dBatSOX2 repeat switch 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
 0 LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
 2 FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
 5 FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
 6 FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
 1 FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
 3 FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
 9 FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
15 FSQADIVKIAGNDGGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
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Supplementary figure 12: specificity test with the BEpSOX2 targeted dBats. 
Both dBats were tested against the BEBat1 reporter as described in Materials and 
Methods. The number of cells analysed is indicated below each pseudodensity plot 
and the vertical bar indicates the threshold Alexa Fluor 594 level above which cells 
were considered as expressing the relevant Bat or TALE construct and included in 
downstream analysis. Colour from blue-green to yellow-red indicates increasing cell 
density. The box plots show fold-change in dsEGFP fluorescence intensity relative to 
the reporter only control for the two dBats against either the BEpSOX2 or BEBat1 
reporters. Median values are given next to the boxes in each case.  !
,
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Supplementary Figure 13: Pseudocolour density blots of fluorescence and extended 
boxplots including outliers for experiments shown in Figures 3, 5-7. 
 
dsEGFP and Alexa Fluor 594 fluorescence levels are shown for all cells analysed for 
the preparation of figures 3 and 5-7. Data are sorted by figure and transfected 
constructs are written above the plot in each case. The number of cells analysed is 
indicated below. The vertical bar indicates the threshold Alexa Fluor 594 level above 
which cells were considered as expressing the relevant Bat or TALE construct and 
included in downstream analysis. The x-axis utilises a logical display. Colour from 
blue-green to yellow-red indicates increasing cell density.  Boxplots are also sorted by 
figure and transfected constructs are given beside each plot. dsEGFP fluorescence is 
given relative to the reporter alone and is shown only for those cells with above-
threshold Alexa Fluor 594 levels.  !
!
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Figure 6 
!!!
,
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,
,
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Supplementary Figure 14: Amino acid sequences of the Bat1 repeat trimers used in 
Figure 8. The sequences corresponding to the Bat repeats are shown in bold and the 
central repeat of the trimer is underlined to allow each repeat to be identified. 
Flanking sequences correspond to sections of AvrBs3 necessary for cloning via the 
previously established toolkit (15). Sequences corresponding to the terminal BpiI 
recognition sites facilitating compatibility with the TALE binding domain assembly 
toolkit are highlighted and are removed during cloning.  
>Bat1 repeat 2 trimer 
EDAETVQRLLPVLCQAHGFSRDDIAKMAGNIGGAQTLQAVLDLESAFRERGFSRDDIAKMAG
NIGGAQTLQAVLDLESAFRERGFSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
LTPEQVVAIASQS 
,
>Bat1 repeat 6 trimer 
EDAETVQRLLPVLCQAHGFSQATIAKIAGNIGGAQALQMVLDLGPALGKRGFSQATIAKIAG
NIGGAQALQMVLDLGPALGKRGFSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
LTPEQVVAIASQS 
,
>Bat1 repeat 8 trimer 
EDAETVQRLLPVLCQAHGFSQATIAKMAGNNGGAQALQTVLDLEPALRKRDFSQATIAKMAG
NNGGAQALQTVLDLEPALRKRDFSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
LTPEQVVAIASQS 
,
>Bat1 repeat 17 trimer 
EDAETVQRLLPVLCQAHGFSRADIVKIAGNGGGAQALKAVLEHEATLDERGFSRADIVKIAG
NGGGAQALKAVLEHEATLDERGFSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
LTPEQVVAIASQS 
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Supplementary Figure 15: Structural predictions for Bat1 based on the structure of 
PthXo1 bound to DNA.  
Homology Model: Created using SWISS-MODEL (38) 
Template: 3UGM PthXo1 
Sequence identity 38.20% 
Range of Bat1 covered by the alignment: 11-767 
GMQE:   0.70,   
QMEANA4:  -6.75,    
Diameter of pore: 16.5-19 Angstroms 
Average inter-repeat angle: 33° !
!!
Model of Bat1 wrapped around BEBat1 (silver) based on the structure of PthXo1 
bound to its target DNA shown from N- to C-terminus going down the page. Each 
repeat is coloured individually.  
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Longitudinal and transverse views of the Bat1 structural prediction (green) aligned to 
the structure of PthXo1 (blue). PthXo1 target DNA is shown (silver). Created in 
UCSF Chimera (39). 
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Table S1: Percentage sequence identities of the Bat proteins 
sorted by domain. 
 NND Repeats 
-1/0 
Consensus 
core repeats 
Repeat 
+1 
Bat1 ⇔ Bat2 50 86 94 97 
Bat1 ⇔ Bat3 39 66 73 67 
Bat2 ⇔ Bat3 50 66 76 67 
Consensus core refers to the consensus formed from an alignment 
of all the core repeats of a single Bat protein. Alignments were 
performed on CLC Main Workbench 6.1. (Gap open cost 10.0, 
Gap extension cost 1.0). Percentage identities shown to two 
significant figures. 
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Table S2: A list of primers used in this study 
Primer name Sequence Notes 
pUC57 BB D Fwd GGG GTC TCT TAA CTA 
GTC TTC GGG CCC GTC 
GAC TG 
Used to create modified TALE toolkit level 
2 vector pUC57-CD-DEST. 5’ 
phosphorylated 
pUC57 BB C Rev CCT TGG TCT CAG GGT 
TAG TCT TCC GAT ATC 
TAG ATG C 
Used to create modified TALE toolkit level 
2 vector pUC57-CD-DEST 
Toolkit_N12_Rev ATT GCT GGC GAT GGC 
CAC CAC C 
 
5’ Phosphorylated. Used to modify RVDs 
of TALE toolkit repeats 
Rep7C_13T_Fwd 
 
ACC GGT GGC AAG CAG 
GCG CTG 
 
Used to create modified TALE toolkit 
repeat 7C_NT 
Rep4_13T_Fwd 
 
ACC GGC AAG CAG GCG 
CTT GAG 
 
Used to create modified TALE toolkit 
repeat 4_NT 
Rep3_ 13D_Fwd 
 
GAC GGT GGC AAG CAG 
GCG CTG 
 
Used to create modified TALE toolkit 
repeat 3_ND 
Rep4_13D_Fwd 
 
GAC GGC AAG CAG GCG 
CTT GAG 
 
Used to create modified TALE toolkit 
repeat 4_ND 
Toolkit_13R_Fwd 
 
CGG GGT GGC AAG CAG 
GCG CTG 
 
Used to create modified TALE toolkit 
repeat 1C_NR 
1/2_13*_Fwd 
 
GGC GGC AGG CCG GCG 
C 
 
Used to create modified TALE toolkit 
repeat D1/2_N* 
rep6_mut_6 ½ Fwd
  
CGA GAG ACC CCG GGA 
TCC GAT ATC TAG 
Used to create B overlap on toolkit repeat 6 
(6 ½ B) 
rep_mut_rep ½ Rev  CTA CCA CCT GCT CCG 
GGG TCA GGC 
Used to create B overlap on toolkit repeat 6 
(6 ½ B). 5’ phosphorylated. 
Linker 5-6 ½ Fwd CGG GTC TCT TGA GGG 
GGA GCG TGA GAC CTG 
Used to create Linker 5-6 in pUC57 with 
two BsaI sites. Repeats 5_NN and 6 ½ B 
were then ligated into linker 5-6 to create 
5B_NN 
Linker 5-6 ½ Rev CAG GTC TCA CGC TCC 
CCC TCA AGA GAC CCG 
Used to create Linker 5-6 in pUC57 with 
two BsaI sites. Repeats 5_NN and 6 ½ B 
were then ligated into linker 5-6 to create 
5B_NN 
Toolkit D ½ BpiI Rev GGG GAA GAC CCT AAC 
CCC GCA GCA GGT GG 
Used to create flexible TALE toolkit half 
repeat modules with the D overlap.  
pUC57 ½ BpiI Rev CCC GAA GAC CCA GCG 
CCG GCC TGC 
Used to create flexible TALE toolkit half 
repeat modules with the D overlap. 
Rep7_D-overlap_Fwd TAA CTG AGA CCT GGG 
CCC GTC GAC TGC AG 
Used to create modified TALE toolkit 
repeat 7D_NS 
Rep7_D-overlap_Rev GGC CAT GGG CCT GGC 
ACA GCA CCG 
Used to create modified TALE toolkit 
repeat 7D_NS 
pVAX GoldenGate + 
Sp6 Fwd 
ATC AAT GTG AGA CCT 
TTC CCG GGT TTG GTC 
TCT GCT TGG GCC CGT 
TTA AAC CCG CTG ATC 
AG 
Used to remove the previous TALEN gene 
from a published TALEN expression 
vector (18), replace it with BsaI sites and 
introduce an Sp6 priming site into the 
CMV promoter. 
pVAX GoldenGate + 
Sp6 Rev 
ATC ACT AGC TTC TAT 
AGT GTC ACC TAA ATC 
AGC TTG AGT CTC CCT 
ATA GTG AGT CG 
Used to remove the previous TALEN gene 
from a published TALEN expression 
vector (18), replace it with BsaI sites and 
introduce an Sp6 priming site into the 
TALE-like DNA binding proteins from Burkholderia rhizoxinica - SUPPLEMENT ! 41 
CMV promoter. 
HA-NLS GoldenGate 
AATG Fwd 
TTG GTC TCT AAT GGG 
CTA CCC TTA CGA CGT 
GC 
 
Used to amplify HA-NLS domain from a 
published TALEN construct (18) and 
introduce BsaI sites. 
HA-NLS GoldenGate 
TATG Rev 
AAT GGT CTC ACA TAG 
CGT GGA TGC CCA CTT 
TCC GC 
 
Used to amplify HA-NLS domain from a 
published TALEN construct (18) and 
introduce BsaI sites. 
3xHA goldengate Fwd TTT GGT CTC TAA TGG 
GGT TAA TTA ACA TCT 
TTT ACC CAT ACG 
 
Used to amplify 3xHA from binary vector 
pGWB13 (37) and introduce BsaI sites 
3xHA goldengate Rev TTT GGT CTC ACA TAC 
CGC TGC ACT GAG CAG 
CGT AAT C 
 
Used to amplify 3xHA from binary vector 
pGWB13 (37) and introduce BsaI sites 
FokI GGTG BpiI Fwd TTT GGT CTC TGG TGG 
TCA GCT AGT GAA ATC 
TGA ATT GGA AGA G 
 
Used to amplify FokI nuclease domain 
from a published TALEN construct (18) 
and introduce BsaI sites. 
FokI GGTG BpiI Rev AAT GGT CTC AAA GCT 
TAT CTC ACC GTT ATT 
AAA TTT CCT TCT CAC 
 
Used to amplify FokI nuclease domain 
from a published TALEN construct (18) 
and introduce BsaI sites. 
Bat1_Block 1 TATG 
Rev 
CAT AAG AGA CCA TTG 
GGA TCG GAT C 
 
Used to modify ‘Bat1 Block1’ (Figure S4) 
for cloning into the pVAX derived human 
cell expression vector and remove start 
codon (provided by N-terminal tag). 
Bat1_Block 1 ATGless 
Fwd  
AGC ACC GCC TTC GTG 
GAC CAA G 
 
5’ Phosphorylated. Used to modify ‘Bat1 
Block1’ (Figure S4) for cloning into the 
pVAX derived human cell expression 
vector and remove start codon (provided by 
N-terminal tag).  
Block 5 GGTG Fwd 
phospho 
 
GGT GTG AGA CCG ACC 
CAA TAT C 
 
5’ Phosphorylated. Used to modify ‘Bat1 
Block5’ (Figure S5) to remove stop codon 
and for cloning into the pVAX derived 
human cell expression vector. 
Block5 Last codon 
Rev 
 
CTG ACG TTC CAG CAG 
CGG AG 
 
Used to modify ‘Bat1 Block5’ (Figure S5) 
to remove stop codon and for cloning into 
the pVAX derived human cell expression 
vector.  
acBat1 AD out Rev 
phospho 
 
GCT GGC CTC CAC CTT 
TCT C 
 
Used to remove VP64 activation domain 
from acBat1 C-terminal domain.  
acBat1 AD out Fwd 
 
TAG GCT TTG AGA CCA 
CGA AG 
 
Used to remove VP64 activation domain 
from acBat1 C-terminal domain. 
acBat1 NLS out Rev 
 
CTT GTC ATC GTC ATC 
CTT GTA GTC 
 
Used to remove the NLS from the acBat1 
C-terminal domain. 
acBat1 NLS out Fwd 
 
GGT TCC GGA CGG GCT 
GAC 
 
5’ phosphorylated. Used to remove the 
NLS from the acBat1 C-terminal domain.  
BAT1rep20 2nd Helix 
Fwd 
 
GCC CTG AAA GCT GTC 
CTG AAG TAT G 
 
Used to create acBat1Δ18-20 and 
acBat1Δ16-20 
BAT1rep20 GG Fwd 
 
GGC GGT GCG CAG GCC 
CTG AAA GCT GTC CTG 
Used to create acBat1Δ14-20 and 
acBat1Δ12-20 
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AAG 
 
BAT1 rep18 1st Helix 
Rev 
 
CTG GGC ACC ACC ACC 
ATT ACC CGC 
 
Used to create acBat1Δ18-20 
BAT1 rep16 1st Helix 
Rev 
 
CTG CGC ACC GCC ATT 
GTT GCC AGC AAC GTT C 
 
Used to create acBat1Δ16-20 
BAT1 rep14 1st Helix 
Rev 
 
GCT ATT GCC CGC GAT 
TTT CAC GAT GTC CGG 
TTG 
 
Used to create acBat1Δ14-20 
BAT1 rep12 1st Helix 
Rev 
 
GGT GTT ACC GGC GAT 
TTT GAC AAT ATC CGG 
CTG 
 
Used to create acBat1Δ12-20 
Bat1 NTD out Fwd TTT AGC CAG TCT GAC 
ATT GTC AAG ATC GC 
5’ phosphorylated. Used to create 
acBat1ΔNTD 
Bat1 NTD out Rev CAT AAG AGA CCA TTG 
GGA TCG GAT C 
Used to create acBat1ΔNTD 
Bat1 CTD out Fwd AAG GTG AGA CCG ACC 
CAA TAT C 
 
5’ phosphorylated. Used to create 
acBat1ΔCTD 
Bat1 CTD out Rev ACC TGC TTG CAT CAG 
CAC CG 
Used to create acBat1ΔCTD 
BEBat1 into Bs3p Fwd TGC TTC TCT TAG TTG 
TGA GGA TGG TTA GG 
 
5’ Phosphorylated. Used to create Bs3p 
BEBat1 for GUS assays and for the creation 
of the Bat1-Fok1 target templates.  
BEBat1 into Bs3p Rev AAGACGTTAGGTTCAAGT
TATCATCCCC 
Used to create Bs3p BEBat1 for GUS assays 
and for the creation of the Bat1-Fok1 target 
templates. 
Bat1-Fok1 target 5bp CTA GCA TAA CGT CTT 
TGC TTC TCT TAG 
 
Used to create the 5bp spacer target for the 
nuclease assays.  
Bat1-Fok1 target 7bp TCT AGA CAT AAC GTC 
TT GCT TCT C 
 
Used to create the 7bp spacer target for the 
nuclease assays. 
Bat1-Fok1 target 11bp TAC GTC TAG ACA TAA 
CGT CTT TGC TTC TC 
 
Used to create the 11bp spacer target for 
the nuclease assays. 
Bat1-Fok1 target 15bp TAC GTA CGT CTA GAC 
ATA ACG TCT TTG CTT 
CTC 
 
Used to create the 15bp spacer target for 
the nuclease assays. 
Bat1-Fok1 target 19bp TAA GCT ACG TAC GTC 
TAG ACA TAA CGT C 
 
Used to create the 19bp spacer target for 
the nuclease assays. 
BE Bat1 TAGA Fwd TAG ACT AAG AGA AGC 
AAA GAC GTT ATA TGC 
 
To get BEBat1 into dsEGFP reporter 
 
BE Bat1 CCTA Rev ATC CGC ATA TAA CGT 
CTT TGC TTC TCT TAG 
 
To get BEBat1 into dsEGFP reporter 
 
,
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Table S3: p-values for two-tailed t-tests without assuming equal 
variances to establish whether affinities differ between interactions of 
Bat1 with BEBat1 derivatives bearing A, C, G or T at the zero position.  
 A0 C0 G0 T0 
A0     
C0 0.589    
G0 0.860 0.860   
T0 0.231 0.382 0.754  
Sample size n=3. (A0, G0, T0) or 5 (C0). Results shown to three decimal 
places. !!
Table S4: Hydrogen bonds formed between repeat residues of Bat1 predicted with UCSF 
Chimera (39). Unless stated, interactions are between side chain and backbone atoms.  
Repeats involved  AA 1 AA 2 Comment 
-1 – 0 Gln 29 Ala 59  
0 – 1 Lys 57 Gly 93  
0 - 1 Tyr 61 Ala 92  
1 – 2 Gly 82 Arg 118 In the inter repeat loop region 
3 – 4 Asn 160 Ala 191  
3 – 4 Gly 162 Thr 194  
2 – 4 Gly 148 Arg 184 In the inter repeat loop region 
4 – 5 Thr 202 His 234  
5 – 6 Lys 222 Gly 258  
6 – 7 Asn 292 Ala 323  
7 – 8 Asn 325 Gly 357  
7 – 8 Gln 349 Arg 343 In the inter repeat loop region 
7 - 8 Asn 326 (N) Asp 359  
8 – 9  Asn 358 Gly 390  
8 – 9 Asn 358 Ala 389  
11 – 12 Lys 420 Gly 456  
11 – 12 Arg 442 Phe 446 (N) Inter repeat connection 
11 – 13 Arg 444 Ser 480 (OH)  
13 – 14 Arg 510 Leu 534 (O)  
13 – 14  Arg 491 Ser 524  
15 – 16 Asn 556 Gly 588  
16 – 17 Asn 589 Gly 621  
16 – 17 Glu 601 Lys 630  
17 – 18 Asp 615 Arg 646 Between two side chains 
17 – 18 Glu 634 Lys 663 Between two side chains 
19 – 20 Glu 700 Lys 728 Between two side chains 
20 - +1 Asn 721 Arg 754 (O)  
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Supplementary Figure 1: Annotated genomic loci bearing MOrTL1 and 2 ORFs.  
 
MOrTL1 (GenBank ECG96326) is a translation of a predicted ORF found in marine 
bacterial genomic contig EM567463.1 (available at GenBank). This contig is an 
assembly of two reads both bearing ORFs encoding similar repeat array proteins: 
JCVI_READ_1093012032286 (a) encoding ECG96325 (b) and 
JCVI_READ_1092963399564 (c) encoding MOrTL1 (d). These sequences form part 
of environmental sample ID 1103283000023 from the Global Oceanic Survey. 
Sample Metadata are available via the CAMERA metagenomics data distribution 
centre: http://camera.crbs.ucsd.edu/projects/details.php?id=CAM_PROJ_GOS. 
Sequences from this dataset were obtained by paired-end Sanger sequencing of a 
plasmid library of sheared microbial DNA.  
 
MOrTL2 (GenBank EBN91409) is a translation of a predicted ORF found in marine 
bacterial genomic contig EN814823.1. This contig is also an assembly of two reads 
each bearing similar repeat protein ORFs: JCVI_READ_1091143078068 (e) 
encoding EBN91408 (f) and JCVI_READ_1091143109172 (f) encoding MOrTL2 
(h). These sequences form part of environmental sample ID 1103283000022 from the 
Global Oceanic Survey.  
 
Synthesised coding sequences for MOrTL1 (i) and MOrTL2 (j) used in this study are 
also provided.  
 
Note that In addition to the sequences presented here a further accession from the 
same metagenomics dataset, GenBank accession EMO47375.1, bears an ORF 
encoding repeats similar to those of MOrLT1. However, there are only three repeats 
in this ORF and it was not taken as a candidate for DNA binding assays in this study.  
 
(a)  
>JCVI_READ_1093012032286 
GTAGGCTGAGGCTTAGATAGTTGGGACAAGTTAGTTGAAAAGGATTGGATAAGAACG
CCATTTTAAAGATTTCAATTTGTAACGGGGCTCATTTGGCGATTACCACGTTACTAG
AAAACTGGGATGCGTTAATAGATTTGGAACTGGAACCCAAAGATATTGTATCTATTG
CGTCTCATGGTGGGGCAACTCAGGCGATTACCACGTTACTAAACAAGTGGGATGACT
TAAGAGATAAGGGACTGGAACCCAAAGATATTGTATCCATTGCGTCTAATAATGGCG
CAACTCAGGCTATTGCTACGTTATTAGCAAAATGGGATTCCTTAATAGCTAAGGGAC
TGCAGCCCAAAGATATTGTATCCATTGCGTCTCATGGTGGGGCAACTCAGGCTATTA
CCACGTTACTAAACAGGTGGGGTGACTTAAGAGCTAAGGAACTGGAACCCAAAGATA
TTGTATCCATTGCGTCTCATGATGGGGCAACTCAGGCTATTACCACGTTACTAGAAA
AATGGGATGAGTTAAGAGCTAAGGGACTGGAACCCAAAGATATTGTATCCATTGCGT
CTCATATTGGCGCAAATCAGACTATTACTACGTTACTAAACAAGTGGGGTGCGTTAA
TAGATTTGGAACTGGAACCCAAAGATATTGTATCCATTGCGTCTCATGGTGGGGCAA
ATAAGGCTATTACCACGTTACTAGAAAAGTGGGCTGCCTTAAGAGCTAAGGAACTGG
AACCCAAAGATATTGTATCCATTGCGTCTCATAATGGAGCAACTCACGCTATTACTA
CGTTACTAAACAAGTGGGCTGCCTTAAGAGCTAAAGAACTGGAACCCAAAGATATTG
TATCCATTGCGTCTCATAATGGAGCAACTCACGCTATTACCATGTTATTAAACAAGT
GGGGTGACTTAAGAGCTAAGAACTGGAACCCAAAGATATTGTGTCCATTGCGTCACA
TGATGGGGCAACTCATGCTATTACTACGTTACTAGAAAATGGGATGAGTTAGAGCTA
ATGGTACTGCACCCAAAGATATTGTATCTATTGCGTCTATATGGCGCAAATCAGCGA
TTTCCACGTTACTAGAAAAGTGGGGTGCGTTATAG 
 
(b)  
>JCVI_READ_1093012032286 translation frame +3  
RLRLR*LGQVS*KGLDKNAILKISICNGAHLAITTLLENWDALIDLE 
LEPKDIVSIASHGGATQAITTLLNKWDDLRDKG 
LEPKDIVSIASNNGATQAIATLLAKWDSLIAKG 
LQPKDIVSIASHGGATQAITTLLNRWGDLRAKE 
LEPKDIVSIASHDGATQAITTLLEKWDELRAKG 
LEPKDIVSIASHIGANQTITTLLNKWGALIDLE 
LEPKDIVSIASHGGANKAITTLLEKWAALRAKE 
LEPKDIVSIASHNGATHAITTLLNKWAALRAKE 
LEPKDIVSIASHNGATHAITMLLNKWGDLRAKN 
WNPKILCPLRHMMGQLMLLLRY*KMG*VRANGTAPKDIVSIASIWRKSAISTLLEKW
GAL* 
(highlighted section = ECG96325) 
 
(c)  
>Reverse complement of JCVI_READ_1092963399564  
ATGGCGCAAATCCAGGCGATTTCCACGTTACTAGAAAAGTGGGGTGCGTTAATAGAT
TTGGAACTGGAACCCAAAGATATGTATCCATGCGTCTCATAATGAGCAAATCAGGCG
ATTACACGTTACTAAACAAGTGGGTGACTTAAGAGCTAAGGAACTGGAACCCAAAGA
TATTGTGTCCATTGCGTCTAATACTGGCGCAAATAAGACTATTACCAGGTTACTAGA
AAAGTGGGGTGACTTAAGAGCTAAGGAACTGGAACCCAAAGATATTGTATCCATTGC
GTCACATGATGGGTCAAATCAGACTATTACAAAGTTACTAGAAAAATGGGATGAGTT
AAGAGCTAAGGGACTGGAGCCCAAAGATATTGTATCCATTGCGTCTCATATTGGCGC
AAATCAGACTATTACTACGTTACTAAACAAGTGGGGTGCGTTAATAGATTTGGAACT
GGAACCCAAAGATATTGTATCCATTGCGTCTCATATTGGCGCAACTCAGGCTATTAC
TACGTTACTAAACAAGTGGGCTGCCTTAAGAGCTAAGGGACTGGACCCCAAAGATAT
TGTATCTATTGCGTCACATGATGGGTCAAATCAGACGATTACAAAGTTACTAGAAAA
ATGGGATGAGTTAAGAGCTAAGGAACTGGAATCCAAAGATATTGTATCCATTGCGTC
TAATAATGGCGCAACTCAGACTATTACCAGGTTACTAGAAAAATGGGATGAGTTAAG
AGCTAAGGGACTGGACCCCAAAGATATTGTATCCATTGCGTCTCATGGTGGTGCAAC
TCAGGCTATTACCACGTTACTAAACAGGTGGGGTGACTTAATAGATTTGGAACTGGA
ACCCAAAGATATTGTATCCATTGCGTCTCATAAAGGAGCAAATCAGGTTATTACTAC
GTTACTAGAAAAGTGGGATGACTTAATTAGTCAGGCATATACTAAGTCTAGCATTGT
GAGTATTGCTTCTACTCAGAATGGCGTATTAGGCCTATTGGAGGCGTTAGGTTAATA
ACATTATTTTCAAAGTAAAAAAGGGTTTATAAATACTGGAATATATTACTGATTATT
AAGTAAGGGAGTCTGCAATCCGTTAC 
 
(d)  
>Reverse complement of JCVI_READ_1092963399564 translation Frame +2  
WRKSRRFPRY*KSGVR**IWN 
WNPK ICIHASHNE QIRRLHVTKQVGDLRAKE 
LEPKDIVSIASNTGANKTITRLLEKWGDLRAKE 
LEPKDIVSIASHDGSNQTITKLLEKWDELRAKG 
LEPKDIVSIASHIGANQTITTLLNKWGALIDLE 
LEPKDIVSIASHIGATQAITTLLNKWAALRAKG 
LDPKDIVSIASHDGSNQTITKLLEKWDELRAKE 
LESKDIVSIASNNGATQTITRLLEKWDELRAKG 
LDPKDIVSIASHGGATQAITTLLNRWGDLIDLE 
LEPKDIVSIASHKGANQVITTLLEKWDDLISQA 
YTKSSIVSIASTQNGVLGLLEALG**HYFQSKKGFINTGIYY*LLSKGVCNPL 
(highlighted section = MOrTL1/ECG96326) 
 
(e)  
>JCVI_READ_1091143078068 
GTGGCCCCGTCGGCTTGACCACATAACTAACTTTTGTTGAGTTTCAGGGTTCAAGCA
TTAACTAATTAGGATTGCATGGTGTGAGAACATATTATTAATTTATATTTTGCAAGG
AGTTTTGTATTTATGAGTAATCAAACAGAGCAAAAAATTCTAAAGTTTAAGCTAGAG
CTGCGCTATCCAACAGAATCAGCTCAATTAATACGTGCTGGATTTAATCGAGATCAA
GCGGATAGGATTATCTTAAGAGGCTCTTCACAACGTACCGTTGCAAAGTTACTGGAA
ATTCACAAGACGTTGTTAGCTCATCCCTATAGAATAACCTACGACGACCTCACTCGA
ATTGCAGCAAGAAATGGAGGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCT
GCCTTAACAGAACTCGGGTTTAGTGCTAAGGATATTGTGCAGATGGTGTCACATGGT
GGAGGCTCTAAAAACTTAGAGGTGGTACAAGCAAACTATGCTGCCTTAACAGGACTC
GGGTTTCGTACTGAGGATATTGTGCAGATGGTGTCACATGATGGAGGCTCTAAAAAC
TTAGCGGCTATGATAGACAAGTCTACTGCCTTAAAAGACCTTGGGTTTCGTACTGAG
GATATTGTGCAGATGGTGTCACATGATGGAAGCTCTAAAAACTTAGCGGCTATGATA
GACAAGTCTACTGCCTTAAAAGGCCTCGGATTTCGTACTGAGGGTATTGTGCAGATG
GTGTCACATGGGTGGAGGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGC
CTTAACAGGACTCGGATTTCGTACTGAGGGTATTGTGCAGATGGTGTCACATGGTGG
AGGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGCCTTAACAGGACTCGG
GTTTCGTACTGAGGATATTGTGCAGATGGTGTCACATGATGGAGGCTCTAAAACTTA
GCGGCTATTATAGACAAGTCTACTGCCTTATAGGCCTTGGGTTTCGTACTGAGGATA
TTGTGCAGATGGTGTCTAACAATGGAGGCTCTAAAACTTAGCGGCTAGATAGACAAG
TCTACTGCCTTAAAAGGCGCCCGATTTCGTACTGAAGAGATTGTTGCCCATGGTGTC
CCATGGGTGGGAGGGCTCTTACAAACTATAAAGGGGGTGGGAGGGCGGAC 
 
(f) 
>JCVI_READ_1091143078068 translation frame +1  
VAPSA*PHN*LLLSFRVQALTN*DCMV*EHIINLY 
FARSFVFMSNQTEQKILKFKLELRYPTESAQLIRAG 
FNRDQADRIILRGSSQRTVAKLLEIHKTLLAHPYR 
ITYDDLTRIAARNGGSKNLVAVQANYAALTELG 
FSAKDIVQMVSHGGGSKNLEVVQANYAALTGLG 
FRTEDIVQMVSHDGGSKNLAAMIDKSTALKDLG 
FRTEDIVQMVSHDGSSKNLAAMIDKSTALKGLG 
FRTEGIVQMVSHGWRL*KLSGGASKLCCLNRTRISY*GYCADGVTWWRL*KLSGGAS
KLCCLNRTRVSY*GYCADGVT*WRL*NLAAIIDKSTAL*ALGFVLRILCRWCLTMEA
LKLSG*IDKSTALKGARFRTEEIVAHGVPWVGGLLQTIKGVGGR 
(highlighted section = EBN19408) 
 
(g)  
>Reverse complement of JCVI_READ_1091143109172  
CTTAGCGGCTATGATAGACAAGTCTACTGCCTTAAAAGACTTCGGGTTTCGTACTGA
GGATATGTGCAGATGGTGTCACATGATGGAGGCTCTAAAAACTTAGCGGCTATGATA
GACAAGTCTACTGCCTTAAAAGGCCTCGGATTTCGTACTGAGGGTATTGTGCAGATG
GTGTCACATGGTGGAGGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGCC
TTAACAGGACTCGGATTTCGTACTGAGGGTATTGTGCAGATGGTGTCACATGGTGGA
GGCTCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGCCTTAACAGGACTCGGG
TTTCGTACTGAGGATATTGTGCAGATGGTGTCACATGATGGAGGCTCTAAAAACTTA
GCGGCTATTATAGACAAGTCTACTGCCTTAACAGGCCTTGGGTTTCGTACTGAGGAT
ATTGTGCAGATGGTGTCTAACAATGGAGGCTCTAAAAACTTAGCGGCTATTATAGAC
AAGTCTACTGCCTTAAAAGGCCTCGGATTTCGTACTGAGGATATTGTGCAGATGGTG
TCACATGGTGGAGGCTCTAAAAACTTAGAGGTGGTGCAAGCAAACTATGCTGCCTTA
ACAGGACTCGGATTTCGTACTGAGGGTATTGTGCAGATGGTGTCACATGGTGGAGGC
TCTAAAAACTTAGTGGCGGTGCAAGCAAACTATGCTGCCTTAACAGGACTCGGGTTT
CGTACTGAGGATATTGTGCAGATGGTGTCACATGATGGAGGCTCTAAAAACTTAGCG
GCTATGATAGACAAGTATACTGCCTTAAAAGACCTTGGGTTTCGTACTGAGGATATT
GTGCAGATGGTGTCACATGATGGAGGCTCTAAAAACTTAGCGGCTATTATAGACAAG
TCTACTGCCTTAAAAGGCCTCGGATTTCTTACTGAGGATATTGTGCAGATGGTGTCA
CATGATGGAGGCTCTAAAAACTTAGAGGTGGTGCAAGCAAGCTATGATACCTTAACA
GAACTCAAGTTTAGTGCTGAGCATCTCAGCCCTTC 
 
(h)  
>Reverse complement of JCVI_READ_1091143109172 translation frame +1  
LSGYDRQVYCLKRLRVSY*GYVQMVSHDGGSKNLAAMIDKSTALKGLG 
FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
FRTEDIVQMVSHDGGSKNLAAIIDKSTALTGLG 
FRTEDIVQMVSNNGGSKNLAAIIDKSTALKGLG 
FRTEDIVQMVSHGGGSKNLEVVQANYAALTGLG 
FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
FRTEDIVQMVSHDGGSKNLAAMIDKYTALKDLG 
FRTEDIVQMVSHDGGSKNLAAIIDKSTALKGLG 
FLTEDIVQMVSHDGGSKNLEVVQASYDTLTELKFSAEHLSP 
(highlighted section = MOrTL2/ EBN19409) 
 
Note, the sequences at the N-terminus of MOrTL2 (RVLCRWCHM) differs from the 
sequence above. This is because MOrTL2 is a translation of the assembled sequence 
not the individual reads. Differences arise in the N-terminal section of MOrTL2 from 
reconciling polymorphic bases between this read and read 1091143078068. Looking 
at translations of the raw reads it seems likely that sequencing did not cover the whole 
insert and further MOrTL repeats separate the two reads.  
 
 
(i) MOrTL 1/ECG96326 – synthesized CDS (GenScript). BsaI restriction enzyme 
binding sites underlined and overlaps italicized. Start and stop codons bold. 
 
>MOrTL1_CDS_Genscript 
GGTCTCATATGGTTGGCGATCTGCGTGCGAAAGAACTGGAACCGAAAGACATTGTGA
GCATTGCCTCTAACACCGGCGCGAATAAAACGATTACCCGCCTGCTGGAAAAATGGG
GCGATCTGCGTGCCAAGGAGCTGGAACCGAAAGATATTGTCAGCATCGCCTCTCATG
ACGGCAGTAACCAGACCATTACGAAACTGCTGGAAAAATGGGATGAACTGCGCGCAA
AAGGTCTGGAACCGAAAGATATCGTGAGTATCGCATCCCACATTGGCGCTAACCAAA
CGATCACCACGCTGCTGAATAAATGGGGTGCACTGATTGATCTGGAATTAGAGCCGA
AAGATATCGTTTCAATCGCTTCGCATATTGGTGCAACCCAGGCTATCACCACGCTGC
TGAACAAATGGGCGGCCCTGCGTGCAAAAGGCCTGGATCCGAAAGACATTGTCAGCA
TCGCTTCTCACGATGGTTCTAATCAAACGATCACCAAGTTACTGGAAAAATGGGACG
AACTGCGCGCCAAAGAACTGGAAAGCAAAGACATTGTGAGTATCGCGTCCAACAATG
GCGCCACCCAGACGATCACCCGTCTGCTGGAGAAGTGGGACGAACTGCGCGCGAAAG
GTCTGGATCCGAAAGATATCGTGAGCATCGCATCGCATGGCGGTGCAACCCAGGCAA
TTACCACGCTGCTGAACCGTTGGGGCGATCTGATCGACCTGGAATTAGAACCTAAAG
ACATTGTGAGCATCGCATCTCACAAAGGTGCTAATCAGGTTATTACCACGCTGCTGG
AAAAATGGGACGACCTGATCAGTCAAGCGTATACCAAATCCTCAATCGTGTCAATCG
CATCAACGCAAAATGGTGTCCTGGGTCTGCTGGAAGCCCTGGGTTAGGGTGAGAGAC
C 
 
(j) MOrTL 2/EBN91409 – Synthesised CDS (GenScript). BsaI restriction enzyme 
binding sites underlined and overlaps italicized. Start and stop codons bold. 
 
>MOrTL2_CDS_Genscript 
GGTCTCATATGATGCGCGTTCTGTGTCGTTGGTGCCACATGGGCGGCGGCTCTAAAA
ATCTGGTTGCTGTTCAAGCTAACTATGCGGCTCTGACGGGCCTGGGTTTTCGTACCG
AAGGCATTGTCCAGATGGTGAGCCATGGCGGTGGCTCTAAAAACCTGGTCGCGGTGC
AAGCCAATTATGCAGCACTGACCGGTCTGGGCTTCCGTACGGAAGATATTGTTCAGA
TGGTCAGTCACGATGGTGGCTCCAAAAACCTGGTTGCAGTCCAAGCTAATTACGCAG
CTCTGACCGGTCTGGGCTTTCGTACGGAAGATATTGTGCAGATGGTTTCACATGATG
GTGGCTCGAAAAACCTGGCGGCCATTATCGACAAAAGTACCGCACTGACGGGTCTGG
GCTTCCGTACCGAAGATATCGTCCAAATGGTGAGCAACAATGGTGGCTCTAAAAATC
TGGCAGCTATTATCGATAAAAGCACCGCCCTGAAAGGTCTGGGCTTCCGCACCGAAG
ATATTGTCCAAATGGTCAGTCACGGTGGCGGTTCCAAAAATCTGGAAGTGGTGCAGG
CCAACTACGCCGCCCTGACGGGTCTGGGCTTTCGCACCGAAGGTATCGTTCAAATGG
TTTCACATGGCGGTGGCTCGAAAAATCTGGTGGCAGTTCAAGCGAACTATGCCGCCT
TAACGGGTCTGGGCTTTCGTACCGAAGATATTGTCCAGATGGTTAGCCACGATGGTG
GCTCTAAGAATCTGGCGGCCATGATTGATAAATATACCGCGCTGAAAGACCTGGGTT
TCCGCACGGAAGATATCGTGCAGATGGTTAGTCATGACGGTGGCTCCAAAAATCTGG
CCGCCATTATCGATAAATCTACGGCGCTGAAAGGTCTGGGCTTTCTGACCGAAGATA
TTGTTCAAATGGTGAGCCACGATGGCGGTAGCAAAAACCTGGAAGTGGTGCAAGCAT
CATACGACACGCTGACGGAACTGAAATTCTAGGGTGAGAGACC 
 
 
Supplementary Figure 2: Heat map of percentage pairwise sequence similarities of 
consensus repeats of different TALE-like groups. Based on alignments of 
representative TALEs and RipTALs, Bat1 and Bat2, MorTl1, and MOrTL2  
 
 
 
 
 
  
Supplementary Figure 3: (a) Protein expression gel for MOrTL1 and MOrTL2 and 
(b) EMSA gel for MOrTL1 against BEMOrTL1. 
 
 
 
 
 
 
 
 
 
 
 
(b)$
(a)$
Supplementary Figure 4: Amino acid sequence of fusion protein EBN91408-
MOrTL2. The two ORFs of genomic accession EN814823.1 (see Figure S1) are 
separated by a frame-shift in the middle of MOrTL1 repeat 1. Removal of a single 
guanine base allows read through of a longer protein designated EBN91408-MOrTL2. 
Although, as noted in Figure S1, the true genomic locus likely contains further 
intervening repeats not covered in the assembly. EBN91408 is underlined.  Repeats 
are numbered and 0 and -1 are uses to designate the sequence degenerate N-terminal 
repeats.  
 
> EBN91408-MOrTL2. 
   MSNQTEQKILKFKLELRYPTESAQLIRAG 
-1 FNRDQADRIILRGSSQRTVAKLLEIHKTLLAHPYR 
0  ITYDDLTRIAARNGGSKNLVAVQANYAALTELG 
1  FSAKDIVQMVSHGGGSKNLEVVQANYAALTGLG 
2  FRTEDIVQMVSHDGGSKNLAAMIDKSTALKDLG 
3  FRTEDIVQMVSHDGSSKNLAAMIDKSTALKGLG 
4  FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
5  FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
6  FRTEDIVQMVSHDGGSKNLVAVQANYAALTGLG 
7  FRTEDIVQMVSHDGGSKNLAAIIDKSTALTGLG 
8  FRTEDIVQMVSNNGGSKNLAAIIDKSTALKGLG 
9  FRTEDIVQMVSHGGGSKNLEVVQANYAALTGLG 
10 FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
11 FRTEDIVQMVSHDGGSKNLAAMIDKYTALKDLG 
12 FRTEDIVQMVSHDGGSKNLAAIIDKSTALKGLG 
13 FLTEDIVQMVSHDGGSKNLEVVQASYDTLTELKF 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 5: Quantifications of protein : DNA relative to free-DNA in 
EMSAs shown in Figure 6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 6:  
 
Maps of E.coli repressor reporter plasmids pMBS6 and pBT102*. TALE-like binding 
elements (BEs) are added to pCherry at the indicated position via PCR. TALE-like 
chimeras were added to pBT102* using BsaI cut-ligation. The pBT102 derivative 
with BsaI digest overlaps TATG (5’) and GGTG (3’) was used for the assembly of 
TALE chimeras. An additional derivative with overlaps CACC (5’) and AAGG (3’) 
but otherwise identical was created for the assembly of Bat1 chimeras. See materials 
and methods section for further details.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Supplementary Figure 7: Sequences of pCherry reporter constructs 
 
pCherry – BE Bat1 
mCherry CDS 
Lac operator 
Binding element Bat1 
 
CGACTGCACGGTGCACCAATGCTTCTGGCGTCAGGCAGCCATCGGAAGCTGTGGTAT
GGCTGTGCAGGTCGTAAATCACTGCATAATTCGTGTCGCTCAAGGCGCACTCCCGTT
CTGGATAATGTTTTTTGCGCCGACATCATAACGGTTCTGGCAAATATTCTGAAATGA
GCTGTTGACAATTAATCATCCGGCTCGTATAATGTGTGGAATTGTGAGCGGATAACA
ATTTCTaagagaagcaaagacgttatGAATTCAAAAGATCTATCGATCGAGGATCCA
GGAGGTACAATCAATGGTGAGCAAGGGCGAGGAGGATAACATGGCCATCATCAAGGA
GTTCATGCGCTTCAAGGTGCACATGGAGGGCTCCGTGAACGGCCACGAGTTCGAGAT
CGAGGGCGAGGGCGAGGGCCGCCCCTACGAGGGCACCCAGACCGCCAAGCTGAAGGT
GACCAAGGGTGGCCCCCTGCCCTTCGCCTGGGACATCCTGTCCCCTCAGTTCATGTA
CGGCTCCAAGGCCTACGTGAAGCACCCCGCCGACATCCCCGACTACTTGAAGCTGTC
CTTCCCCGAGGGCTTCAAGTGGGAGCGCGTGATGAACTTCGAGGACGGCGGCGTGGT
GACCGTGACCCAGGACTCCTCCCTGCAGGACGGCGAGTTCATCTACAAGGTGAAGCT
GCGCGGCACCAACTTCCCCTCCGACGGCCCCGTAATGCAGAAGAAGACCATGGGCTG
GGAGGCCTCCTCCGAGCGGATGTACCCCGAGGACGGCGCCCTGAAGGGCGAGATCAA
GCAGAGGCTGAAGCTGAAGGACGGCGGCCACTACGACGCTGAGGTCAAGACCACCTA
CAAGGCCAAGAAGCCCGTGCAGCTGCCCGGCGCCTACAACGTCAACATCAAGTTGGA
CATCACCTCCCACAACGAGGACTACACCATCGTGGAACAGTACGAACGCGCCGAGGG
CCGCCACTCCACCGGCGGCATGGACGAGCTGTACAAGTAA 
 
Underlined sequence differs between the various reporters, with capital letters  
indicating sequences corresponding to MOrTL repeats 
 
BE Bat1 M1 6-10 
aagagAACGTaagacgttat 
 
BE Bat1 M2 6-10 
aagagTCCGTaagacgttat 
 
BE dTALE-Bat1 M2 6-10 
aagagCGTTCaagacgttat 
 
BE Bat1 GGTTG 
aagagGGTTGaagacgttat 
 
BE Bat1 TTGGT 
aagagTTGGTaagacgttat 
 
 
 
 
 
  
Supplementary Figure 8: Sequences of (a) Bat1-MOrTL and (b) TALE-MOrTL 
reporter constructs 
 
(a) 
Bat1 constructs expressed form pDEST-17 are preceded by an N-terminal His-Tag of 
sequence: MSYYHHHHHHLESTSLYKKAGSAAAPFM  
  
 
>Bat1 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
0  LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
1  FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
2  FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
3  FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
4  FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
5  FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
6  FSQATIAKIAGNIGGAQALQMVLDLGPALGKRG 
7  FSQATIAKIAGNIGGAQALQTVLDLEPALCERG 
8  FSQATIAKMAGNNGGAQALQTVLDLEPALRKRD 
9  FRQADIIKIAGNDGGAQALQAVIEHGPTLRQHG 
10 FNLADIVKMAGNIGGAQALQAVLDLKPVLDEHG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
 
In PBT102 (extra C-terminal residues from cloning vector): 
… GGTLIIPDLHSRKSKTSDRRLLT 
 
>Bat1M1 6-10 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
0  LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
1  FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
2  FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
3  FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
4  FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
5  FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
6  LEPKDIVSIASHIGANQTITTLLNKWGALIDLE 
7  LEPKDIVSIASHIGATQAITTLLNKWAALRAKG 
8  LDPKDIVSIASHDGSNQTITKLLEKWDELRAKE 
9  LESKDIVSIASNNGATQTITRLLEKWDELRAKG 
10 LDPKDIVSIASHGGATQAITTLLNRWGDLIDLG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
 
In PBT102 (extra C-terminal residues from cloning vector) 
… GGTLIIPDLHSRKSKTSDRRLLT 
 
>Bat1M2 6-10 
NND MSTAFVDQDKQMANRLN 
-1 LSPLERSKIEKQYGGATTLAFISNKQNELAQI 
0  LSRADILKIASYDCAAHALQAVLDCGPMLGKRG 
1  FSQSDIVKIAGNIGGAQALQAVLDLESMLGKRG 
2  FSRDDIAKMAGNIGGAQTLQAVLDLESAFRERG 
3  FSQADIVKIAGNNGGAQALYSVLDVEPTLGKRG 
4  FSRADIVKIAGNTGGAQALHTVLDLEPALGKRG 
5  FSRIDIVKIAANNGGAQALHAVLDLGPTLRECG 
6  FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
7  FRTEDIVQMVSHDGGSKNLVAVQANYAALTGLG 
8  FRTEDIVQMVSHDGGSKNLAAIIDKSTALTGLG 
9  FRTEDIVQMVSNNGGSKNLAAIIDKSTALKGLG 
10 FRTEDIVQMVSHGGGSKNLEVVQANYAALTGLG 
11 FSQPDIVKMAGNIGGAQALQAVLSLGPALRERG 
12 FSQPDIVKIAGNTGGAQALQAVLDLELTLVEHG 
13 FSQPDIVRITGNRGGAQALQAVLALELTLRERG 
14 FSQPDIVKIAGNSGGAQALQAVLDLELTFRERG 
15 FSQADIVKIAGNDGGTQALHAVLDLERMLGERG 
16 FSRADIVNVAGNNGGAQALKAVLEHEATLNERG 
17 FSRADIVKIAGNGGGAQALKAVLEHEATLDERG 
18 FSRADIVRIAGNGGGAQALKAVLEHGPTLNERG 
19 FNLTDIVEMAANSGGAQALKAVLEHGPTLRQRG 
20 LSLIDIVEIASN-GGAQALKAVLKYGPVLMQAG 
+1 RSNEEIVHVAARRGGAGRIRKMVAP---LLERQ 
 
in PBT102 (extra C-terminal residues from cloning vector) 
… GGTLIIPDLHSRKSKTSDRRLLT 
 
 
 
 
 
 
 
 
(b)  
dTALE-Bat1 In pDEST-17 (E.coli protein expression and purification construct): 
Underlined sequences represent peptide tags, N-terminal HA and C-terminal 3xflag 
with flexible linker.  
MSYYHHHHHHLESTSLYKKAGSAAAPF 
 
>dTALE-Bat1 In pDEST-17 
MDLRTLGYSQQQQEKIKPKVRSTVAQHHEALVGHGFTHAHIVALSQHPAALGTVAVK
YQDMIAALPE 
-1 ATHEAIVGVGKQWSGARALEALLTVAGELRGPPLQ 
0  LDTGQLLKIAKRGGVTAVEAVHAWRNALTGAPLN 
1  LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
2  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
3  LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
4  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
5  LTPQQVVAIASNNGGKQALETVQRLLPVLCQAHG 
6  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
7  LTPQQVVAIASNIGGKQALETVQALLPVLCQAHG 
8  LTPEQVVAIASNNGGKQALETVQALLPVLCQAHG 
9  LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
11 LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
15 LTPQQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPQQVVAIASNGGGKQALETVQALLPVLCQAHG 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACLGGRPALDAVKKGLPHAPALIKRT 
NRRIPERTSHRVA 
GGGGGGSGGGGSGGGGSDYKDHDGDYKDHDIDYKDDDDKGSSPKKKRKVEAS 
 
 
In pBT102 (E.coli expression, repressor assay construct): 
 
These constructs lack the N-terminal HA tag but otherwise are identical from the N-
terminus until after the C-terminal degenerate repeats: the TALE-C-terminal section 
is longer and there is a C-terminal GFP.  
… 
+1 LTPQQVVAIASNGGGRPALESIVAQLSRPDPALAA 
+2 LTNDHLVALACLGGRPALDAVKKGLPHAPALIKRT 
NRRIPERTSHRVADHAQVVRVLGFFQCHSHPAQAFDDAMTQFGMS 
GSVSKGEELFTGVVPILVELDGDVNGHKFSVRGEGEGDATIGKLTLKFICTTGKLPV
PWPTLVTTLTYGVQCFSRYPDHMKQHDFFKSAMPEGYVQERTISFKDDGKYKTRAVV
KFEGDTLVNRIELKGTDFKEDGNILGHKLEYNFNSHNVYITADKQKNGIKANFTVRH
NVEDGSVQLADHYQQNTPIGDGPVLLPDNHYLSTQTVLSKDPNEKRDHMVLHEYVNA
AGIT 
 
 
 
 
>dTALE-Bat1M1 6-10 
 
1  LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
2  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
3  LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
4  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
5  LTPQQVVAFASNNGGKQALTKLLEKWDELRAKG 
6  LEPKDIVSIASHIGANQTITTLLNKWGALIDLE 
7  LEPKDIVSIASHIGATQAITTLLNKWAALRAKG 
8  LDPKDIVSIASHDGSNQTITKLLEKWDELRAKE 
9  LESKDIVSIASNNGATQTITRLLEKWDELRAKG 
10 LDPKDIVSIASHGGATQAITTLLNRWGDLIDLE 
11 LEPKDIVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
15 LTPQQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPQQVVAIASNGGGKQALETVQALLPVLCQAHG 
 
>dTALE-Bat1M2 6-10 
… 
1  LTPQQVVAIASNIGGKQALETVQRLLPVLCQAHG 
2  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
3  LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
4  LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
5  LTPQQVVAIASNNGGKQALVAVQANYAALTGLG 
6  FRTEDIVQMVSHDGGSKNLAAIIDKSTALTGLG 
7  FRTEDIVQMVSNNGGSKNLAAIIDKSTALKGLG 
8  FRTEDIVQMVSHGGGSKNLEVVQANYAALTGLG 
9  FRTEGIVQMVSHGGGSKNLVAVQANYAALTGLG 
10 FRTEDIVQMVSHDGGSKNLAAMIDKYTALKDLG 
11 FRTEDIVAIASNIGGKQALETVQRLLPVLCQAHG 
12 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASNIGGKQALETVQRLLPVLCQAHG 
15 LTPQQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPEQVVAIASNNGGKQALETVQRLLPVLCQAHG 
17 LTPQQVVAIASNGGGKQALETVQALLPVLCQAHG 
… 
 
 
 
 
 
 
 
 
 
Supplementary Figure 9: MD Analyses (Root Mean Square Deviation of atomic 
positions) for models of Bat1-MOrTL chimeras with their target DNA over 50 ns. 
RMSD plots are shown for protein and DNA for Bat1M2 6-10 (a) and Bat1M1 6-10 (b). 
The plots show the protein C-alpha RMSDs after least squares fit to the protein C-
alpha (red lines) as well as the DNA RMSDs after least squares fit to DNA (blue 
lines). That both protein and DNA in parallel over the course of the simulations 
indicates a stable interaction.  (a)$
(b)$
Supplementary Figure 10: Molecular Dynamics Analysis (energy): 
Potential energy of Bat1M2 6-10 (a) and Bat1M1 6-10 (b) bound to their DNA targets, over 
a period of 50 nanoseconds.  
 
  (a)$
(b)$
Supplementary Figure 11: Core repeat alignments of a representative RipTAL 
(Brg11) and TALE (AvrBs3). Alignments were constructed with CLC Main 
Workbench and images generated with Boxshade. Conserved residues are shown as 
white letters on a black background.  The BSRs are highlighted in bold-italic font.  
>RipTAL (Brg11) 
 1 LTPQQVVAIASNTGGkRALEAVCVQLPVLRAAPYR 
 2 LSTEQVVAIASNKGGkQALEAVKAHLLDLLGAPYV 
 3 LDTEQVVAIASHNGGkQALEAVKADLLDLRGAPYA 
 4 LSTEQVVAIASHNGGkQALEAVKADLLELRGAPYA 
 5 LSTEQVVAIASHNGGkQALEAVKAHLLDLRGVPYA 
 6 LSTEQVVAIASHNGGkQALEAVKAQLLDLRGAPYA 
 7 LSTAQVVAIASNGGGkQALEGIGEQLLKLRTAPYG 
 8 LSTEQVVAIASHDGGkQALEAVGAQLVALRAAPYA 
 9 LSTEQVVAIASNKGGkQALEAVKAQLLELRGAPYA 
10 LSTAQVVAIASHDGGnQALEAVGTQLVALRAAPYA 
11 LSTEQVVAIASHDGGkQALEAVGAQLVALRAAPYA 
12 LNTEQVVAIASSHGGkQALEAVRALFPDLRAAPYA 
13 LSTAQLVAIASNPGGkQALEAVRALFRELRAAPYA 
14 LSTEQVVAIASNHGGkQALEAVRALFRGLRAAPYG 
15 LSTAQVVAIASSNGGkQALEAVWALLPVLRATPYD 
16 LNTAQIVAIASHDGGkPALEAVWAKLPVLRGAPYA 
>TALE (AvrBs3) 
 1 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 2 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 3 LTPQQVVAIASNSGGKQALETVQRLLPVLCQAHG 
 4 LTPEQVVAIASNGGGKQALETVQRLLPVLCQAHG 
 5 LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 6 LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 7 LTPEQVVAIASNIGGKQALETVQALLPVLCQAHG 
 8 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
 9 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
10 LTPQQVVAIASNGGGKQALETVQRLLPVLCQAHG 
11 LTPEQVVAIASNSGGKQALETVQALLPVLCQAHG 
12 LTPEQVVAIASNSGGKQALETVQRLLPVLCQAHG 
13 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
14 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
15 LTPEQVVAIASHDGGKQALETVQRLLPVLCQAHG 
16 LTPQQVVAIASNGGGRPALETVQRLLPVLCQAHG 
 
 
 
 
 
 
 
 
 
Supplementary Table 1: The TALE code 
 
A reference guide for the specificities of commonly occurring BSRs, based on several 
publications: 
1: Yang et al., 2014 
2: de Lange et al.,  2014 
3: Boch et al., 2009 
4: Cong et al., 2012 
Boch et al., 2009; de Lange et al., 2013; Mak, Bradley, & Cernadas, 2012; Meckler et 
al., 2013; Moscou & Bogdanove, 2009; Yang et al., 2014). 
 
BSR Best-match 2nd best Tolerated Mismatch  
Gly T - A, G, C (2, 4) - 
GlySL C, Cme  - T, A, G (3, 4)  - 
Asp C -  A(3,4) G, T 
Ile A - - G, C, T 
Ser A, G, C  T (1)  
Arg G A - C, T 
His G - A, C (2) C, T 
Lys G -  A, C, T 
 
Note: since specificity is only a measure of relative affinity the absolute affinities for 
BSRs to their best-match or mismatch bases can vary greatly. See Meckler et al., 
Nucl. Acids Res., 2013 for more detail on this.  
 
 
Supplementary Table 2: A list of oligonucleotides used in this study 
Primer name Sequence Notes 
EMSA probes 
BEMOrTL1 EMSA 
Fwd TAGCACAACGTGCTGAC 
EMSA Probe for non-chimeric 
MOrTL1 protein 
BEMOrTL1 EMSA 
Rev GTCAGCACGTTGTGCTA 
EMSA Probe for non-chimeric 
MOrTL1 protein 
BEMOrTL2 EMSA 
Fwd 
TAGCTTCCGTTCCCTGA
C 
EMSA Probe for non-chimeric 
MOrTL2 protein 
BEMOrTL2 EMSA 
Rev 
GTCAGGGAACGGAAGCT
A 
EMSA Probe for non-chimeric 
MOrTL2 protein 
BEBat1 M1 6-10 
EMSA Fwd 
TAGACTAAGAGAACGTA
AGACGTTATATGC 
EMSA probe for BatM1 6-10 and 
dTALE-Bat1M1 6-10 
 
BEBat1 M1 6-10 
EMSA Rev 
GCATATAACGTCTTACG
TTCTCTTAGTCTA 
EMSA probe for BatM1 6-10 and 
dTALE-Bat1M1 6-10 
 
BEBat1 M2 6-10 
EMSA Fwd 
TAGACTAAGAGTCCGTA
AGACGTTATATGC 
EMSA probe for BatM2 6-10  
 
BEBat1 M2 6-10 
EMSA Rev 
GCATATAACGTCTTACG
GACTCTTAGTCTA 
EMSA probe for BatM2 6-10  
 
BEdTALE-Bat1 
M2 6-10 EMSA 
TAGACTAAGAGCGTTCA
AGACGTTATATGC 
EMSA probe for dTALE- BatM2 6-10  
 
Fwd 
BEdTALE-Bat1 
M2 6-10 EMSA 
Rev 
GCATATAACGTCTTGAA
CGCTCTTAGTCTA 
EMSA probe for dTALE- BatM2 6-10  
 
BEBat1 GGTTG 
EMSA Fwd 
TAGACTAAGAGGGTTGA
AGACGTTATATGC 
OFF-target EMSA probe for all 
except dTALE-Bat1M2 6-10 
BEBat1 GGTTG 
EMSA REv 
GCATATAACGTCTTCAA
CCCTCTTAGTCTA 
OFF-target EMSA probe for all 
except dTALE-Bat1M2 6-10 
BEBat1 TTGGT 
EMSA Fwd 
TAGACTAAGAGTTGGTA
AGACGTTATATGC 
OFF-target EMSA probe dTALE-
Bat1M2 6-10 
BEBat1 TTGGT 
EMSA Rev 
GCATATAACGTCTTAAC
CACTCTTAGTCTA 
OFF-target EMSA probe dTALE-
Bat1M2 6-10 
Primers for PCR mutagenesis 
MOrTL1 Bat1 
Block2 Mimic 
Fwd  
GGTCTCTTGGGCTGGAA
CCGAAAGATATCGTG 
To create MOrTL repeat blocks to 
insert into Bat1 
MOrTL1 Bat1 
Block2 Mimic Rev 
GGTCTCAAACCCAGGTC
GATCAGATCGCCCC 
To create MOrTL repeat blocks to 
insert into Bat1 
MOrTL2 Bat1 
Block2 Mimic 
Fwd  
GGTCTCTTGGGTTTCGT
ACCGAAGGCATTGTCCA 
To create MOrTL repeat blocks to 
insert into Bat1 
MOrTL2 Bat1 
Block2 Mimic Rev 
GGTCTCAAACCCAGACC
CGTCAGGGCGGCGTAG 
To create MOrTL repeat blocks to 
insert into Bat1 
MOrTL1 dTALE 
5B mimic Fwd 
GAAGACTCTCTGACGAA
ACTGCTGGAAAAATG 
To create MOrTL repeat blocks to 
insert into dTALE-Bat1 
MOrTL1 dTALE 
5B mimic Rev 
GAAGACTCCGCTACAAT
GTCTTTAGGTTCTAATT
C 
To create MOrTL repeat blocks to 
insert into dTALE-Bat1 
MOrTL2 dTALE 
5B mimic Fwd 
GAAGACTCTCTGGTTGC
AGTCCAAGCTAATTACG
C 
To create MOrTL repeat blocks to 
insert into dTALE-Bat1 
MOrTL2dTALE 
5B mimic Rev 
GAAGACTCCGCTACGAT
ATCTTCCGTGCGGAAAC 
To create MOrTL repeat blocks to 
insert into dTALE-Bat1 
GFP-VS-Fwd 
ATGGTGTCTAAGGGCGA
AGAACTC 
To create a GFP only pBT102 
expression plasmid 
TATG_BsaI_Rev 
AAGAGACCCCTGCATGC
AAGC 
To create a GFP only pBT102 
expression plasmid 
pMBS6 BEBat1 MX 
6-10 Fwd 
AAGACGTTATGAATTCA
AAAGATCTATCGA 
To get BEBat1 M1 or M2 6-10 into 
pMBS6 
pMBS6 BEBat1 M1 
6-10 Rev 
ACGTTCTCTTAGAAATT
GTTACCGCTC To get BEBat1 M1 6-10 into pMBS6 
pMBS6 BEBat1 M2 
6-10 Rev 
ACGGACTCTTAGAAATT
GTTATCCGCTC To get BEBat1 M2 6-10 into pMBS6 
AvrBs3DeltaCTD
Rev 
GCTCATCCCGAACTGCG
TCA 
To create C-terminal TALE 
truncation derivate to match Politz 
et al. LacO dTALE 
AvrBs3DeltaCTD
Fwd 
AAGGTGAGACCTTTGGG
ATCCGA 
To create C-terminal TALE 
truncation derivate to match Politz 
et al. LacO dTALE 
   
pMBS6 BEdTALE-
Bat1 M2 6-10 Rev 
GAACGCTCTTGAAATTG
TTATCCGCTC 
To get BEdTALE-Bat1 M2 6-10 into 
pMBS6 
BsaI AAGG Rev 
CCT TTG AGA CCG 
GTC GAC CTG C 
To create a goldengate version of 
E.coli expression vector pBT102 
BsaI GGTG Rev 
CAC CTG AGA CCG 
GTC GAC CTG 
To create a goldengate version of 
E.coli expression vector pBT102 
BsaI TATG Fwd  
TAT GTG AGA CCG 
CGG CCC CTC 
To create a goldengate version of 
E.coli expression vector pBT102 
Sequencing primers 
Sco5B MidSeqF 
TATCGATAAAAGCACCG
CCC 
To sequence central section of 
pDEST17 dTALE-Bat1M2 6-10 
Sco5B MidSeqR 
ACCGTGACTGACCATTT
GGA 
To sequence central section of 
pDEST17 dTALE-Bat1M2 6-10 
  
Supplementary Table 3: Averaged base-BSR distances from MD model  
of Bat1 M1 6-10. Average distances over all MD snapshots between BSR Cα-atom 
and the ring nitrogen that connects nucleobase and deoxyribose moieties. MOrTL 
pairs are highlighted in green. 
 
BSR Nucleotide Average distance (nm) SD 
ILE 95 DA 1 0,742 0,044 
ILE 128 DA 2 0,719 0,022 
ASN 161 DG 3 0,666 0,026 
THR 194 DA 4 0,706 0,027 
ASN 227 DG 5 0,669 0,029 
ILE 260 DA 6 0,753 0,040 
ILE 293 DA 7 0,830 0,075 
ASP 326 DC 8 0,853 0,088 
ASN 359 DG 9 0,888 0,050 
GLY 392 DT 10 0,815 0,044 
ILE 425 DA 11 0,742 0,029 
THR 458 DA 12 0,708 0,042 
ARG 491 DT 13 0,854 0,047 
SER 524 DA 14 0,696 0,043 
ASP 557 DC 15 0,709 0,026 
ASN 590 DG 16 0,671 0,025 
GLY 623 DT 17 0,754 0,026 
GLY 656 DT 18 0,782 0,030 
SER 689 DA 19 0,661 0,032 
  
Supplementary Table 4: Averaged base-BSR distances from MD model  
of Bat1 M2 6-10. Average distances over all MD snapshots between BSR Cα-atom and 
the ring nitrogen that connects nucleobase and deoxyribose moieties. MOrTL pairs 
are highlighted in green. 
 
BSR Nucleotide Average distance (nm) SD 
ILE 95 DA 1 0,728 0,028 
ILE 128 DA 2 0,707 0,026 
ASN 161 DG 3 0,674 0,029 
THR 194 DA 4 0,716 0,028 
ASN 227 DG 5 0,642 0,021 
GLY 260 DT 6 0,738 0,030 
ASP 293 DC 7 0,739 0,047 
ASP 326 DC 8 0,763 0,068 
ASN 359 DG 9 0,816 0,100 
GLY 392 DT 10 0,815 0,056 
ILE 425 DA 11 0,767 0,044 
THR 458 DA 12 0,708 0,042 
ARG 491 DT 13 0,869 0,051 
SER 524 DA 14 0,715 0,042 
ASP 557 DC 15 0,698 0,021 
ASN 590 DG 16 0,685 0,033 
GLY 623 DT 17 0,739 0,027 
GLY 656 DT 18 0,773 0,035 
SER 689 DA 19 0,661 0,022 
 
 
Supplementary Table 5: TALE-likes used in the creation of repeat sequence logos 
shown in Figure 7. GenBank designations are given where relevant to avoid 
ambiguity.  
 
TALEs AvrBs3, AvrBs4, AvrXa27, AvrXa7, PthXo1 
(ACD58243), PthB (NP_942641), AvrHah1, 
Hax2, Hax3, Hax4 TalC (AEK86668),AvrPth3, 
PthA (AAC43587) 
RipTALs Brg11, CCA82456,CAQ18687 
Bats BAT1_BURRH, Bat2 (E5AW45), 
Bat3(E5AW43), RipTALI_14, YP_003750492 
MOrTL1 EBN91408, EBN91409, ECG96325, ECG96326 
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